assays_CURB,assays_BAFO,assays_VARII,assays_ASSTI,assays_ASCA,assays_ASSOR,assays_ASSI,assays_ASTTY,assays_ASSUBFRA,assays_ASTIS,assays_ASSST,assays_DI,assays_TII,assays_T,assays_SRASI,assays_RELTY,assays_SI,assays_ASSCTY,assays_Descri,assays_CHI,assays_CEI,assays_CONFISCO,assays_ASST
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7524,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL618647,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7525,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,CHEMBL618648,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7526,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL618649,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7527,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL618650,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7528,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,CHEMBL618651,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7529,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL876497,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7530,In vivo,,Lung,,9866,2048.0,50597,,N,1,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL618652,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7531,In vivo,,Lung,,9866,2048.0,50597,,N,1,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,CHEMBL618653,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7532,In vivo,,Lung,,9866,2048.0,50597,,N,1,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL618654,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7533,,,,,6351,,50597,,N,1,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,CHEMBL618655,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7534,,,,,1465,,50597,,N,1,,Compound was tested for solubility in water,CHEMBL618656,,1,A
Intermediate,BAO_0000100,,,,,7535,,,,,5182,,22229,,U,1,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),CHEMBL618657,,0,P
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7536,,,,,17847,,50597,,N,1,,Solubility was determined,CHEMBL618658,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7537,,,,,15339,,50597,,N,1,,solubility in water (ug/mL) at 37 degree C.,CHEMBL618659,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7538,,,,,5202,,50597,,N,1,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,CHEMBL618660,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7539,,,,,1088,,50597,,N,1,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,CHEMBL618661,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7540,,,,,3169,,50597,,N,1,,Half life in rats,CHEMBL873807,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7541,,,,,5353,,50597,,N,1,,Half life in Dawley rat,CHEMBL618662,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7542,In vivo,,,,2864,,50597,,N,1,,Half life period after 3 mg/kg iv administration,CHEMBL618663,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7543,In vivo,,,,2864,,50597,,N,1,,Half life period after 3 mg/kg iv administration in rat,CHEMBL618664,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7544,In vivo,,,,2864,,50597,,N,1,,Half life period after 3 mg/kg iv administration in the rat,CHEMBL618665,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7545,,,,,6362,,50597,,N,1,,Half life period in female Sprague-Dawley rats,CHEMBL876498,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7546,,,,,6249,,50597,,N,1,,Half life period in rat,CHEMBL618666,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7547,,,,,3169,,50597,,N,1,,Half-life in rats was determined,CHEMBL620440,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7548,,,,,3169,,50597,,N,1,,Half-life in rats with metabolic oxidation,CHEMBL620441,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7549,,,,,3169,,50597,,N,1,,Half-life in rats,CHEMBL620442,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7550,In vivo,,,,17260,,50597,,N,1,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL620443,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7551,In vivo,,,,17260,,50597,,N,1,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL620444,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7552,In vivo,,,,17260,,50597,,N,1,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL620445,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7553,In vivo,,,,17260,,50597,,N,1,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL620446,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7554,,,Plasma,,2879,1969.0,50597,,N,1,,Biological half-life measured in plasma of rat,CHEMBL620447,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7555,,,Plasma,,2879,1969.0,50597,,N,1,,Biological half-life measured in plasma of rat; 22-25,CHEMBL621129,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7556,,,Plasma,,2879,1969.0,50597,,N,1,,Biological half-life measured in plasma of rat; 9-16,CHEMBL621130,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7557,In vivo,,,,3184,,50597,,N,1,,Compound was evaluated for its half life when administered intravenously in rat,CHEMBL873808,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7558,In vivo,,,,4891,,50597,,N,1,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,CHEMBL876598,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7559,In vivo,,,,429,,50597,,N,1,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,CHEMBL621131,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7560,In vivo,,,,5656,,50597,,N,1,,Half life (T1/2) after oral administration in rat,CHEMBL621132,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7561,In vivo,,,,4413,,50597,,N,1,,Half life of compound after iv administration of 20 mg/kg dose in rat,CHEMBL621133,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,7562,In vivo,,,,3598,,50597,,N,1,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL621312,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7563,,,,,17267,,50597,,N,1,,Half life of compound was determined in rat,CHEMBL621313,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7564,,,Blood,,4727,178.0,50597,,N,1,,Half life of compound was determined in rat blood,CHEMBL621314,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7565,In vivo,,,,17651,,50597,,N,1,,Half life at 1 mg/kg was determined in rat,CHEMBL621315,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7566,In vivo,,,,17651,,50597,,N,1,,Half life at 10 mg/kg was determined in rat,CHEMBL621316,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7567,,,,,401,,50597,,N,1,,Half life in rats,CHEMBL621317,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7568,,,,,4942,,50597,,N,1,,Half life in rats in hours,CHEMBL621318,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7569,In vivo,,,,17735,,50597,,N,1,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,CHEMBL621319,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7570,In vivo,,,,6056,,50597,,N,1,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,CHEMBL621377,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7571,,,,,5213,,50597,,N,1,,Half life was determined,CHEMBL621378,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7572,In vivo,,,,6616,,50597,,N,1,,Half life after i.v. administration,CHEMBL876599,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7573,In vivo,,,,5937,,50597,,N,1,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,CHEMBL621379,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7574,,,Plasma,,5819,1969.0,50597,,N,1,,Half life in rat plasma,CHEMBL621380,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7575,,,Plasma,,5819,1969.0,50597,,N,1,,Half life in rat plasma; Not detected,CHEMBL621381,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7576,,,,,6803,,50597,,N,1,,Half life in rats,CHEMBL618515,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7577,In vivo,,,,17804,,50597,,N,1,,Half life period of compound was determined after peroral administration,CHEMBL618516,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7578,In vivo,,,,17804,,50597,,N,1,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,CHEMBL618517,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7579,,,,,5948,,50597,,N,1,,Half life period in rat,CHEMBL618518,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7580,In vivo,,,,1916,,50597,,N,1,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,CHEMBL618519,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7581,In vivo,,,,1916,,50597,,N,1,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,CHEMBL618698,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7582,In vivo,,,,1916,,50597,,N,1,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,CHEMBL618862,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7583,In vivo,,,,4890,,50597,,N,1,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL618863,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7584,In vivo,,,,17764,,50597,,N,1,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,CHEMBL618864,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7585,In vivo,,,,4727,,50597,,N,1,,Half life time in rat the dose of 2 mg/kg,CHEMBL618865,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7586,In vivo,,,,17509,,50597,,N,1,,Half-life 24 hr after 10 mg/kg iv administration in rats,CHEMBL618866,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7587,In vivo,,,,17509,,50597,,N,1,,Half-life 24 hr after 2 mg/kg iv administration in rats,CHEMBL618867,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7588,,,,,6597,,50597,,N,1,,Half-life consistent with the observed metabolic steady state in rats,CHEMBL875828,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7589,In vivo,,,,17735,,50597,,N,1,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,CHEMBL618868,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7590,,,,,6597,,50597,,N,1,,Half-life for oxidative metabolic stability was determined using male human,CHEMBL618869,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7591,In vivo,,,,17670,,50597,,N,1,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL618870,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7592,,,Plasma,,1696,1969.0,50597,,N,1,,Half-life in rat plasma,CHEMBL618871,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7593,,,Plasma,,1742,1969.0,50597,,N,1,,Half-life in rat plasma was determined,CHEMBL618872,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7594,,,,,17800,,50597,,N,1,,Half-life in rats was determined,CHEMBL873816,,1,A
Autocuration,BAO_0000218,,,,,7595,,,,,12923,,22224,,U,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,CHEMBL618873,,0,A
Autocuration,BAO_0000019,,,,,7596,,,,,11954,,22224,,U,1,,Area under curve after oral dose of 0.1 mg//kg,CHEMBL621602,,0,A
Autocuration,BAO_0000218,,,,,7597,,,,,11954,,22224,,U,1,,Area under curve after oral dose of 0.3 mg/kg,CHEMBL621603,,0,A
Autocuration,BAO_0000218,,,,,7598,,,,,11954,,22224,,U,1,,Area under curve after oral dose of 1 mg/kg,CHEMBL621604,,0,A
Autocuration,BAO_0000218,,,,,7599,,,,,11954,,22224,,U,1,,Area under curve after oral dose of 10 mg/kg,CHEMBL621605,,0,A
Autocuration,BAO_0000218,,,,,7600,,,,,11954,,22224,,U,1,,Area under curve after oral dose of 23.4 mg/kg,CHEMBL621606,,0,A
Autocuration,BAO_0000218,,,,,7601,,,,,11954,,22224,,U,1,,Area under curve after oral dose of 3 mg/kg,CHEMBL621607,,0,A
Autocuration,BAO_0000218,,,,,7602,,,,,11954,,22224,,U,1,,Area under curve after oral dose of 3.87 mg/kg,CHEMBL621608,,0,A
Autocuration,BAO_0000019,,,,,7603,,,,,5237,,22224,,U,1,,Area under curve was determined,CHEMBL621609,,0,A
Autocuration,BAO_0000218,,,,,7604,,,,,4026,,22224,,U,1,,Area under curve at a dose of 10 mg/kg,CHEMBL621610,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7605,,,,,5237,,50597,,N,1,,Area under curve was determined; ND=No data,CHEMBL621611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7606,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL621612,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7607,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,CHEMBL622308,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7608,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622309,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7609,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,CHEMBL622310,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7610,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,CHEMBL622311,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7611,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,CHEMBL622312,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7612,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622931,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7613,,,,,14793,,50597,,N,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,CHEMBL622932,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7614,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7615,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,CHEMBL622737,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7616,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622738,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7617,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,CHEMBL622739,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7618,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,CHEMBL622740,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7619,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,CHEMBL622741,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7620,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622742,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7621,,,Plasma,,14793,1969.0,50597,,N,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,CHEMBL622743,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7622,,,Plasma,,11637,1969.0,50594,,N,1,,AUC in mice,CHEMBL622744,,1,A
Autocuration,BAO_0000019,,,,,7623,,,,,11149,,22224,,U,1,,Area under curve was measured from the graph obtained from concentration Vs time,CHEMBL624134,,0,A
Autocuration,BAO_0000019,,,,,7624,,,,,10016,,22224,,U,1,,Area under curve value of compound per hour after oral administration,CHEMBL624135,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7625,,,,,17796,,50597,,N,1,,Area under curve was determined after oral administration in rats,CHEMBL624136,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7626,,,,,17796,,50597,,N,1,,Area under curve was determined after oral administration in rats; No data,CHEMBL624137,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7627,,,,,17796,,50597,,N,1,,Area under curve was determined after oral administration in rats;No data,CHEMBL624320,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7628,,,,,12923,,50588,,N,1,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,CHEMBL624321,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7629,,,,,15372,,50597,,N,1,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,CHEMBL624322,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7630,,,,,15372,,50597,,N,1,,Area under curve was determined for the compound after iv dose of 5.06 in rats,CHEMBL624323,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7631,,,,,15372,,50597,,N,1,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,CHEMBL624324,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7632,,,,,15372,,50597,,N,1,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,CHEMBL624325,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7633,,,,,15372,,50597,,N,1,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,CHEMBL624326,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7634,,,,,15372,,50597,,N,1,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,CHEMBL624327,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7635,,,,,15372,,50597,,N,1,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,CHEMBL624328,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7636,,,,,14169,,50588,,N,1,,Area under curve was determined in Dogs after peroral administration,CHEMBL627848,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7637,,,,,14169,,50597,,N,1,,Area under curve was determined in Rats after peroral administration,CHEMBL627849,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7638,,,,,14258,,50597,,N,1,,Area under curve was determined in carotid blood of rat when administered intradermally,CHEMBL627850,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7639,,,,,14258,,50597,,N,1,,Area under curve was determined in portal blood of rat when administered intradermally,CHEMBL627851,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7640,,,,,15011,,50594,,N,1,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627852,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7641,,,,,15011,,50594,,N,1,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL627853,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7642,,,,,15011,,50594,,N,1,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),CHEMBL627854,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7643,,,,,15011,,50594,,N,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627855,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7644,,,,,15011,,50594,,N,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),CHEMBL627856,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7645,,,,,15011,,50594,,N,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL875339,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7646,,,,,15011,,50594,,N,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),CHEMBL627857,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7647,In vivo,,Spleen,,11195,2106.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,CHEMBL627858,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7648,,,Blood,,10130,178.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,CHEMBL627859,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7649,,,Brain,,10130,955.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,CHEMBL627860,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7650,,,Heart,,10130,948.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,CHEMBL627019,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7651,,,Liver,,10130,2107.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,CHEMBL627020,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7652,,,Lung,,10130,2048.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,CHEMBL627021,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7653,,,Muscle tissue,,10130,2385.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,CHEMBL627022,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7654,,,,,10130,,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,CHEMBL627023,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7655,,,Spleen,,10130,2106.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,CHEMBL627024,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7656,,,Thyroid gland,,10130,2046.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,CHEMBL627025,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7657,,,Kidney,,10130,2113.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,CHEMBL627026,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7658,,,Blood,,10130,178.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,CHEMBL627027,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7659,,,Brain,,10130,955.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,CHEMBL627028,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7660,,,Heart,,10130,948.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,CHEMBL627029,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7661,,,Kidney,,10130,2113.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,CHEMBL627030,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7662,,,Liver,,10130,2107.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,CHEMBL627031,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7663,,,Lung,,10130,2048.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,CHEMBL627032,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7664,,,Muscle tissue,,10130,2385.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,CHEMBL627033,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7665,,,,,10130,,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,CHEMBL627034,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7666,,,Spleen,,10130,2106.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,CHEMBL627035,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7667,,,Thyroid gland,,10130,2046.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,CHEMBL627036,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7668,,,Blood,,10130,178.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,CHEMBL875340,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7669,,,Heart,,10130,948.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,CHEMBL627037,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7670,,,Kidney,,10130,2113.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,CHEMBL627038,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7671,,,Liver,,10130,2107.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,CHEMBL627039,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7672,,,Muscle tissue,,10130,2385.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,CHEMBL627040,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7673,,,Spleen,,10130,2106.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,CHEMBL624663,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7674,,,Thyroid gland,,10130,2046.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,CHEMBL625963,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7675,,,Brain,,10130,955.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,CHEMBL876799,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7676,,,Lung,,10130,2048.0,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,CHEMBL626133,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7677,,,,,10130,,50597,,N,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,CHEMBL626134,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7678,,,,,6295,,50597,,N,1,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,CHEMBL626135,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7679,,,,,6296,,50597,,N,1,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,CHEMBL626136,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7680,,,,,6296,,50597,,N,1,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,CHEMBL626137,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7681,,,,,6295,,50597,,N,1,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,CHEMBL626138,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7682,,,,,6296,,50597,,N,1,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,CHEMBL626139,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7683,In vivo,,,,17260,,50597,,N,1,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL626140,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7684,In vivo,,,,17260,,50597,,N,1,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL626141,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7685,,,,,17686,,50597,,N,1,,C24h in rat p.o. at 20 mg/kg concentration,CHEMBL626142,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7686,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL627930,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7687,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,CHEMBL627931,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7688,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL627932,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7689,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL627933,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7690,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,CHEMBL627934,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7691,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL627935,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7692,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,CHEMBL627936,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7693,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,CHEMBL627937,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7694,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL627938,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7695,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,CHEMBL627939,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7696,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,CHEMBL627940,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7697,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL627941,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7698,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL876800,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7699,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,CHEMBL627942,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7700,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,CHEMBL627943,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7701,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,CHEMBL627944,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7702,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,CHEMBL627945,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7703,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,CHEMBL628584,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7704,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,CHEMBL628585,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7705,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,CHEMBL628586,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7706,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,CHEMBL628587,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7707,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,CHEMBL628588,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7708,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,CHEMBL628589,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7709,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,CHEMBL625304,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7710,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,CHEMBL625305,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7711,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,CHEMBL625306,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7712,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,CHEMBL625307,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7713,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,CHEMBL625308,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7714,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,CHEMBL627740,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7715,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,CHEMBL627741,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7716,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL627742,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7717,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,CHEMBL627743,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7718,In vivo,,Blood,,9866,178.0,50597,,N,1,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,CHEMBL627744,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7719,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,CHEMBL627745,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7720,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL627746,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7721,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,CHEMBL627747,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7722,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,CHEMBL876810,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7723,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,CHEMBL627748,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7724,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL627749,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7725,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL627750,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7726,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,CHEMBL618728,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7727,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,CHEMBL618729,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7728,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,CHEMBL618730,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7729,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,CHEMBL618731,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7730,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,CHEMBL618732,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7731,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,CHEMBL618733,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7732,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,CHEMBL618734,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7733,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,CHEMBL618735,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7734,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,CHEMBL876602,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7735,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,CHEMBL618736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7736,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,CHEMBL618737,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7737,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,CHEMBL618738,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7738,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,CHEMBL618739,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7739,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,CHEMBL618740,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7740,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL618741,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7741,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,CHEMBL618742,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7742,In vivo,,Bone,,9866,10000001.0,50597,,N,1,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,CHEMBL618743,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7743,In vivo,,Plasma,,17752,1969.0,50597,,N,1,,Half-life from rat plasma at a single oral dose of 25 mg/kg,CHEMBL618744,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7744,,,,,5610,,50597,,N,1,,Half-life in male rat,CHEMBL618745,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7745,In vivo,,,,5939,,50597,,N,1,,Half-life in rat after peroral administration at 10 mg/kg concentration,CHEMBL620479,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7746,In vivo,,,,5939,,50597,,N,1,,Half-life in rat after peroral administration at 5 mg/kg concentration,CHEMBL620480,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7747,In vivo,,,,17771,,50597,,N,1,,Half-life in rat at a dose of 3 mg/kg,CHEMBL620481,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7748,,,,,1974,,50597,,N,1,,Half-life was evaluated in rats,CHEMBL620482,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7749,,,,,4239,,50597,,N,1,,Half-life was measured in rat,CHEMBL876603,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7750,In vivo,,,,6681,,50597,,N,1,,Half-life period for the compound was determined in rats at 50 mg/kg dose,CHEMBL620483,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7751,In vivo,,,,17752,,50597,,N,1,,Half-life period in rats after intravenous administration at 5 mg/kg,CHEMBL620484,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7752,In vivo,,,,6046,,50597,,N,1,,Half-life period in rat at 10 mg/kg,CHEMBL620485,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7753,In vivo,,,,6685,,50597,,N,1,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",CHEMBL620486,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7754,In vivo,,,,6685,,50597,,N,1,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",CHEMBL620487,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7755,In vivo,,,,6685,,50597,,N,1,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",CHEMBL620488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7756,In vivo,,,,4727,,50597,,N,1,,Half-life time in rat the dose of 2 mg/kg,CHEMBL620489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7757,In vivo,,,,1088,,50597,,N,1,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,CHEMBL620490,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7758,In vivo,,,,5610,,50597,,N,1,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,CHEMBL620491,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7759,In vivo,,Plasma,,3032,1969.0,50597,,N,1,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",CHEMBL876604,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7760,In vivo,,,,5199,,50597,,N,1,,Oral half life was determined,CHEMBL620492,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7761,In vivo,,,,14941,,50597,,N,1,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL620493,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7762,In vivo,,,,4408,,50597,,N,1,,Pharmacokinetic property (t1/2) in rat,CHEMBL620494,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7763,,,Plasma,,2552,1969.0,50597,,N,1,,Plasma elimination half-life was determined,CHEMBL620495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7764,In vivo,,Plasma,,5199,1969.0,50597,,N,1,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,CHEMBL620496,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7765,In vivo,,Plasma,,15662,1969.0,50597,,N,1,,Plasma half life was observed after intravenous administration in rat,CHEMBL620497,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7766,,,Plasma,,1465,1969.0,50597,,N,1,,Plasma half-life was determined,CHEMBL620498,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7767,In vivo,,Plasma,,1446,1969.0,50597,,N,1,,Plasma half-life following oral administration in Fisher rats,CHEMBL620499,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7768,,,Plasma,,6824,1969.0,50597,,N,1,,Plasma half-life in rat,CHEMBL620500,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7769,In vivo,,Plasma,,17533,1969.0,50597,,N,1,,Plasmatic Half-life after intravenous administration to rat,CHEMBL873809,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7770,In vivo,,,,5979,,50597,,N,1,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,CHEMBL620501,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7771,In vivo,,,,4689,,50597,,N,1,,Terminal half life after intravenous administration (1 mg/kg) in rat,CHEMBL620502,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7772,In vivo,,,,4689,,50597,,N,1,,Terminal half life in Rat at a oral dose of 5 mg/kg,CHEMBL620503,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7773,In vivo,,,,2463,,50597,,N,1,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,CHEMBL620504,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7774,In vivo,,,,4883,,50597,,N,1,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,CHEMBL876605,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7775,In vivo,,,,4883,,50597,,N,1,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,CHEMBL620505,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7776,In vivo,,Plasma,,15662,1969.0,50597,,N,1,,plasma half life was observed after intravenous administration in rat,CHEMBL873811,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,7777,In vivo,,,,3598,,50597,,N,1,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL624016,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7778,,,,,4576,,50597,,N,1,,Half life of compound determined in rat,CHEMBL624017,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7779,,,,,4576,,50597,,N,1,,Mean residence time determined in rat,CHEMBL624018,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7780,,,,,4576,,50597,,N,1,,Plasma half life determined in rat,CHEMBL624019,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7781,In vivo,,Brain,,4910,955.0,50597,,N,1,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,CHEMBL624020,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7782,In vivo,,,,4891,,50597,,N,1,,Compound was evaluated for pharmacokinetic parameter maximum time period,CHEMBL624201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7783,In vivo,,,,429,,50597,,N,1,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,CHEMBL872528,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7784,In vivo,,,,5974,,50597,,N,1,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL624202,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7785,In vivo,,,,5974,,50597,,N,1,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL624203,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7786,In vivo,,,,5974,,50597,,N,1,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL624350,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7787,In vivo,,,,5974,,50597,,N,1,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL621320,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7788,In vivo,,,,17582,,50597,,N,1,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,CHEMBL621321,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7789,,,,,4026,,50597,,N,1,,Maximum time (Tmax) required to reach Cmax in rats,CHEMBL621322,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7790,In vivo,,,,4890,,50597,,N,1,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,CHEMBL621323,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7791,In vivo,,,,6571,,50597,,N,1,,Maximum time of clearance of compound in rats after peroral administration,CHEMBL621324,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7792,,,,,4727,,50597,,N,1,,Maximum time at the dose of 2 mg/kg in rat,CHEMBL621325,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7793,In vivo,,Plasma,,17651,1969.0,50597,,N,1,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,CHEMBL875837,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7794,In vivo,,Plasma,,17651,1969.0,50597,,N,1,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,CHEMBL621326,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7795,In vivo,,,,14465,,50597,,N,1,,Tmax in Guinea pig (PO dose),CHEMBL621327,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7796,In vivo,,,,14941,,50597,,N,1,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL621328,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7797,In vivo,,,,5960,,50597,,N,1,,Pharmacokinetic parameter (Tmax) in rat,CHEMBL621329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7798,In vivo,,,,5022,,50597,,N,1,,Pharmacokinetic parameter (Tmax) was estimated,CHEMBL621330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7799,In vivo,,,,4408,,50597,,N,1,,Pharmacokinetic property (Tmax) in rat,CHEMBL621331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7800,In vivo,,,,5983,,50597,,N,1,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,CHEMBL621332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7801,In vivo,,,,4689,,50597,,N,1,,T max in Rat at a oral dose of 5 mg/kg,CHEMBL621333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7802,In vivo,,,,2792,,50597,,N,1,,T max was determined at 10 mg/kg po dose in rats,CHEMBL621334,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7803,,,,,15011,,50594,,N,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),CHEMBL621335,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7804,,,,,14180,,50588,,N,1,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,CHEMBL621336,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7805,,,,,14180,,50597,,N,1,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,CHEMBL621337,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7806,,,,,14599,,50588,,N,1,,Area under curve was measured after i.v. administration into Beagle dog.,CHEMBL621338,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7807,,,,,14599,,50588,,N,1,,Area under curve was measured after iv administration into Beagle dog,CHEMBL875838,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7808,,,,,14599,,50588,,N,1,,Area under curve was measured after po administration into Beagle dog,CHEMBL621339,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7809,,,,,14599,,50588,,N,1,,Area under curve was measured after po administration into Beagle dog.,CHEMBL621340,,1,A
Autocuration,BAO_0000218,,,,,7810,,,,,15675,,22224,,U,1,,Area under curve was measured at peroral dose of 3 mg/kg,CHEMBL621341,,0,A
Autocuration,BAO_0000019,,,,,7811,,,,,12706,,22224,,U,1,,Area under curve was measured by using concentration Vs time,CHEMBL621342,,0,A
Autocuration,BAO_0000019,,,,,7812,,,,,12706,,22224,,U,1,,Area under curve was measured by using concentration Vs time; not tested,CHEMBL621343,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7813,,,,,9750,,50594,,N,1,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),CHEMBL621344,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7814,,,,,9750,,50594,,N,1,,Area under curve(AUC) was measured in mice after oral administration.,CHEMBL621345,,1,A
Autocuration,BAO_0000019,,,,,7815,,,,,14691,,22224,,U,1,,Area under curve(AUC) value of the compound,CHEMBL621346,,0,A
Autocuration,BAO_0000218,,,,,7816,,,,,14691,,22224,,U,1,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,CHEMBL621347,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7817,,,,,14691,,50588,,N,1,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,CHEMBL621348,,1,A
Autocuration,BAO_0000019,,,,,7818,,,Blood,,2939,178.0,22224,,U,1,,Area under curve(carotid artery) was determined by the availability in blood,CHEMBL621349,,0,A
Autocuration,BAO_0000019,,,,,7819,,,Blood,,2939,178.0,22224,,U,1,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,CHEMBL621350,,0,A
Autocuration,BAO_0000019,,,,,7820,,,Blood,,2939,178.0,22224,,U,1,,Area under curve(carotid artery) was determined by the availability in blood; No data,CHEMBL875839,,0,A
Autocuration,BAO_0000019,,,,,7821,,,Blood,,2939,178.0,22224,,U,1,,Area under curve(portal vein) was determined by the availability in blood,CHEMBL620211,,0,A
Autocuration,BAO_0000019,,,,,7822,,,Blood,,2939,178.0,22224,,U,1,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,CHEMBL620212,,0,A
Autocuration,BAO_0000019,,,,,7823,,,Blood,,2939,178.0,22224,,U,1,,Area under curve(portal vein) was determined by the availability in blood; No data,CHEMBL620213,,0,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,7824,,,Plasma,,9552,1969.0,50797,,N,1,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",CHEMBL620214,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,7825,,,Plasma,,9552,1969.0,50797,,N,1,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",CHEMBL620215,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,7826,,,Plasma,,9552,1969.0,50797,,N,1,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,CHEMBL620216,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7827,,,Plasma,,9552,1969.0,50588,,N,1,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",CHEMBL620888,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7828,,,Plasma,,9552,1969.0,50588,,N,1,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",CHEMBL620889,,1,A
Autocuration,BAO_0000019,,,,,7829,,,Plasma,,9552,1969.0,22224,,U,1,,Area under plasma concentration vs time curve observed in rats for 0-3 h,CHEMBL620890,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7830,,,Plasma,,11911,1969.0,50597,,N,1,,Area under plasma time curve determined in male rat,CHEMBL620891,,1,A
Autocuration,BAO_0000019,,,,,7831,,,,,16618,,22224,,U,1,,Area under the MAP curve measured over 5 min.,CHEMBL620892,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7832,,,,,14387,,50594,,N,1,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,CHEMBL621079,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,7833,,,,,14387,,50594,,N,1,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,CHEMBL621080,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7834,,,,,12836,,50588,,N,1,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,CHEMBL621081,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,7835,,,,,12836,,100712,,N,1,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,CHEMBL621082,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7836,,,,,12836,,50597,,N,1,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,CHEMBL621083,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7837,,,,,14339,,50588,,N,1,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,CHEMBL621084,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7838,,,,,14339,,50588,,N,1,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,CHEMBL621085,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7839,,,,,14339,,50588,,N,1,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,CHEMBL621086,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7840,,,,,10524,,50588,,N,1,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),CHEMBL621087,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7841,,,,,9994,,50588,,N,1,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),CHEMBL622607,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7842,,,,,11325,,50588,,N,1,,Serum AUC in marmosets (IV dose),CHEMBL622608,,1,A
Autocuration,BAO_0000019,,,,,7843,,,,,12536,,22224,,U,1,,Area under the curve after intravenous administration at a dose of 10 umol/kg,CHEMBL624481,,0,A
Autocuration,BAO_0000019,,,,,7844,,,,,12536,,22224,,U,1,,Area under the curve after intravenous administration at a dose of 2 umol/kg,CHEMBL624482,,0,A
Autocuration,BAO_0000019,,,,,7845,,,,,12536,,22224,,U,1,,Area under the curve after intravenous administration at a dose of 4 umol/kg,CHEMBL624483,,0,A
Autocuration,BAO_0000019,,,,,7846,,,,,12536,,22224,,U,1,,Area under the curve after intravenous administration at a dose of 40 umol/kg,CHEMBL624484,,0,A
Autocuration,BAO_0000019,,,,,7847,,,,,12536,,22224,,U,1,,Area under the curve after intravenous administration at a dose of 5 umol/kg,CHEMBL624485,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7848,,,,,15556,,50597,,N,1,,Area under the curve for fumarate salt was evaluated in F344 Rats.,CHEMBL624486,,1,A
Autocuration,BAO_0000019,,,,,7849,,,,,2809,,22224,,U,1,,Area under the curve for the compound was calculated.,CHEMBL624487,,0,A
Autocuration,BAO_0000019,,,,,7850,,,,,9511,,22224,,U,1,,Area under the curve in concentration/ time,CHEMBL624488,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7851,,,,,12818,,50597,,N,1,,Area under the curve administered intraintestinal in rats.,CHEMBL624489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7852,,,,,12818,,50597,,N,1,,Area under the curve administered intravenously in rats.,CHEMBL625184,,1,A
Autocuration,BAO_0000019,,,,,7853,,,,,15118,,22224,,U,1,,Area under the curve during intravenous administration,CHEMBL625185,,0,A
Autocuration,BAO_0000019,,,,,7854,,,,,15118,,22224,,U,1,,Area under the curve during intravenous administration; Not determined,CHEMBL875954,,0,A
Autocuration,BAO_0000019,,,,,7855,,,,,15118,,22224,,U,1,,Area under the curve during systemic administration,CHEMBL625186,,0,A
Autocuration,BAO_0000019,,,,,7856,,,,,15118,,22224,,U,1,,Area under the curve during systemic administration; Not determined,CHEMBL625187,,0,A
Autocuration,BAO_0000019,,,,,7857,,,,,2632,,22224,,U,1,,Area under the curve was calculated for the compound.,CHEMBL625188,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7858,,,,,14346,,50588,,N,1,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,CHEMBL625189,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,7859,,,,,14346,,50588,,N,1,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,CHEMBL625190,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7860,,,,,14346,,50597,,N,1,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,CHEMBL621733,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7861,,,,,14346,,50597,,N,1,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,CHEMBL621734,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7862,,,,,11149,,50597,,N,1,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,CHEMBL621735,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7863,,,Plasma,,17796,1969.0,50597,,N,1,,Clearance of the drug was measured in the plasma of rat; No data,CHEMBL621736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7864,,,Plasma,,5247,1969.0,50597,,N,1,,The pharmacokinetic parameter plasma clearance in vivo in rats,CHEMBL621737,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7865,,,,,4727,,50597,,N,1,,Plasma clearance at the dose of 2 mg/kg in rat,CHEMBL621738,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7866,In vivo,,,,5654,,50597,,N,1,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL622806,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7867,In vivo,,,,5654,,50597,,N,1,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL623519,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7868,In vivo,,,,17260,,50597,,N,1,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL623520,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7869,In vivo,,,,17065,,50597,,N,1,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL623521,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7870,In vivo,,,,17671,,50597,,N,1,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL623522,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7871,In vivo,,,,6672,,50597,,N,1,,Clearance rate in rat,CHEMBL623523,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7872,In vivo,,,,6673,,50597,,N,1,,Clearance rate in rat,CHEMBL623690,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7873,In vivo,,,,5978,,50597,,N,1,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623691,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7874,In vivo,,,,5978,,50597,,N,1,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623692,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7875,In vivo,,,,5978,,50597,,N,1,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623693,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7876,In vivo,,,,5978,,50597,,N,1,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623694,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7877,In vivo,,,,4413,,50597,,N,1,,Clearance of compound after iv administration of 20 mg/kg dose in rat,CHEMBL623695,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7878,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL623696,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7879,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL623697,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,7880,In vivo,,Plasma,,5005,1969.0,22224,,U,1,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,CHEMBL623698,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7881,In vivo,,Plasma,,5005,1969.0,22224,,U,1,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,CHEMBL623699,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7882,In vivo,,,,15765,,50597,,N,1,,Mean (%CV) PK parameters for CL(mL/min/kg).,CHEMBL623700,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7883,In vivo,,,,3747,,50597,,N,1,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,CHEMBL623701,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7884,In vivo,,Plasma,,16366,1969.0,50597,,N,1,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,CHEMBL623702,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7885,In vivo,,,,4199,,50597,,N,1,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,CHEMBL623703,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7886,In vivo,,,,17267,,50597,,N,1,,Plasma clearance in rat was determined,CHEMBL623704,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7887,In vivo,,,,6535,,50597,,N,1,,Plasma clearance in rat after administration of 2 mg/kg iv,CHEMBL623705,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7888,In vivo,,,,6535,,50597,,N,1,,Plasma clearance in rat after administration of 2 mg/kg iv,CHEMBL623706,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7889,In vivo,,,,5041,,50597,,N,1,,Plasma clearance was determined,CHEMBL623707,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7890,In vivo,,,,5960,,50597,,N,1,,Plasma clearance in rat,CHEMBL623708,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7891,In vivo,,,,5937,,50597,,N,1,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,CHEMBL623709,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7892,In vivo,,,,5871,,50597,,N,1,,Plasma clearance in rat by iv administration,CHEMBL623710,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7893,In vivo,,,,5874,,50597,,N,1,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,CHEMBL623711,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7894,In vivo,,,,6504,,50597,,N,1,,Plasma clearance in rat p.o.,CHEMBL623712,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7895,In vivo,,,,6803,,50597,,N,1,,Plasma clearance in rats,CHEMBL623713,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7896,In vivo,,,,5041,,50597,,N,1,,Plasma clearance was determined; ND denotes no data,CHEMBL623714,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7897,In vivo,,,,5041,,50597,,N,1,,Plasma clearance was determined; ND denotes not determined,CHEMBL623715,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7898,In vivo,,,,1916,,50597,,N,1,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,CHEMBL623716,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7899,In vivo,,,,5199,,50597,,N,1,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,CHEMBL622980,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7900,In vivo,,,,16367,,50597,,N,1,,Plasma administration to rats,CHEMBL622981,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7901,In vivo,,,,6362,,50597,,N,1,,Plasma clearance of the compound in female Sprague-Dawley rats,CHEMBL622982,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7902,In vivo,,,,15662,,50597,,N,1,,Plasma clearance was observed after intravenous administration in rat,CHEMBL622983,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7903,In vivo,,,,6215,,50597,,N,1,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,CHEMBL622984,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7904,In vivo,,,,1466,,50597,,N,1,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,CHEMBL622985,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7905,In vivo,,Plasma,,15662,1969.0,50597,,N,1,,plasma clearance was observed after intravenous administration in rat,CHEMBL623631,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7906,In vivo,,,,4723,,50597,,N,1,,In vivo CL/F determined,CHEMBL623632,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7907,In vivo,,Plasma,,2792,1969.0,50597,,N,1,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,CHEMBL623633,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7908,In vivo,,Plasma,,2792,1969.0,50597,,N,1,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,CHEMBL623634,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7909,In vivo,,,,5213,,50597,,N,1,,Compound was tested for the lower blood clearance in rat,CHEMBL623635,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7910,In vivo,,,,4687,,50597,,N,1,,Evaluated for the low clearance in rat (in vivo),CHEMBL621195,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7911,In vivo,,,,3371,,50597,,N,1,,Pharmacokinetic property (CLb)of the compound was determined in rat,CHEMBL621196,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7912,In vivo,,,,4690,,50597,,N,1,,Rapid clearance after intravenous administration in rat was determined,CHEMBL875287,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7913,In vivo,,,,5702,,50597,,N,1,,Clearance measured in rat,CHEMBL621197,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7914,In vivo,,Plasma,,740,1969.0,50597,,N,1,,Compound was evaluated for plasma clearance in rat,CHEMBL621198,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7915,In vivo,,Plasma,,4853,1969.0,50597,,N,1,,Low plasma clearance was calculated in rat,CHEMBL621199,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7916,In vivo,,,,5789,,50597,,N,1,,Pharmacokinetic property (Clp) in rat,CHEMBL621200,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7917,In vivo,,,,4527,,50597,,N,1,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,CHEMBL621201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7918,In vivo,,,,4527,,50597,,N,1,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,CHEMBL621202,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7919,In vivo,,,,6518,,50597,,N,1,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,CHEMBL621203,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7920,In vivo,,,,6518,,50597,,N,1,,Plasma clearance after IV dosing at 1 mg/kg in rat,CHEMBL621204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7921,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,CHEMBL621205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7922,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,CHEMBL621206,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7923,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,CHEMBL621207,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7924,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,CHEMBL621208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7925,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,CHEMBL621209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7926,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,CHEMBL876484,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7927,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL621210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7928,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,CHEMBL621211,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7929,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,CHEMBL621212,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7930,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,CHEMBL621213,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7931,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,CHEMBL621214,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7932,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,CHEMBL621215,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7933,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,CHEMBL621216,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7934,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,CHEMBL621217,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7935,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,CHEMBL621218,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7936,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,CHEMBL621219,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7937,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,CHEMBL621220,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7938,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,CHEMBL621221,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7939,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,CHEMBL621222,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7940,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,CHEMBL621223,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7941,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,CHEMBL876485,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7942,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL621224,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7943,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,CHEMBL621225,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7944,In vivo,,Heart,,9866,948.0,50597,,N,1,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,CHEMBL621226,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7945,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,CHEMBL621227,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7946,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL621228,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7947,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,CHEMBL621229,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7948,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,CHEMBL621230,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7949,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,CHEMBL621231,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7950,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL621232,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7951,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL621233,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7952,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,CHEMBL621234,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7953,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,CHEMBL621235,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7954,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL621236,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7955,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,CHEMBL621237,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7956,In vivo,,Kidney,,9866,2113.0,50597,,N,1,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,CHEMBL876486,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7957,In vivo,,Intestine,,9866,160.0,50597,,N,1,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,CHEMBL622436,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7958,In vivo,,Intestine,,9866,160.0,50597,,N,1,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,CHEMBL622437,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7959,In vivo,,Intestine,,9866,160.0,50597,,N,1,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,CHEMBL622438,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7960,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,CHEMBL622439,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7961,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,CHEMBL622440,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7962,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,CHEMBL622441,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7963,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,CHEMBL622442,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7964,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,CHEMBL622443,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7965,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL622444,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7966,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,CHEMBL622445,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7967,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL622446,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7968,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL622447,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7969,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,CHEMBL622448,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7970,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,CHEMBL622449,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7971,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,CHEMBL622450,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7972,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,CHEMBL622451,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7973,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,CHEMBL622452,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7974,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,CHEMBL622453,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7975,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,CHEMBL622454,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7976,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,CHEMBL622455,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7977,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,CHEMBL876024,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7978,In vivo,,,,2792,,50597,,N,1,,T max was determined at 3 mg/kg po dose in rats,CHEMBL622456,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7979,In vivo,,,,15078,,50597,,N,1,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL622457,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7980,In vivo,,,,15078,,50597,,N,1,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL622458,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7981,,,,,15022,,50597,,N,1,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,CHEMBL622459,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7982,,,,,15022,,50597,,N,1,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,CHEMBL873343,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7983,,,,,15022,,50597,,N,1,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,CHEMBL622460,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7984,,,Plasma,,4576,1969.0,50597,,N,1,,Time for maximum plasma concentration determined in rat,CHEMBL622461,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7985,In vivo,,Plasma,,6681,1969.0,50597,,N,1,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,CHEMBL622462,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7986,In vivo,,,,16365,,50597,,N,1,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,CHEMBL622463,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7987,In vivo,,,,16365,,50597,,N,1,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,CHEMBL622464,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7988,In vivo,,,,16365,,50597,,N,1,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,CHEMBL622465,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7989,In vivo,,,,16365,,50597,,N,1,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,CHEMBL622466,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7990,In vivo,,,,16365,,50597,,N,1,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,CHEMBL622467,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7991,,,Plasma,,6824,1969.0,50597,,N,1,,Time of maximum plasma concentration in rat,CHEMBL622468,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7992,,,Plasma,,6685,1969.0,50597,,N,1,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",CHEMBL876025,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7993,,,Plasma,,6685,1969.0,50597,,N,1,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",CHEMBL622469,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7994,,,Plasma,,6685,1969.0,50597,,N,1,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",CHEMBL622470,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7995,In vivo,,,,15662,,50597,,N,1,,Time required to reach maximum concentration (Cmax) after oral administration in rat,CHEMBL622471,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7996,,,Plasma,,1742,1969.0,50597,,N,1,,Time required to reach maximum concentration in rat plasma,CHEMBL622472,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7997,In vivo,,Plasma,,2774,1969.0,50597,,N,1,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,CHEMBL622473,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7998,In vivo,,Plasma,,5199,1969.0,50597,,N,1,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,CHEMBL624282,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,7999,In vivo,,Plasma,,12873,1969.0,50597,,N,1,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL624283,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8000,In vivo,,Plasma,,12873,1969.0,50597,,N,1,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL624284,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8001,In vivo,,Plasma,,1916,1969.0,50597,,N,1,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,CHEMBL624285,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8002,In vivo,,,,16367,,50597,,N,1,,Time to reach Cmax after oral administration to rats,CHEMBL624286,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8003,In vivo,,,,16366,,50597,,N,1,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,CHEMBL624287,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8004,,,,,216,,50597,,N,1,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,CHEMBL624288,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8005,In vivo,,Plasma,,6410,1969.0,50597,,N,1,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,CHEMBL624289,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8006,In vivo,,Plasma,,6410,1969.0,50597,,N,1,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,CHEMBL873344,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8007,In vivo,,,,6215,,50597,,N,1,,Tmax after peroral administration (10 mg/kg) was determined in rat,CHEMBL619623,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,8008,In vivo,,,,3598,,50597,,N,1,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL621399,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8009,In vivo,,,,4527,,50597,,N,1,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL621400,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8010,In vivo,,,,17670,,50597,,N,1,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL621401,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8011,,,,,1465,,50597,,N,1,,Tmax was determined,CHEMBL621402,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8012,,,,,2552,,50597,,N,1,,Tmax was determined,CHEMBL621403,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8013,In vivo,,,,5656,,50597,,N,1,,Tmax after oral administration in rat,CHEMBL621121,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8014,In vivo,,,,17764,,50597,,N,1,,Tmax after peroral administration in rats at 2.4 uM/kg,CHEMBL872525,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8015,,,,,5610,,50597,,N,1,,Tmax in male rat,CHEMBL621122,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8016,In vivo,,,,6046,,50597,,N,1,,Tmax in rat at 10 mg/kg,CHEMBL621123,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8017,In vivo,,,,5874,,50597,,N,1,,Tmax in rat by po administration at a dose of 40 mg/kg,CHEMBL621124,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8018,,,,,17596,,50597,,N,1,,Tmax in rats,CHEMBL621125,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8019,In vivo,,,,17804,,50597,,N,1,,Tmax was measured in rats after peroral administration at 5 mg/kg,CHEMBL621126,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8020,In vivo,,,,1908,,50597,,N,1,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,CHEMBL621127,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8021,In vivo,,,,2959,,50597,,N,1,,Tmax value after administration of 20 mg/Kg oral dose in rat,CHEMBL621128,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8022,In vivo,,,,6757,,50597,,N,1,,Tmax value at a dose of 10 mg/kg in male SD rats,CHEMBL618263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8023,In vivo,,,,6757,,50597,,N,1,,Tmax value at a dose of 100 mg/kg in male SD rats,CHEMBL618264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8024,In vivo,,,,6757,,50597,,N,1,,Tmax value at a dose of 50 mg/kg in male SD rats,CHEMBL618265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8025,In vivo,,Plasma,,4186,1969.0,50597,,N,1,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL618266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8026,In vivo,,,,15662,,50597,,N,1,,time required to reach maximum concentration (Cmax) after oral administration in rat,CHEMBL618267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8027,,,Urine,,429,1088.0,50597,,N,1,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),CHEMBL618450,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8028,,,Urine,,429,1088.0,50597,,N,1,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),CHEMBL618451,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8029,,,,,5546,,50597,,N,1,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,CHEMBL618452,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8030,,,Urine,,3173,1088.0,50597,,N,1,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,CHEMBL618453,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8031,,,Urine,,3173,1088.0,50597,,N,1,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,CHEMBL618454,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8032,,,Urine,,3173,1088.0,50597,,N,1,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,CHEMBL618455,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8033,In vivo,,,,4257,,50597,,N,1,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,CHEMBL618456,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8034,In vivo,,,,6011,,50597,,N,1,,Compound distribution in rat tissues was determined,CHEMBL618457,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8035,In vivo,,,,5472,,50597,,N,1,,Volume of distribution was evaluated in rat,CHEMBL618458,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8036,,,,,14346,,50597,,N,1,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,CHEMBL618459,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8037,,,,,14346,,50597,,N,1,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,CHEMBL876733,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,8038,,,,,14346,,50588,,N,1,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,CHEMBL618460,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8039,,,,,14346,,50597,,N,1,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,CHEMBL618461,,1,A
Autocuration,BAO_0000019,,,,,8040,,,,,15469,,22224,,U,1,,Area under the curve was determined after oral administration (300 uM/Kg),CHEMBL618462,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8041,,,,,14346,,50597,,N,1,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,CHEMBL618463,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8042,,,,,14346,,50597,,N,1,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,CHEMBL618464,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8043,,,,,14346,,50597,,N,1,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,CHEMBL618465,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8044,,,,,14346,,50597,,N,1,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,CHEMBL618466,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8045,,,,,14346,,50597,,N,1,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,CHEMBL618467,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8046,,,,,15372,,50597,,N,1,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,CHEMBL618468,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,8047,,,Plasma,,12935,1969.0,50588,,N,1,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,CHEMBL618469,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,8048,,,Plasma,,12935,1969.0,50588,,N,1,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,CHEMBL618470,,1,A
Autocuration,BAO_0000218,,,,,8049,,,,,14813,,22224,,U,1,,Plasma drug AUC in rat (PO dose),CHEMBL618471,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8050,,,,,15792,,50594,,N,1,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,CHEMBL618472,,1,A
Autocuration,BAO_0000218,,,,,8051,,,,,3579,,22224,,U,1,,Area under was determined at a dose of 30 mg/kg,CHEMBL618473,,0,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,8052,,,,,12487,,50506,,N,1,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,CHEMBL621699,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8053,,,,,12487,,50597,,N,1,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,CHEMBL621700,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8054,,,,,12487,,50597,,N,1,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,CHEMBL621701,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,8055,,,,,12487,,50506,,N,1,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,CHEMBL621702,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,8056,,,,,12487,,50588,,N,1,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,CHEMBL621703,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,8057,,,,,12487,,50588,,N,1,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,CHEMBL621704,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8058,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",CHEMBL624259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8059,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",CHEMBL624260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8060,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",CHEMBL624430,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8061,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",CHEMBL624431,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8062,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",CHEMBL624432,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8063,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",CHEMBL624433,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8064,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",CHEMBL624434,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8065,,,,,12902,,50597,,N,1,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",CHEMBL624435,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8066,,,,,12745,,50594,,N,1,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,CHEMBL618570,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8067,,,,,12745,,50594,,N,1,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL618571,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8068,,,,,12745,,50594,,N,1,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,CHEMBL618572,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8069,,,,,12745,,50594,,N,1,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL618573,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8070,,,,,12745,,50594,,N,1,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,CHEMBL619267,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8071,,,,,12745,,50594,,N,1,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL619431,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8072,,,,,12745,,50594,,N,1,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,CHEMBL619432,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8073,,,,,12745,,50594,,N,1,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL619433,,1,A
Autocuration,BAO_0000218,,,,,8074,,,Plasma,,13298,1969.0,22224,,U,1,,AUC in mice after oral dose (50 mg/kg),CHEMBL619434,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8075,,,Serum,,12226,1977.0,50594,,N,1,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,CHEMBL619435,,1,A
Autocuration,BAO_0000019,,,,,8076,,,Plasma,,12634,1969.0,22224,,U,1,,AUC (0-4 hr) ug/ml/h,CHEMBL619436,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8077,,,,,14810,,50597,,N,1,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,CHEMBL619437,,1,A
Autocuration,BAO_0000218,,,,,8078,,,,,13889,,22224,,U,1,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,CHEMBL619438,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8079,,,,,10018,,50594,,N,1,,Compound was evaluated for Area under curve in mice,CHEMBL619439,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8080,,,,,8758,,50597,,N,1,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,CHEMBL619440,,1,A
Autocuration,BAO_0000218,,,,,8081,,,,,8758,,22224,,U,1,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,CHEMBL619441,,0,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8082,,,,,8758,,50597,,N,1,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,CHEMBL619442,,1,A
Autocuration,BAO_0000019,,,,,8083,,,,,2249,,22224,,U,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,CHEMBL875156,,0,A
Autocuration,BAO_0000019,,,,,8084,,,,,2249,,22224,,U,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,CHEMBL619443,,0,A
Autocuration,BAO_0000019,,,,,8085,,,,,2249,,22224,,U,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,CHEMBL619444,,0,A
Autocuration,BAO_0000019,,,,,8086,,,,,2249,,22224,,U,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,CHEMBL623464,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8087,,,,,15115,,50594,,N,1,,Compound was evaluated for area under curve when administered through oral route in mouse,CHEMBL623465,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8088,In vivo,,,,6518,,50597,,N,1,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,CHEMBL623466,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8089,In vivo,,,,6518,,50597,,N,1,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,CHEMBL623467,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8090,In vivo,,,,6249,,50597,,N,1,,Plasma clearance in rat,CHEMBL623468,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8091,In vivo,,,,2463,,50597,,N,1,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,CHEMBL622660,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8092,In vivo,,,,4969,,50597,,N,1,,Plasma clearance rate in Sprague-Dawley rats,CHEMBL622661,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8093,In vivo,,,,17720,,50597,,N,1,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL622662,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8094,In vivo,,,,3457,,50597,,N,1,,Pharmacokinetic property (total body clearance) in rat,CHEMBL622663,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8095,In vivo,,,,5983,,50597,,N,1,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,CHEMBL622664,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8096,,,,,6295,,50597,,N,1,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,CHEMBL622665,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8097,,,,,6296,,50597,,N,1,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,CHEMBL622666,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8098,In vivo,,,,17686,,50597,,N,1,,Cl in rat i.v. at 2 mg/kg concentration,CHEMBL621615,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8099,In vivo,,,,17764,,50597,,N,1,,Clearance of compound after intravenous administration in rats at 24 uM/kg,CHEMBL621616,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8100,In vivo,,,,5503,,50597,,N,1,,Clearance was determined,CHEMBL621617,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8101,In vivo,,,,4368,,50597,,N,1,,Clearance by intravenous administration of 3.4 mg/kg in rat,CHEMBL621618,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8102,In vivo,,,,6005,,50597,,N,1,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,CHEMBL621619,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8103,In vivo,,,,5031,,50597,,N,1,,Clearance rate after i.v. administration in rats,CHEMBL621620,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8104,In vivo,,,,4890,,50597,,N,1,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL621786,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8105,In vivo,,,,5182,,50597,,N,1,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,CHEMBL621787,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8106,In vivo,,,,5979,,50597,,N,1,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,CHEMBL621788,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8107,In vivo,,,,5656,,50597,,N,1,,Clearance (Cl) after oral administration in rat,CHEMBL621789,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8108,In vivo,,,,17804,,50597,,N,1,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,CHEMBL621790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8109,In vivo,,Plasma,,4839,1969.0,50597,,N,1,,Compound was tested for plasma clearance in rat,CHEMBL621791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8110,In vitro,Microsomes,,,5041,,50597,,N,1,,In vitro microsome metabolism clearance in rat was determined,CHEMBL621792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8111,In vitro,Microsomes,,,5041,,50597,,N,1,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,CHEMBL621793,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8112,In vivo,,,,5974,,50597,,N,1,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL621794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8113,In vivo,,Plasma,,5496,1969.0,50597,,N,1,,In vivo plasma clearance was determined,CHEMBL621795,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8114,In vivo,,,,5739,,50597,,N,1,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,CHEMBL621796,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8115,In vivo,,Liver,,5676,2107.0,50597,,N,1,Hepatocyte,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,CHEMBL621797,401.0,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8116,In vivo,,,,4239,,50597,,N,1,,Pharmacokinetic property (Plasma clearance) was measured in rat,CHEMBL621798,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8117,In vivo,,,,5676,,50597,,N,1,,Pharmacokinetic property (clearance) in rat i.v.,CHEMBL621799,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8118,In vivo,,,,1918,,50597,,N,1,,"Plasma Clearance was evaluated in rats, iv",CHEMBL621800,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8119,In vivo,,,,17800,,50597,,N,1,,Plasma clearance (in vivo) in rats was determined,CHEMBL621801,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8120,In vivo,,,,6056,,50597,,N,1,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,CHEMBL621802,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8121,In vivo,,,,5496,,50597,,N,1,,Plasma clearance was determined,CHEMBL618596,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8122,In vivo,,,,5939,,50597,,N,1,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,CHEMBL618597,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8123,In vivo,,,,5939,,50597,,N,1,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,CHEMBL618598,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8124,In vivo,,,,17752,,50597,,N,1,,Plasma clearance in rats,CHEMBL618599,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8125,In vivo,,,,4576,,50597,,N,1,,Plasma clearance rate determined in rat,CHEMBL618600,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8126,In vivo,,,,6011,,50597,,N,1,,Plasma clearance was determined in rat,CHEMBL618601,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8127,In vivo,,,,5510,,50597,,N,1,,Plasma clearance was determined,CHEMBL618602,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8128,In vivo,,,,5948,,50597,,N,1,,Plasma clearance value in rat,CHEMBL618603,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8129,Ex vivo,,Liver,,6125,2107.0,50597,,N,1,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,CHEMBL618604,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8130,In vivo,,,,4839,,50597,,N,1,,Clearance in rat,CHEMBL618605,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8131,In vivo,,,,17686,,50597,,N,1,,Total body clearance in rat i.v. at 2 mg/kg concentration,CHEMBL618606,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8132,In vivo,,,,6571,,50597,,N,1,,Clearance of compound in rats after intravenous administration,CHEMBL618607,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8133,In vivo,,,,3364,,50597,,N,1,,Clearance after iv administration to rats,CHEMBL618608,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8134,In vivo,,,,13569,,50597,,N,1,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,CHEMBL618609,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8135,In vivo,,,,13569,,50597,,N,1,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,CHEMBL618610,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8136,In vivo,,,,13569,,50597,,N,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,CHEMBL618611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8137,In vivo,,,,13569,,50597,,N,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,CHEMBL618612,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8138,In vivo,,,,13569,,50597,,N,1,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,CHEMBL618613,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8139,In vivo,,,,13569,,50597,,N,1,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,CHEMBL621076,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8140,In vivo,,,,13569,,50597,,N,1,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,CHEMBL621077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8141,In vivo,,,,17670,,50597,,N,1,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL621078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8142,In vivo,,,,5970,,50597,,N,1,,Clearance in rat,CHEMBL621251,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8143,In vivo,,,,6495,,50597,,N,1,,Clearance in rat after oral administration at 10 mg/kg,CHEMBL621252,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8144,In vivo,,,,4590,,50597,,N,1,,Clearance in rat.,CHEMBL621253,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8145,In vivo,,,,6193,,50597,,N,1,,Clearance rate following an oral dose of 20 mg/kg in rats,CHEMBL621254,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8146,In vivo,,,,2832,,50597,,N,1,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,CHEMBL621255,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8147,In vivo,,Plasma,,1052,1969.0,50597,,N,1,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,CHEMBL621256,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8148,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,CHEMBL621257,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8149,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,CHEMBL621258,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8150,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,CHEMBL621259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8151,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,CHEMBL621260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8152,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,CHEMBL876494,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8153,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,CHEMBL621261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8154,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,CHEMBL621262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8155,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL621263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8156,In vivo,,Liver,,9866,2107.0,50597,,N,1,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,CHEMBL621264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8157,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,CHEMBL621265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8158,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,CHEMBL621266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8159,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,CHEMBL621267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8160,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,CHEMBL621268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8161,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,CHEMBL621269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8162,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,CHEMBL621270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8163,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,CHEMBL621271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8164,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,CHEMBL621272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8165,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,CHEMBL621273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8166,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,CHEMBL621274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8167,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,CHEMBL876495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8168,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,CHEMBL621275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8169,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,CHEMBL621276,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8170,In vivo,,Muscle tissue,,9866,2385.0,50597,,N,1,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,CHEMBL621277,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8171,In vivo,,Intestine,,9866,160.0,50597,,N,1,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,CHEMBL621278,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8172,In vivo,,Intestine,,9866,160.0,50597,,N,1,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,CHEMBL621279,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8173,In vivo,,Intestine,,9866,160.0,50597,,N,1,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),CHEMBL621280,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8174,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,CHEMBL621281,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8175,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,CHEMBL621282,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8176,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,CHEMBL621283,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8177,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,CHEMBL621284,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8178,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,CHEMBL621285,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8179,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,CHEMBL621286,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8180,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,CHEMBL623220,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8181,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,CHEMBL623221,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8182,In vivo,,Spleen,,9866,2106.0,50597,,N,1,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,CHEMBL876029,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8183,In vivo,,Stomach,,9866,945.0,50597,,N,1,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,CHEMBL623222,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8184,In vivo,,Stomach,,9866,945.0,50597,,N,1,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,CHEMBL623223,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8185,In vivo,,Stomach,,9866,945.0,50597,,N,1,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,CHEMBL621445,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8186,In vivo,,Blood,,13950,178.0,50597,,N,1,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621446,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8187,In vivo,,Blood,,13950,178.0,50597,,N,1,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL621447,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8188,In vivo,,Blood,,13950,178.0,50597,,N,1,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619681,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8189,In vivo,,Blood,,13950,178.0,50597,,N,1,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL619682,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8190,In vivo,,Blood,,13950,178.0,50597,,N,1,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL619683,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8191,In vivo,,Brain,,13950,955.0,50597,,N,1,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL619684,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8192,In vivo,,Brain,,13950,955.0,50597,,N,1,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL619685,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8193,In vivo,,Brain,,13950,955.0,50597,,N,1,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619686,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8194,In vivo,,Brain,,13950,955.0,50597,,N,1,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL619687,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8195,In vivo,,Brain,,13950,955.0,50597,,N,1,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL619688,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8196,In vivo,,Heart,,13950,948.0,50597,,N,1,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL619689,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8197,In vivo,,Heart,,13950,948.0,50597,,N,1,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL619690,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8198,In vivo,,Heart,,13950,948.0,50597,,N,1,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619691,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8199,In vivo,,,,6062,,50597,,N,1,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,CHEMBL619692,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,8200,,,,,3598,,50597,,N,1,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL619693,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8201,In vivo,,,,1908,,50597,,N,1,,Vc value after IV dose at a dose of 5 mg/kg in rats.,CHEMBL619694,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8202,In vivo,,,,17596,,50597,,N,1,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,CHEMBL619695,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8203,In vivo,,,,4891,,50597,,N,1,,Compound was evaluated for pharmacokinetic parameter volume of distribution,CHEMBL619696,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8204,In vivo,,,,740,,50597,,N,1,,Compound was evaluated for volume of distribution in rat,CHEMBL619697,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8205,In vivo,,,,16366,,50597,,N,1,,Steady state volume distribution was determined; steady state(ss),CHEMBL619698,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8206,In vivo,,,,3364,,50597,,N,1,,Steady state volume of distribution after iv administration to rats,CHEMBL619699,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8207,In vivo,,,,2552,,50597,,N,1,,Steady state volume of distribution dosing at 3 mg/kg iv,CHEMBL619700,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8208,In vivo,,,,406,,50597,,N,1,,The compound was evaluated for volume of distribution in rat,CHEMBL619701,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8209,In vivo,,,,12500,,50597,,N,1,,The compound was tested for volume of distribution in rat,CHEMBL619702,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8210,In vivo,,,,12500,,50597,,N,1,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,CHEMBL620335,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8211,In vivo,,,,5656,,50597,,N,1,,Volume distribution (VD) after oral administration in rat,CHEMBL620336,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8212,In vivo,,,,17671,,50597,,N,1,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL620337,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8213,In vivo,,,,1094,,50597,,N,1,,Volume distribution in rat,CHEMBL620520,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8214,In vivo,,,,5833,,50597,,N,1,,Volume distribution in rat,CHEMBL620521,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8215,In vivo,,,,5939,,50597,,N,1,,Volume distribution in rat after peroral administration at 10 mg/kg,CHEMBL875825,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8216,In vivo,,,,5939,,50597,,N,1,,Volume distribution in rat after peroral administration at 5 mg/kg,CHEMBL620522,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8217,In vivo,,,,6005,,50597,,N,1,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,CHEMBL620523,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8218,In vivo,,,,1696,,50597,,N,1,,Volume of distribution in rat.,CHEMBL620524,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8219,In vivo,,,,6672,,50597,,N,1,,Volume of distribution in rat,CHEMBL620525,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8220,In vivo,,,,6673,,50597,,N,1,,Volume of distribution in rat,CHEMBL620526,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8221,In vivo,,,,5871,,50597,,N,1,,Volume of distribution in rat by iv administration,CHEMBL620527,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8222,In vivo,,,,6803,,50597,,N,1,,Volume of distribution in rats,CHEMBL620528,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8223,In vivo,,,,5199,,50597,,N,1,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,CHEMBL620529,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8224,,,,,4727,,50597,,N,1,,Volume distribution at the dose of 2 mg/kg in rat,CHEMBL620530,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8225,In vivo,,,,16367,,50597,,N,1,,Steady state volume of distribution was determined,CHEMBL620531,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,8226,In vivo,,,,5005,,22224,,U,1,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,CHEMBL620532,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8227,In vivo,,,,5005,,22224,,U,1,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,CHEMBL620533,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8228,In vivo,,,,5005,,22224,,U,1,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,CHEMBL620534,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8229,In vivo,,,,15765,,50597,,N,1,,Mean (%CV) PK parameters for Vdss(mL/kg).,CHEMBL620535,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8230,In vivo,,,,2792,,50597,,N,1,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,CHEMBL875826,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8231,In vivo,,,,2792,,50597,,N,1,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,CHEMBL620536,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8232,In vivo,,,,5334,,50597,,N,1,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,CHEMBL620537,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8233,In vivo,,,,5334,,50597,,N,1,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,CHEMBL618526,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8234,In vivo,,,,5739,,50597,,N,1,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,CHEMBL618527,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8235,In vivo,,,,5789,,50597,,N,1,,Pharmacokinetic property (Vdss) in rat,CHEMBL618528,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8236,In vivo,,,,4239,,50597,,N,1,,Pharmacokinetic property (vdss) was measured in rat,CHEMBL618529,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8237,In vivo,,,,4709,,50597,,N,1,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,CHEMBL618530,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8238,In vivo,,,,6642,,50597,,N,1,,Volume of distribution in rat,CHEMBL618531,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8239,In vivo,,,,5247,,50597,,N,1,,The pharmacokinetic parameter volume of distribution in vivo in rats,CHEMBL618532,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8240,In vivo,,,,17720,,50597,,N,1,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL618533,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8241,In vivo,,,,17686,,50597,,N,1,,Vdss in rat i.v. at 2 mg/kg concentration,CHEMBL618534,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8242,In vivo,,,,4689,,50597,,N,1,,Volume distribution after intravenous administration (1 mg/kg) in rat,CHEMBL618535,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8243,In vivo,,,,5654,,50597,,N,1,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL618536,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8244,In vivo,,,,5654,,50597,,N,1,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL618537,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8245,In vivo,,,,4527,,50597,,N,1,,Volume distribution at a dose of 10 uM/kg in rat was determined,CHEMBL618538,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8246,In vivo,,,,4521,,50597,,N,1,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL618539,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8247,In vivo,,,,6057,,50597,,N,1,,Volume distribution was calculated in rat,CHEMBL618540,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8248,In vivo,,,,5510,,50597,,N,1,,Volume distribution was determined,CHEMBL618541,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8249,In vivo,,,,2938,,50597,,N,1,,Volume of distribution after intravenous administration was evaluated in rat,CHEMBL618542,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8250,In vivo,,,,6679,,50597,,N,1,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL622544,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8251,In vivo,,,,6685,,50597,,N,1,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",CHEMBL622545,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8252,In vivo,,,,6685,,50597,,N,1,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",CHEMBL622546,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8253,In vivo,,,,6685,,50597,,N,1,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",CHEMBL622547,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8254,In vivo,,,,5145,,50597,,N,1,,Volume of distribution in steady state was determined in rat,CHEMBL622548,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8255,In vivo,,,,6467,,50597,,N,1,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,CHEMBL622549,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8256,In vivo,,,,6467,,50597,,N,1,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,CHEMBL622550,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8257,,,,,15115,,50594,,N,1,,Compound was evaluated for area under curve when administered through oral route to mouse,CHEMBL622551,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8258,,,,,8758,,50597,,N,1,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,CHEMBL622552,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8259,,,,,8758,,50597,,N,1,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,CHEMBL622553,,1,A
Autocuration,BAO_0000218,,,,,8260,In vivo,,,,8267,,22224,,U,1,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,CHEMBL622554,,0,F
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,8261,,,,,8267,,50588,,N,1,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,CHEMBL622555,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8262,,,,,14239,,50594,,N,1,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,CHEMBL622556,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8263,,,,,14239,,50594,,N,1,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,CHEMBL622557,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8264,,,Blood,,10754,178.0,50594,,N,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,CHEMBL622558,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8265,,,Blood,,10754,178.0,50594,,N,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,CHEMBL622559,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,8266,,,,,10754,,50588,,N,1,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,CHEMBL622560,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8267,,,,,14681,,50597,,N,1,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,CHEMBL622561,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8268,,,,,14681,,50597,,N,1,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,CHEMBL622562,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8269,,,,,14681,,50597,,N,1,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,CHEMBL622563,,1,A
Autocuration,BAO_0000019,,,,,8270,,,,,13118,,22224,,U,1,,Concentration of compound in Central nervous system,CHEMBL622564,,0,A
Autocuration,BAO_0000019,,,,,8271,,,,,13118,,22224,,U,1,,Concentration of compound in Central nervous system; Not detectable,CHEMBL622565,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8272,,,,,13318,,50594,,N,1,,"Concentration of diester in the blood, following oral administration in mice",CHEMBL622566,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8273,,,,,13318,,50594,,N,1,,"Concentration of monoester in the blood, following oral administration in mice",CHEMBL624515,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8274,,,,,13318,,50594,,N,1,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,CHEMBL624516,,1,A
Autocuration,BAO_0000019,,,,,8275,,,,,15692,,22224,,U,1,,Evaluated for Pharmacokinetic property: Area under the curve,CHEMBL624517,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8276,,,,,14839,,50594,,N,1,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,CHEMBL624518,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8277,,,,,14839,,100710,,N,1,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,CHEMBL624519,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8278,,,,,14839,,100710,,N,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,CHEMBL624520,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8279,,,,,14839,,100710,,N,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,CHEMBL624521,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8280,,,,,14839,,100710,,N,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,CHEMBL624522,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8281,,,,,14839,,100710,,N,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,CHEMBL624523,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8282,,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL624409,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8283,,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",CHEMBL624410,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8284,,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL624411,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8285,,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",CHEMBL623531,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8286,,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL623532,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8287,,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",CHEMBL623533,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,8288,,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL623534,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8289,,,,,14839,,50594,,N,1,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,CHEMBL623535,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8290,,,,,14839,,50594,,N,1,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,CHEMBL623536,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8291,,,,,14839,,50594,,N,1,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,CHEMBL623537,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8292,,,,,14839,,50594,,N,1,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,CHEMBL623538,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8293,,,,,14839,,50594,,N,1,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,CHEMBL623539,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8294,,,,,14839,,50594,,N,1,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,CHEMBL623540,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8295,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",CHEMBL623541,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8296,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",CHEMBL623542,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8297,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",CHEMBL623543,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8298,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",CHEMBL623544,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8299,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",CHEMBL623545,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8300,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",CHEMBL623546,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8301,In vivo,,Plasma,,5408,1969.0,50597,,N,1,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,CHEMBL623547,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8302,In vivo,,,,6827,,50597,,N,1,,High i.v. clearance in Dawley rats,CHEMBL623548,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8303,In vitro,Microsomes,Liver,,17538,2107.0,50597,,N,1,,In vitro clearance in rat liver microsomes,CHEMBL623549,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8304,In vitro,Microsomes,Liver,,6331,2107.0,50597,,N,1,,Intrinsic clearance in rat liver microsomes was determined,CHEMBL623550,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8305,In vitro,,Liver,,5948,2107.0,50597,,N,1,Hepatocyte,Intrinsic clearance in rat hepatocytes was determined,CHEMBL875276,401.0,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8306,In vivo,,,,4026,,50597,,N,1,,Plasma Clearance was determined,CHEMBL621872,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8307,In vivo,,,,6647,,50597,,N,1,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,CHEMBL621873,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8308,In vivo,,,,1696,,50597,,N,1,,Plasma clearance in rat.,CHEMBL621874,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8309,In vivo,,,,6597,,50597,,N,1,,Plasma clearance in rats,CHEMBL621875,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8310,In vivo,,,,347,,50597,,N,1,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,CHEMBL621876,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8311,In vivo,,,,16423,,50597,,N,1,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,CHEMBL621877,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8312,In vivo,,,,2879,,50597,,N,1,,Plasma clearance was measured in rat,CHEMBL621878,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8313,In vivo,,,,4883,,50597,,N,1,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,CHEMBL621879,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8314,In vivo,,Plasma,,5328,1969.0,50597,,N,1,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",CHEMBL621880,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8315,In vivo,,,,5160,,50597,,N,1,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,CHEMBL621881,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8316,In vivo,,,,17582,,50597,,N,1,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL621882,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8317,In vivo,,,,17651,,50597,,N,1,,Total clearance at 1 mg/kg was determined in rat,CHEMBL875283,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8318,In vivo,,,,17651,,50597,,N,1,,Total clearance at 10 mg/kg was determined in rat,CHEMBL621883,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8319,In vivo,,,,6596,,50597,,N,1,,Clearance in rat,CHEMBL621884,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8320,In vivo,,,,4796,,50597,,N,1,,Plasma clearance rate determined in rats,CHEMBL621885,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8321,In vivo,,,,6850,,50597,,N,1,,Clearance of compound in rat was evaluated,CHEMBL621886,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8322,In vivo,,Plasma,,5932,1969.0,50597,,N,1,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,CHEMBL621887,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8323,In vivo,,,,3371,,50597,,N,1,,Pharmacokinetic property (blood clearance) in rat,CHEMBL621888,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8324,In vivo,,,,2083,,50597,,N,1,,Plasma clearance in rat,CHEMBL621889,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8325,In vivo,,,,4942,,50597,,N,1,,Plasma clearance in rats,CHEMBL621890,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8326,In vitro,Microsomes,Liver,,6838,2107.0,50597,,N,1,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,CHEMBL621891,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8327,In vivo,,,,5353,,50597,,N,1,,Clearance in Dawley rat,CHEMBL621892,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8328,In vivo,,,,6641,,50597,,N,1,,Clearance rat,CHEMBL621893,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8329,In vivo,,,,6641,,50597,,N,1,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),CHEMBL621894,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8330,In vivo,,,,6641,,50597,,N,1,,Clearance rat; Not determined,CHEMBL621895,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8331,In vivo,,,,6444,,50597,,N,1,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,CHEMBL875284,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8332,In vivo,,,,6444,,50597,,N,1,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,CHEMBL618699,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8333,In vivo,,,,6444,,50597,,N,1,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,CHEMBL618700,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8334,In vivo,,,,6211,,50597,,N,1,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL618701,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8335,In vivo,,Plasma,,12873,1969.0,50597,,N,1,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",CHEMBL876600,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8336,In vivo,,,,6570,,50597,,N,1,,Clearance of compound in rat after 1 mg/kg i.v. administration,CHEMBL618702,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8337,In vivo,,,,3341,,50597,,N,1,,Compound was evaluated for Hepatic clearance in rat,CHEMBL618703,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8338,In vivo,,,,4891,,50597,,N,1,,In vivo clearance after 5 mg/kg dose,CHEMBL618704,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8339,In vivo,,Plasma,,1094,1969.0,50597,,N,1,,Compound was tested for plasma clearance in rats,CHEMBL618705,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8340,In vivo,,,,2938,,50597,,N,1,,Hepatic clearance after intravenous administration was evaluated in rat,CHEMBL618706,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8341,In vivo,,,,17853,,50597,,N,1,,Lower clearance in rat (i.v.) at 0.5 mpk,CHEMBL618707,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8342,In vivo,,Plasma,,6049,1969.0,50597,,N,1,,Pharmacokinetic parameter expressed as plasma clearance in rat,CHEMBL618708,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8343,In vivo,,,,5789,,50597,,N,1,,Pharmacokinetic property (Clp) in rat,CHEMBL618709,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8344,In vivo,,,,4514,,50597,,N,1,,Plasma clearance in Sprague-Dawley rats,CHEMBL618710,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8345,In vivo,,,,6448,,50597,,N,1,,Plasma clearance (Clp) in rat,CHEMBL618711,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8346,In vivo,,,,6062,,50597,,N,1,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,CHEMBL618712,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8347,In vivo,,,,5710,,50597,,N,1,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,CHEMBL618713,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8348,In vivo,,,,4709,,50597,,N,1,,Plasma clearance after intravenous administration of 1 mg/kg in rat,CHEMBL618714,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8349,In vivo,,,,4521,,50597,,N,1,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL618715,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8350,In vivo,,,,1742,,50597,,N,1,,Plasma clearance in rat was determined,CHEMBL618716,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8351,In vivo,,,,6057,,50597,,N,1,,Plasma clearance measured in rat,CHEMBL876601,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8352,In vivo,,,,6057,,50597,,N,1,,Plasma clearance was calculated in rat,CHEMBL618717,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8353,In vivo,,,,5145,,50597,,N,1,,Plasma clearance in rat,CHEMBL618718,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8354,In vivo,,,,5833,,50597,,N,1,,Plasma clearance in rat,CHEMBL618719,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8355,In vivo,,,,6453,,50597,,N,1,,Plasma clearance in rat,CHEMBL618720,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8356,In vivo,,,,6640,,50597,,N,1,,Plasma clearance in rat,CHEMBL618721,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8357,In vivo,,,,6305,,50597,,N,1,,Plasma clearance in rats,CHEMBL621477,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8358,In vivo,,,,6642,,50597,,N,1,,Plasma clearance in rat,CHEMBL621478,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8359,In vivo,,,,5472,,50597,,N,1,,Plasma clearance was evaluated in rat,CHEMBL621479,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8360,In vivo,,,,5472,,50597,,N,1,,Plasma clearance was evaluated in rat; Not tested,CHEMBL621480,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8361,In vivo,,,,5144,,50597,,N,1,,Plasma clearance rate was determined for the compound in rat,CHEMBL621481,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8362,In vivo,,,,6685,,50597,,N,1,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",CHEMBL621482,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8363,In vivo,,,,6685,,50597,,N,1,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",CHEMBL621483,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8364,In vivo,,,,6685,,50597,,N,1,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",CHEMBL621484,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8365,In vivo,,Heart,,13950,948.0,50597,,N,1,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL621485,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8366,In vivo,,Heart,,13950,948.0,50597,,N,1,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL621486,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8367,In vivo,,Intestine,,13950,160.0,50597,,N,1,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621487,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8368,In vivo,,Intestine,,13950,160.0,50597,,N,1,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL621488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8369,In vivo,,Intestine,,13950,160.0,50597,,N,1,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL621489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8370,In vivo,,Intestine,,13950,160.0,50597,,N,1,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL621490,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8371,In vivo,,Intestine,,13950,160.0,50597,,N,1,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL621491,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8372,In vivo,,Kidney,,13950,2113.0,50597,,N,1,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621492,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8373,In vivo,,Kidney,,13950,2113.0,50597,,N,1,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,CHEMBL621493,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8374,In vivo,,Kidney,,13950,2113.0,50597,,N,1,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL621494,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8375,In vivo,,Kidney,,13950,2113.0,50597,,N,1,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL621495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8376,In vivo,,Kidney,,13950,2113.0,50597,,N,1,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL621496,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8377,In vivo,,Liver,,13950,2107.0,50597,,N,1,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621497,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8378,In vivo,,Liver,,13950,2107.0,50597,,N,1,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL621498,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8379,In vivo,,Liver,,13950,2107.0,50597,,N,1,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL621499,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8380,In vivo,,Liver,,13950,2107.0,50597,,N,1,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,CHEMBL618634,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8381,In vivo,,Liver,,13950,2107.0,50597,,N,1,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL618635,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8382,In vivo,,Lung,,13950,2048.0,50597,,N,1,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL618636,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8383,In vivo,,Lung,,13950,2048.0,50597,,N,1,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL619737,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8384,In vivo,,Lung,,13950,2048.0,50597,,N,1,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619738,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8385,In vivo,,Lung,,13950,2048.0,50597,,N,1,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL624329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8386,In vivo,,Lung,,13950,2048.0,50597,,N,1,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL624330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8387,In vivo,,Muscle tissue,,13950,2385.0,50597,,N,1,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL624331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8388,In vivo,,Muscle tissue,,13950,2385.0,50597,,N,1,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL624332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8389,In vivo,,Muscle tissue,,13950,2385.0,50597,,N,1,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL624333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8390,In vivo,,Muscle tissue,,13950,2385.0,50597,,N,1,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL624334,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8391,In vivo,,Muscle tissue,,13950,2385.0,50597,,N,1,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL624335,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8392,In vivo,,Spleen,,13950,2106.0,50597,,N,1,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL620016,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8393,In vivo,,Spleen,,13950,2106.0,50597,,N,1,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL620169,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8394,In vivo,,Spleen,,13950,2106.0,50597,,N,1,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL620170,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8395,In vivo,,Spleen,,13950,2106.0,50597,,N,1,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,CHEMBL620171,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8396,In vivo,,Spleen,,13950,2106.0,50597,,N,1,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL620172,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8397,In vivo,,Stomach,,13950,945.0,50597,,N,1,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL620173,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8398,In vivo,,Stomach,,13950,945.0,50597,,N,1,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,CHEMBL620174,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8399,In vivo,,Stomach,,13950,945.0,50597,,N,1,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL620175,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8400,In vivo,,Stomach,,13950,945.0,50597,,N,1,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL620176,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8401,In vivo,,Stomach,,13950,945.0,50597,,N,1,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL620177,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8402,,,Cerebellum,,13950,2037.0,50597,,N,1,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620178,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8403,,,Cerebellum,,13950,2037.0,50597,,N,1,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620179,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8404,,,,,13950,,50597,,N,1,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620180,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8405,In vivo,,,,6570,,50597,,N,1,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,CHEMBL620181,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8406,In vivo,,,,6571,,50597,,N,1,,Volume of distribution of compound in rats after intravenous administration,CHEMBL620182,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8407,In vivo,,,,6453,,50597,,N,1,,Volume of distribution in rat,CHEMBL620183,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8408,In vivo,,,,6444,,50597,,N,1,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,CHEMBL620184,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8409,In vivo,,,,6444,,50597,,N,1,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,CHEMBL620185,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8410,In vivo,,,,6444,,50597,,N,1,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,CHEMBL620186,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8411,In vivo,,,,5353,,50597,,N,1,,Volume of distribution was determined in Dawley rat,CHEMBL620187,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8412,In vivo,,,,5334,,50597,,N,1,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,CHEMBL620188,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8413,In vivo,,,,5334,,50597,,N,1,,Volume of distribution was reported in Sprague-Dawley rat,CHEMBL620189,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8414,In vivo,,,,6641,,50597,,N,1,,Volumes of distribution in rat after peroral administration,CHEMBL620190,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8415,In vivo,,,,6641,,50597,,N,1,,Volumes of distribution in rat after po administration,CHEMBL620191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8416,In vivo,,,,6641,,50597,,N,1,,Volumes of distribution in rat after po administration; Not determined,CHEMBL620192,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8417,In vivo,,,,5676,,50597,,N,1,,Pharmacokinetic property (Volume) in rat i.v.,CHEMBL620193,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8418,In vivo,,,,6410,,50597,,N,1,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,CHEMBL620194,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8419,In vivo,,,,17670,,50597,,N,1,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL876730,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8420,In vivo,,,,6495,,50597,,N,1,,Volume distribution in rat after oral administration at 10 mg/kg,CHEMBL620195,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8421,In vivo,,,,5408,,50597,,N,1,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,CHEMBL620196,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8422,In vivo,,,,4883,,50597,,N,1,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,CHEMBL620197,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8423,In vivo,,,,6647,,50597,,N,1,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,CHEMBL620198,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8424,In vivo,,,,6495,,50597,,N,1,,Volume of distribution in rats,CHEMBL620199,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8425,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL620200,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8426,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL620201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8427,In vivo,,,,5974,,50597,,N,1,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL620202,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8428,In vivo,,,,5974,,50597,,N,1,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL620203,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8429,In vivo,,,,5974,,50597,,N,1,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,CHEMBL620204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8430,In vivo,,,,5974,,50597,,N,1,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL620205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8431,In vivo,,,,5960,,50597,,N,1,,Pharmacokinetic parameter (Vss) in rat,CHEMBL624664,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8432,In vivo,,,,5676,,50597,,N,1,,Pharmacokinetic property (Volume) in rat i.v.,CHEMBL624665,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8433,,,,,5948,,50597,,N,1,,Pharmacokinetic property (Vss) in rat,CHEMBL624666,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8434,In vivo,,,,5979,,50597,,N,1,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,CHEMBL624667,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8435,In vivo,,,,5978,,50597,,N,1,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,CHEMBL624668,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8436,In vivo,,,,5978,,50597,,N,1,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL624669,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8437,In vivo,,,,5978,,50597,,N,1,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL624670,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8438,In vivo,,,,5978,,50597,,N,1,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL624671,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8439,In vivo,,,,6448,,50597,,N,1,,Steady state volume distribution in rat,CHEMBL624672,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8440,In vivo,,Plasma,,12873,1969.0,50597,,N,1,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",CHEMBL624673,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8441,In vivo,,,,4576,,50597,,N,1,,Steady state volume of distribution determined in rat,CHEMBL624674,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8442,In vivo,,,,17582,,50597,,N,1,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL624675,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8443,In vivo,,,,1466,,50597,,N,1,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,CHEMBL621728,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8444,,,,,5182,,50597,,N,1,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,CHEMBL621729,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8445,,,,,5182,,50597,,N,1,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,CHEMBL621730,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8446,In vivo,,,,6535,,50597,,N,1,,Volume distribution in rat after administration of 2 mg/kg iv,CHEMBL621731,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8447,In vivo,,,,6535,,50597,,N,1,,Volume distribution in rat after administration of 2 mg/kg iv,CHEMBL621732,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8448,In vivo,,,,5041,,50597,,N,1,,Volume in steady state distribution value was determined,CHEMBL621908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8449,In vivo,,,,5041,,50597,,N,1,,Volume in steady state distribution value was determined; ND denotes no data,CHEMBL875347,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8450,In vivo,,,,5041,,50597,,N,1,,Volume in steady state distribution value was determined; ND denotes not determined,CHEMBL621909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8451,In vivo,,,,17065,,50597,,N,1,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL621910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8452,In vivo,,,,6597,,50597,,N,1,,Volume of distribution at steady state was evaluated in rats,CHEMBL621911,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8453,In vivo,,,,15662,,50597,,N,1,,Volume of distribution at steady state was observed after intravenous administration in rat,CHEMBL621912,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8454,In vivo,,,,6485,,50597,,N,1,,Volume of distribution in steady state was determined in rat,CHEMBL621913,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8455,In vivo,,,,17655,,50597,,N,1,,Volume of distribution in steady state was determined in rat,CHEMBL621914,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8456,In vivo,,,,6616,,50597,,N,1,,Volume of distribution after i.v. administration,CHEMBL621915,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8457,In vivo,,,,1916,,50597,,N,1,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,CHEMBL621916,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8458,In vivo,,Liver,,16438,2107.0,50594,,N,1,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",CHEMBL621917,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8459,In vivo,,Liver,,16438,2107.0,50594,,N,1,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",CHEMBL621918,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8460,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,Biodistribution of compound (oxidized form) in spleen tissue,CHEMBL621919,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8461,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",CHEMBL621920,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8462,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",CHEMBL621921,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8463,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622401,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8464,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",CHEMBL875348,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8465,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",CHEMBL622402,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8466,In vivo,,Blood,,16438,178.0,50594,,N,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,CHEMBL622403,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8467,In vivo,,Blood,,16438,178.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622404,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8468,In vivo,,Brain,,16438,955.0,50594,,N,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,CHEMBL622405,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8469,In vivo,,Brain,,16438,955.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",CHEMBL622406,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8470,In vivo,,Brain,,16438,955.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622407,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8471,In vivo,,Heart,,16438,948.0,50594,,N,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,CHEMBL622408,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8472,In vivo,,Heart,,16438,948.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",CHEMBL622409,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8473,In vivo,,Heart,,16438,948.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622410,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8474,In vivo,,Kidney,,16438,2113.0,50594,,N,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,CHEMBL622411,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8475,In vivo,,Kidney,,16438,2113.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",CHEMBL627864,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8476,In vivo,,Kidney,,16438,2113.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL627865,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8477,In vivo,,Liver,,16438,2107.0,50594,,N,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,CHEMBL627866,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8478,In vivo,,Liver,,16438,2107.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL627751,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8479,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,CHEMBL627752,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8480,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",CHEMBL627753,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8481,In vivo,,Spleen,,16438,2106.0,50594,,N,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL627754,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8482,,,,,12467,,50594,,N,1,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,CHEMBL627755,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8483,In vivo,,Brain,,17208,955.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL627756,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8484,In vivo,,Brain,,17208,955.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627757,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8485,In vivo,,Brain,,17208,955.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627758,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8486,In vivo,,Brain,,17208,955.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627759,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8487,In vivo,,Brain,,17208,955.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627760,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8488,In vivo,,Brain,,17208,955.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627761,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8489,In vivo,,Heart,,17208,948.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL876811,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8490,In vivo,,Heart,,17208,948.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627762,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8491,In vivo,,Heart,,17208,948.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627763,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8492,In vivo,,Heart,,17208,948.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627764,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8493,In vivo,,Heart,,17208,948.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627765,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8494,In vivo,,Heart,,17208,948.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627766,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8495,In vivo,,Kidney,,17208,2113.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL627767,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8496,In vivo,,Kidney,,17208,2113.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627768,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8497,In vivo,,Kidney,,17208,2113.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL628422,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8498,In vivo,,Kidney,,17208,2113.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL628423,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8499,In vivo,,,,5089,,50597,,N,1,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,CHEMBL628424,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8500,In vivo,,,,5089,,50597,,N,1,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,CHEMBL628425,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8501,In vivo,,,,4257,,50597,,N,1,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,CHEMBL628426,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8502,In vivo,,,,6679,,50597,,N,1,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL628427,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8503,In vivo,,,,5546,,50597,,N,1,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,CHEMBL626938,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8504,In vivo,,,,6141,,50597,,N,1,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,CHEMBL626939,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8505,In vivo,,,,5334,,50597,,N,1,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,CHEMBL626940,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8506,In vivo,,,,5334,,50597,,N,1,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,CHEMBL626941,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8507,In vivo,,,,5334,,50597,,N,1,,Plasma clearance was reported in Sprague-Dawley rat,CHEMBL626942,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8508,In vivo,,,,4689,,50597,,N,1,,Plasma clearance after intravenous administration (1 mg/kg) in rat,CHEMBL876812,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8509,In vivo,,,,6848,,50597,,N,1,,Plasma clearance of compound in rats was evaluated,CHEMBL626943,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8510,In vivo,,,,6848,,50597,,N,1,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,CHEMBL626944,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8511,In vivo,,,,6467,,50597,,N,1,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,CHEMBL626945,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8512,In vivo,,,,6467,,50597,,N,1,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,CHEMBL626946,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8513,In vivo,,,,4956,,50597,,N,1,,Plasma clearance rate in Sprague-Dawley rats,CHEMBL626856,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8514,In vivo,,,,5529,,50597,,N,1,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),CHEMBL626857,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8515,In vivo,,Plasma,,406,1969.0,50597,,N,1,,The compound was evaluated for plasma clearance in rat,CHEMBL626858,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8516,In vivo,,Plasma,,17655,1969.0,50597,,N,1,,Total plasma clearance in rat,CHEMBL627018,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8517,In vivo,,Blood,,3293,178.0,50597,,N,1,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,CHEMBL625331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8518,In vivo,,Blood,,4075,178.0,50597,,N,1,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,CHEMBL625332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8519,In vivo,,,,2792,,50597,,N,1,,C max was determined at 10 mg/kg po dose in rats,CHEMBL877590,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8520,In vivo,,,,2792,,50597,,N,1,,C max was determined at 3 mg/kg po dose in rats,CHEMBL625333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8521,In vivo,,,,17594,,50597,,N,1,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,CHEMBL625334,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8522,In vivo,,,,17594,,50597,,N,1,,Cmax after single intravenous bolus of 1 mg/kg in rats,CHEMBL625335,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8523,In vivo,,,,4762,,50597,,N,1,,Cmax of compound at 5 mg/kg after po administration was determined in rat,CHEMBL625336,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8524,In vivo,,,,17509,,50597,,N,1,,Cmax 24 hr after 10 mg/kg oral administration in rats,CHEMBL625337,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8525,In vivo,,,,17509,,50597,,N,1,,Cmax 24 hr after 2 mg/kg oral administration in rats,CHEMBL625338,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8526,In vivo,,Plasma,,1466,1969.0,50597,,N,1,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL625339,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8527,In vivo,,,,6535,,50597,,N,1,,Cmax in rat after administration of 2 mg/kg iv,CHEMBL625340,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8528,In vivo,,,,6535,,50597,,N,1,,Cmax in rat after administration of 2 mg/kg iv,CHEMBL625341,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8529,In vivo,,,,3169,,50597,,N,1,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,CHEMBL622687,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8530,In vivo,,Plasma,,6515,1969.0,50597,,N,1,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,CHEMBL622688,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8531,In vivo,,Blood,,11149,178.0,50597,,N,1,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,CHEMBL622689,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8532,In vivo,,Blood,,11149,178.0,50597,,N,1,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,CHEMBL620295,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8533,In vivo,,,,17858,,50597,,N,1,,Cmax after 10 mg/kg oral administration in rat,CHEMBL620296,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8534,In vivo,,,,6518,,50597,,N,1,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,CHEMBL620297,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8535,In vivo,,,,6518,,50597,,N,1,,Cmax after IV dosing at 1 mg/kg in rat; no data,CHEMBL620298,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8536,In vivo,,,,4426,,50597,,N,1,,Cmax after oral administration at 20 mpk in rats,CHEMBL620299,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8537,In vivo,,,,4426,,50597,,N,1,,Cmax after oral administration at 20 mpk in rats; Not performed.,CHEMBL620300,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8538,In vivo,,,,4426,,50597,,N,1,,Cmax after oral administration at 20 mpk in rats d; Not performed.,CHEMBL620301,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8539,In vivo,,,,5656,,50597,,N,1,,Cmax after oral administration in rat,CHEMBL620302,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8540,In vivo,,,,6518,,50597,,N,1,,Cmax after oral administration at a dose of 2 mg/kg in rat,CHEMBL620303,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8541,In vivo,,,,6518,,50597,,N,1,,Cmax after oral administration at a dose of 4 mg/kg in rat,CHEMBL620304,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8542,In vivo,,,,6113,,50597,,N,1,,Cmax in rats after 20 mg/kg oral dose,CHEMBL620305,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8543,In vivo,,,,17764,,50597,,N,1,,Cmax after peroral administration in rats at 2.4 uM/kg,CHEMBL620306,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8544,In vivo,,,,4756,,50597,,N,1,,Cmax at the dose of 2 mg/Kg administered perorally in rats,CHEMBL620307,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8545,In vivo,,,,4756,,50597,,N,1,,Cmax at the dose of 5 mg/Kg administered perorally in rats,CHEMBL620308,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8546,In vivo,,,,6402,,50597,,N,1,,Cmax by administering at 20 mg/kg p.o. in rats,CHEMBL620309,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8547,In vivo,,,,5610,,50597,,N,1,,Cmax in male rat,CHEMBL620310,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8548,In vivo,,,,5207,,50597,,N,1,,Cmax in rat,CHEMBL620311,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8549,In vivo,,,,6011,,50597,,N,1,,Cmax in rat,CHEMBL620312,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8550,In vivo,,,,6504,,50597,,N,1,,Cmax in rat,CHEMBL620313,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8551,In vivo,,,,6046,,50597,,N,1,,Cmax in rat at 10 mg/kg,CHEMBL620314,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8552,In vivo,,,,6504,,50597,,N,1,,Cmax in rat at the dose of 1 mg/kg i.v.,CHEMBL620315,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8553,In vivo,,,,5874,,50597,,N,1,,Cmax in rat by po administration at a dose of 40 mg/kg,CHEMBL620316,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8554,In vivo,,,,17686,,50597,,N,1,,Cmax in rat p.o. at 20 mg/kg concentration,CHEMBL620317,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8555,In vivo,,,,5836,,50597,,N,1,,Cmax in rats,CHEMBL620318,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8556,In vivo,,,,17596,,50597,,N,1,,Cmax in rats,CHEMBL620319,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8557,In vivo,,,,16423,,50597,,N,1,,Cmax was evaluated after 20 uM/kg of peroral administration,CHEMBL620320,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8558,In vivo,,,,17804,,50597,,N,1,,Cmax was measured in rats after peroral administration at 3 mg/kg,CHEMBL620321,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8559,In vivo,,,,1908,,50597,,N,1,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,CHEMBL620322,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8560,,,,,13950,,50597,,N,1,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620323,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8561,,,Frontal cortex,,13950,1870.0,50597,,N,1,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620324,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8562,,,Frontal cortex,,13950,1870.0,50597,,N,1,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620325,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8563,,,Hippocampus,,13950,10000000.0,50597,,N,1,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620326,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8564,,,Hippocampus,,13950,10000000.0,50597,,N,1,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620327,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8565,,,,,13950,,50597,,N,1,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620328,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8566,,,,,13950,,50597,,N,1,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8567,,,Midbrain,,13950,1891.0,50597,,N,1,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8568,,,Midbrain,,13950,1891.0,50597,,N,1,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL875286,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8569,,,,,13950,,50597,,N,1,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8570,,,,,13950,,50597,,N,1,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8571,,,Striatum,,13950,2435.0,50597,,N,1,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8572,,,Striatum,,13950,2435.0,50597,,N,1,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620334,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8573,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL621015,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8574,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL621016,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8575,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL621191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8576,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL621192,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8577,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL621193,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8578,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL621194,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8579,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL624204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8580,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL624205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8581,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL624206,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8582,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL624207,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8583,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL624208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8584,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL624209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8585,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL624210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8586,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL624211,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8587,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL624212,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8588,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL624213,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8589,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL876611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8590,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL624214,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8591,,,Blood,,16434,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL624215,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8592,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL624216,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8593,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL624217,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8594,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL624218,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8595,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL624219,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8596,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL624220,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8597,,,Blood,,16435,178.0,50597,,N,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL624221,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8598,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL624222,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8599,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL624223,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8600,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL624224,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8601,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL624225,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8602,In vivo,,,,17764,,50597,,N,1,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,CHEMBL622420,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8603,In vivo,,,,5031,,50597,,N,1,,Volume of steady state distribution after i.v. administration in rats,CHEMBL622421,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8604,In vivo,,,,6215,,50597,,N,1,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,CHEMBL622422,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8605,In vivo,,,,17671,,50597,,N,1,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL622423,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8606,In vivo,,,,17752,,50597,,N,1,,Vss was determined,CHEMBL622424,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8607,In vivo,,,,6596,,50597,,N,1,,Vss in rat,CHEMBL622425,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8608,In vivo,,,,16423,,50597,,N,1,,Vss was evaluated after 10 uM/kg of intra arterial administration,CHEMBL876612,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8609,In vivo,,,,15662,,50597,,N,1,,volume of distribution at steady state was observed after intravenous administration in rat,CHEMBL622426,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8610,In vivo,,,,6062,,50597,,N,1,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,CHEMBL622427,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8611,In vivo,,,,5874,,50597,,N,1,,Pharmacokinetic (PK) parameter Vz in rat,CHEMBL622428,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8612,In vivo,,,,4942,,50597,,N,1,,Volume distribution in rats,CHEMBL622429,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8613,In vivo,,,,17796,,50597,,N,1,,Volume of distribution in rat; No data,CHEMBL622430,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8614,In vivo,,,,4890,,50597,,N,1,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL622431,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8615,,,Ileum,,15765,2116.0,50597,,N,1,,% absorption predicted from in vitro rat ileum transport studies,CHEMBL622432,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8616,In vivo,,,,13569,,50597,,N,1,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,CHEMBL622433,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8617,In vivo,,,,13569,,50597,,N,1,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,CHEMBL622434,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8618,In vivo,,,,13569,,50597,,N,1,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,CHEMBL622435,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8619,In vivo,,,,13569,,50597,,N,1,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),CHEMBL618748,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8620,In vivo,,,,13569,,50597,,N,1,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,CHEMBL618749,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8621,In vivo,,,,13569,,50597,,N,1,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,CHEMBL618750,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8622,In vivo,,,,13569,,50597,,N,1,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,CHEMBL618751,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8623,In vivo,,,,13569,,50597,,N,1,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,CHEMBL618752,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8624,In vivo,,,,4576,,50597,,N,1,,Oral bioavailability in rat,CHEMBL618753,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8625,In vivo,,Plasma,,750,1969.0,50597,,N,1,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,CHEMBL618754,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8626,In vivo,,,,750,,50597,,N,1,,Oral bioavailability in rat,CHEMBL618755,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8627,In vivo,,,,4590,,50597,,N,1,,Oral bioavailability in rat,CHEMBL618756,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8628,In vivo,,,,1716,,50597,,N,1,,Oral bioavailability in rat,CHEMBL618757,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8629,In vivo,,,,1974,,50597,,N,1,,Bioavailability in rat,CHEMBL618758,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8630,In vivo,,,,4502,,50597,,N,1,,Oral bioavailability in rat (dose 30 mg/kg),CHEMBL621088,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8631,,,,,3371,,50597,,N,1,,Pharmacokinetic property (cLogP) in rat,CHEMBL621089,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8632,,,Blood,,9099,178.0,50597,,N,1,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,CHEMBL621090,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8633,,,Blood,,9099,178.0,50597,,N,1,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,CHEMBL621091,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8634,In vivo,,,,4590,,50597,,N,1,,Clearance in rat.,CHEMBL876731,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8635,In vivo,,,,3184,,50597,,N,1,,Compound was evaluated for its clearance when administered intravenously in rat,CHEMBL621092,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8636,In vivo,,,,16456,,50597,,N,1,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL621093,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8637,,,,,4199,,50597,,N,1,,Blood: Brain distribution ratio is determined in rat,CHEMBL621094,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8638,,,,,4199,,50597,,N,1,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,CHEMBL621095,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8639,,,,,4199,,50597,,N,1,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,CHEMBL621096,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8640,In vivo,,Kidney,,8677,2113.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL621097,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8641,,,,,7449,,50597,,N,1,,Percent dose excreted in 0-48 hours administered ip to male rat,CHEMBL621098,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8642,,,Cerebellum,,11977,2037.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621099,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8643,,,Cerebellum,,11977,2037.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621100,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8644,,,Cerebellum,,11977,2037.0,50597,,N,1,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL621101,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8645,,,Cerebellum,,11977,2037.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621102,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8646,,,Cerebellum,,11977,2037.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL876732,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8647,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621103,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8648,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621104,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8649,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL621105,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8650,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621106,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8651,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621107,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8652,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621108,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8653,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621109,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8654,In vivo,,Kidney,,17208,2113.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL621110,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8655,In vivo,,Kidney,,17208,2113.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL621111,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8656,In vivo,,Liver,,17208,2107.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL622541,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8657,In vivo,,Liver,,17208,2107.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL622542,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8658,In vivo,,Liver,,17208,2107.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL622543,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8659,In vivo,,Liver,,17208,2107.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624412,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8660,In vivo,,Liver,,17208,2107.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624413,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8661,In vivo,,Liver,,17208,2107.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624414,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8662,In vivo,,Lung,,17208,2048.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL624415,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8663,In vivo,,Lung,,17208,2048.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624416,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8664,In vivo,,Lung,,17208,2048.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624417,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8665,In vivo,,Lung,,17208,2048.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624418,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8666,In vivo,,Lung,,17208,2048.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624419,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8667,In vivo,,Lung,,17208,2048.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624420,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8668,In vivo,,Muscle tissue,,17208,2385.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),CHEMBL624421,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8669,In vivo,,Muscle tissue,,17208,2385.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624422,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8670,In vivo,,Muscle tissue,,17208,2385.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624423,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8671,In vivo,,Muscle tissue,,17208,2385.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL625123,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8672,In vivo,,Muscle tissue,,17208,2385.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL625124,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8673,In vivo,,Muscle tissue,,17208,2385.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL625125,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8674,In vivo,,Zone of skin,,17208,14.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL625126,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8675,In vivo,,Zone of skin,,17208,14.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626947,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8676,In vivo,,Zone of skin,,17208,14.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626948,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8677,In vivo,,Zone of skin,,17208,14.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626949,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8678,In vivo,,Zone of skin,,17208,14.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626950,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8679,In vivo,,Zone of skin,,17208,14.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626951,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8680,In vivo,,Spleen,,17208,2106.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL626952,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8681,In vivo,,Spleen,,17208,2106.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626953,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8682,In vivo,,Spleen,,17208,2106.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626954,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8683,In vivo,,Spleen,,17208,2106.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626955,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8684,In vivo,,Spleen,,17208,2106.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626956,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8685,In vivo,,Spleen,,17208,2106.0,50594,,N,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626957,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8686,In vivo,,Blood,,17208,178.0,50594,,N,1,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL626958,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8687,In vivo,,Blood,,17208,178.0,50594,,N,1,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626959,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8688,In vivo,,Blood,,17208,178.0,50594,,N,1,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626960,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8689,In vivo,,Blood,,17208,178.0,50594,,N,1,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626961,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8690,In vivo,,Blood,,17208,178.0,50594,,N,1,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627589,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8691,In vivo,,Blood,,17208,178.0,50594,,N,1,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627590,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8692,,,,,3132,,50594,,N,1,,Time taken for EC90 was determined when tested in mouse,CHEMBL627591,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8693,,,,,3132,,50594,,N,1,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,CHEMBL627592,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8694,In vivo,,,,16597,,50594,,N,1,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),CHEMBL627593,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8695,,,,,5727,,50594,,N,1,,Half life in mice,CHEMBL627594,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8696,In vivo,,,,5302,,50594,,N,1,,Half life period in mouse after 10 mg/Kg dose,CHEMBL876813,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8697,In vivo,,,,5302,,50594,,N,1,,Half life period in mouse after 10 mg/kg dose,CHEMBL627595,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8698,In vivo,,,,6348,,50594,,N,1,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,CHEMBL627596,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8699,In vivo,,,,5964,,50597,,N,1,,Cmax value at 5 mg/kg po was determined in rat,CHEMBL627597,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8700,In vivo,,,,6078,,50597,,N,1,,Cmax value evaluated in rat,CHEMBL627598,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8701,In vivo,,Brain,,5206,955.0,50597,,N,1,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,CHEMBL627599,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8702,In vivo,,,,2959,,50597,,N,1,,Cmax value after administration of 20 mg/Kg oral dose in rat,CHEMBL627600,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8703,In vivo,,,,5964,,50597,,N,1,,Cmax value at 1 mg/kg po in rat,CHEMBL627601,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8704,In vivo,,,,5964,,50597,,N,1,,Cmax value at 5 mg/kg po in rat,CHEMBL627776,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8705,In vivo,,,,6757,,50597,,N,1,,Cmax value at a dose of 10 mg/kg in male SD rats,CHEMBL627777,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8706,In vivo,,,,6757,,50597,,N,1,,Cmax value at a dose of 100 mg/kg in male SD rats,CHEMBL627778,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8707,In vivo,,,,6757,,50597,,N,1,,Cmax value at a dose of 50 mg/kg in male SD rats,CHEMBL627779,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8708,In vivo,,,,17617,,50597,,N,1,,Cmax value in rats at 10 mg/kg,CHEMBL876814,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8709,In vivo,,,,1445,,50597,,N,1,,Cmax value was evaluated in rats at a dose of 20 mg/kg,CHEMBL627780,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8710,In vivo,,,,6082,,50597,,N,1,,Cmax value was determined after peroral administration of 20 mg/kg in rat,CHEMBL627781,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8711,In vivo,,,,1446,,50597,,N,1,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,CHEMBL627782,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8712,In vivo,,Plasma,,5407,1969.0,50597,,N,1,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,CHEMBL627783,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8713,In vivo,,Plasma,,2690,1969.0,50597,,N,1,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,CHEMBL627784,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8714,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL627785,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8715,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL627786,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8716,In vivo,,Plasma,,4891,1969.0,50597,,N,1,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,CHEMBL627787,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8717,In vivo,,Plasma,,2807,1969.0,50597,,N,1,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,CHEMBL627788,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8718,In vivo,,Plasma,,2807,1969.0,50597,,N,1,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,CHEMBL626579,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8719,In vivo,,Plasma,,2807,1969.0,50597,,N,1,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,CHEMBL626580,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8720,In vivo,,,,3634,,50597,,N,1,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,CHEMBL876815,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8721,In vivo,,Plasma,,1881,1969.0,50597,,N,1,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,CHEMBL626581,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8722,In vivo,,Plasma,,1881,1969.0,50597,,N,1,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,CHEMBL626582,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8723,In vivo,,,,429,,50597,,N,1,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,CHEMBL626583,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8724,In vivo,,,,5974,,50597,,N,1,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL626205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8725,In vivo,,,,5974,,50597,,N,1,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL626206,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8726,In vivo,,,,5974,,50597,,N,1,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL626207,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8727,In vivo,,,,5974,,50597,,N,1,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL623882,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8728,In vivo,,,,17582,,50597,,N,1,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,CHEMBL623883,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8729,In vivo,,,,17582,,50597,,N,1,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,CHEMBL623884,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8730,In vivo,,Plasma,,3032,1969.0,50597,,N,1,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",CHEMBL623885,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8731,In vivo,,Plasma,,6295,1969.0,50597,,N,1,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,CHEMBL623886,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8732,In vivo,,,,6619,,50597,,N,1,,Maximal concentration in rat was determined,CHEMBL623887,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8733,In vivo,,,,6616,,50597,,N,1,,Maximal concentration after i.v. administration,CHEMBL623888,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8734,In vivo,,Plasma,,3249,1969.0,50597,,N,1,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,CHEMBL623889,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8735,In vivo,,Plasma,,17791,1969.0,50597,,N,1,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,CHEMBL623890,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8736,In vivo,,Plasma,,17791,1969.0,50597,,N,1,,Cmax in rat plasma after oral dose (50 mg/Kg),CHEMBL623891,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8737,In vivo,,Plasma,,1360,1969.0,50597,,N,1,,Maximal plasma concentration was determined.,CHEMBL623892,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8738,In vivo,,Plasma,,2552,1969.0,50597,,N,1,,Maximal plasma drug concentration was determined,CHEMBL623893,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8739,In vivo,,,,6571,,50597,,N,1,,Maximal concentration in rats after peroral administration,CHEMBL877616,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8740,In vivo,,,,6570,,50597,,N,1,,Maximum concentration in rat after 2 mg/kg peroral administration,CHEMBL623894,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8741,In vivo,,Plasma,,6567,1969.0,50597,,N,1,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,CHEMBL623895,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8742,In vivo,,,,3031,,50597,,N,1,,Maximum concentration of compound in rat was evaluated.,CHEMBL623896,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8743,In vivo,,,,3436,,50597,,N,1,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,CHEMBL623897,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8744,In vivo,,,,3436,,50597,,N,1,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,CHEMBL623898,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8745,In vivo,,,,2083,,50597,,N,1,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,CHEMBL623899,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8746,In vivo,,,,3436,,50597,,N,1,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,CHEMBL623900,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8747,In vivo,,,,4527,,50597,,N,1,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL623901,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8748,In vivo,,,,1974,,50597,,N,1,,Maximum concentration was evaluated in rats,CHEMBL623902,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8749,In vivo,,Cerebrospinal fluid,,3307,1359.0,50597,,N,1,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,CHEMBL623903,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8750,In vivo,,Plasma,,3307,1969.0,50597,,N,1,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,CHEMBL623904,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8751,In vivo,,Plasma,,1916,1969.0,50597,,N,1,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,CHEMBL877617,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8752,In vivo,,,,1500,,50597,,N,1,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,CHEMBL623905,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8753,In vivo,,,,1500,,50597,,N,1,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,CHEMBL623906,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8754,In vivo,,Plasma,,4186,1969.0,50597,,N,1,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL623907,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8755,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL623908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8756,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,CHEMBL623909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8757,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL623910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8758,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL623911,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8759,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL623912,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8760,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL624616,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8761,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL624617,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8762,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL624618,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8763,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL624619,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8764,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL624794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8765,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL624795,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8766,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL623921,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8767,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL623922,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8768,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL623923,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8769,,,,,16434,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL623924,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8770,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL623925,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8771,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL623926,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8772,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL623927,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8773,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL623928,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8774,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL623929,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8775,,,,,16435,,50597,,N,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL623930,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8776,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL623931,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8777,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622165,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8778,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL621249,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8779,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL621250,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8780,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL621448,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8781,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL621449,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8782,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL621450,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8783,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL621451,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8784,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL621452,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8785,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL621453,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8786,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL621454,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8787,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL621455,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8788,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL621456,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8789,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL625145,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8790,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL875847,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8791,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL625146,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8792,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL625147,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8793,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL625148,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8794,,,Brain,,16434,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL625149,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8795,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL625150,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8796,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL625151,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8797,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL625152,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8798,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL625153,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8799,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL625154,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8800,,,Brain,,16435,955.0,50597,,N,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL625155,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8801,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL625156,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8802,,,,,11977,,50597,,N,1,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624354,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8803,,,Hippocampus,,11977,10000000.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624355,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8804,,,Hippocampus,,11977,10000000.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624356,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8805,,,Hippocampus,,11977,10000000.0,50597,,N,1,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624357,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8806,,,Hippocampus,,11977,10000000.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624358,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8807,,,Striatum,,11977,2435.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624359,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8808,,,Striatum,,11977,2435.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624360,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8809,,,Striatum,,11977,2435.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL624361,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8810,,,Striatum,,11977,2435.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624362,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8811,,,Striatum,,11977,2435.0,50597,,N,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624363,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8812,In vivo,,Blood,,11977,178.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624364,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8813,In vivo,,Blood,,11977,178.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624365,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8814,In vivo,,Blood,,11977,178.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624366,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8815,In vivo,,Blood,,11977,178.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624367,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8816,In vivo,,Brain,,11977,955.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624368,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8817,In vivo,,Brain,,11977,955.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624369,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8818,In vivo,,Brain,,11977,955.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL624370,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8819,In vivo,,Brain,,11977,955.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625069,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8820,In vivo,,Brain,,11977,955.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625070,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8821,In vivo,,Heart,,11977,948.0,50597,,N,1,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626051,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8822,In vivo,,Heart,,11977,948.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626052,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8823,In vivo,,Heart,,11977,948.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL626053,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8824,In vivo,,Heart,,11977,948.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626054,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8825,In vivo,,Heart,,11977,948.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626055,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8826,In vivo,,Kidney,,11977,2113.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626056,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8827,In vivo,,Kidney,,11977,2113.0,50597,,N,1,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626057,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8828,In vivo,,Kidney,,11977,2113.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625193,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8829,In vivo,,Kidney,,11977,2113.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625194,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8830,In vivo,,Liver,,11977,2107.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625195,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8831,In vivo,,Liver,,11977,2107.0,50597,,N,1,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625196,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8832,In vivo,,Liver,,11977,2107.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL625197,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8833,In vivo,,Liver,,11977,2107.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625198,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8834,In vivo,,Liver,,11977,2107.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627929,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8835,In vivo,,Lung,,11977,2048.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627074,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8836,In vivo,,Lung,,11977,2048.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627075,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8837,In vivo,,Lung,,11977,2048.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL627076,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8838,In vivo,,Lung,,11977,2048.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8839,In vivo,,Lung,,11977,2048.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8840,In vivo,,Muscle tissue,,11977,2385.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),CHEMBL627079,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8841,In vivo,,,,4573,,50594,,N,1,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,CHEMBL873824,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8842,In vivo,,Plasma,,3132,1969.0,50594,,N,1,,Half life in mouse plasma was determined at dose 25 mg/kg,CHEMBL627080,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8843,,,,,17718,,50594,,N,1,,Half life was determined,CHEMBL627081,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8844,In vivo,,,,17728,,50594,,N,1,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,CHEMBL627082,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8845,In vivo,,,,5961,,50594,,N,1,,Half-life in male mice after 1 mg/kg intravenous dose,CHEMBL627083,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8847,,,Plasma,,17731,1969.0,50594,,N,1,,Half life in mice plasma,CHEMBL627085,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8848,,,,,17592,,50594,,N,1,,Half life in mouse,CHEMBL627086,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8849,In vivo,,Plasma,,3132,1969.0,50594,,N,1,,Half life in mouse plasma at dose 25 mg/kg,CHEMBL627087,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8850,In vivo,,,,17729,,50594,,N,1,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,CHEMBL627088,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8851,In vivo,,,,17729,,50594,,N,1,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,CHEMBL627089,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8852,In vivo,,,,17729,,50594,,N,1,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,CHEMBL627090,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8853,In vivo,,,,3277,,50594,,N,1,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),CHEMBL627091,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8854,In vivo,,,,3760,,50594,,N,1,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",CHEMBL627092,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8855,In vivo,,,,3760,,50594,,N,1,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",CHEMBL876785,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8856,In vivo,,,,2862,,50594,,N,1,,Half-life by iv administration in mouse,CHEMBL627093,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8857,In vivo,,,,2862,,50594,,N,1,,Half-life by oral administration in mouse,CHEMBL627094,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8858,,,,,5980,,50594,,N,1,,Half-life in mice,CHEMBL627095,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8859,,,Brain,,6159,955.0,50594,,N,1,,Half-life using mouse brain homogenate,CHEMBL627096,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8860,,,,,6254,,50594,,N,1,,Half-life was measured in mice,CHEMBL627097,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8861,In vivo,,,,6062,,50594,,N,1,,Half-life was measured in mouse after an iv dose of 1 mg/kg,CHEMBL627098,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8862,,,Blood,,1574,178.0,50594,,N,1,,Half-life period was determined in mouse blood,CHEMBL627099,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8863,,,Brain,,56,955.0,50594,,N,1,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",CHEMBL627100,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8864,,,Plasma,,993,1969.0,50594,,N,1,,Plasma half life in mouse,CHEMBL627101,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8865,,,,,6652,,50594,,N,1,,Stability of the peptide in the presence of mouse serum,CHEMBL627102,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8866,,,,,17852,,50594,,N,1,,Terminal half life of compound was determined in mouse,CHEMBL627103,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8867,In vivo,,,,2675,,50594,,N,1,,Terminal half life was evaluated in mice after intravenous administration,CHEMBL627104,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8868,In vivo,,,,2675,,50594,,N,1,,Terminal half life was evaluated in mice after oral administration,CHEMBL627105,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8869,,,,,499,,50594,,N,1,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,CHEMBL876786,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8870,,,,,499,,50594,,N,1,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,CHEMBL873825,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8871,,,,,499,,50594,,N,1,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,CHEMBL627106,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8872,In vivo,,,,14239,,50594,,N,1,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,CHEMBL626336,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8873,In vivo,,,,5506,,50594,,N,1,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",CHEMBL877462,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8874,In vivo,,,,5506,,50594,,N,1,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",CHEMBL626337,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8875,,,,,17734,,50594,,N,1,,Half life after intraperitoneal administration of 100 mg/kg in mice,CHEMBL626338,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8876,In vivo,,,,17728,,50594,,N,1,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,CHEMBL626339,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8877,In vivo,,,,17728,,50594,,N,1,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,CHEMBL626340,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8878,In vivo,,,,17728,,50594,,N,1,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,CHEMBL625377,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8879,In vivo,,,,17728,,50594,,N,1,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,CHEMBL625378,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,8880,In vivo,,,,17728,,50594,,N,1,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,CHEMBL625379,,1,A
Autocuration,BAO_0000251,,9823.0,,Sus scrofa,8881,,Microsomes,,,14294,,22224,,U,1,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),CHEMBL625380,,0,A
Autocuration,BAO_0000251,,9823.0,,Sus scrofa,8882,,Microsomes,,,14294,,22224,,U,1,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),CHEMBL625381,,0,A
Autocuration,BAO_0000019,,9823.0,,Sus scrofa,8883,,,,,6056,,22224,,U,1,,Stability to porcine renal DHP-I,CHEMBL625382,,0,A
Autocuration,BAO_0000218,,9823.0,,Sus scrofa,8884,In vivo,,,,1317,,22224,,U,1,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,CHEMBL873828,,0,A
Autocuration,BAO_0000218,,9823.0,,Sus scrofa,8885,In vivo,,,,1317,,22224,,U,1,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,CHEMBL625383,,0,A
Autocuration,BAO_0000019,,9823.0,,Sus scrofa,8886,,,,,5229,,22224,,U,1,,Half-life of the parent prodrug in porcine esterase solution,CHEMBL625384,,0,A
Autocuration,BAO_0000019,,9823.0,,Sus scrofa,8887,,,,,4231,,22224,,U,1,,"First order rate constant, k was determined in in pig liver Esterase",CHEMBL625385,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8888,,,Liver,,4231,2107.0,22224,,U,1,,Half life of the in pig liver Esterase,CHEMBL625386,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8889,,,Liver,,5318,2107.0,22224,,U,1,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,CHEMBL623571,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8890,,,Liver,,5318,2107.0,22224,,U,1,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,CHEMBL623572,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8891,,,Liver,,5318,2107.0,22224,,U,1,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,CHEMBL623573,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8892,,,Liver,,3305,2107.0,22224,,U,1,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,CHEMBL623574,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8893,,,Liver,,3305,2107.0,22224,,U,1,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,CHEMBL623575,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8894,,,Liver,,2842,2107.0,22224,,U,1,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,CHEMBL623749,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8895,,,Liver,,2842,2107.0,22224,,U,1,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,CHEMBL623750,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8896,In vitro,,Liver,,889,2107.0,22224,,U,1,,Half-life in vitro in pig liver,CHEMBL623751,,0,A
Autocuration,BAO_0000221,,9823.0,,Sus scrofa,8897,,,Liver,,1904,2107.0,22224,,U,1,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,CHEMBL623752,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8898,In vivo,,Plasma,,4186,1969.0,50597,,N,1,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,CHEMBL623753,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8899,In vivo,,Plasma,,2774,1969.0,50597,,N,1,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,CHEMBL623754,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8900,In vivo,,Plasma,,1742,1969.0,50597,,N,1,,Maximum concentration in rat plasma was determined,CHEMBL623755,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8901,In vivo,,,,3169,,50597,,N,1,,Maximum concentration in rats,CHEMBL623756,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8902,In vivo,,,,3169,,50597,,N,1,,Maximum concentration in rats at 1-2 hours,CHEMBL623757,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8903,In vivo,,,,2081,,50597,,N,1,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,CHEMBL623758,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8904,In vivo,,Brain,,3307,955.0,50597,,N,1,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,CHEMBL623759,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8905,In vivo,,,,4727,,50597,,N,1,,Maximum concentration at the dose of 2 mg/kg in rat,CHEMBL623760,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8906,In vivo,,,,6597,,50597,,N,1,,Maximum concentration was evaluated in rats,CHEMBL623761,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8907,In vivo,,Plasma,,16365,1969.0,50597,,N,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,CHEMBL623762,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8908,In vivo,,Plasma,,16365,1969.0,50597,,N,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,CHEMBL877594,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8909,In vivo,,Plasma,,16365,1969.0,50597,,N,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,CHEMBL623763,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8910,In vivo,,Plasma,,16365,1969.0,50597,,N,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,CHEMBL623764,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8911,In vivo,,Plasma,,16365,1969.0,50597,,N,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,CHEMBL623765,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8912,In vivo,,Blood,,2591,178.0,50597,,N,1,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,CHEMBL623766,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8913,In vivo,,Blood,,2591,178.0,50597,,N,1,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,CHEMBL623767,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8914,In vivo,,Blood,,2591,178.0,50597,,N,1,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,CHEMBL623768,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8915,In vivo,,Plasma,,5978,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623769,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8916,In vivo,,Plasma,,5978,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623770,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8917,In vivo,,Plasma,,5978,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623771,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8918,In vivo,,Plasma,,5978,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623772,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8919,In vivo,,Plasma,,5978,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,CHEMBL623773,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8920,In vivo,,Plasma,,5978,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,CHEMBL623774,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8921,In vivo,,Plasma,,5978,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,CHEMBL623775,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8922,In vivo,,,,14465,,50597,,N,1,,Cmax in rat (PO dose),CHEMBL623776,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8923,In vivo,,Plasma,,4723,1969.0,50597,,N,1,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL622191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8924,In vivo,,Plasma,,4723,1969.0,50597,,N,1,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL622192,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8925,In vivo,,Plasma,,4576,1969.0,50597,,N,1,,Maximum plasma concentration determined in rat,CHEMBL622193,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8926,In vivo,,Plasma,,12873,1969.0,50597,,N,1,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL622194,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8927,In vivo,,Plasma,,12873,1969.0,50597,,N,1,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL622195,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8928,In vivo,,Plasma,,6824,1969.0,50597,,N,1,,Maximum plasma concentration in rat,CHEMBL622196,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8929,In vivo,,Plasma,,17065,1969.0,50597,,N,1,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL622197,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8930,In vivo,,Plasma,,2932,1969.0,50597,,N,1,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,CHEMBL622198,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8931,In vivo,,Plasma,,2932,1969.0,50597,,N,1,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,CHEMBL622199,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8932,In vivo,,Plasma,,2879,1969.0,50597,,N,1,,Maximum plasma concentration of compound was measured in rat,CHEMBL622200,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8933,In vivo,,Plasma,,2864,1969.0,50597,,N,1,,Maximum plasma concentration after 20 mg/kg oral administration in rat,CHEMBL622201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8934,In vivo,,Plasma,,16367,1969.0,50597,,N,1,,Maximum plasma concentration after oral administration to rats,CHEMBL623990,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8935,In vivo,,Plasma,,17717,1969.0,50597,,N,1,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623991,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8936,In vivo,,Plasma,,17717,1969.0,50597,,N,1,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",CHEMBL623992,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8937,In vivo,,Plasma,,17717,1969.0,50597,,N,1,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623993,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8938,In vivo,,Plasma,,17717,1969.0,50597,,N,1,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,CHEMBL623994,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8939,In vivo,,Plasma,,17720,1969.0,50597,,N,1,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,CHEMBL623995,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8940,In vivo,,Plasma,,17720,1969.0,50597,,N,1,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL623996,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8941,In vivo,,Plasma,,17720,1969.0,50597,,N,1,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,CHEMBL623997,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8942,In vivo,,Plasma,,4516,1969.0,50597,,N,1,,Maximum plasma concentration dosed orally in rats,CHEMBL623998,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8943,In vivo,,Plasma,,4516,1969.0,50597,,N,1,,Maximum plasma concentration dosed orally in rats after 6 hours,CHEMBL623999,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8944,In vivo,,Plasma,,4516,1969.0,50597,,N,1,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,CHEMBL624000,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8945,In vivo,,Plasma,,5199,1969.0,50597,,N,1,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,CHEMBL624001,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8946,In vivo,,Plasma,,17538,1969.0,50597,,N,1,,Maximum plasma concentration in rat after po administration,CHEMBL624002,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8947,In vivo,,Plasma,,6685,1969.0,50597,,N,1,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",CHEMBL624003,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8948,In vivo,,Plasma,,6685,1969.0,50597,,N,1,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",CHEMBL624004,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8949,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL624005,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8950,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL624006,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8951,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL624007,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8952,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL624008,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8953,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL624009,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8954,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL874387,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8955,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL624010,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8956,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,CHEMBL624011,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8957,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL624012,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8958,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL624013,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8959,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL624736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8960,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL624737,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8961,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL624738,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8962,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL624739,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8963,,,Heart,,16434,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL624740,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8964,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL624896,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8965,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL624897,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8966,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL624108,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8967,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL624109,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8968,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL624110,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8969,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL624111,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8970,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL624112,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8971,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL624113,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8972,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL619709,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8973,,,Heart,,16435,948.0,50597,,N,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL619710,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8974,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL619711,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8975,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL619712,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8976,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL619713,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8977,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL619714,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8978,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL619715,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8979,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL619716,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8980,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL619717,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8981,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL619718,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8982,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL619719,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8983,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL875329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8984,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL619720,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8985,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL619721,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8986,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL619722,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8987,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL619723,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8988,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL619724,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8989,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL619725,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8990,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL619726,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8991,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL619727,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8992,,,Kidney,,16434,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL619728,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8993,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL619729,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8994,In vivo,,Muscle tissue,,11977,2385.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619730,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8995,In vivo,,Muscle tissue,,11977,2385.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619731,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8996,In vivo,,Muscle tissue,,11977,2385.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL619732,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8997,In vivo,,Muscle tissue,,11977,2385.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619733,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8998,In vivo,,Muscle tissue,,11977,2385.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619734,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,8999,In vivo,,Zone of skin,,11977,14.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619735,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9000,In vivo,,Zone of skin,,11977,14.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL875330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9001,In vivo,,Zone of skin,,11977,14.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL628465,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9002,In vivo,,Zone of skin,,11977,14.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628466,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9003,In vivo,,Zone of skin,,11977,14.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628467,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9004,In vivo,,Spleen,,11977,2106.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628468,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9005,In vivo,,Spleen,,11977,2106.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628469,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9006,In vivo,,Spleen,,11977,2106.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL628470,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9007,In vivo,,Spleen,,11977,2106.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628471,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9008,In vivo,,Spleen,,11977,2106.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628472,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9009,In vivo,,Thyroid gland,,11977,2046.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9010,In vivo,,Thyroid gland,,11977,2046.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625192,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9011,In vivo,,Thyroid gland,,11977,2046.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL875337,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9012,In vivo,,Thyroid gland,,11977,2046.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626341,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9013,In vivo,,Thyroid gland,,11977,2046.0,50597,,N,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626342,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9014,In vivo,,Liver,,11977,2107.0,50597,,N,1,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621943,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9015,,,,,3748,,50597,,N,1,,Half life in rats,CHEMBL621944,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9016,,,,,15765,,50597,,N,1,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,CHEMBL621945,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9017,,,,,4871,,50597,,N,1,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),CHEMBL621946,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9018,,,,,4871,,50597,,N,1,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,CHEMBL621947,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9019,,,,,4872,,50597,,N,1,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),CHEMBL621948,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9020,,,,,4872,,50597,,N,1,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,CHEMBL621949,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9021,,,,,5413,,50597,,N,1,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),CHEMBL621950,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9022,,,,,5413,,50597,,N,1,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,CHEMBL621951,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9023,In vivo,,Blood,,15272,178.0,50597,,N,1,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,CHEMBL621952,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9024,,,Liver,,4689,2107.0,50597,,N,1,,Stability (%) in rat liver microsomes,CHEMBL621953,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9025,,,,,6057,,50597,,N,1,,Area under curve was calculated after intravenous administration,CHEMBL621954,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9026,,,,,6057,,50597,,N,1,,Area under the curve was calculated after iv administration in rat,CHEMBL621955,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9027,,,,,6057,,50597,,N,1,,Area under the curve was calculated in rat after peroral administration,CHEMBL621956,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9028,,,,,6211,,50597,,N,1,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL621957,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9029,,,,,5710,,50597,,N,1,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,CHEMBL621958,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9030,,,,,5710,,50597,,N,1,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,CHEMBL621959,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9031,,,,,17853,,50597,,N,1,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,CHEMBL621960,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9032,,,,,17853,,50597,,N,1,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,CHEMBL621961,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9033,,,,,15765,,50597,,N,1,,p value of the compound,CHEMBL621962,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9034,,,,,15765,,50597,,N,1,,p value of the compound,CHEMBL876787,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9035,,,,,15765,,50597,,N,1,,p value of the compound,CHEMBL621963,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9036,,,Stomach,,6175,945.0,50597,,N,1,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622637,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9037,,,Stomach,,6175,945.0,50597,,N,1,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622638,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9038,,,Stomach,,6175,945.0,50597,,N,1,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL626561,,1,A
Autocuration,BAO_0000019,,9986.0,,Oryctolagus cuniculus,9039,,,,,7991,,22224,,U,1,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),CHEMBL626562,,0,F
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9040,,,,,429,,22224,,U,1,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),CHEMBL626563,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9041,,,,,429,,22224,,U,1,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),CHEMBL626564,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9042,In vivo,,,,6253,,22224,,U,1,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,CHEMBL626565,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9043,In vivo,,,,6253,,22224,,U,1,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,CHEMBL626566,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9044,In vivo,,,,3615,,22224,,U,1,,Clearance rate in rabbits,CHEMBL626567,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9045,In vivo,,,,4059,,22224,,U,1,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,CHEMBL626568,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9046,In vivo,,,,5124,,22224,,U,1,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,CHEMBL626569,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9047,In vivo,,,,5124,,22224,,U,1,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,CHEMBL626570,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9048,In vivo,,,,5124,,22224,,U,1,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,CHEMBL626571,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9049,In vivo,,,,429,,22224,,U,1,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,CHEMBL626572,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9050,In vivo,,Plasma,,4059,1969.0,22224,,U,1,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,CHEMBL626573,,0,A
Autocuration,BAO_0000251,,9986.0,,Oryctolagus cuniculus,9051,,Microsomes,Liver,,9659,2107.0,22224,,U,1,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,CHEMBL626574,,0,A
Autocuration,BAO_0000251,,9986.0,,Oryctolagus cuniculus,9052,,Microsomes,Liver,,9659,2107.0,22224,,U,1,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,CHEMBL626575,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9053,,,,,3639,,22224,,U,1,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,CHEMBL626576,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9054,,,,,3639,,22224,,U,1,,Dose at which bioavailability of perorally administered compound was tested in rabbit,CHEMBL626577,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9055,In vivo,,,,3639,,22224,,U,1,,The compound was tested for its bioavailability in rabbit (by oral dosage).,CHEMBL626578,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9056,In vivo,,,,5124,,22224,,U,1,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,CHEMBL625263,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9057,In vivo,,,,5124,,22224,,U,1,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,CHEMBL625264,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9058,In vivo,,,,5124,,22224,,U,1,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,CHEMBL625265,,0,A
Autocuration,BAO_0000251,,9986.0,,Oryctolagus cuniculus,9059,,Microsomes,,,14294,,22224,,U,1,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),CHEMBL625266,,0,A
Autocuration,BAO_0000251,,9986.0,,Oryctolagus cuniculus,9060,,Microsomes,,,14294,,22224,,U,1,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),CHEMBL876796,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9061,In vivo,,,,429,,22224,,U,1,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,CHEMBL625267,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9062,In vivo,,Plasma,,5124,1969.0,22224,,U,1,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,CHEMBL625268,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9063,In vivo,,Plasma,,5124,1969.0,22224,,U,1,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,CHEMBL625269,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9064,In vivo,,Plasma,,5124,1969.0,22224,,U,1,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,CHEMBL624689,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9065,In vivo,,,,429,,22224,,U,1,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,CHEMBL624690,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9066,,,Urine,,429,1088.0,22224,,U,1,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),CHEMBL624691,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9067,,,Urine,,429,1088.0,22224,,U,1,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),CHEMBL624692,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9068,In vivo,,,,4059,,22224,,U,1,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,CHEMBL624693,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9069,In vivo,,,,4137,,22224,,U,1,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,CHEMBL624694,,0,A
Autocuration,BAO_0000221,,9986.0,,Oryctolagus cuniculus,9070,In vitro,,,,11672,,22224,,U,1,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,CHEMBL877596,,0,A
Autocuration,BAO_0000019,,9986.0,,Oryctolagus cuniculus,9071,,,,,12886,,22224,,U,1,,Time within which only 10% of the drug was degraded,CHEMBL624695,,0,A
Autocuration,BAO_0000221,,9986.0,,Oryctolagus cuniculus,9072,,,Liver,,3853,2107.0,22224,,U,1,,Half life period in rabbit liver homogenate,CHEMBL624696,,0,A
Autocuration,BAO_0000019,,9986.0,,Oryctolagus cuniculus,9073,,,,,3615,,22224,,U,1,,Half life value in rabbits,CHEMBL624697,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9074,In vivo,,Blood,,6253,178.0,22224,,U,1,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,CHEMBL624698,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9075,In vivo,,Blood,,6253,178.0,22224,,U,1,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,CHEMBL624699,,0,A
Autocuration,BAO_0000218,,9986.0,,Oryctolagus cuniculus,9076,In vivo,,,,6077,,22224,,U,1,,Half-life period in rabbits following intravenous administration at 2 mg/kg,CHEMBL624700,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9077,,,Plasma,,17617,1969.0,50597,,N,1,,AUC 0-8 hr value in rats at 10 mg/kg,CHEMBL622903,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9078,,,Plasma,,17594,1969.0,50597,,N,1,,AUC after administration at 2000 mg/kg/day in rats,CHEMBL622904,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9079,,,Plasma,,6149,1969.0,50597,,N,1,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,CHEMBL622905,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9080,,,Plasma,,17260,1969.0,50597,,N,1,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL622906,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9081,,,Plasma,,17260,1969.0,50597,,N,1,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL622907,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9082,,,Plasma,,6644,1969.0,50597,,N,1,,AUC in rat after oral administration at 10.5 mg/kg dose,CHEMBL622908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9083,,,Plasma,,6644,1969.0,50597,,N,1,,AUC in rat after oral administration at 11.2 mg/kg dose,CHEMBL622909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9084,,,Plasma,,6644,1969.0,50597,,N,1,,AUC in rat after oral administration at 9.7 mg/kg dose,CHEMBL622910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9085,,,Brain,,6495,955.0,50597,,N,1,,AUC in rat brain after oral administration at 10 mg/kg,CHEMBL622911,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9086,,,Plasma,,6504,1969.0,50597,,N,1,,AUC in rat p.o.,CHEMBL622912,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9087,,,Plasma,,17686,1969.0,50597,,N,1,,AUC in rat p.o. at 20 mg/kg concentration,CHEMBL622913,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9088,,,Plasma,,6495,1969.0,50597,,N,1,,AUC in rat plasma after oral administration at 10 mg/kg,CHEMBL622914,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9089,,,Plasma,,216,1969.0,50597,,N,1,,AUC in rats,CHEMBL622915,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9090,,,Plasma,,1908,1969.0,50597,,N,1,,AUC value after IV dose at a dose of 5 mg/kg in rats.,CHEMBL622916,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9091,,,Plasma,,1908,1969.0,50597,,N,1,,AUC value after oral dose at a dose of 10 mg/kg in rats.,CHEMBL622917,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9092,In vivo,,Plasma,,6685,1969.0,50597,,N,1,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",CHEMBL622918,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9093,In vivo,,Plasma,,216,1969.0,50597,,N,1,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,CHEMBL622919,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9094,In vivo,,Plasma,,6049,1969.0,50597,,N,1,,Maximum plasma concentration was evaluated in rat,CHEMBL622920,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9095,In vivo,,Plasma,,2463,1969.0,50597,,N,1,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,CHEMBL622921,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9096,In vivo,,Plasma,,6679,1969.0,50597,,N,1,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,CHEMBL622922,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9097,In vivo,,Plasma,,6681,1969.0,50597,,N,1,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,CHEMBL622923,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9098,In vivo,,Plasma,,4890,1969.0,50597,,N,1,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,CHEMBL877604,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9099,In vivo,,Plasma,,6410,1969.0,50597,,N,1,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,CHEMBL622924,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9100,In vivo,,Plasma,,6410,1969.0,50597,,N,1,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL622925,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9101,In vivo,,Plasma,,16366,1969.0,50597,,N,1,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,CHEMBL622926,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9102,In vivo,,Plasma,,6227,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,CHEMBL623625,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,9103,In vivo,,Plasma,,3598,1969.0,50597,,N,1,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL623626,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9104,In vivo,,Plasma,,1465,1969.0,50597,,N,1,,Maximum plasma drug concentration was determined,CHEMBL623627,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9105,In vivo,,,,4368,,50597,,N,1,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,CHEMBL623628,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9106,In vivo,,Plasma,,15662,1969.0,50597,,N,1,,Mean peak plasma concentration was observed after intravenous administration in rat,CHEMBL623629,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9107,In vivo,,Plasma,,15662,1969.0,50597,,N,1,,Mean peak plasma concentration was observed after oral administration in rat,CHEMBL623630,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9108,In vivo,,,,5355,,50597,,N,1,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,CHEMBL623804,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9109,In vivo,,,,5355,,50597,,N,1,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,CHEMBL623805,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9110,In vivo,,Plasma,,1567,1969.0,50597,,N,1,,Peak oral plasma concentration was determined in rats by oral administration,CHEMBL623806,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9111,In vivo,,Plasma,,4026,1969.0,50597,,N,1,,Peak plasma concentration (Cmax) was determined,CHEMBL623807,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9112,In vivo,,Plasma,,6193,1969.0,50597,,N,1,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,CHEMBL623808,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9113,In vivo,,Plasma,,4026,1969.0,50597,,N,1,,Peak plasma concentration (Cmax) in rats,CHEMBL623809,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9114,In vivo,,Plasma,,6485,1969.0,50597,,N,1,,Peak plasma concentration at 1 mg/kg peroral administration,CHEMBL623810,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9115,In vivo,,Plasma,,17655,1969.0,50597,,N,1,,Peak plasma concentration in rat,CHEMBL623811,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9116,In vivo,,Plasma,,14941,1969.0,50597,,N,1,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL623812,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9117,In vivo,,,,5394,,50597,,N,1,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,CHEMBL877605,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9118,In vivo,,,,4408,,50597,,N,1,,Pharmacokinetic property (Cmax) in rat,CHEMBL623813,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9119,In vivo,,,,5983,,50597,,N,1,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,CHEMBL623814,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9120,In vivo,,,,4878,,50597,,N,1,,Cmax in rat after 3mg/kg oral dose,CHEMBL623815,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9121,In vivo,,,Sprague-Dawley,5862,,50597,,N,1,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,CHEMBL623816,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9122,In vivo,,,,4517,,50597,,N,1,,Cmax in rats after 20 mg/kg oral dose,CHEMBL623145,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9123,In vivo,,Plasma,,5932,1969.0,50597,,N,1,,Cmax in rat plasma after 30mg/kg oral dose,CHEMBL623146,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9124,In vivo,,Plasma,,5436,1969.0,50597,,N,1,,Plasma concentration after oral administration of 100 mg/kg to rats,CHEMBL623147,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9125,In vivo,,Brain,,4910,955.0,50597,,N,1,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,CHEMBL623042,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9126,In vivo,,,,4950,,50597,,N,1,,Tested for the Cmax in rat at 10 mg/kg per orally,CHEMBL623043,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9127,In vivo,,,,15078,,50597,,N,1,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL623044,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9128,In vivo,,,,15078,,50597,,N,1,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL623045,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9129,In vivo,,,,3360,,50597,,N,1,,Bioavailability as oral Cmax in rats at 30 mins,CHEMBL623046,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9130,In vivo,,,,3360,,50597,,N,1,,Bioavailability as oral Cmax in rats at 6hr,CHEMBL623226,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9131,In vivo,,,,15022,,50597,,N,1,,The maximum concentration of compound was measured at the dose of 100 umol/kg,CHEMBL623227,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9132,In vivo,,,,15022,,50597,,N,1,,The maximum concentration of compound was measured at the dose of 300 umol/kg,CHEMBL623228,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9133,In vivo,,,,15022,,50597,,N,1,,The maximum concentration of compound was measured at the dose of 30 umol/kg,CHEMBL623229,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9134,In vivo,,Plasma,,5160,1969.0,50597,,N,1,,The maximum plasma levels for the compounds were determined by LC-MS.,CHEMBL623230,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9135,In vivo,,Plasma,,15662,1969.0,50597,,N,1,,mean peak plasma concentration was observed after intravenous administration in rat,CHEMBL623231,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9136,In vivo,,Plasma,,15662,1969.0,50597,,N,1,,mean peak plasma concentration was observed after oral administration in rat,CHEMBL623232,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9137,,,,,4709,,50597,,N,1,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,CHEMBL623233,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9138,,,,,3535,,50597,,N,1,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,CHEMBL623234,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9139,,,,,3535,,50597,,N,1,,Concentration in plasma (portal) following oral dose in rats at 1 hr,CHEMBL623235,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9140,,,,,3535,,50597,,N,1,,Concentration in plasma (portal) following oral dose in rats at 2 hr,CHEMBL623236,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9141,,,,,3535,,50597,,N,1,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,CHEMBL623237,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9142,,,,,3535,,50597,,N,1,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,CHEMBL623238,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9143,,,,,3535,,50597,,N,1,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,CHEMBL623239,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9144,In vivo,,Plasma,,5005,1969.0,22224,,U,1,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,CHEMBL623240,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9145,,,Hypothalamus,,6326,1898.0,50597,,N,1,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",CHEMBL623241,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9146,,,Hypothalamus,,6326,1898.0,50597,,N,1,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",CHEMBL623242,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9147,,,,,6326,,50597,,N,1,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",CHEMBL874394,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9148,,,,,6326,,50597,,N,1,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",CHEMBL623243,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9149,,,,,17411,,50597,,N,1,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL623244,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9150,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL623245,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9151,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL623246,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9152,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL623247,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9153,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL623248,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9154,,,Kidney,,16435,2113.0,50597,,N,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL623249,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9155,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL625072,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9156,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL625073,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9157,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL625074,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9158,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL625075,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9159,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,CHEMBL625076,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9160,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL625077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9161,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL625078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9162,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL874395,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9163,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL625079,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9164,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL625080,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9165,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL625081,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9166,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL625082,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9167,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL625083,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9168,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL625084,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9169,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL625085,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9170,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL625086,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9171,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL625087,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9172,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL625088,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9173,,,Liver,,16434,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL622205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9174,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL622206,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9175,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL622207,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9176,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL622366,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9177,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL622367,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9178,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL875331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9179,,,Liver,,16435,2107.0,50597,,N,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL622368,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9180,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL622369,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9181,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622370,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9182,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL622371,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9183,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL622372,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9184,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL622373,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9185,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL622374,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9186,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL622375,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9187,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,CHEMBL622376,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9188,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL622377,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9189,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL622378,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9190,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL622379,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9191,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL622380,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9192,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL622381,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9193,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL622382,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9194,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,CHEMBL622383,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9195,,,Stomach,,6175,945.0,50597,,N,1,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL875332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9196,,,Stomach,,6175,945.0,50597,,N,1,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622384,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9197,,,Stomach,,6175,945.0,50597,,N,1,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622385,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9198,,,Stomach,,6175,945.0,50597,,N,1,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622386,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9199,,,,,10839,,50597,,N,1,,The compound was tested for the plasma binding in rat,CHEMBL622387,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9200,,,,,16459,,50597,,N,1,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",CHEMBL622388,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9201,,,,,16459,,50597,,N,1,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",CHEMBL622389,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9202,,,,,16459,,50597,,N,1,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",CHEMBL622390,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9203,,,,,16459,,50597,,N,1,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),CHEMBL622391,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9204,,,,,16459,,50597,,N,1,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),CHEMBL622392,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9205,,,,,16459,,50597,,N,1,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),CHEMBL622393,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9206,,,,,3278,,50597,,N,1,,Plasma level at 2 hr after administration of the compound,CHEMBL622394,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9207,,,,,3278,,50597,,N,1,,plasma level at 2 hr after administration of the compound,CHEMBL622395,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9208,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 1 min,CHEMBL622396,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9209,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 10 min,CHEMBL624894,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9210,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 10 mins,CHEMBL624895,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9211,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 2 hr,CHEMBL624058,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9212,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 3 min,CHEMBL624059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9213,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 3 mins,CHEMBL624060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9214,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 5 min,CHEMBL624061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9215,,,Serum,,4684,1977.0,50597,,N,1,,Stability in rat serum measured as % recovery at 5 mins,CHEMBL624062,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9216,In vivo,,,,16456,,50597,,N,1,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL624063,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9217,In vivo,,,,16456,,50597,,N,1,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL624064,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9218,,,Plasma,,723,1969.0,50597,,N,1,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,CHEMBL624065,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9219,,,Plasma,,723,1969.0,50597,,N,1,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,CHEMBL624066,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9220,In vivo,,,,5160,,50597,,N,1,,Half life tested in mature male rat at a dose of 30 mg/kg,CHEMBL877490,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9221,In vivo,,,,4709,,50597,,N,1,,Half life after intravenous administration of 1 mg/kg in rat,CHEMBL874442,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9222,In vivo,,,,5633,,50597,,N,1,,Half life period after administration (30 mg/kg) in rat,CHEMBL626890,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9223,In vivo,,,,5302,,50597,,N,1,,Half life period in rat after 5 mg/Kg dose,CHEMBL626891,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9224,In vivo,,,,5302,,50597,,N,1,,Half life period in rat after 5 mg/kg dose,CHEMBL626892,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9225,,,,,17791,,50597,,N,1,,Half life period was determined,CHEMBL626893,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9226,,,,,17791,,50597,,N,1,,Half life period was evaluated in rat,CHEMBL626894,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9227,,,,,17791,,50597,,N,1,,Half life period was evaluated in rat; 0.5-1.0,CHEMBL626895,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9228,,,,,17791,,50597,,N,1,,Half life period was evaluated in rat; 5.9-7.5,CHEMBL626896,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9229,,,Plasma,,14512,1969.0,50597,,N,1,,Half-life in rat plasma,CHEMBL626897,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9230,,,,,6230,,50597,,N,1,,Half-life time in rat was determined,CHEMBL626898,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9231,In vivo,,,,3364,,50597,,N,1,,Terminal half-life after iv administration to rats,CHEMBL626899,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9232,In vivo,,,,6874,,50597,,N,1,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,CHEMBL626900,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9233,,,,,857,,50597,,N,1,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,CHEMBL626901,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9234,In vivo,,,,858,,50597,,N,1,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),CHEMBL626902,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9235,In vivo,,,,858,,50597,,N,1,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),CHEMBL626903,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9236,In vivo,,,,5355,,50597,,N,1,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,CHEMBL874443,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9237,In vivo,,,,5355,,50597,,N,1,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,CHEMBL626904,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9238,,,,,6305,,50597,,N,1,,Half life in rats,CHEMBL626905,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9239,In vivo,,Plasma,,13501,1969.0,50597,,N,1,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,CHEMBL873830,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9240,In vivo,,,,17594,,50597,,N,1,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,CHEMBL626906,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9241,In vivo,,Plasma,,4186,1969.0,50597,,N,1,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL631076,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9242,,,Plasma,,2932,1969.0,50597,,N,1,,Biological half-life was measured in plasma of rats,CHEMBL631077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9243,In vivo,,,,17065,,50597,,N,1,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL631078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9244,In vivo,,,,15765,,50597,,N,1,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,CHEMBL631079,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9245,In vivo,,,,2713,,50597,,N,1,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,CHEMBL631080,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9246,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL631081,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9247,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL631239,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9248,,,Plasma,,740,1969.0,50597,,N,1,,Compound was evaluated for plasma half life in rat,CHEMBL631240,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9249,,,Plasma,,6597,1969.0,50597,,N,1,,AUC value at a dose of 5 mg/kg (p.o.) in rats,CHEMBL631241,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9250,,,Plasma,,2959,1969.0,50597,,N,1,,AUC value after administration of 20 mg/Kg oral dose in rat,CHEMBL631242,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9251,,,Plasma,,17594,1969.0,50597,,N,1,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,CHEMBL631243,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9252,,,Plasma,,17596,1969.0,50597,,N,1,,AUC0-96 after administration at 50 mg/kg,CHEMBL874444,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9253,,,Plasma,,17594,1969.0,50597,,N,1,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,CHEMBL631244,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9254,,,,,3293,,50597,,N,1,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",CHEMBL631245,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9255,,,,,6757,,50597,,N,1,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,CHEMBL627162,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9256,,,,,6757,,50597,,N,1,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,CHEMBL627163,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9257,,,,,6757,,50597,,N,1,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,CHEMBL627164,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9258,,,Kidney,,5979,2113.0,50597,,N,1,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,CHEMBL627165,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9259,,,,,5979,,50597,,N,1,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,CHEMBL627166,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9260,,,,,5979,,50597,,N,1,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,CHEMBL627167,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9261,,,,,4026,,50597,,N,1,,Area under curve (AUC) at a dose of 30 mg/kg in rats,CHEMBL627822,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9262,,,,,5355,,50597,,N,1,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,CHEMBL627823,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9263,,,,,5355,,50597,,N,1,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,CHEMBL627824,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9264,,,,,5355,,50597,,N,1,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,CHEMBL627825,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9265,,,,,5633,,50597,,N,1,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,CHEMBL627826,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9266,,,,,1716,,50597,,N,1,,Area under curve (Pharmacokinetic property) was determined,CHEMBL627827,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9267,,,,,1716,,50597,,N,1,,Area under curve (Pharmacokinetic property) of the compound; Not determined,CHEMBL627828,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9268,,,,,4689,,50597,,N,1,,Area under curve after intravenous administration (1 mg/kg) in rat,CHEMBL627829,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9269,,,,,4527,,50597,,N,1,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,CHEMBL627830,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9270,,,,,4527,,50597,,N,1,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL627831,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9271,,,,,15662,,50597,,N,1,,Area under curve in male SD rats was observed after oral administration in rat,CHEMBL627832,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9272,,,,,4413,,50597,,N,1,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,CHEMBL627833,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,9273,,,,,3598,,50597,,N,1,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL627834,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,9274,,,,,3598,,50597,,N,1,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL628004,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9275,,,,,5964,,50597,,N,1,,Area under curve at 5 mg/kg po was determined in rat,CHEMBL628005,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9276,,,,,4689,,50597,,N,1,,Area under curve in Rat at a oral dose of 5 mg/kg,CHEMBL628006,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9277,,,,,4186,,50597,,N,1,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL628007,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9278,,,,,5510,,50597,,N,1,,Area under curve was determined,CHEMBL625676,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9279,,,,,17858,,50597,,N,1,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,CHEMBL631309,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9280,,,,,17804,,50597,,N,1,,Area under curve after intravenous administration at 3 mg/kg,CHEMBL631310,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9281,,,,,6106,,50597,,N,1,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,CHEMBL631311,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9282,,,,,5964,,50597,,N,1,,Area under curve at 4 hr in rat,CHEMBL631312,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9283,,,,,4026,,50597,,N,1,,Area under curve at a dose of 30 mg/kg,CHEMBL631313,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9284,,,,,4756,,50597,,N,1,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,CHEMBL631314,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9285,,,,,4756,,50597,,N,1,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,CHEMBL631315,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9286,,,,,5862,,50597,,N,1,,Area under curve for a 2-mpk po dose in SD rats,CHEMBL631316,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9287,,,,,5862,,50597,,N,1,,Area under curve in SD rats,CHEMBL631317,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9288,,,,,6644,,50597,,N,1,,Area under curve in rat after oral administration at 13 mg/kg dose,CHEMBL874471,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9289,,,,,5871,,50597,,N,1,,Area under curve in rat by po administration at 0-24 hr,CHEMBL631318,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9290,,,Plasma,,5919,1969.0,50597,,N,1,,Area under curve in rat plasma,CHEMBL631319,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9291,,,,,5939,,50597,,N,1,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,CHEMBL631320,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9292,,,,,5939,,50597,,N,1,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,CHEMBL631321,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9293,,,,,10,,50597,,N,1,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,CHEMBL631322,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9294,,,,,11149,,50597,,N,1,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,CHEMBL631323,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9295,,,,,5302,,50597,,N,1,,Area under curve value in rat at a dose of 5 mg/kg,CHEMBL631324,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9296,,,,,17796,,50597,,N,1,,Area under curve was determined after oral administration in rats,CHEMBL631325,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9297,,,,,4890,,50597,,N,1,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,CHEMBL631326,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9298,,,,,6011,,50597,,N,1,,Area under curve was determined after peroral administration in rat,CHEMBL631327,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9299,,,,,5375,,50597,,N,1,,Area under curve was determined at a dose 30 mpk administered orally.,CHEMBL631328,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9300,,,,,17764,,50597,,N,1,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,CHEMBL631329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9301,,,,,4368,,50597,,N,1,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,CHEMBL627217,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9302,,,,,5610,,50597,,N,1,,Area under curve was determined in male rat,CHEMBL626352,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9303,,,,,5833,,50597,,N,1,,Area under curve was determined in rat after PO administration,CHEMBL626353,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9304,,,,,4257,,50597,,N,1,,Area under curve was determined in rat after a 3 mg/kg of oral dose,CHEMBL626354,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9305,,,,,5937,,50597,,N,1,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,CHEMBL626355,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9306,,,,,5932,,50597,,N,1,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,CHEMBL626356,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9307,,,,,5932,,50597,,N,1,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,CHEMBL626357,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9308,,,,,17411,,50597,,N,1,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL626358,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9309,,,,,17411,,50597,,N,1,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL626359,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9310,,,Plasma,,17771,1969.0,50597,,N,1,,Peak plasma concentration in rat at a dose of 3 mg/kg,CHEMBL626360,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9311,,,,,1628,,50597,,N,1,,Plasma concentration at 2 hr in rats was evaluated.,CHEMBL626361,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9312,,,,,1628,,50597,,N,1,,Plasma concentration at 2 hr in rats was evaluated; Not available,CHEMBL626362,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9313,,,,,17411,,50597,,N,1,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL626363,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9314,,,,,4910,,50597,,N,1,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626970,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9315,,,,,4910,,50597,,N,1,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626971,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9316,,,Plasma,,4910,1969.0,50597,,N,1,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626972,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9317,,,Plasma,,4910,1969.0,50597,,N,1,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626973,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9318,,,Plasma,,4910,1969.0,50597,,N,1,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626974,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9319,,,Plasma,,4910,1969.0,50597,,N,1,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL874592,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9320,,,,,5510,,50597,,N,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,CHEMBL626975,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9321,,,,,5510,,50597,,N,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,CHEMBL626976,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9322,,,,,5510,,50597,,N,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,CHEMBL626977,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9323,,,,,5510,,50597,,N,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,CHEMBL626978,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9324,,,,,16427,,50597,,N,1,,PK study was carried to determine the relative absorption ranking in rat.,CHEMBL626979,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9325,In vivo,,Plasma,,4689,1969.0,50597,,N,1,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,CHEMBL626980,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9326,,,Blood,,11450,178.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",CHEMBL626981,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9327,,,Blood,,11450,178.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",CHEMBL626982,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9328,,,Blood,,11450,178.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",CHEMBL626983,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9329,,,Blood,,11450,178.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",CHEMBL622522,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9330,,,Blood,,11450,178.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",CHEMBL622523,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9331,,,Blood,,11450,178.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",CHEMBL622524,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9332,,,Brain,,11450,955.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",CHEMBL622525,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9333,,,Brain,,11450,955.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",CHEMBL622526,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9334,,,Brain,,11450,955.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",CHEMBL619849,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9335,,,Brain,,11450,955.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",CHEMBL619850,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9336,,,Brain,,11450,955.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",CHEMBL623864,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9337,,,Brain,,11450,955.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",CHEMBL623865,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9338,,,Heart,,11450,948.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",CHEMBL623866,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9339,,,Heart,,11450,948.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",CHEMBL623867,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9340,,,Heart,,11450,948.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",CHEMBL877615,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9341,,,Heart,,11450,948.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",CHEMBL623868,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9342,,,Heart,,11450,948.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",CHEMBL623869,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9343,,,Heart,,11450,948.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",CHEMBL623870,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9344,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,CHEMBL623871,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9345,,,Lung,,16434,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL623872,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9346,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL622129,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9347,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL622130,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9348,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL622131,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9349,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL622132,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9350,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL622133,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9351,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL622134,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9352,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL622135,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9353,,,Lung,,16435,2048.0,50597,,N,1,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL622136,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9354,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL622137,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9355,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622138,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9356,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL623017,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9357,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL623018,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9358,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL623019,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9359,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL623020,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9360,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,CHEMBL623021,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9361,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,CHEMBL623022,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9362,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL623023,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9363,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL623024,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9364,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL623025,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9365,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL620545,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9366,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL620546,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9367,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL620547,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9368,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL620548,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9369,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL620549,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9370,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL620550,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9371,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,CHEMBL620551,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9372,,,Muscle tissue,,16434,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL620552,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9373,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL620553,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9374,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL620554,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9375,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL875845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9376,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL620555,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9377,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL620556,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9378,,,Muscle tissue,,16435,2385.0,50597,,N,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL620557,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9379,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL620558,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9380,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL620559,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9381,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL622939,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9382,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL622940,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9383,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL622941,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9384,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL622942,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9385,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL622943,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9386,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL622944,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9387,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL622945,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9388,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL622946,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9389,,,,,3341,,50597,,N,1,,Compound was evaluated for terminal half life in rat,CHEMBL622947,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9390,In vivo,,Plasma,,3634,1969.0,50597,,N,1,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,CHEMBL622948,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9391,In vivo,,Plasma,,3634,1969.0,50597,,N,1,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,CHEMBL622949,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9392,,,,,4839,,50597,,N,1,,Compound was tested for its half life in rat,CHEMBL622950,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,9393,In vivo,,Plasma,,5005,1969.0,22224,,U,1,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,CHEMBL622951,,0,A
Intermediate,BAO_0000366,,10116.0,,Rattus norvegicus,9394,,,Plasma,,5005,1969.0,22224,,U,1,,Compound was tested for its plasma half life in Sprague Dawley rats,CHEMBL622952,,0,A
Intermediate,BAO_0000366,,10116.0,,Rattus norvegicus,9395,,,Plasma,,5005,1969.0,22224,,U,1,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,CHEMBL622953,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9396,,,Plasma,,1094,1969.0,50597,,N,1,,Compound was tested for plasma half-life period in rat,CHEMBL873818,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9397,In vivo,,,,5031,,50597,,N,1,,Elimination half life after i.v. administration of compound in rats,CHEMBL622954,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9398,In vivo,,,,6518,,50597,,N,1,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,CHEMBL622955,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9399,In vivo,,,,6518,,50597,,N,1,,Elimination half-life after IV dosing at 1 mg/kg in rat,CHEMBL875229,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9400,In vivo,,,,6518,,50597,,N,1,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,CHEMBL622956,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9401,In vivo,,,,6518,,50597,,N,1,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,CHEMBL622957,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9402,In vivo,,Brain,,5408,955.0,50597,,N,1,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,CHEMBL622958,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9403,In vivo,,Plasma,,5408,1969.0,50597,,N,1,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL622959,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9404,In vivo,,Brain,,5408,955.0,50597,,N,1,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,CHEMBL622960,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9405,In vivo,,Plasma,,5408,1969.0,50597,,N,1,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL622961,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9406,In vivo,,,,4687,,50597,,N,1,,Evaluated for the half life in rat (in vivo),CHEMBL622962,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9407,,,,,6640,,50597,,N,1,,Hafl life in rat,CHEMBL622963,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9408,,,,,6640,,50597,,N,1,,Hafl life rat,CHEMBL622964,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9409,,,,,6641,,50597,,N,1,,Hafl life rat,CHEMBL622965,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9410,,,,,6640,,50597,,N,1,,Hafl life rat; Not determined,CHEMBL622966,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9411,,,,,6641,,50597,,N,1,,Hafl life rat; Not determined,CHEMBL622967,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9412,In vivo,,Kidney,,17411,2113.0,50597,,N,1,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622968,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9413,In vivo,,Liver,,17411,2107.0,50597,,N,1,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622969,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9414,In vivo,,Lung,,17411,2048.0,50597,,N,1,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL875327,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9415,In vivo,,,,6570,,50597,,N,1,,Half life in rat after 1 mg/kg i.v. administration,CHEMBL628638,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9416,In vivo,,,,6570,,50597,,N,1,,Half life in rat after 2 mg/kg peroral administration,CHEMBL628639,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9417,In vivo,,,,17411,,50597,,N,1,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL625840,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9418,In vivo,,,,4722,,50597,,N,1,,Half life of 10 mg/kg oral dose determined in rats,CHEMBL625841,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9419,In vivo,,,,5978,,50597,,N,1,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL625842,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9420,In vivo,,,,5978,,50597,,N,1,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL625843,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9421,In vivo,,,,5978,,50597,,N,1,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL625844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9422,In vivo,,,,5978,,50597,,N,1,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL873822,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9423,In vivo,,,,5978,,50597,,N,1,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL625845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9424,In vivo,,,,5978,,50597,,N,1,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL627059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9425,In vivo,,,,5978,,50597,,N,1,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL627060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9426,In vivo,,,,5978,,50597,,N,1,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL627061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9427,In vivo,,,,4762,,50597,,N,1,,Half life of compound at 5 mg/kg after po administration was determined in rat,CHEMBL627709,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9428,In vivo,,,,5327,,50597,,N,1,,Half life of compound determined after intravenous administration to rat,CHEMBL627710,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9429,,,,,4847,,50597,,N,1,,Half life of compound was determined in rat,CHEMBL627711,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9430,In vivo,,Plasma,,17720,1969.0,50597,,N,1,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL627712,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9431,In vivo,,,,4723,,50597,,N,1,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627713,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9432,In vivo,,,,4723,,50597,,N,1,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627714,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,9433,In vivo,,,,4256,,22224,,U,1,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,CHEMBL627889,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9434,In vivo,,,,4256,,22224,,U,1,,Half life determined in rat by intravenous administration,CHEMBL627890,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9435,In vivo,,,,4722,,50597,,N,1,,Half life determined in rats after iv administration,CHEMBL627891,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9436,In vivo,,Plasma,,6535,1969.0,50597,,N,1,,Half life in rat plasma after administration of 2 mg/kg iv,CHEMBL627892,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9437,In vivo,,Plasma,,6535,1969.0,50597,,N,1,,Half life in rat plasma after administration of 2 mg/kg iv,CHEMBL627893,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9438,,,Plasma,,1435,1969.0,50597,,N,1,,Half life in rat plasma was determined,CHEMBL627894,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9439,,,Plasma,,1435,1969.0,50597,,N,1,,Half life in rat plasma was determined; NA means not applicable,CHEMBL627895,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9440,,,,,5206,,50597,,N,1,,Half life in rat was tested,CHEMBL627896,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9441,,,Plasma,,6080,1969.0,50597,,N,1,,Half life measured in rat plasma,CHEMBL627897,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9442,,,,,4449,,50597,,N,1,,Half life recorded in rats,CHEMBL627898,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9443,,,,,6057,,50597,,N,1,,Half life was calculated,CHEMBL627899,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9444,,,,,6057,,50597,,N,1,,Half life was calculated in rat,CHEMBL873823,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9445,,,,,3747,,50597,,N,1,,Half life was determined,CHEMBL627900,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9446,In vivo,,,,17858,,50597,,N,1,,Half life after 10 mg/kg oral administration in rat,CHEMBL627901,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9447,In vivo,,,,16365,,50597,,N,1,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,CHEMBL627902,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9448,In vivo,,,,16365,,50597,,N,1,,Half life after administering orally a dose of 30 mg/kg,CHEMBL627903,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9449,,,,,5031,,50597,,N,1,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,CHEMBL627904,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9450,,,,,4722,,50597,,N,1,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,CHEMBL627905,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9451,,,,,6078,,50597,,N,1,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,CHEMBL627906,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9452,,,,,6078,,50597,,N,1,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,CHEMBL627907,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9453,,,,,6078,,50597,,N,1,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,CHEMBL876783,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9454,,,,,6078,,50597,,N,1,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,CHEMBL627908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9455,,,,,17065,,50597,,N,1,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL627909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9456,,,,,1353,,50597,,N,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,CHEMBL627910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9457,,,,,1353,,50597,,N,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),CHEMBL627911,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9458,,,,,1353,,50597,,N,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),CHEMBL627912,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9459,,,,,1353,,50597,,N,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),CHEMBL627913,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9460,,,,,1353,,50597,,N,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),CHEMBL627914,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9461,,,,,16423,,50597,,N,1,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,CHEMBL627915,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9462,,,,,16423,,50597,,N,1,,Area under the curve was evaluated after 20 uM/kg of peroral administration,CHEMBL627916,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9463,,,,,6062,,50597,,N,1,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,CHEMBL627917,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9464,,,,,6056,,50597,,N,1,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,CHEMBL627918,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9465,,,,,5182,,50597,,N,1,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,CHEMBL627919,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9466,,,,,6410,,50597,,N,1,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,CHEMBL627920,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9467,,,,,6410,,50597,,N,1,,Area under the curve was evaluated at an oral dose of 30 mg/kg,CHEMBL627921,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9468,,,,,4723,,50597,,N,1,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627922,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9469,,,,,4723,,50597,,N,1,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL876784,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9470,,,,,4723,,50597,,N,1,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627923,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9471,,,,,4723,,50597,,N,1,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9472,,,,,4723,,50597,,N,1,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9473,,,,,4723,,50597,,N,1,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9474,,,Plasma,,2463,1969.0,50597,,N,1,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,CHEMBL627994,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9475,,,,,4709,,50597,,N,1,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,CHEMBL627995,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9476,,,,,4075,,50597,,N,1,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,CHEMBL627996,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9477,,,,,5394,,50597,,N,1,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,CHEMBL627997,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9478,,,,,2661,,50597,,N,1,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL627998,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9479,,,,,2661,,50597,,N,1,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL628640,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9480,,,,,2661,,50597,,N,1,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL628641,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9481,,,,,2661,,50597,,N,1,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL628642,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9482,,,,,17791,,50597,,N,1,,Compound was evaluated for area under the curve expressed as (h*ug/ml),CHEMBL628643,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9483,,,,,2591,,50597,,N,1,,Compound was tested for area under curve in rat,CHEMBL628644,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9484,,,,,6567,,50597,,N,1,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,CHEMBL628645,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9485,,,,,6211,,50597,,N,1,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL628646,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9486,,,,,5529,,50597,,N,1,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),CHEMBL628647,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9487,,,,,5408,,50597,,N,1,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,CHEMBL628648,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9488,,,,,5408,,50597,,N,1,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL625358,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9489,,,,,5408,,50597,,N,1,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,CHEMBL625359,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9490,,,,,5408,,50597,,N,1,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL625360,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9491,,,,,429,,50597,,N,1,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),CHEMBL625361,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9492,,,,,429,,50597,,N,1,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),CHEMBL625362,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9493,,,,,429,,50597,,N,1,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),CHEMBL625363,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9494,,,,,4796,,50597,,N,1,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,CHEMBL625364,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9495,,,,,5974,,50597,,N,1,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL625365,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9496,,,,,5974,,50597,,N,1,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL625366,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9497,,,,,5974,,50597,,N,1,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL625367,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9498,,,Kidney,,11450,2113.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",CHEMBL625368,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9499,,,Kidney,,11450,2113.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",CHEMBL625369,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9500,,,Kidney,,11450,2113.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",CHEMBL625370,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9501,,,Kidney,,11450,2113.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",CHEMBL625371,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9502,,,Kidney,,11450,2113.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",CHEMBL625372,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9503,,,Kidney,,11450,2113.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",CHEMBL625373,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9504,,,Liver,,11450,2107.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",CHEMBL625374,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9505,,,Liver,,11450,2107.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",CHEMBL877593,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9506,,,Liver,,11450,2107.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",CHEMBL625375,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9507,,,Liver,,11450,2107.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",CHEMBL625376,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9508,,,Liver,,11450,2107.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",CHEMBL621973,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9509,,,Liver,,11450,2107.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",CHEMBL621974,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9510,,,Lung,,11450,2048.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",CHEMBL621975,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9511,,,Lung,,11450,2048.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",CHEMBL622166,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9512,,,Lung,,11450,2048.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",CHEMBL622167,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9513,,,Lung,,11450,2048.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",CHEMBL622168,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9514,,,Lung,,11450,2048.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",CHEMBL622169,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9515,,,Lung,,11450,2048.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",CHEMBL622170,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9516,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",CHEMBL622171,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9517,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",CHEMBL622172,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9518,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",CHEMBL622173,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9519,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",CHEMBL622174,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9520,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",CHEMBL622175,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9521,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",CHEMBL622176,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9522,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",CHEMBL622177,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9523,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",CHEMBL622178,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9524,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",CHEMBL622179,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9525,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",CHEMBL622180,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9526,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL622181,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9527,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL622182,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9528,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL622183,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9529,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL622184,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9530,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL622185,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9531,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL622186,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9532,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL622187,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9533,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,CHEMBL625002,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9534,,,,,16434,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,CHEMBL622090,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9535,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL622091,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9536,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL622092,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9537,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL622093,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9538,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL622094,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9539,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL622095,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9540,,,,,16435,,50597,,N,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL622264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9541,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL622265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9542,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9543,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL622267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9544,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL622268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9545,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL622269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9546,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL625071,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9547,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL621621,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9548,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL621622,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9549,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL621623,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9550,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL621624,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9551,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL621625,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9552,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL621626,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9553,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL621627,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9554,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL621628,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9555,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL875328,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9556,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL621629,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9557,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL621630,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9558,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL621631,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9559,,,Spleen,,16434,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL621632,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9560,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL621633,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9561,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL621634,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9562,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL621635,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9563,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL621636,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9564,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL621637,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9565,,,Spleen,,16435,2106.0,50597,,N,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL621638,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9566,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL618883,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9567,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL618884,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9568,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL628627,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9569,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL628628,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9570,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL628629,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9571,In vivo,,,,16365,,50597,,N,1,,Half life after administering orally a dose of 3 mg/kg,CHEMBL628630,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9572,In vivo,,,,16365,,50597,,N,1,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,CHEMBL628631,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9573,In vivo,,,,16365,,50597,,N,1,,Half life after administering intravenously a dose of 1 mg/kg,CHEMBL628632,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9574,In vivo,,,,526,,50597,,N,1,,Half life after oral dosing in rats,CHEMBL628633,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9575,In vivo,,,,16365,,50597,,N,1,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,CHEMBL628634,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9576,In vivo,,,,4368,,50597,,N,1,,Half life by intravenous administration of 3.4 mg/kg in rat,CHEMBL627789,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9577,,,,,3371,,50597,,N,1,,Half life in rat,CHEMBL627790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9578,,,,,6448,,50597,,N,1,,Half life in rat,CHEMBL627791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9579,,,,,6453,,50597,,N,1,,Half life in rat,CHEMBL627792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9580,In vivo,,,,4353,,50597,,N,1,,Half life in rat after intravenous administration of the compound,CHEMBL627793,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9581,In vivo,,Plasma,,4353,1969.0,50597,,N,1,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,CHEMBL627794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9582,In vivo,,,,4353,,50597,,N,1,,Half life in rat after po administration of the compound,CHEMBL627795,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9583,In vivo,,,,4353,,50597,,N,1,,Half life in rat after po administration of the compound; ND means Not determined,CHEMBL627796,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9584,In vivo,,Plasma,,4353,1969.0,50597,,N,1,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,CHEMBL875335,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9585,In vivo,,Plasma,,4353,1969.0,50597,,N,1,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,CHEMBL627797,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9586,In vivo,,,,5789,,50597,,N,1,,Half life in rat i.v.,CHEMBL627798,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9587,In vivo,,,,17686,,50597,,N,1,,Half life in rat i.v. at 2 mg/kg concentration,CHEMBL627799,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9588,,,,,6495,,50597,,N,1,,Half life in rats,CHEMBL627800,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9589,In vivo,,,,484,,50597,,N,1,,Half life in rats after intravenous administration,CHEMBL627801,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9590,In vivo,,,,6467,,50597,,N,1,,Half life in rats at the dose of 1.0 mpk by i.v. administration,CHEMBL627802,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,9591,,,,,6642,,50597,,N,1,,Half life in rat,CHEMBL627803,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9592,In vivo,,,,16367,,50597,,N,1,,Half life was evaluated after intravenous administration to rats,CHEMBL873820,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9593,,,,,1369,,50597,,N,1,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),CHEMBL627804,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9594,,,,,5472,,50597,,N,1,,Half life was evaluated in rat,CHEMBL627805,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9595,,,,,6049,,50597,,N,1,,Half life was evaluated in rat,CHEMBL627806,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9596,,,,,5472,,50597,,N,1,,Half life was evaluated in rat; Not tested,CHEMBL627107,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9597,In vivo,,,,16366,,50597,,N,1,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,CHEMBL627108,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9598,In vivo,,,,11149,,50597,,N,1,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,CHEMBL627109,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9599,In vivo,,Blood,,11149,178.0,50597,,N,1,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,CHEMBL627110,,1,A
Intermediate,BAO_0000218,,9443.0,,Primates,9600,In vivo,,,,2891,,22224,,U,1,,Half life was measured in monkey at dose of 10 mg/kg by po administration,CHEMBL627111,,0,A
Intermediate,BAO_0000218,,9443.0,,Primates,9601,In vivo,,,,2891,,22224,,U,1,,Half life was measured in monkey at dose of 10 mg/kg by po administration,CHEMBL627112,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9602,In vivo,,,,2891,,22224,,U,1,,Half life was measured in rat at dose of 30 mg/kg by iv administration,CHEMBL627113,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9603,In vivo,,,,2891,,22224,,U,1,,Half life was measured in rat at dose of 30 mg/kg by po administration,CHEMBL627114,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9604,,,,,4026,,50597,,N,1,,Half life (t1/2) was determined,CHEMBL627115,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9605,,,,,4527,,50597,,N,1,,Half life period at a dose of 10 uM/kg in rat was determined,CHEMBL627116,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9606,In vivo,,,,4527,,50597,,N,1,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,CHEMBL627117,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9607,,,,,5503,,50597,,N,1,,Half life period was determined,CHEMBL627118,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9608,In vivo,,,,4426,,50597,,N,1,,Half life period after intravenous administration at 20 mpk in rats,CHEMBL627119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9609,In vivo,,,,4426,,50597,,N,1,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,CHEMBL627120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9610,In vivo,,,,6109,,50597,,N,1,,Half life period after intravenous administration in rat,CHEMBL626922,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9611,In vivo,,,,5654,,50597,,N,1,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL626923,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9612,In vivo,,,,5654,,50597,,N,1,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL626924,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9613,,,Plasma,,4755,1969.0,50597,,N,1,,Half life period in 80% rat plasma at 37 degree Centigrade,CHEMBL626925,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9614,,,,,5862,,50597,,N,1,,Half life period in SD rats,CHEMBL626926,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9615,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),CHEMBL626927,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9616,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),CHEMBL626928,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9617,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626929,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9618,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626930,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9619,,,,,5960,,50597,,N,1,,Half life period in rat,CHEMBL626931,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9620,,,,,6103,,50597,,N,1,,Half life period in rat,CHEMBL626932,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9621,,,,,6317,,50597,,N,1,,Half life period in rat,CHEMBL626933,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9622,In vivo,,,,6644,,50597,,N,1,,Half life period in rat after oral administration at 10.5 mg/kg dose,CHEMBL873826,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9623,In vivo,,,,6644,,50597,,N,1,,Half life period in rat after oral administration at 11.2 mg/kg dose,CHEMBL626934,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9624,In vivo,,,,6644,,50597,,N,1,,Half life period in rat after oral administration at 13 mg/kg dose,CHEMBL626935,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9625,In vivo,,,,6644,,50597,,N,1,,Half life period in rat after oral administration at 9.7 mg/kg dose,CHEMBL626936,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9626,,,,,5974,,50597,,N,1,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL626937,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9627,,,,,6295,,50597,,N,1,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,CHEMBL625906,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9628,,,,,6296,,50597,,N,1,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,CHEMBL625907,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9629,,,,,16427,,50597,,N,1,,PK study was carried to determine AUC (area under curve) value in rat,CHEMBL625908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9630,,,,,16367,,50597,,N,1,,Pharmacokinetic parameter AUC after intravenous administration to rats,CHEMBL625909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9631,,,,,16367,,50597,,N,1,,Pharmacokinetic parameter AUC after oral administration to rats,CHEMBL625910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9632,,,,,16365,,50597,,N,1,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,CHEMBL625911,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9633,,,,,16365,,50597,,N,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,CHEMBL625912,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9634,,,,,16365,,50597,,N,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,CHEMBL626538,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9635,,,,,16365,,50597,,N,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,CHEMBL876794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9636,,,,,16365,,50597,,N,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,CHEMBL626539,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9637,,,,,16365,,50597,,N,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,CHEMBL626540,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9638,,,,,5394,,50597,,N,1,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,CHEMBL626541,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9639,,,,,5394,,50597,,N,1,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,CHEMBL626542,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9640,,,,,2792,,50597,,N,1,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,CHEMBL626543,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9641,,,,,2792,,50597,,N,1,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,CHEMBL626544,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9642,,,,,2792,,50597,,N,1,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,CHEMBL626545,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9643,,,,,2792,,50597,,N,1,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,CHEMBL626546,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9644,,,,,5334,,50597,,N,1,,Pharmacokinetic parameter area under curve was reported,CHEMBL626547,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9645,,,,,4408,,50597,,N,1,,Pharmacokinetic property (AUC) in rat,CHEMBL626548,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9646,,,,,5983,,50597,,N,1,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,CHEMBL626549,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9647,,,,,4397,,50597,,N,1,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,CHEMBL626550,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9648,,,,,4397,,50597,,N,1,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,CHEMBL626551,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9649,,,,,5491,,50597,,N,1,,Pharmacokinetic property was determined,CHEMBL623777,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9650,,,,,5491,,50597,,N,1,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,CHEMBL623778,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9651,,,,,5491,,50597,,N,1,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,CHEMBL623779,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9652,,,Plasma,,4199,1969.0,50597,,N,1,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL623780,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9653,,,Plasma,,4199,1969.0,50597,,N,1,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL622015,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9654,,,Plasma,,4199,1969.0,50597,,N,1,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL622016,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9655,,,,,5173,,50597,,N,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",CHEMBL622017,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9656,,,,,5173,,50597,,N,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",CHEMBL622018,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9657,,,,,5173,,50597,,N,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",CHEMBL622019,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9658,,,,,5173,,50597,,N,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",CHEMBL622020,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9659,,,,,16366,,50597,,N,1,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,CHEMBL622021,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9660,,,,,16366,,50597,,N,1,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,CHEMBL622022,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9661,,,,,5327,,50597,,N,1,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,CHEMBL622023,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9662,,,,,6681,,50597,,N,1,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,CHEMBL622024,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9663,,,,,12873,,50597,,N,1,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),CHEMBL622693,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9664,,,,,12873,,50597,,N,1,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),CHEMBL622694,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9665,,,,,6685,,50597,,N,1,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",CHEMBL622695,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9666,,,,,6685,,50597,,N,1,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",CHEMBL622696,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9667,,,,,6685,,50597,,N,1,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",CHEMBL622697,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9668,,,,,6619,,50597,,N,1,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",CHEMBL622874,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9669,,,,,6619,,50597,,N,1,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",CHEMBL622875,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9670,,,,,10363,,50597,,N,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,CHEMBL622876,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9671,,,,,4796,,50597,,N,1,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,CHEMBL622877,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9672,,,,,4910,,50597,,N,1,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,CHEMBL622878,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9673,,,Plasma,,4910,1969.0,50597,,N,1,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,CHEMBL622879,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9674,,,,,4839,,50597,,N,1,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,CHEMBL877602,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9675,,,,,15078,,50597,,N,1,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL622880,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9676,,,,,15078,,50597,,N,1,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL622881,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9677,,,,,15078,,50597,,N,1,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL622882,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9678,,,,,15078,,50597,,N,1,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL622883,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9679,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",CHEMBL622884,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9680,,,Thyroid gland,,11450,2046.0,50597,,N,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",CHEMBL622885,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9681,,,,,8151,,50597,,N,1,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,CHEMBL622886,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9682,,,,,8151,,50597,,N,1,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL622887,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9683,,,Urine,,8151,1088.0,50597,,N,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,CHEMBL622888,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9684,In vivo,,Blood,,8677,178.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622889,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9685,In vivo,,Blood,,8677,178.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622890,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9686,In vivo,,Blood,,8677,178.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622891,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9687,In vivo,,Blood,,8677,178.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL877603,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9688,In vivo,,Brain,,8677,955.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622892,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9689,In vivo,,Brain,,8677,955.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622893,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9690,In vivo,,Brain,,8677,955.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622894,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9691,In vivo,,Brain,,8677,955.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622895,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9692,In vivo,,Brain,,8677,955.0,50597,,N,1,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,CHEMBL622896,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9693,In vivo,,Heart,,8677,948.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622897,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9694,In vivo,,Heart,,8677,948.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622898,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9695,In vivo,,Heart,,8677,948.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622899,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9696,In vivo,,Kidney,,8677,2113.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622900,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9697,In vivo,,Kidney,,8677,2113.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624114,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9698,In vivo,,Kidney,,8677,2113.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624115,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9699,In vivo,,Kidney,,8677,2113.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624116,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9700,In vivo,,Liver,,8677,2107.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624117,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9701,In vivo,,Liver,,8677,2107.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624118,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9702,In vivo,,Liver,,8677,2107.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9703,In vivo,,Liver,,8677,2107.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9704,In vivo,,Lung,,8677,2048.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624121,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9705,In vivo,,Lung,,8677,2048.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624122,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9706,In vivo,,Lung,,8677,2048.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624123,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9707,In vivo,,Lung,,8677,2048.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624124,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9708,In vivo,,Muscle tissue,,8677,2385.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624125,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9709,In vivo,,Muscle tissue,,8677,2385.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624126,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9710,In vivo,,Muscle tissue,,8677,2385.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624127,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9711,In vivo,,Muscle tissue,,8677,2385.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624128,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9712,In vivo,,Zone of skin,,8677,14.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624129,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9713,In vivo,,Zone of skin,,8677,14.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624130,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9714,In vivo,,Zone of skin,,8677,14.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622340,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9715,In vivo,,Zone of skin,,8677,14.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622341,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9716,In vivo,,Intestine,,8677,160.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622342,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9717,In vivo,,Intestine,,8677,160.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622343,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9718,In vivo,,Intestine,,8677,160.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622344,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9719,In vivo,,Intestine,,8677,160.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622345,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9720,In vivo,,Spleen,,8677,2106.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622346,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9721,In vivo,,Spleen,,8677,2106.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622347,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9722,In vivo,,Spleen,,8677,2106.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622348,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9723,In vivo,,Spleen,,8677,2106.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622349,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9724,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL622350,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9725,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL622351,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9726,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL622352,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9727,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL622353,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9728,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL622354,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9729,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL622355,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9730,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL622356,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9731,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL622357,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9732,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL622358,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9733,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL622359,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9734,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL874393,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9735,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL622872,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9736,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL622873,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9737,,,,,16434,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL623047,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9738,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL623048,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9739,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL623049,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9740,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL623050,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9741,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL623051,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9742,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL623052,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9743,,,,,16435,,50597,,N,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL626343,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9744,,,,,16434,,50597,,N,1,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL626344,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9745,,,,,16434,,50597,,N,1,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL626345,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9746,,,,,16434,,50597,,N,1,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL626346,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9747,,,,,16434,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL626347,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9748,,,,,16434,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL626348,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9749,,,,,16434,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL626349,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9750,,,,,16435,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL626350,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9751,,,,,16435,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL626351,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9752,,,,,16435,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL627650,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9753,,,,,16435,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL627651,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9754,,,,,16435,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL627652,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9755,,,,,16435,,50597,,N,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL627653,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9756,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,CHEMBL627654,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9757,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,CHEMBL627835,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9758,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,CHEMBL627836,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9759,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,CHEMBL627837,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9760,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,CHEMBL627838,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9761,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,CHEMBL875338,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9762,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,CHEMBL627839,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9763,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,CHEMBL627840,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9764,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,CHEMBL627841,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9765,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,CHEMBL627842,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9766,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,CHEMBL627843,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9767,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,CHEMBL627844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9768,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,CHEMBL627845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9769,In vivo,,,,5874,,50597,,N,1,,Half life period in rat by iv administration at a dose of 3 mg/kg,CHEMBL627846,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9770,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),CHEMBL627847,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9771,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),CHEMBL873821,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9772,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626079,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9773,,,Plasma,,1515,1969.0,50597,,N,1,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626080,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9774,,,Plasma,,5491,1969.0,50597,,N,1,,Half life period was evaluated in rat plasma,CHEMBL626081,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9775,,,Plasma,,5491,1969.0,50597,,N,1,,Half life period was evaluated in rat plasma; Not tested,CHEMBL875344,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9776,,,,,1918,,50597,,N,1,,Half life period was evaluated in rats,CHEMBL626082,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9777,In vivo,,,,1918,,50597,,N,1,,"Half life period was evaluated in rats, iv",CHEMBL626250,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9778,In vivo,,,,6113,,50597,,N,1,,Half life period after intravenous administration at 5 mg/kg in rat,CHEMBL626251,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9779,In vivo,,,,5546,,50597,,N,1,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,CHEMBL626252,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9780,In vivo,,,,5553,,50597,,N,1,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,CHEMBL626253,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9781,,,Plasma,,4188,1969.0,50597,,N,1,,Half life stability of compound was evaluated in rat plasma,CHEMBL626254,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9782,In vivo,,,,6215,,50597,,N,1,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,CHEMBL626255,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9783,In vivo,,,,6141,,50597,,N,1,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,CHEMBL626256,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9784,In vivo,,,,5182,,50597,,N,1,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,CHEMBL626257,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9785,In vivo,,,,5182,,50597,,N,1,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,CHEMBL626258,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9786,In vivo,,,,5710,,50597,,N,1,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,CHEMBL626259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9787,In vivo,,,,5789,,50597,,N,1,,Half in rat i.v.,CHEMBL626260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9788,In vivo,,,,6011,,50597,,N,1,,Half period in rat after intravenous administration,CHEMBL875345,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9789,In vivo,,,,17594,,50597,,N,1,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,CHEMBL626261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9790,In vitro,,Liver,,12357,2107.0,50597,,N,1,,Half-life measured in in vitro Cathepsin B assay in rat liver,CHEMBL626262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9791,,,,,5210,,50597,,N,1,,Half-life of compound was determined in rats,CHEMBL626263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9792,In vivo,,,,17596,,50597,,N,1,,Half-life at 10 mg/kg in rat upon intravenous administration,CHEMBL625270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9793,,,,,6672,,50597,,N,1,,Half-life determined in rat,CHEMBL625271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9794,,,,,6673,,50597,,N,1,,Half-life determined in rat,CHEMBL625272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9795,In vivo,,Brain,,4910,955.0,50597,,N,1,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,CHEMBL625273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9796,,,Plasma,,3741,1969.0,50597,,N,1,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",CHEMBL625274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9797,In vivo,,,,17671,,50597,,N,1,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL625275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9798,In vivo,,Plasma,,4910,1969.0,50597,,N,1,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,CHEMBL625276,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9799,,,Plasma,,17537,1969.0,50597,,N,1,,Half-life in rat plasma,CHEMBL625277,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9800,,,Plasma,,4965,1969.0,50597,,N,1,,Half-life in rat plasma was determined,CHEMBL625278,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9801,,,Plasma,,17537,1969.0,50597,,N,1,,Half-life in rat plasma; Not tested,CHEMBL625279,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9802,,,Serum,,6124,1977.0,50597,,N,1,,Half-life in rat serum,CHEMBL625280,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9803,,,Serum,,6124,1977.0,50597,,N,1,,Half-life in rat serum; na is not available,CHEMBL876797,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9804,,,,,6078,,50597,,N,1,,Half-life was calculated in rat,CHEMBL625281,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9805,,,Plasma,,17668,1969.0,50597,,N,1,,Half-life was calculated in rat plasma,CHEMBL873827,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9806,,,,,3185,,50597,,N,1,,Half-life was determined,CHEMBL625282,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9807,,,,,4883,,50597,,N,1,,Half-life was determined,CHEMBL625283,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9808,In vivo,,,,2959,,50597,,N,1,,Half-life after administration of 20 mg/Kg oral dose in rat,CHEMBL625284,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9809,In vivo,,,,4029,,50597,,N,1,,Half-life after administration of 3.2 mg/kg intravenously in male rat,CHEMBL625285,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9810,In vivo,,,,4029,,50597,,N,1,,Half-life after intravenous administration in female rat,CHEMBL625286,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9811,In vivo,,,,4029,,50597,,N,1,,Half-life after intravenous administration in male rat,CHEMBL625287,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9812,In vivo,,,,6180,,50597,,N,1,,Half-life after intravenous dose in rat,CHEMBL625288,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9813,,,Liver,,1557,2107.0,50597,,N,1,,Half-life in a rat liver homogenate preparation,CHEMBL625289,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9814,,,Plasma,,12500,1969.0,50597,,N,1,,Half-life in plasma of rat,CHEMBL625290,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9815,,,Plasma,,12500,1969.0,50597,,N,1,,Half-life in plasma of rat at dose of 3-10 mgkg,CHEMBL876798,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9816,,,,,5064,,50597,,N,1,,Half-life in rat,CHEMBL625291,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9817,,,,,5145,,50597,,N,1,,Half-life in rat,CHEMBL625292,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9818,,,,,5147,,50597,,N,1,,Half-life in rat,CHEMBL625293,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9819,,,,,5833,,50597,,N,1,,Half-life in rat,CHEMBL622832,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9820,,,,,6596,,50597,,N,1,,Half-life in rat,CHEMBL622833,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9821,,,,,17655,,50597,,N,1,,Half-life in rat,CHEMBL622834,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9822,In vivo,,,,6495,,50597,,N,1,,Half-life in rat after oral administration at 10 mg/kg,CHEMBL622835,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9823,In vivo,,,,17538,,50597,,N,1,,Half-life in rat after po administration at a dose of 10 mg/kg,CHEMBL622836,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9824,In vivo,,,,17538,,50597,,N,1,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,CHEMBL622837,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9825,In vivo,,,,10,,50597,,N,1,,Half-life in rat at 3 mg/kg dose administered intravenously,CHEMBL622838,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9826,,,Brain,,17669,955.0,50597,,N,1,,Half-life in rat brain homogenate,CHEMBL622839,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9827,,,Plasma,,17065,1969.0,50597,,N,1,,Half-life in rat plasma,CHEMBL622840,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9828,,,,,4333,,50597,,N,1,,Half-life in rats,CHEMBL622841,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9829,,,,,6827,,50597,,N,1,,Half-life in Dawley rats,CHEMBL622842,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9830,In vitro,,Plasma,,889,1969.0,50597,,N,1,,Half-life in vitro in rat plasma,CHEMBL622843,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9831,In vitro,,Plasma,,889,1969.0,50597,,N,1,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,CHEMBL622844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9832,,,,,3747,,50597,,N,1,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",CHEMBL622845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9833,,,,,15022,,50597,,N,1,,The area under the curve of compound was measured at the dose of 100 umol/kg,CHEMBL622846,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9834,,,,,15022,,50597,,N,1,,The area under the curve of compound was measured at the dose of 300 umol/kg,CHEMBL622847,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9835,,,,,15022,,50597,,N,1,,The area under the curve of compound was measured at the dose of 30 umol/kg,CHEMBL622848,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9836,In vivo,,,,3360,,50597,,N,1,,Bioavailability as oral AUC in rats,CHEMBL622849,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9837,,,Plasma,,5334,1969.0,50597,,N,1,,The plasma concentration versus time curve (AUC) was determined,CHEMBL622850,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9838,,,,,17411,,50597,,N,1,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL876807,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9839,,,,,17411,,50597,,N,1,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622851,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9840,,,,,17411,,50597,,N,1,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622852,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9841,,,,,6570,,50597,,N,1,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,CHEMBL622853,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9842,,,,,6570,,50597,,N,1,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,CHEMBL622854,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9843,,,,,17411,,50597,,N,1,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622855,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9844,,,Plasma,,14941,1969.0,50597,,N,1,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL622856,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9845,,,Plasma,,14941,1969.0,50597,,N,1,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL622857,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9846,,,Plasma,,17538,1969.0,50597,,N,1,,AUC in rat after po administration at a dose of 10 mg/kg,CHEMBL622858,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9847,,,Plasma,,17752,1969.0,50597,,N,1,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,CHEMBL622859,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9848,,,,,17509,,50597,,N,1,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,CHEMBL622860,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9849,,,,,17509,,50597,,N,1,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,CHEMBL622861,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9850,,,,,17509,,50597,,N,1,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,CHEMBL622862,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9851,,,,,17509,,50597,,N,1,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,CHEMBL622863,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9852,,,,,17509,,50597,,N,1,,Area under curve value 6 hr after po administration in rat,CHEMBL623817,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9853,,,,,17717,,50597,,N,1,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623818,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9854,,,,,17717,,50597,,N,1,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",CHEMBL623819,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9855,,,,,17717,,50597,,N,1,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623820,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9856,,,,,17717,,50597,,N,1,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,CHEMBL623821,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9857,,,Plasma,,6642,1969.0,50597,,N,1,,AUC normalized for dose (AUCN) in rat,CHEMBL623822,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9858,,,,,6640,,50597,,N,1,,Area under curve in rat after p.o. administration,CHEMBL623823,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9859,,,,,6641,,50597,,N,1,,Area under curve in rat after p.o. administration,CHEMBL623824,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9860,,,,,6641,,50597,,N,1,,Area under curve in rat after p.o. administration; Not determined,CHEMBL623825,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9861,,,,,6641,,50597,,N,1,,Area under curve in rat after peroral administration,CHEMBL622070,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9862,,,,,3603,,50597,,N,1,,Area under curve (carotid artery) value of the compound,CHEMBL622071,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9863,,,,,3550,,50597,,N,1,,Bioavailability expressed as the area under curve of rat carotid artery,CHEMBL622072,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9864,,,,,15662,,50597,,N,1,,Area under curve in male SD rats was observed after intravenous administration in rat,CHEMBL622073,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9865,,,,,17720,,50597,,N,1,,Area under curve of the compound was determined,CHEMBL622074,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9866,,,,,5407,,50597,,N,1,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,CHEMBL622075,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9867,,,Plasma,,17752,1969.0,50597,,N,1,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,CHEMBL622076,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9868,,,Plasma,,17752,1969.0,50597,,N,1,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,CHEMBL622077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9869,,,,,3603,,50597,,N,1,,Area under curve (portal vein) value of the compound,CHEMBL622078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9870,,,,,3550,,50597,,N,1,,Bioavailability expressed as the area under curve of rat portal vein,CHEMBL622079,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9871,,,Plasma,,17655,1969.0,50597,,N,1,,Area Under plasma concentration time curve in rat upon peroral administration,CHEMBL622080,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9872,,,,,17582,,50597,,N,1,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,CHEMBL877612,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9873,,,,,17582,,50597,,N,1,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,CHEMBL622081,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9874,,,,,17791,,50597,,N,1,,Compound was evaluated for oral bioavailability in rats,CHEMBL622082,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9875,,,,,17791,,50597,,N,1,,Compound was evaluated for oral bioavailability in rats after iv administration,CHEMBL622083,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9876,,,,,17791,,50597,,N,1,,Compound was evaluated for oral bioavailability in rats; 30-80,CHEMBL622084,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9877,,,,,17791,,50597,,N,1,,Compound was evaluated for oral bioavailability in rats; 50-60,CHEMBL622085,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9878,,,,,17791,,50597,,N,1,,Compound was evaluated for oral bioavailability in rats; no data,CHEMBL622086,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9879,,,,,17791,,50597,,N,1,,Compound was evaluated for oral bioavailability in rats; peptide,CHEMBL622087,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9880,,,Blood,,7768,178.0,50597,,N,1,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",CHEMBL622088,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9881,,,Blood,,7768,178.0,50597,,N,1,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",CHEMBL622089,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9882,,,Blood,,7768,178.0,50597,,N,1,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",CHEMBL623685,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9883,,,Blood,,7768,178.0,50597,,N,1,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",CHEMBL623686,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9884,In vivo,,Stomach,,8677,945.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL623687,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9885,In vivo,,Stomach,,8677,945.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL623688,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9886,In vivo,,Stomach,,8677,945.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL623689,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9887,In vivo,,Stomach,,8677,945.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622485,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9888,In vivo,,Thyroid gland,,8677,2046.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622486,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9889,In vivo,,Thyroid gland,,8677,2046.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL877613,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9890,In vivo,,Thyroid gland,,8677,2046.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622487,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9891,In vivo,,Thyroid gland,,8677,2046.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9892,In vivo,,Heart,,8677,948.0,50597,,N,1,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9893,,,Urine,,6899,1088.0,50597,,N,1,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,CHEMBL622490,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9894,,,Urine,,6899,1088.0,50597,,N,1,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,CHEMBL622491,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9895,,,Liver,,6899,2107.0,50597,,N,1,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,CHEMBL622492,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9896,,,Urine,,6899,1088.0,50597,,N,1,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,CHEMBL622493,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9897,,,Urine,,6899,1088.0,50597,,N,1,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,CHEMBL622494,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9898,,,Muscle tissue,,8677,2385.0,50597,,N,1,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9899,,,,,6899,,50597,,N,1,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,CHEMBL622496,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9900,,,Urine,,6899,1088.0,50597,,N,1,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,CHEMBL622497,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9901,,,,,2189,,50597,,N,1,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,CHEMBL622498,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9902,,,Urine,,2189,1088.0,50597,,N,1,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,CHEMBL624918,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9903,,,Urine,,2189,1088.0,50597,,N,1,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,CHEMBL624919,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9904,In vivo,,Blood,,10839,178.0,50597,,N,1,,Biodistribution of compound in rat blood after 5 min of administration,CHEMBL624920,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9905,In vivo,,Blood,,10839,178.0,50597,,N,1,,Biodistribution of compound in rat blood after 5 min of administration.,CHEMBL624921,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9906,In vivo,,Brain,,10839,955.0,50597,,N,1,,Biodistribution of compound in rat brain after 5 min of administration,CHEMBL624922,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9907,In vivo,,Heart,,10839,948.0,50597,,N,1,,Biodistribution of compound in rat heart after 5 min of administration,CHEMBL624923,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9908,In vivo,,Heart,,10839,948.0,50597,,N,1,,Biodistribution of compound in rat heart after 5 min of administration.,CHEMBL624924,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9909,In vivo,,Kidney,,10839,2113.0,50597,,N,1,,Biodistribution of compound in rat kidney after 5 min of administration,CHEMBL624925,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9910,In vivo,,Kidney,,10839,2113.0,50597,,N,1,,Biodistribution of compound in rat kidney after 5 min of administration.,CHEMBL624926,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9911,In vivo,,Liver,,10839,2107.0,50597,,N,1,,Biodistribution of compound in rat liver after 5 min of administration,CHEMBL624927,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9912,In vivo,,Liver,,10839,2107.0,50597,,N,1,,Biodistribution of compound in rat liver after 5 min of administration.,CHEMBL874402,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9913,In vivo,,Lung,,10839,2048.0,50597,,N,1,,Biodistribution of compound in rat lung after 5 min of administration,CHEMBL624928,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9914,In vivo,,Lung,,10839,2048.0,50597,,N,1,,Biodistribution of compound in rat lung after 5 min of administration.,CHEMBL624929,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9915,In vivo,,Muscle tissue,,10839,2385.0,50597,,N,1,,Biodistribution of compound in rat muscle after 5 min of administration,CHEMBL624930,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9916,In vivo,,Muscle tissue,,10839,2385.0,50597,,N,1,,Biodistribution of compound in rat muscle after 5 min of administration.,CHEMBL624931,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9917,,,Heart,,4043,948.0,50597,,N,1,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624932,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9918,,,Heart,,4043,948.0,50597,,N,1,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624933,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9919,,,Liver,,4043,2107.0,50597,,N,1,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624934,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9920,,,Liver,,4043,2107.0,50597,,N,1,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624935,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9921,,,,,4043,,50597,,N,1,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624936,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9922,,,,,4043,,50597,,N,1,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624937,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9923,,,Spleen,,4043,2106.0,50597,,N,1,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624938,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9924,,,Spleen,,4043,2106.0,50597,,N,1,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624939,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9925,,,,,4043,,50597,,N,1,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624940,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9926,,,,,4043,,50597,,N,1,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL874403,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9927,,,,,1446,,50597,,N,1,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,CHEMBL624941,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9928,,,Urine,,9971,1088.0,50597,,N,1,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,CHEMBL624942,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9929,,,Urine,,9971,1088.0,50597,,N,1,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,CHEMBL624943,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9930,In vivo,,,,5765,,50597,,N,1,,% Bioavailability after 1 day of the drug administration in rats,CHEMBL624944,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9931,In vivo,,,,5765,,50597,,N,1,,% Bioavailability after 4 day of the drug administration in rats,CHEMBL624945,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9932,In vivo,,,,4257,,50597,,N,1,,Absolute bioavailability was evaluated in rat,CHEMBL624946,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9933,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,CHEMBL624947,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9934,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,CHEMBL624948,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9935,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,CHEMBL624949,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9936,,,Kidney,,13091,2113.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,CHEMBL622025,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9937,,,Kidney,,13091,2113.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,CHEMBL622026,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9938,,,Kidney,,13091,2113.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,CHEMBL622027,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9939,,,Kidney,,13091,2113.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,CHEMBL622028,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9940,,,Liver,,13091,2107.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,CHEMBL622029,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9941,,,Liver,,13091,2107.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,CHEMBL622208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9942,,,Liver,,13091,2107.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,CHEMBL622209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9943,,,Liver,,13091,2107.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,CHEMBL622210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9944,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,CHEMBL622211,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9945,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,CHEMBL622212,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9946,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,CHEMBL622213,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9947,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,CHEMBL874404,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9948,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,CHEMBL620452,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9949,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,CHEMBL620453,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9950,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,CHEMBL620454,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9951,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,CHEMBL624067,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9952,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,CHEMBL624068,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9953,,,Female gonad,,13091,992.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,CHEMBL624069,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9954,,,Female gonad,,13091,992.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,CHEMBL624070,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9955,,,Female gonad,,13091,992.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,CHEMBL624071,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9956,,,Uterus,,13091,995.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,CHEMBL624072,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9957,,,Uterus,,13091,995.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,CHEMBL624073,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9958,,,Uterus,,13091,995.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,CHEMBL624788,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9959,,,Uterus,,13091,995.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,CHEMBL624789,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9960,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,CHEMBL624790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9961,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,CHEMBL624791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9962,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,CHEMBL624792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9963,,,,,13091,,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,CHEMBL624793,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9964,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,CHEMBL877491,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9965,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,CHEMBL624957,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9966,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,CHEMBL624958,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9967,,,Muscle tissue,,13091,2385.0,50597,,N,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,CHEMBL624959,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9968,,,,,11977,,50597,,N,1,,Dissociation constant was determined,CHEMBL624960,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9969,,,,,14941,,50597,,N,1,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL624961,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9970,,,,,15078,,50597,,N,1,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL624962,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9971,,,,,15078,,50597,,N,1,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL624963,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9972,,,,,4755,,50597,,N,1,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,CHEMBL624964,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9973,,,,,589,,50597,,N,1,,LogP value was evaluated in the in situ rat gut perfusion assay,CHEMBL624965,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9974,In vivo,,,,17582,,50597,,N,1,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL624966,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9975,In vivo,,,,5031,,50597,,N,1,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,CHEMBL624967,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9976,In vivo,,,,17764,,50597,,N,1,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,CHEMBL624968,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9977,,,,,17720,,50597,,N,1,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL624969,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,9978,,,,,2862,,50597,,N,1,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,CHEMBL624970,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9979,,,,,16423,,50597,,N,1,,Half-life was evaluated after 10 uM/kg of intra arterial administration,CHEMBL624971,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9980,In vivo,,,,16423,,50597,,N,1,,Half-life was evaluated after 20 uM/kg of peroral administration,CHEMBL624972,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9981,In vivo,,,,6005,,50597,,N,1,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,CHEMBL624973,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9982,,,Plasma,,2938,1969.0,50597,,N,1,,Half-life was evaluated in plasma of rat,CHEMBL624974,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9983,In vivo,,,,6410,,50597,,N,1,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,CHEMBL624975,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9984,In vivo,,,,6410,,50597,,N,1,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL877492,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9985,In vivo,,,,6062,,50597,,N,1,,Half-life was measured in rat after an iv dose of 1 mg/kg,CHEMBL624976,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9986,In vivo,,,,6571,,50597,,N,1,,Half-life period of compound in rats after peroral administration,CHEMBL624977,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9987,,,Plasma,,3136,1969.0,50597,,N,1,,Half-life period of compound was measured in rat plasma.,CHEMBL626848,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9988,,,Plasma,,3136,1969.0,50597,,N,1,,Half-life period of compound was measured in rat plasma; ND is not determined,CHEMBL626849,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9989,,,Plasma,,3136,1969.0,50597,,N,1,,Half-life period of compound was measured in rat plasma; not determined,CHEMBL626850,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9990,In vivo,,,,4521,,50597,,N,1,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL626851,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9991,In vivo,,,,5871,,50597,,N,1,,Half-life period in rat by iv administration,CHEMBL626852,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9992,In vivo,,,,6077,,50597,,N,1,,Half-life period in rats following intravenous administration at 2 mg/kg,CHEMBL626853,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9993,In vivo,,,,6679,,50597,,N,1,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL626854,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9994,,,,,5144,,50597,,N,1,,Half-life period was determined for the compound in rat,CHEMBL627486,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9995,In vivo,,,,4498,,50597,,N,1,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",CHEMBL627487,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9996,In vivo,,,,4498,,50597,,N,1,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",CHEMBL627488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9997,In vivo,,,,1908,,50597,,N,1,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,CHEMBL627489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9998,In vivo,,,,6211,,50597,,N,1,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL627490,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,9999,In vivo,,,,5529,,50597,,N,1,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),CHEMBL873829,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10000,In vivo,,,,6444,,50597,,N,1,,Half-life was determined in rat at a dose of 1 mpk i.v.,CHEMBL627655,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10001,In vivo,,,,6444,,50597,,N,1,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,CHEMBL625994,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10002,In vivo,,,,6444,,50597,,N,1,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,CHEMBL625995,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10003,,,,,5207,,50597,,N,1,,Half-life in rat,CHEMBL625996,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10004,In vitro,,Plasma,,530,1969.0,50597,,N,1,,In vitro half life in rat plasma,CHEMBL625850,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10005,In vitro,,Plasma,,1116,1969.0,50597,,N,1,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",CHEMBL625851,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10006,In vitro,,,,3219,,50597,,N,1,,In vitro half life in rat,CHEMBL625852,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10007,In vivo,,,,6109,,50597,,N,1,,In vivo half life period after intravenous administration in rat,CHEMBL625853,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10008,In vivo,,,,17582,,50597,,N,1,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL625854,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10009,In vivo,,,,17582,,50597,,N,1,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,CHEMBL874450,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10010,In vivo,,,,5974,,50597,,N,1,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL625855,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10011,In vivo,,,,5974,,50597,,N,1,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL625856,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10012,In vivo,,,,5974,,50597,,N,1,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL625857,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10013,In vivo,,,,5974,,50597,,N,1,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL873831,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10014,In vivo,,,,17853,,50597,,N,1,,Longer half-life in rat (i.v.) at 0.5 mpk,CHEMBL625858,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10015,In vivo,,,,17853,,50597,,N,1,,Longer half-life in rat (p.o.) at 2.0 mpk,CHEMBL625859,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10016,,,,,3457,,50597,,N,1,,Pharmacokinetic property (half life) in rat,CHEMBL625860,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10017,In vivo,,,,2792,,50597,,N,1,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,CHEMBL625861,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10018,In vivo,,,,2792,,50597,,N,1,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,CHEMBL625862,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10019,In vivo,,,,2792,,50597,,N,1,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,CHEMBL625863,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10020,In vivo,,,,2792,,50597,,N,1,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,CHEMBL625864,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10021,In vivo,,,,5739,,50597,,N,1,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,CHEMBL625865,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10022,In vivo,,,,15765,,50597,,N,1,,Pharmacokinetic half time was determined intravenously in rats.,CHEMBL625866,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10023,In vivo,,Plasma,,6567,1969.0,50597,,N,1,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,CHEMBL625867,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10024,,,Plasma,,2448,1969.0,50597,,N,1,,Plasma half life of hydrolysis of the compound,CHEMBL625868,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10025,In vivo,,Plasma,,5423,1969.0,50597,,N,1,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,CHEMBL625869,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10026,,,Plasma,,4853,1969.0,50597,,N,1,,Plasma half life period was calculated in rat,CHEMBL874451,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10027,,,Plasma,,4514,1969.0,50597,,N,1,,Plasma half-life in Sprague-Dawley rats,CHEMBL625870,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10028,,,Plasma,,4514,1969.0,50597,,N,1,,Plasma half-life in Sprague-Dawley rats; Not determined,CHEMBL625871,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10029,,,Plasma,,1500,1969.0,50597,,N,1,,Plasma half-life in rats,CHEMBL625872,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10030,,,Plasma,,1500,1969.0,50597,,N,1,,Plasma half-life in rats; <MQL,CHEMBL625873,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10031,,,Plasma,,5334,1969.0,50597,,N,1,,Plasma half-life period (0-8 h) was determined,CHEMBL625874,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10032,,,Plasma,,5334,1969.0,50597,,N,1,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,CHEMBL625875,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10033,In vivo,,Plasma,,5334,1969.0,50597,,N,1,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,CHEMBL625876,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10034,In vivo,,Plasma,,5334,1969.0,50597,,N,1,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,CHEMBL631258,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10035,,,Plasma,,4956,1969.0,50597,,N,1,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,CHEMBL631259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10036,,,Plasma,,4956,1969.0,50597,,N,1,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,CHEMBL631260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10037,,,Blood,,7768,178.0,50597,,N,1,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",CHEMBL631261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10038,,,Blood,,7768,178.0,50597,,N,1,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",CHEMBL631262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10039,,,Blood,,7768,178.0,50597,,N,1,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",CHEMBL631263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10040,,,,,7768,,50597,,N,1,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",CHEMBL631264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10041,,,,,7768,,50597,,N,1,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",CHEMBL631265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10042,,,,,7768,,50597,,N,1,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",CHEMBL631266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10043,,,,,7768,,50597,,N,1,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",CHEMBL631267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10044,,,,,7768,,50597,,N,1,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",CHEMBL631268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10045,,,,,7768,,50597,,N,1,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",CHEMBL631269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10046,,,,,7768,,50597,,N,1,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",CHEMBL631270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10047,,,Heart,,7768,948.0,50597,,N,1,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",CHEMBL631271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10048,,,Heart,,7768,948.0,50597,,N,1,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",CHEMBL631272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10049,,,Heart,,7768,948.0,50597,,N,1,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",CHEMBL631273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10050,,,Heart,,7768,948.0,50597,,N,1,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",CHEMBL631274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10051,,,Heart,,7768,948.0,50597,,N,1,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",CHEMBL631275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10052,,,Heart,,7768,948.0,50597,,N,1,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",CHEMBL626984,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10053,,,Heart,,7768,948.0,50597,,N,1,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",CHEMBL626985,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10054,,,Liver,,7768,2107.0,50597,,N,1,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",CHEMBL626986,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10055,,,Liver,,7768,2107.0,50597,,N,1,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",CHEMBL626987,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10056,,,Liver,,7768,2107.0,50597,,N,1,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",CHEMBL626988,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10057,,,Liver,,7768,2107.0,50597,,N,1,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",CHEMBL626989,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10058,,,Liver,,7768,2107.0,50597,,N,1,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",CHEMBL626990,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10059,,,Liver,,7768,2107.0,50597,,N,1,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",CHEMBL626991,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10060,,,Liver,,7768,2107.0,50597,,N,1,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",CHEMBL626992,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10061,,,Lung,,7768,2048.0,50597,,N,1,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",CHEMBL626993,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10062,,,Lung,,7768,2048.0,50597,,N,1,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",CHEMBL874593,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10063,,,Lung,,7768,2048.0,50597,,N,1,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",CHEMBL626994,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10064,,,Lung,,7768,2048.0,50597,,N,1,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",CHEMBL626995,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10065,,,Lung,,7768,2048.0,50597,,N,1,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",CHEMBL626190,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10066,,,Lung,,7768,2048.0,50597,,N,1,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",CHEMBL626191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10067,,,Lung,,7768,2048.0,50597,,N,1,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",CHEMBL626364,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10068,,,Thyroid gland,,7768,2046.0,50597,,N,1,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",CHEMBL626365,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10069,,,Thyroid gland,,7768,2046.0,50597,,N,1,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",CHEMBL626366,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10070,,,Thyroid gland,,7768,2046.0,50597,,N,1,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",CHEMBL626367,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10071,,,Thyroid gland,,7768,2046.0,50597,,N,1,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",CHEMBL626368,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10072,,,Thyroid gland,,7768,2046.0,50597,,N,1,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",CHEMBL626369,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10073,,,Thyroid gland,,7768,2046.0,50597,,N,1,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",CHEMBL626370,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10074,In vivo,,,,4498,,50597,,N,1,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",CHEMBL626371,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10075,In vivo,,,,4498,,50597,,N,1,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",CHEMBL626372,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10076,In vivo,,,,3603,,50597,,N,1,,Bioavailability after a dose of 10 mg/kg p.o.,CHEMBL626373,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10077,In vivo,,,,6215,,50597,,N,1,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,CHEMBL626374,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10078,In vivo,,,,5710,,50597,,N,1,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,CHEMBL626375,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10079,In vivo,,,,5710,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),CHEMBL626376,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10080,In vivo,,,,5676,,50597,,N,1,,Bioavailability in rat po was determined,CHEMBL626377,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10081,In vivo,,,,17667,,50597,,N,1,,Bioavailability of compound at 10 mg/kg in rat after oral administration,CHEMBL626378,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10082,In vivo,,,,17667,,50597,,N,1,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,CHEMBL626379,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10083,In vivo,,,,6848,,50597,,N,1,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL626380,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10084,In vivo,,,,6848,,50597,,N,1,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL626381,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10085,In vivo,,,,17267,,50597,,N,1,,Bioavailability in rat,CHEMBL626382,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10086,In vivo,,,,6362,,50597,,N,1,,Bioavailability in rat (Sprague-Dawley) (female),CHEMBL626383,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10087,In vivo,,,,17671,,50597,,N,1,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL874652,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10088,In vivo,,,,17671,,50597,,N,1,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),CHEMBL626384,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10089,In vivo,,,,4333,,50597,,N,1,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,CHEMBL626385,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10090,In vivo,,,,6077,,50597,,N,1,,Bioavailability in rat at an oral dose of 2 mg/kg,CHEMBL626386,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10091,In vivo,,,,3278,,50597,,N,1,,Bioavailability in rat,CHEMBL626387,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10092,In vivo,,,,5964,,50597,,N,1,,Bioavailability in rat,CHEMBL626388,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10093,In vivo,,,,4884,,50597,,N,1,,Bioavailability in rat,CHEMBL626389,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10094,In vivo,,,,4905,,50597,,N,1,,Bioavailability in rat,CHEMBL626390,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10095,In vivo,,,,4884,,50597,,N,1,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,CHEMBL626391,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10096,In vivo,,,,6850,,50597,,N,1,,Bioavailability in rat,CHEMBL626392,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10097,In vivo,,,,2864,,50597,,N,1,,Oral bioavailability in rat,CHEMBL626393,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10098,In vivo,,,,5780,,50597,,N,1,,Bioavailability was determined in rat,CHEMBL623026,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10099,In vivo,,,,1465,,50597,,N,1,,Bioavailability,CHEMBL623027,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10100,In vivo,,,,5199,,50597,,N,1,,Bioavailability,CHEMBL623028,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10101,In vivo,,,,5765,,50597,,N,1,,Bioavailability in rat after 1 day dosing,CHEMBL623029,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10102,In vivo,,,,5765,,50597,,N,1,,Bioavailability in rat after 4 day dosing,CHEMBL623030,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10103,In vivo,,,,6518,,50597,,N,1,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,CHEMBL623031,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10104,In vivo,,,,6518,,50597,,N,1,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,CHEMBL623032,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10105,In vivo,,,,6518,,50597,,N,1,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,CHEMBL623033,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10106,In vivo,,,,6518,,50597,,N,1,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,CHEMBL623034,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10107,In vivo,,,,2083,,50597,,N,1,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,CHEMBL623035,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10108,In vivo,,,,17260,,50597,,N,1,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL623036,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10109,In vivo,,,,4956,,50597,,N,1,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL623037,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10110,In vivo,,,,4368,,50597,,N,1,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,CHEMBL623038,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10111,In vivo,,Plasma,,17752,1969.0,50597,,N,1,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,CHEMBL874385,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10112,In vivo,,,,1446,,50597,,N,1,,Bioavailability in rat (Fisher) (fasted),CHEMBL623039,,1,A
Intermediate,BAO_0000218,,9443.0,,Primates,10113,In vivo,,,,2891,,22224,,U,1,,Bioavailability in monkey after po administration of 10 mg/kg dose,CHEMBL623040,,0,A
Intermediate,BAO_0000218,,9443.0,,Primates,10114,In vivo,,,,2891,,22224,,U,1,,Oral bioavailability in monkey (dose 10 mg/kg),CHEMBL623041,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10115,In vivo,,,,6672,,50597,,N,1,,Bioavailability in rat,CHEMBL623741,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10116,In vivo,,,,6673,,50597,,N,1,,Bioavailability in rat,CHEMBL623742,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10117,In vivo,,,,17655,,50597,,N,1,,Bioavailability in rat,CHEMBL623743,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10118,In vivo,,,,17796,,50597,,N,1,,Bioavailability in rat,CHEMBL623744,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10119,In vivo,,,,17853,,50597,,N,1,,Bioavailability in rat (dose 2.0 mg/kg p.o.),CHEMBL623745,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10120,In vivo,,,,4521,,50597,,N,1,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),CHEMBL623746,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10121,In vivo,,,,4940,,50597,,N,1,,Oral bioavailability in rat (dose 5 mg/kg p.o.),CHEMBL623747,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10122,In vivo,,,,2891,,22224,,U,1,,Bioavailability in rat after po administration of 30 mg/kg dose,CHEMBL623748,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10123,In vivo,,,,2891,,22224,,U,1,,Bioavailability in rat after po administration of 30 mg/kg dose,CHEMBL623916,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10124,In vivo,,,,4521,,50597,,N,1,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL623917,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10125,In vivo,,,,17686,,50597,,N,1,,Bioavailability in rat (dose 2 mg/kg i.v.),CHEMBL623918,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10126,In vivo,,,,17796,,50597,,N,1,,Bioavailability in rat,CHEMBL874386,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10127,In vivo,,Plasma,,17796,1969.0,50597,,N,1,,Bioavailability in rat; Only traces detected in rat plasma,CHEMBL623919,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10128,In vivo,,,,5064,,50597,,N,1,,Bioavailability in rat,CHEMBL623920,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10129,In vivo,,,,5147,,50597,,N,1,,Bioavailability upon oral administration of compound,CHEMBL623148,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10130,In vivo,,,,1916,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),CHEMBL623149,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10131,In vivo,,,,6049,,50597,,N,1,,Bioavailability in rat,CHEMBL623150,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10132,In vivo,,,,1445,,50597,,N,1,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",CHEMBL623151,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10133,In vivo,,,,1445,,50597,,N,1,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",CHEMBL623152,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,10134,,,,,2862,,50597,,N,1,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,CHEMBL623153,,1,F
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,10135,,,,,2862,,50597,,N,1,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,CHEMBL623154,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10136,,,,,4194,,50597,,N,1,,In vitro and metabolic stability was determined,CHEMBL623155,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10137,,,,,4194,,50597,,N,1,,In vitro metabolic stability in rat hepatocytes,CHEMBL623156,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10138,,,,,5486,,50597,,N,1,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,CHEMBL623157,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10139,In vitro,,Liver,,17582,2107.0,50597,,N,1,Hepatocyte,Metabolic rate for compound was observed in rat hepatocytes,CHEMBL623158,401.0,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10140,,,,,5600,,50597,,N,1,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,CHEMBL623159,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10141,,,,,14294,,50597,,N,1,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),CHEMBL874390,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10142,,,,,14294,,50597,,N,1,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),CHEMBL623160,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10143,,,,,14294,,50597,,N,1,,Metabolism of compound in rat S9 microsomes; Trace,CHEMBL623161,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10144,,,,,17847,,50597,,N,1,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,CHEMBL623162,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10145,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,CHEMBL623163,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10146,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,CHEMBL623164,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10147,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,CHEMBL623165,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10148,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,CHEMBL623166,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10149,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,CHEMBL624983,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10150,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,CHEMBL624984,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10151,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,CHEMBL624985,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10152,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,CHEMBL622970,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10153,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,CHEMBL622971,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10154,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,CHEMBL622972,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10155,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,CHEMBL622973,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10156,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,CHEMBL622974,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10157,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,CHEMBL622975,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10158,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,CHEMBL622976,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10159,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,CHEMBL622977,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10160,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,CHEMBL624351,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10161,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,CHEMBL624352,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10162,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,CHEMBL624353,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10163,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,CHEMBL622397,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10164,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,CHEMBL622398,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10165,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,CHEMBL622399,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10166,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,CHEMBL622400,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10167,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,CHEMBL628428,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10168,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,CHEMBL628590,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10169,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,CHEMBL628591,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10170,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,CHEMBL628592,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10171,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,CHEMBL628593,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10172,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,CHEMBL875333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10173,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,CHEMBL628594,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10174,,,Plasma,,4969,1969.0,50597,,N,1,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,CHEMBL628595,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10175,,,Plasma,,6737,1969.0,50597,,N,1,,Stability in rat plasma was determined,CHEMBL628596,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10176,,,Plasma,,6737,1969.0,50597,,N,1,,Stability in rat plasma was determined; ND= no data,CHEMBL628597,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10177,,,Plasma,,5089,1969.0,50597,,N,1,,Tested for plasma half life period in rat (0-8 hr),CHEMBL628598,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10178,,,Plasma,,5089,1969.0,50597,,N,1,,Tested for plasma half life period in rat (0-8 hr); Not determined,CHEMBL628599,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10179,In vivo,,,,1466,,50597,,N,1,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,CHEMBL628600,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10180,In vivo,,,,1466,,50597,,N,1,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL628601,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10181,,,,,4950,,50597,,N,1,,Tested for the half life in rat,CHEMBL628602,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10182,In vitro,,,,2412,,50597,,N,1,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,CHEMBL628603,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10183,In vitro,,,,2412,,50597,,N,1,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,CHEMBL628604,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10184,In vitro,,,,2412,,50597,,N,1,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,CHEMBL628605,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10185,In vitro,,,,2412,,50597,,N,1,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,CHEMBL628606,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10186,In vitro,,,,2412,,50597,,N,1,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,CHEMBL628607,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10187,,,,,15022,,50597,,N,1,,The biological half life the compound was measured at the dose of 100 umol/kg,CHEMBL628608,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10188,,,,,15022,,50597,,N,1,,The biological half life the compound was measured at the dose of 30 umol/kg,CHEMBL628609,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10189,,,Plasma,,406,1969.0,50597,,N,1,,The compound was evaluated for plasma half life period in rat,CHEMBL628610,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10190,In vivo,,,,15078,,50597,,N,1,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL873819,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10191,In vivo,,,,15078,,50597,,N,1,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL628611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10192,In vivo,,,,5247,,50597,,N,1,,The pharmacokinetic parameter half-life period in vivo in rats,CHEMBL628612,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10193,In vivo,,,,5041,,50597,,N,1,,"The pharmacokinetic property, Half-life was determined",CHEMBL628613,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10194,In vivo,,,,5041,,50597,,N,1,,"The pharmacokinetic property, Half-life in rat in vivo",CHEMBL628614,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10195,In vivo,,,,5041,,50597,,N,1,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",CHEMBL628615,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10196,In vivo,,,,5041,,50597,,N,1,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",CHEMBL628616,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10197,,,Plasma,,3918,1969.0,50597,,N,1,,The plasma half life period in rats,CHEMBL627924,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10198,,,Liver,,2906,2107.0,50597,,N,1,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,CHEMBL627925,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10199,In vivo,,,,6467,,50597,,N,1,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,CHEMBL627926,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10200,,,,,5510,,50597,,N,1,,t1/2 (apparent elimination)of the compound was determined,CHEMBL627927,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10201,,,,,3788,,50597,,N,1,,t1/2 value in rat,CHEMBL627928,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10202,,,,,17796,,50597,,N,1,,Half life in rat,CHEMBL627539,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10203,In vivo,,Plasma,,12873,1969.0,50597,,N,1,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",CHEMBL876790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10204,In vivo,,,,5983,,50597,,N,1,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,CHEMBL858186,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10205,,,,,15765,,50597,,N,1,,Half-life period in fasted rats,CHEMBL627540,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10206,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL627541,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10207,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL627715,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10208,In vivo,,,,429,,50597,,N,1,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,CHEMBL627716,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10209,,,,,17655,,50597,,N,1,,Maximum time required to achieve Cmax was determined in rat,CHEMBL627717,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10210,In vivo,,,,17717,,50597,,N,1,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL627718,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10211,In vivo,,,,17717,,50597,,N,1,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL627719,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10212,In vivo,,,,17717,,50597,,N,1,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,CHEMBL627720,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10213,In vivo,,,,6570,,50597,,N,1,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,CHEMBL627721,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10214,In vivo,,,,6570,,50597,,N,1,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,CHEMBL627722,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10215,In vivo,,,,5978,,50597,,N,1,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL627723,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10216,In vivo,,,,5978,,50597,,N,1,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL626058,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10217,In vivo,,,,5978,,50597,,N,1,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL626059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10218,In vivo,,,,5978,,50597,,N,1,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL626060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10219,In vivo,,Plasma,,17720,1969.0,50597,,N,1,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL626061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10220,In vivo,,,,4723,,50597,,N,1,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL876791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10221,In vivo,,,,4723,,50597,,N,1,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626062,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10222,In vivo,,,,4756,,50597,,N,1,,Tmax at the dose of 2 mg/Kg administered perorally in rats,CHEMBL626063,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10223,In vivo,,,,4756,,50597,,N,1,,Tmax at the dose of 5 mg/Kg administered perorally in rats,CHEMBL626064,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10224,In vivo,,Plasma,,17720,1969.0,50597,,N,1,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,CHEMBL626065,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10225,In vivo,,Plasma,,17720,1969.0,50597,,N,1,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,CHEMBL626066,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10226,In vivo,,,,1466,,50597,,N,1,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL626067,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10227,,,,,7449,,50597,,N,1,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,CHEMBL626068,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10228,,,,,7449,,50597,,N,1,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,CHEMBL626069,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10229,,,,,7449,,50597,,N,1,,Percent total excretion of 3-methoxyacetaminophen glucuronide,CHEMBL626070,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10230,,,,,7449,,50597,,N,1,,Percent total excretion of N-methoxyacetaminophen glucuronide,CHEMBL626071,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10231,,,,,7449,,50597,,N,1,,Percent total excretion of N-methoxyacetaminophen sulfate,CHEMBL626072,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10232,,,,,7449,,50597,,N,1,,Percent total excretion of acetaminophen,CHEMBL626073,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10233,,,Thyroid gland,,7768,2046.0,50597,,N,1,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",CHEMBL626741,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10234,,,,,17655,,50597,,N,1,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",CHEMBL626742,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10235,,,,,17735,,50597,,N,1,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,CHEMBL626743,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10236,,,,,5960,,50597,,N,1,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,CHEMBL876792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10237,,,,,17735,,50597,,N,1,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,CHEMBL626744,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10238,,,,,7116,,50597,,N,1,,Compound was tested for antidiuretic activity in rats,CHEMBL626745,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10239,In vivo,,Plasma,,4878,1969.0,50597,,N,1,,AUC in rat after 3mg/kg oral dose,CHEMBL626746,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10240,,,,,5939,,50597,,N,1,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,CHEMBL626747,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10241,,,,,5939,,50597,,N,1,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,CHEMBL626748,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10242,,,,,16367,,50597,,N,1,,Bioavailability administered orally at a dose of 10 mg/kg to rats,CHEMBL626749,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10243,,,,,16366,,50597,,N,1,,Oral Bioavailability was determined,CHEMBL626750,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10244,,,,,4426,,50597,,N,1,,Oral bioavailability in rat,CHEMBL626751,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10245,,,,,4426,,50597,,N,1,,Oral bioavailability in rat; Not performed.,CHEMBL626913,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10246,,,,,5041,,50597,,N,1,,Bioavailability,CHEMBL626914,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10247,,,,,5041,,50597,,N,1,,Bioavailability was determined; ND denotes no data,CHEMBL626915,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10248,,,,,1500,,50597,,N,1,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,CHEMBL626916,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10249,,,,,1500,,50597,,N,1,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,CHEMBL626917,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10250,,,,,17409,,50597,,N,1,,Binding towards rat plasma protein at 10 uM,CHEMBL626918,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10251,,,,,17409,,50597,,N,1,,Binding towards rat plasma protein at 100 uM,CHEMBL626919,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10252,In vivo,,,,2959,,50597,,N,1,,Bioavailability in rat (dose 20 mg/kg p.o.),CHEMBL626920,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10253,In vivo,,,,13501,,50597,,N,1,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,CHEMBL621976,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10254,In vivo,,,,6567,,50597,,N,1,,Bioavailability in rat after 5 mg/kg oral gavage,CHEMBL877599,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10255,In vivo,,,,6571,,50597,,N,1,,Bioavailability in rat,CHEMBL621977,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10256,In vivo,,,,6715,,50597,,N,1,,Bioavailability in rat (dose 1 mg/kg i.v.),CHEMBL621978,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10257,In vivo,,,,6715,,50597,,N,1,,Bioavailability in rat (dose 3 mg/kg p.o.),CHEMBL621979,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10258,In vivo,,,,2932,,50597,,N,1,,Oral bioavailability in rat,CHEMBL621980,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10259,In vivo,,,,4171,,50597,,N,1,,Bioavailability of the compound in rats after administration of 30 mg/kg,CHEMBL621981,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10260,In vivo,,,,17509,,50597,,N,1,,Bioavailability after administration of 10 mg/kg in rats,CHEMBL621982,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10261,In vivo,,,,17509,,50597,,N,1,,Bioavailability after administration of 2 mg/kg in rats,CHEMBL882953,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10262,In vivo,,,,4527,,50597,,N,1,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL621983,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10263,In vivo,,,,4026,,50597,,N,1,,Bioavailability in dogs was determined; high,CHEMBL621984,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10264,In vivo,,,,6659,,50597,,N,1,,Bioavailability in monkey after intravenous administration at 1 mpk,CHEMBL621985,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10265,In vivo,,,,6659,,50597,,N,1,,Bioavailability in monkey after peroral administration at 10 mpk,CHEMBL621986,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10266,In vivo,,,,6659,,50597,,N,1,,Bioavailability in rat after intravenous administration at 1 mpk,CHEMBL621987,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10267,In vivo,,,,6659,,50597,,N,1,,Bioavailability in rat after intravenous administration at 2 mpk,CHEMBL877600,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10268,In vivo,,,,6659,,50597,,N,1,,Bioavailability in rat after peroral administration at 30 mpk,CHEMBL621988,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10269,In vivo,,,,6659,,50597,,N,1,,Bioavailability in rat after peroral administration at at 100 mpk,CHEMBL621989,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10270,In vivo,,,,6597,,50597,,N,1,,Bioavailability in rats was evaluated,CHEMBL621990,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10271,In vivo,,,,1202,,50597,,N,1,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,CHEMBL621991,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10272,In vivo,,,,1202,,50597,,N,1,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,CHEMBL621992,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10273,In vivo,,,,1202,,50597,,N,1,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,CHEMBL621993,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10274,In vivo,,,,1202,,50597,,N,1,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,CHEMBL621994,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10275,In vivo,,,,5207,,50597,,N,1,,Bioavailability in rat,CHEMBL621995,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10276,In vivo,,,,5970,,50597,,N,1,,Bioavailability in rat,CHEMBL621996,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10277,In vivo,,,,17538,,50597,,N,1,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL621997,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10278,In vivo,,,,17538,,50597,,N,1,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,CHEMBL621998,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10279,In vivo,,,,1466,,50597,,N,1,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL621999,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10280,In vivo,,,,2879,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622000,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10281,In vivo,,,,2879,,50597,,N,1,,Bioavailability was measured in rat after oral administration; 2-4,CHEMBL622001,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10282,In vivo,,,,2879,,50597,,N,1,,Bioavailability was measured in rat after oral administration; 3-7,CHEMBL622002,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10283,In vivo,,,,3777,,50597,,N,1,,Bioavailability in rat (intraduodenal administration),CHEMBL622003,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10284,In vivo,,,,3777,,50597,,N,1,,Bioavailability in rat (intraduodenal administration),CHEMBL877601,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10285,In vivo,,,,3777,,50597,,N,1,,Oral bioavailability in rat,CHEMBL624871,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10286,In vivo,,,,3777,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622004,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10287,In vivo,,,,5423,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),CHEMBL882954,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10288,In vivo,,,,16365,,50597,,N,1,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,CHEMBL622005,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10289,In vivo,,,,16365,,50597,,N,1,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,CHEMBL622006,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10290,In vivo,,,,4239,,50597,,N,1,,Bioavailability was measured in rat,CHEMBL622007,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10291,In vivo,,,,5438,,50597,,N,1,,Bioavailability was reported,CHEMBL622008,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10292,In vivo,,,,5334,,50597,,N,1,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL622009,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10293,In vivo,,,,5334,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL622010,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10294,In vivo,,,,4199,,50597,,N,1,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL622011,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10295,In vivo,,,,4199,,50597,,N,1,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),CHEMBL622012,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10296,In vivo,,,,4199,,50597,,N,1,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),CHEMBL622013,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10297,In vivo,,,,4890,,50597,,N,1,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL622014,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10298,In vivo,,,,2792,,50597,,N,1,,Bioavailability was determined at 3 mg/kg po dose in rats,CHEMBL624749,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10299,In vivo,,,,5529,,50597,,N,1,,Oral bioavailability in rat (dose 2 mg/kg),CHEMBL624750,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10300,In vivo,,,,6685,,50597,,N,1,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",CHEMBL624751,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10301,In vivo,,,,6685,,50597,,N,1,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",CHEMBL624752,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10302,In vivo,,,,6685,,50597,,N,1,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",CHEMBL624753,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10303,In vivo,,,,6005,,50597,,N,1,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,CHEMBL624754,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10304,In vivo,,,,6410,,50597,,N,1,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,CHEMBL624755,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10305,In vivo,,,,6410,,50597,,N,1,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL624756,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10306,In vivo,,,,6103,,50597,,N,1,,Bioavailability in rat,CHEMBL624757,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10307,In vivo,,,,6410,,50597,,N,1,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,CHEMBL624758,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10308,In vivo,,,,6410,,50597,,N,1,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL622270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10309,In vivo,,,,5353,,50597,,N,1,,Bioavailability in rat (Sprague-Dawley),CHEMBL622271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10310,In vivo,,,,4727,,50597,,N,1,,Bioavailability in rat at the dose of 2 mg/kg,CHEMBL622272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10311,In vivo,,,,17804,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10312,In vivo,,,,5809,,50597,,N,1,,Bioavailability in rat (cannulated) (dose 2 mg/kg),CHEMBL622274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10313,In vivo,,,,17804,,50597,,N,1,,Bioavailability value of compound in rats was determined after peroral administration,CHEMBL622275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10314,In vivo,,,,3634,,50597,,N,1,,Oral bioavailability in rat (dose 20 mg/kg),CHEMBL622276,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10315,In vivo,,,,3341,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622277,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10316,In vivo,,,,2690,,50597,,N,1,,Oral bioavailability in rat (dose 5 mg/kg),CHEMBL622278,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10317,In vivo,,,,3184,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622279,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10318,In vivo,,,,740,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622280,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10319,In vivo,,,,1806,,50597,,N,1,,Compound was evaluated for oral bioavailability in rats; 15-27 %,CHEMBL624083,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10320,In vivo,,,,4891,,50597,,N,1,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,CHEMBL624084,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10321,In vivo,,,,3634,,50597,,N,1,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),CHEMBL624085,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10322,In vivo,,,,64,,50597,,N,1,,Compound was tested for bioavailability in rats,CHEMBL624086,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10323,In vivo,,,,4839,,50597,,N,1,,Bioavailability in rat,CHEMBL624087,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10324,In vivo,,,,1094,,50597,,N,1,,Oral bioavailability in rat,CHEMBL624088,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,10325,In vivo,,,,5005,,22224,,U,1,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,CHEMBL624089,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10326,In vivo,,,,5005,,22224,,U,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL624090,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10327,In vivo,,,,4687,,50597,,N,1,,Evaluated for the bioavailability in rat (in vivo),CHEMBL624091,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10328,In vivo,,,,17804,,50597,,N,1,,F value of compound in rats was determined after peroral administration,CHEMBL624092,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10329,In vivo,,,,5974,,50597,,N,1,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL624093,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10330,In vivo,,,,5974,,50597,,N,1,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL624094,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10331,In vivo,,,,5974,,50597,,N,1,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL624095,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10332,In vivo,,,,5974,,50597,,N,1,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL624096,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10333,In vivo,,,,1088,,50597,,N,1,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",CHEMBL624097,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10334,In vivo,,,,1742,,50597,,N,1,,Maximum fall in carotid flow in rat,CHEMBL624098,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10335,In vivo,,,,4689,,50597,,N,1,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,CHEMBL874392,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10336,In vivo,,,,2463,,50597,,N,1,,Oral bioavailability in rat (dose 5 mg/kg),CHEMBL624099,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10337,In vivo,,,,5654,,50597,,N,1,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL624100,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10338,In vivo,,,,5654,,50597,,N,1,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL624101,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10339,In vivo,,,,6874,,50597,,N,1,,Oral bioavailability in rat (male Wistar),CHEMBL624102,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10340,In vivo,,,,5633,,50597,,N,1,,Oral bioavailability after administration (30 mg/kg) in rat; good,CHEMBL624103,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10341,In vivo,,,,5496,,50597,,N,1,,Oral bioavailability at the dose of 2 mg/kg in rat,CHEMBL624104,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10342,In vivo,,,,2358,,50597,,N,1,,Oral bioavailability determined in rats,CHEMBL624105,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10343,In vivo,,,,16456,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),CHEMBL624106,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10344,In vivo,,,,5302,,50597,,N,1,,Oral bioavailability in rat (dose single 10 mg/kg),CHEMBL624107,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10345,In vivo,,,,5302,,50597,,N,1,,Oral bioavailability in rat (dose single 10 mg/kg),CHEMBL623943,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10346,In vivo,,,,5302,,50597,,N,1,,Oral bioavailability in rat (dose 5 mg/kg,CHEMBL623944,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10347,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,CHEMBL623945,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10348,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,CHEMBL623946,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10349,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,CHEMBL623947,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10350,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,CHEMBL623948,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10351,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,CHEMBL623949,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10352,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,CHEMBL623950,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10353,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,CHEMBL874398,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10354,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,CHEMBL623951,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10355,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,CHEMBL623952,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10356,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,CHEMBL623953,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10357,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,CHEMBL623954,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10358,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,CHEMBL623955,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10359,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,CHEMBL623956,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10360,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,CHEMBL627807,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10361,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,CHEMBL627808,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10362,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,CHEMBL627809,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10363,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,CHEMBL627810,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10364,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",CHEMBL627811,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10365,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",CHEMBL627812,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10366,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",CHEMBL627813,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10367,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",CHEMBL627814,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10368,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",CHEMBL875336,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10369,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",CHEMBL627815,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10370,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",CHEMBL627816,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10371,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",CHEMBL627817,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10372,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",CHEMBL627818,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10373,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",CHEMBL627819,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10374,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",CHEMBL627820,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10375,,,,,11020,,50597,,N,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",CHEMBL627821,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10376,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,CHEMBL628464,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10377,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,CHEMBL626239,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10378,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,CHEMBL626240,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10379,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,CHEMBL626241,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10380,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,CHEMBL626242,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10381,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,CHEMBL626243,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10382,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,CHEMBL626244,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10383,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,CHEMBL626907,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10384,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,CHEMBL626908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10385,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,CHEMBL626909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10386,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,CHEMBL626910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10387,,,,,7449,,50597,,N,1,,Percent total excretion of acetaminophen cysteine conjugate,CHEMBL875342,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10388,,,,,7449,,50597,,N,1,,Percent total excretion of acetaminophen glucuronide,CHEMBL626911,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10389,,,,,7449,,50597,,N,1,,Percent total excretion of acetaminophen sulfate,CHEMBL626912,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10390,,,,,7449,,50597,,N,1,,Percent total excretion of acetaminophen-mercapturic acid,CHEMBL627065,,1,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10391,,,Urine,,3172,1088.0,50597,,N,1,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,CHEMBL627066,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10392,In vivo,,,,16456,,50597,,N,1,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL627067,,1,A
Autocuration,BAO_0000218,,8656.0,,ratrat,10393,In vivo,,Muscle tissue,,10839,2385.0,22224,,U,1,,Biodistribution of compound in rat muscle after 5 min of administration,CHEMBL627068,,0,A
Autocuration,BAO_0000218,,8656.0,,ratrat,10394,In vivo,,Muscle tissue,,10839,2385.0,22224,,U,1,,Biodistribution of compound in rat muscle after 5 min of administration.,CHEMBL627069,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10395,In vivo,,,,5334,,22224,,U,1,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL627070,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10396,In vivo,,,,5334,,22224,,U,1,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL627071,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10397,In vivo,,,,5334,,22224,,U,1,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL627072,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10398,In vivo,,,,5334,,22224,,U,1,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL627073,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10399,In vivo,,,,5334,,22224,,U,1,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL625387,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10400,In vivo,,,,5334,,22224,,U,1,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL625388,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10401,In vivo,,Plasma,,5334,1969.0,22224,,U,1,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL625389,,0,A
Autocuration,BAO_0000218,,9940.0,,Ovis aries,10402,In vivo,,Plasma,,5334,1969.0,22224,,U,1,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL875343,,0,A
Intermediate,BAO_0000218,,8570.0,,Serpentes,10403,,,,,1735,,50497,,N,1,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),CHEMBL876795,,1,A
Intermediate,BAO_0000218,,8570.0,,Serpentes,10404,,,,,1469,,50497,,N,1,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,CHEMBL626552,,1,A
Intermediate,BAO_0000218,,8570.0,,Serpentes,10405,,,,,1336,,50497,,N,1,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,CHEMBL626553,,1,A
Autocuration,BAO_0000366,,9606.0,,Homo sapiens,10406,,,Plasma,,12403,1969.0,22224,,U,1,,The human biological plasma half life of the compound,CHEMBL626554,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10407,,,Urine,,8151,1088.0,50597,,N,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,CHEMBL626555,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10408,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,CHEMBL626556,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10409,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,CHEMBL626557,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10410,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,CHEMBL626558,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10411,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,CHEMBL626559,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10412,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,CHEMBL626560,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10413,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,CHEMBL876803,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10414,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,CHEMBL627964,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10415,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,CHEMBL627965,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10416,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,CHEMBL627966,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10417,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,CHEMBL627967,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10418,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,CHEMBL627968,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10419,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,CHEMBL627969,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10420,,,,,8004,,50597,,N,1,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,CHEMBL627970,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10421,,,Blood,,8004,178.0,50597,,N,1,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,CHEMBL627971,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10422,,,Blood,,8004,178.0,50597,,N,1,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,CHEMBL627972,,1,A
Expert,BAO_0000357,,9606.0,,Homo sapiens,10423,,,,,15917,,180,,D,1,,Dissociation constant against binding to human cyclophilin A,CHEMBL856029,,9,B
Expert,BAO_0000019,,9913.0,,Bos taurus,10424,,,,,12396,,11591,,H,1,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,CHEMBL627973,,8,B
Autocuration,BAO_0000019,,,,,10425,,,,,7065,,22224,,U,1,,-Log C was determined by performing the electroshock minimum test,CHEMBL627974,,0,A
Autocuration,BAO_0000019,,,,,10426,,,,,7065,,22224,,U,1,,-Log C was determined by performing the foot shock test,CHEMBL627975,,0,A
Autocuration,BAO_0000019,,,,,10427,,,,,7065,,22224,,U,1,,-Log C was determined by performing the incl screen test,CHEMBL627976,,0,A
Autocuration,BAO_0000019,,,,,10428,,,,,7065,,22224,,U,1,,-Log C was determined by performing the maximum electroshock test,CHEMBL627977,,0,A
Autocuration,BAO_0000019,,,,,10429,,,,,7065,,22224,,U,1,,-Log C was determined by performing the pentylenetetrazole test,CHEMBL627978,,0,A
Autocuration,BAO_0000019,,,,,10430,,,,,12415,,22224,,U,1,,Tested for experimental arotinoid inhibitory dose,CHEMBL627979,,0,A
Autocuration,BAO_0000019,,,,,10431,,,,,10256,,22224,,U,1,,Negative log transformed activity,CHEMBL876804,,0,A
Autocuration,BAO_0000019,,,,,10432,,,,,7991,,22224,,U,1,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",CHEMBL627980,,0,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,10433,,,,,14342,,50512,,N,1,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,CHEMBL627981,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,10434,,,,,14342,,50512,,N,1,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,CHEMBL627982,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,10435,,,,,14342,,50512,,N,1,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,CHEMBL627983,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,10436,,,Ileum,,14342,2116.0,50512,,N,1,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,CHEMBL627984,,1,A
Autocuration,BAO_0000100,,,,,10437,,,,,6047,,22229,,U,1,,Solubility in water was determined; values expressed as -log,CHEMBL627985,,0,P
Autocuration,BAO_0000019,,,,,10438,,,,,17269,,22224,,U,1,,Ratio of Kcat to that of Km was determined,CHEMBL627986,,0,A
Autocuration,BAO_0000019,,,,,10439,,,,,10026,,22224,,U,1,,Observed first order rate constant,CHEMBL627987,,0,A
Autocuration,BAO_0000019,,,,,10440,,,,,14583,,22224,,U,1,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,CHEMBL627988,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10441,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL627989,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10442,In vivo,,,,2661,,50597,,N,1,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL627990,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10443,In vivo,,,,4029,,50597,,N,1,,Oral Bioavailability after administration of 10 mg/kg in male rat,CHEMBL876805,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10444,In vivo,,,,17735,,50597,,N,1,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),CHEMBL627991,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10445,In vivo,,,,4576,,50597,,N,1,,Oral bioavailability in rat,CHEMBL627992,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10446,In vivo,,,,17582,,50597,,N,1,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,CHEMBL627993,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10447,In vivo,,,,17651,,50597,,N,1,,Oral bioavailability at 1 mg/kg was determined in rat,CHEMBL622817,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10448,In vivo,,,,17651,,50597,,N,1,,Oral bioavailability at 10 mg/kg was determined in rat,CHEMBL622818,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10449,In vivo,,,,17670,,50597,,N,1,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",CHEMBL622819,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10450,In vivo,,,,5045,,50597,,N,1,,Oral bioavailability in rat,CHEMBL872267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10451,In vivo,,,,1696,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622820,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10452,In vivo,,,,17764,,50597,,N,1,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,CHEMBL622821,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10453,In vivo,,,,6448,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622822,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10454,In vivo,,,,6596,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622823,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10455,In vivo,,,,17547,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622824,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10456,In vivo,,,,17771,,50597,,N,1,,Oral bioavailability in rat at a dose of 3 mg/kg,CHEMBL622825,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10457,In vivo,,,,6495,,50597,,N,1,,Oral bioavailability in rat after oral administration at 10 mg/kg,CHEMBL622901,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10458,In vivo,,,,4558,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622902,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10459,In vivo,,,,17596,,50597,,N,1,,Oral bioavailability in rat,CHEMBL621844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10460,In vivo,,,,6827,,50597,,N,1,,Oral bioavailability in Dawley rats,CHEMBL621845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10461,In vivo,,,,4026,,50597,,N,1,,Oral bioavailability,CHEMBL621846,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10462,In vivo,,,,10,,50597,,N,1,,Oral bioavailability in rat (dose 30 mg/kg),CHEMBL621847,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10463,In vivo,,,,17717,,50597,,N,1,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL877609,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10464,In vivo,,,,17717,,50597,,N,1,,Bioavailability in rat (dose 3 mg/kg i.v.),CHEMBL621848,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10465,In vivo,,,,17717,,50597,,N,1,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL621849,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10466,In vivo,,,,17717,,50597,,N,1,,Oral bioavailability in rat (dose 60 mg/kg p.o.),CHEMBL622030,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10467,In vivo,,,,4796,,50597,,N,1,,Percent oral bioavailability determined in rats,CHEMBL622031,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10468,In vivo,,,,4883,,50597,,N,1,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,CHEMBL622032,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10469,In vivo,,,,2137,,50597,,N,1,,The compound was evaluated for bioavailability in rats; 32-51,CHEMBL622033,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10470,In vivo,,,,2959,,50597,,N,1,,Bioavailability in rat (dose 20 mg/kg p.o.),CHEMBL622034,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10471,In vivo,,,,1361,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622035,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10472,In vivo,,,,4727,,50597,,N,1,,Bioavailability percent in rat at the dose of 2 mg/kg,CHEMBL882966,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10473,In vivo,,,,16423,,50597,,N,1,,Bioavailability was evaluated after 20 uM/kg of peroral administration,CHEMBL622036,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10474,In vivo,,,,5206,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622037,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10475,In vivo,,,,6448,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622038,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10476,In vivo,,,,17723,,50597,,N,1,,Bioavailability in rats,CHEMBL622039,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10477,In vivo,,Blood,,17738,178.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,CHEMBL622040,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10478,In vivo,,Blood,,17738,178.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,CHEMBL622041,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10479,In vivo,,Blood,,17738,178.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,CHEMBL622042,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10480,In vivo,,Blood,,17738,178.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,CHEMBL622043,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10481,In vivo,,Blood,,17738,178.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,CHEMBL622044,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10482,In vivo,,Bone,,17738,10000001.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,CHEMBL622045,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10483,In vivo,,Bone,,17738,10000001.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,CHEMBL622046,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10484,In vivo,,Bone,,17738,10000001.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,CHEMBL622047,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10485,In vivo,,Bone,,17738,10000001.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,CHEMBL877610,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10486,In vivo,,Brain,,17738,955.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,CHEMBL622048,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10487,In vivo,,Brain,,17738,955.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,CHEMBL622049,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10488,In vivo,,Brain,,17738,955.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,CHEMBL622050,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10489,In vivo,,Brain,,17738,955.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,CHEMBL622051,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10490,In vivo,,,,17738,,50597,,N,1,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,CHEMBL622052,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10491,In vivo,,,,17738,,50597,,N,1,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,CHEMBL622053,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10492,In vivo,,,,17738,,50597,,N,1,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,CHEMBL622054,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10493,In vivo,,,,17738,,50597,,N,1,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,CHEMBL622055,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10494,In vivo,,,,5237,,50597,,N,1,,Oral bioavailability in rats was determined; High,CHEMBL622056,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10495,In vivo,,,,5503,,50597,,N,1,,Oral bioavailability in the rat was determined,CHEMBL622057,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10496,In vivo,,,,15765,,50597,,N,1,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,CHEMBL628008,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10497,In vivo,,,,15660,,50597,,N,1,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),CHEMBL622058,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10498,In vivo,,,,5978,,50597,,N,1,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10499,In vivo,,,,5978,,50597,,N,1,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10500,In vivo,,,,5978,,50597,,N,1,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10501,In vivo,,,,5978,,50597,,N,1,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622062,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10502,In vivo,,,,5656,,50597,,N,1,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,CHEMBL622063,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,10503,In vivo,,,,3598,,50597,,N,1,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL877611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10504,In vivo,,,,4216,,50597,,N,1,,Oral bioavailability of compound in Sprague Dawley rats,CHEMBL622064,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10505,In vivo,,,,17839,,50597,,N,1,,Oral bioavailability of compound in rat,CHEMBL622065,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10506,In vivo,,,,6570,,50597,,N,1,,Oral bioavailability in rat (dose 2 mg/kg),CHEMBL622066,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10507,In vivo,,,,5334,,50597,,N,1,,Oral bioavailability of compound in rat was determined,CHEMBL622067,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10508,In vivo,,,,6886,,50597,,N,1,,Oral bioavailability of compound in rats,CHEMBL622068,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10509,In vivo,,,,5210,,50597,,N,1,,Oral bioavailability of compound was determined in rats,CHEMBL622069,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10510,In vivo,,,,4170,,50597,,N,1,,Oral bioavailability at a dose of 30 mg/kg in rats,CHEMBL624796,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10511,In vivo,,,,6028,,50597,,N,1,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL624797,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10512,In vivo,,,,6028,,50597,,N,1,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL623053,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10513,In vivo,,,,6078,,50597,,N,1,,Oral bioavailability evaluated in rat,CHEMBL623054,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10514,In vivo,,,,6168,,50597,,N,1,,Oral bioavailability in fasted rat,CHEMBL623055,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10515,In vivo,,,,6168,,50597,,N,1,,Oral bioavailability in fed rat,CHEMBL623056,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10516,In vivo,,,,5160,,50597,,N,1,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),CHEMBL623057,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10517,In vivo,,,,6057,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623058,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10518,In vivo,,,,6535,,50597,,N,1,,Oral bioavailability in rat (dose 10 mg/kg p.o.),CHEMBL623059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10519,In vivo,,,,6535,,50597,,N,1,,Oral bioavailability in rat after administration of 10 mg/kg po,CHEMBL623060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10520,In vivo,,,,4194,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10521,In vivo,,,,6230,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623062,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10522,In vivo,,,,6619,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623063,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10523,In vivo,,,,17607,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623064,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10524,In vivo,,,,4942,,50597,,N,1,,Oral bioavailability in ratrs,CHEMBL623065,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10525,In vivo,,,,4942,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623066,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10526,In vivo,,,,6646,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623067,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10527,In vivo,,,,5237,,50597,,N,1,,Oral bioavailability in rats was determined; High,CHEMBL623068,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10528,In vivo,,,,6646,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623069,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10529,In vivo,,,,4449,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623070,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10530,In vivo,,,,6057,,50597,,N,1,,Oral bioavailability was calculated in rat,CHEMBL623071,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10531,In vivo,,,,2552,,50597,,N,1,,Oral bioavailability,CHEMBL623072,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10532,In vivo,,,,5496,,50597,,N,1,,Oral bioavailability,CHEMBL623073,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10533,In vivo,,,,6484,,50597,,N,1,,Oral bioavailability,CHEMBL623074,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10534,In vivo,,,,6485,,50597,,N,1,,Oral bioavailability,CHEMBL623075,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10535,In vivo,,,,6616,,50597,,N,1,,Oral bioavailability after i.v. administration,CHEMBL623076,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10536,In vivo,,,,4969,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL623077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10537,In vivo,,,,5862,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley),CHEMBL623078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10538,In vivo,,,,4514,,50597,,N,1,,Oral bioavailability in Sprague-Dawley rats,CHEMBL623079,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10539,In vivo,,,,4514,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL623080,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10540,In vivo,,,,4514,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL623081,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10541,In vivo,,,,5546,,50597,,N,1,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,CHEMBL623082,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10542,In vivo,,,,6168,,50597,,N,1,,Oral bioavailability in fasted rat,CHEMBL874400,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10543,In vivo,,,,6168,,50597,,N,1,,Oral bioavailability in fed rat,CHEMBL623083,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10544,In vivo,,,,3624,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623084,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10545,In vivo,,,,5213,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623085,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10546,In vivo,,,,5496,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623086,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10547,In vivo,,,,5553,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623087,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10548,In vivo,,,,5833,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623088,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10549,In vivo,,,,5836,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623089,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10550,In vivo,,,,5865,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623090,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10551,In vivo,,,,5960,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623091,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10552,In vivo,,,,6249,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623092,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10553,In vivo,,,,6448,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623093,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10554,In vivo,,,,6453,,50597,,N,1,,Oral bioavailability in rat,CHEMBL874401,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10555,In vivo,,,,6640,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623094,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10556,In vivo,,,,17607,,50597,,N,1,,Oral bioavailability in rat,CHEMBL623095,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10557,In vivo,,,,5939,,50597,,N,1,,Oral bioavailability in rat after peroral administration at 10 mg/kg,CHEMBL623096,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10558,In vivo,,,,5939,,50597,,N,1,,Oral bioavailability in rat after peroral administration at 5 mg/kg,CHEMBL624913,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10559,In vivo,,,,6281,,50597,,N,1,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),CHEMBL624914,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10560,In vivo,,,,5874,,50597,,N,1,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,CHEMBL624915,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10561,In vivo,,,,5213,,50597,,N,1,,Oral bioavailability in rat; Not measured,CHEMBL624916,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10562,In vivo,,,,4964,,50597,,N,1,,Oral bioavailability in rat,CHEMBL624917,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10563,,,,,11020,,50597,,N,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,CHEMBL625157,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10564,,,Liver,,6251,2107.0,50597,,N,1,,In vitro metabolic potential in rat liver microsomes,CHEMBL625158,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10565,In vivo,,,,1568,,50597,,N,1,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",CHEMBL625159,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10566,In vivo,,,,3032,,50597,,N,1,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",CHEMBL625160,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10567,In vivo,,,,3748,,50597,,N,1,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,CHEMBL625161,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10568,In vivo,,,,401,,50597,,N,1,,Oral bioavailability in rat,CHEMBL625162,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10569,In vivo,,,,6512,,50597,,N,1,,Oral bioavailability in rat,CHEMBL625163,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10570,In vivo,,,,17617,,50597,,N,1,,Oral bioavailability in rats at 10 mg/kg,CHEMBL625164,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10571,In vivo,,,,6679,,50597,,N,1,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL625165,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10572,In vivo,,,,6742,,50597,,N,1,,Oral bioavailability in rat,CHEMBL625166,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10573,,,,,589,,50597,,N,1,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,CHEMBL625167,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10574,,,,,589,,50597,,N,1,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,CHEMBL625168,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10575,In vivo,,,,3185,,50597,,N,1,,Plasma clearance of the compound,CHEMBL625169,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10576,In vivo,,,,17596,,50597,,N,1,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,CHEMBL626264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10577,In vivo,,,,2713,,50597,,N,1,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,CHEMBL626265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10578,In vivo,,Plasma,,12500,1969.0,50597,,N,1,,The compound was tested for plasma clearance in rat,CHEMBL626266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10579,In vivo,,Plasma,,12500,1969.0,50597,,N,1,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,CHEMBL626267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10580,,,,,2713,,50597,,N,1,,Plasma concentration upon oral administration of 1 mg/Kg in rats,CHEMBL626268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10581,,,,,1446,,50597,,N,1,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,CHEMBL626269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10582,,,,,6227,,50597,,N,1,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,CHEMBL626270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10583,,,,,4709,,50597,,N,1,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,CHEMBL626271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10584,,,,,5510,,50597,,N,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",CHEMBL626272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10585,,,,,5510,,50597,,N,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",CHEMBL626273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10586,,,,,5510,,50597,,N,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",CHEMBL875346,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10587,,,,,5510,,50597,,N,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",CHEMBL626274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10588,,,,,4514,,50597,,N,1,,Compound was tested for protein binding in rat plasma,CHEMBL626275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10589,,,,,2713,,50597,,N,1,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,CHEMBL624646,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10590,,,,,2713,,50597,,N,1,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,CHEMBL624647,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10591,,,Liver,,5340,2107.0,50597,,N,1,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,CHEMBL624648,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10592,,,,,12058,,50597,,N,1,,Area under curve ratio was determined (po/iv) in rat,CHEMBL624649,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10593,,,,,11195,,50597,,N,1,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,CHEMBL624650,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10594,,,,,11195,,50597,,N,1,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,CHEMBL624651,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10595,,,,,11195,,50597,,N,1,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,CHEMBL624652,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10596,,,,,6495,,50597,,N,1,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,CHEMBL624653,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10597,,,,,6078,,50597,,N,1,,Ratio of AUCbrain to AUCplasma,CHEMBL624654,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10598,,,,,5656,,50597,,N,1,,Ratio of brain to plasma,CHEMBL624655,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10599,,,,,4910,,50597,,N,1,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,CHEMBL624656,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10600,,,,,4910,,50597,,N,1,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,CHEMBL624657,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10601,,,,,4910,,50597,,N,1,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,CHEMBL624658,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10602,,,,,10130,,50597,,N,1,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,CHEMBL624659,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10603,,,,,10130,,50597,,N,1,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,CHEMBL624660,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10604,,,,,10130,,50597,,N,1,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,CHEMBL624661,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10605,,,,,5213,,50597,,N,1,,Steady state brain :blood ratio was determined,CHEMBL624662,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10606,,,,,4910,,50597,,N,1,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL625199,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10607,,,,,4910,,50597,,N,1,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,CHEMBL625200,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10608,,,,,4910,,50597,,N,1,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL625201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10609,,,,,4910,,50597,,N,1,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,CHEMBL625202,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10610,,,,,2083,,50597,,N,1,,Percentage recovery after 3h incubation with rat hapatocytes was determined,CHEMBL625203,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10611,,,,,2082,,50597,,N,1,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,CHEMBL625204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10612,,,,,2082,,50597,,N,1,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,CHEMBL625205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10613,,,,,6351,,50597,,N,1,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,CHEMBL625206,,1,A
Autocuration,BAO_0000019,,,,,10614,,,,,14583,,22224,,U,1,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",CHEMBL625207,,0,A
Autocuration,BAO_0000019,,,,,10615,,,,,14583,,22224,,U,1,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,CHEMBL625208,,0,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,10616,,,,,4608,,50587,,N,1,Caco-2,In vivo absorption in Caco-2 cell line monolayers was determined,CHEMBL625209,495.0,1,A
Autocuration,BAO_0000100,,,,,10617,,,,,13668,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625210,,0,P
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10618,,,,,5669,,50597,,N,1,,Area under curve was determine after peroral administration at 10 mpk in Rat,CHEMBL625211,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,10619,,,,,5669,,50797,,N,1,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,CHEMBL625212,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10620,,,,,5669,,50597,,N,1,,Area under curve was determine after peroral administration at 160 mpk in Rat,CHEMBL625213,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10621,,,,,5669,,50597,,N,1,,Area under curve was determine after peroral administration at 20 mpk in Rat,CHEMBL625214,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10622,,,,,5669,,50597,,N,1,,Area under curve was determine after peroral administration at 50 mpk in Rat,CHEMBL874542,,1,A
Autocuration,BAO_0000100,,,,,10623,,,,,6472,,22229,,U,1,,Calculated partition coefficient (clogP) (AlogP),CHEMBL625215,,0,P
Autocuration,BAO_0000019,,,,,10624,,,,,15106,,22224,,U,1,,Activated partial thromboplastin time measured,CHEMBL625216,,0,A
Autocuration,BAO_0000100,,,,,10625,,,,,15207,,22224,,U,1,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),CHEMBL625217,,0,P
Autocuration,BAO_0000100,,,,,10626,,,,,15207,,22224,,U,1,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),CHEMBL625218,,0,P
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10627,,,Plasma,,13941,1969.0,50588,,N,1,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,CHEMBL622864,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10628,,,Plasma,,13941,1969.0,50597,,N,1,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,CHEMBL622865,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10629,,,Plasma,,13941,1969.0,50597,,N,1,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,CHEMBL622866,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10630,,,Plasma,,13941,1969.0,50588,,N,1,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,CHEMBL622867,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,10631,,,Plasma,,15240,1969.0,50512,,N,1,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,CHEMBL876808,,1,A
Autocuration,BAO_0000019,,,,,10632,,,Brain,,10655,955.0,22224,,U,1,,AUC in brain,CHEMBL627725,,0,A
Autocuration,BAO_0000019,,,,,10633,,,Serum,,10655,1977.0,22224,,U,1,,AUC in serum,CHEMBL627726,,0,A
Autocuration,BAO_0000019,,,,,10634,,,Plasma,,6504,1969.0,22224,,U,1,,AUC was determined,CHEMBL627727,,0,A
Autocuration,BAO_0000019,,,,,10635,,,Plasma,,10615,1969.0,22224,,U,1,,AUC of the compound.,CHEMBL627728,,0,A
Autocuration,BAO_0000019,,,,,10636,,,Plasma,,10353,1969.0,22224,,U,1,,AUC value (0-4 hr),CHEMBL627729,,0,A
Autocuration,BAO_0000019,,,,,10637,,,Plasma,,14907,1969.0,22224,,U,1,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",CHEMBL627730,,0,A
Autocuration,BAO_0000019,,,,,10638,,,Plasma,,14907,1969.0,22224,,U,1,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,CHEMBL627731,,0,A
Autocuration,BAO_0000019,,,,,10639,,,Plasma,,14907,1969.0,22224,,U,1,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",CHEMBL627732,,0,A
Autocuration,BAO_0000019,,,,,10640,,,Plasma,,14907,1969.0,22224,,U,1,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",CHEMBL627733,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10641,,,Plasma,,16359,1969.0,50597,,N,1,,AUC(area under curve) was determined after intravenous administration in rats,CHEMBL627734,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10642,,,Plasma,,16359,1969.0,50597,,N,1,,AUC(area under curve) was determined after oral administration in rats,CHEMBL627735,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,10643,,,Plasma,,15240,1969.0,50512,,N,1,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,CHEMBL627736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10644,,,Plasma,,15240,1969.0,50597,,N,1,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,CHEMBL876809,,1,A
Autocuration,BAO_0000019,,,,,10645,,,,,15469,,22224,,U,1,,Area Under Curve after oral dosing of 100 uM/Kg,CHEMBL627737,,0,A
Autocuration,BAO_0000019,,,,,10646,,,,,15469,,22224,,U,1,,Area Under Curve after oral dosing of 30 uM/Kg,CHEMBL627738,,0,A
Autocuration,BAO_0000019,,,,,10647,,,,,13520,,22224,,U,1,,Area Under Curve was measured by ploting the graph between concentration verses time,CHEMBL627739,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10648,,,,,17025,,50588,,N,1,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,CHEMBL626143,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,10649,,,,,17025,,22224,,U,1,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,CHEMBL626144,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,10650,,,,,17025,,50592,,N,1,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,CHEMBL626145,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10651,,,,,17025,,50597,,N,1,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,CHEMBL626146,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10652,,,Blood,,12032,178.0,50597,,N,1,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,CHEMBL626147,,1,A
Autocuration,BAO_0000019,,,,,10653,,,,,10291,,22224,,U,1,,Area under curve (AUC) was determined,CHEMBL626148,,0,A
Autocuration,BAO_0000218,,,,,10654,,,,,5767,,22224,,U,1,,Area under curve (AUC) following ip administration at 1 mg/kg,CHEMBL626149,,0,A
Autocuration,BAO_0000019,,,,,10655,,,,,1434,,22224,,U,1,,Area under curve (AUC) was determined; ND is Not determined,CHEMBL626150,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10656,,,,,14925,,50588,,N,1,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,CHEMBL626151,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10657,,,,,14925,,50588,,N,1,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,CHEMBL626152,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10658,,,,,14925,,50588,,N,1,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,CHEMBL626153,,1,A
Autocuration,BAO_0000019,,,,,10659,,,,,1434,,22224,,U,1,,Area under curve (AUR) was determined,CHEMBL626154,,0,A
Autocuration,BAO_0000019,,,,,10660,,,,,11883,,22224,,U,1,,Area under curve at 1 uM/dg administered intravenously,CHEMBL626155,,0,A
Autocuration,BAO_0000019,,,,,10661,,,,,11883,,22224,,U,1,,Area under curve at 10 uM/dg administered perorally,CHEMBL626156,,0,A
Autocuration,BAO_0000019,,,,,10662,,,,,11883,,22224,,U,1,,Area under curve at 2 uM/dg administered intravenously,CHEMBL626157,,0,A
Autocuration,BAO_0000019,,,,,10663,,,,,11883,,22224,,U,1,,Area under curve at 20 uM/dg administered perorally,CHEMBL626158,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10664,,,,,15233,,50588,,N,1,,Area under curve at a peroral dose of 3 mg/kg in dog,CHEMBL626159,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10665,,,,,15233,,50597,,N,1,,Area under curve at a peroral dose of 3 mg/kg in rat,CHEMBL626160,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10666,,,,,15233,,50588,,N,1,,Area under curve at an iv dose of 1 mg/kg in dog,CHEMBL626161,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10667,,,,,15233,,50597,,N,1,,Area under curve at an iv dose of 1 mg/kg in rat,CHEMBL626162,,1,A
Autocuration,BAO_0000019,,,,,10668,,,,,12978,,22224,,U,1,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,CHEMBL626163,,0,A
Autocuration,BAO_0000019,,,,,10669,,,,,12978,,22224,,U,1,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,CHEMBL626164,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10670,,,,,11355,,50594,,N,1,,Area under curve measured as conc vs time after intravenous administration to mice.,CHEMBL626165,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10671,,,,,11355,,50594,,N,1,,Area under curve measured as conc vs time after peroral administration to mice.,CHEMBL626166,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10672,,,,,12923,,50588,,N,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,CHEMBL626167,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10673,,,,,12923,,50588,,N,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,CHEMBL626168,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10674,,,,,12923,,50588,,N,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,CHEMBL877463,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10675,,,,,12923,,50588,,N,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,CHEMBL626169,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10676,In vivo,,Heart,,17738,948.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,CHEMBL626170,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10677,In vivo,,Heart,,17738,948.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,CHEMBL626171,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10678,In vivo,,Heart,,17738,948.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,CHEMBL626172,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10679,In vivo,,Heart,,17738,948.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,CHEMBL626173,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10680,In vivo,,Kidney,,17738,2113.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,CHEMBL626174,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10681,In vivo,,Kidney,,17738,2113.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,CHEMBL626175,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10682,In vivo,,Kidney,,17738,2113.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,CHEMBL626176,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10683,In vivo,,Kidney,,17738,2113.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,CHEMBL626177,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10684,In vivo,,Kidney,,17738,2113.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,CHEMBL622499,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10685,In vivo,,Liver,,17738,2107.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,CHEMBL622500,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10686,In vivo,,Liver,,17738,2107.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,CHEMBL622501,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10687,In vivo,,Liver,,17738,2107.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,CHEMBL622502,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10688,In vivo,,Liver,,17738,2107.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,CHEMBL622503,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10689,In vivo,,Liver,,17738,2107.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,CHEMBL877614,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10690,In vivo,,Lung,,17738,2048.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,CHEMBL624839,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10691,In vivo,,Lung,,17738,2048.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,CHEMBL624840,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10692,In vivo,,Lung,,17738,2048.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,CHEMBL624841,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10693,In vivo,,Lung,,17738,2048.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,CHEMBL624842,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10694,In vivo,,Muscle tissue,,17738,2385.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,CHEMBL624843,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10695,In vivo,,Muscle tissue,,17738,2385.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,CHEMBL624844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10696,In vivo,,Muscle tissue,,17738,2385.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,CHEMBL624845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10697,In vivo,,Muscle tissue,,17738,2385.0,50597,,N,1,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,CHEMBL621904,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10698,In vivo,,Blood,,11195,178.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,CHEMBL621905,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10699,In vivo,,Blood,,11195,178.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,CHEMBL874382,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10700,In vivo,,Blood,,11195,178.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,CHEMBL621906,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10701,In vivo,,Brain,,11195,955.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,CHEMBL621907,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10702,In vivo,,Brain,,11195,955.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,CHEMBL622096,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10703,In vivo,,Brain,,11195,955.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,CHEMBL622097,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10704,In vivo,,Heart,,11195,948.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,CHEMBL622098,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10705,In vivo,,Heart,,11195,948.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,CHEMBL622099,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10706,In vivo,,Heart,,11195,948.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,CHEMBL622100,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10707,In vivo,,Kidney,,11195,2113.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,CHEMBL622101,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10708,In vivo,,Kidney,,11195,2113.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,CHEMBL622102,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10709,In vivo,,Kidney,,11195,2113.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,CHEMBL622103,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10710,In vivo,,Liver,,11195,2107.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,CHEMBL622104,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10711,In vivo,,Liver,,11195,2107.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,CHEMBL622105,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10712,In vivo,,Liver,,11195,2107.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,CHEMBL622106,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10713,In vivo,,Lung,,11195,2048.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,CHEMBL622107,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10714,In vivo,,Lung,,11195,2048.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,CHEMBL622108,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10715,In vivo,,Lung,,11195,2048.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,CHEMBL622109,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10716,In vivo,,Muscle tissue,,11195,2385.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,CHEMBL622110,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10717,In vivo,,Muscle tissue,,11195,2385.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,CHEMBL622111,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10718,In vivo,,Muscle tissue,,11195,2385.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,CHEMBL874383,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10719,In vivo,,Zone of skin,,11195,14.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,CHEMBL622112,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10720,In vivo,,Zone of skin,,11195,14.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,CHEMBL622113,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10721,In vivo,,Zone of skin,,11195,14.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,CHEMBL622114,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10722,In vivo,,Spleen,,11195,2106.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,CHEMBL622115,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10723,In vivo,,Spleen,,11195,2106.0,50597,,N,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,CHEMBL622116,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10724,In vivo,,,,6193,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622117,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10725,In vivo,,,,6803,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622118,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10726,In vivo,,,,6647,,50597,,N,1,,Oral bioavailability in rats at 6 mg/kg,CHEMBL622119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10727,In vivo,,,,6647,,50597,,N,1,,Oral bioavailability in rat (dose 6 mg/kg),CHEMBL622120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10728,In vivo,,,,6647,,50597,,N,1,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,CHEMBL622121,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10729,In vivo,,,,6640,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622122,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10730,In vivo,,,,6641,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622123,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10731,In vivo,,,,6641,,50597,,N,1,,Oral bioavailability in rat,CHEMBL622124,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10732,In vivo,,,,6642,,50597,,N,1,,Bioavailability in rat,CHEMBL622125,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10733,In vivo,,,,5472,,50597,,N,1,,Oral bioavailability,CHEMBL622126,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10734,In vivo,,,,6141,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL620455,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10735,In vivo,,,,4390,,50597,,N,1,,Oral bioavailability in rat,CHEMBL620456,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10736,In vivo,,,,5472,,50597,,N,1,,Oral bioavailability in rat,CHEMBL620457,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10737,In vivo,,,,5472,,50597,,N,1,,Oral bioavailability was evaluated; Not tested,CHEMBL620458,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10738,In vivo,,,,5438,,50597,,N,1,,Oral bioavailability,CHEMBL620459,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10739,In vivo,,,,4883,,50597,,N,1,,Oral bioavailability in rat by oral dosing,CHEMBL620460,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10740,In vivo,,,,1908,,50597,,N,1,,Oral bioavailability in rat (dose 10 mg/kg p.o.),CHEMBL620461,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10741,In vivo,,,,4853,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley),CHEMBL620462,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10742,In vivo,,,,4853,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL620463,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10743,In vivo,,,,4853,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL620464,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10744,In vivo,,,,4853,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL620465,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10745,In vivo,,,,4853,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),CHEMBL620466,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10746,In vivo,,,,4853,,50597,,N,1,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,CHEMBL620467,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10747,In vivo,,,,4853,,50597,,N,1,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,CHEMBL620468,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10748,In vivo,,,,12873,,50597,,N,1,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,CHEMBL620469,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10749,In vivo,,,,12873,,50597,,N,1,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,CHEMBL620470,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10750,In vivo,,,,3169,,50597,,N,1,,Oral bioavailability in rat,CHEMBL620471,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10751,In vivo,,,,6305,,50597,,N,1,,Oral bioavailability in rat,CHEMBL620472,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10752,In vivo,,,,4762,,50597,,N,1,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,CHEMBL620473,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10753,In vivo,,,,17847,,50597,,N,1,,Oral bioavailability in rat,CHEMBL620474,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10754,In vivo,,,,6211,,50597,,N,1,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),CHEMBL620475,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10755,In vivo,,,,6011,,50597,,N,1,,Oral bioavailability in rat,CHEMBL620476,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10756,In vivo,,,,6317,,50597,,N,1,,Oral bioavailability in rat,CHEMBL620477,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10757,In vivo,,,,6644,,50597,,N,1,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,CHEMBL620478,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10758,In vivo,,,,6644,,50597,,N,1,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,CHEMBL618768,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10759,In vivo,,,,6644,,50597,,N,1,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,CHEMBL618769,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10760,In vivo,,,,6644,,50597,,N,1,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,CHEMBL618770,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10761,In vivo,,,,6113,,50597,,N,1,,Oral bioavailability (dose 20 mg/kg p.o.),CHEMBL618771,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10762,In vivo,,,,5937,,50597,,N,1,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,CHEMBL618772,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10763,In vivo,,,,5711,,50597,,N,1,,Oral bioavailability in rat at 10 mg/kg of the compound,CHEMBL618773,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10764,In vivo,,,,17717,,50597,,N,1,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL875842,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10765,In vivo,,,,17717,,50597,,N,1,,Bioavailability in rat (dose 3 mg/kg i.v.),CHEMBL618774,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10766,In vivo,,,,17717,,50597,,N,1,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL618775,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10767,In vivo,,,,17717,,50597,,N,1,,Oral bioavailability in rat (dose 60 mg/kg p.o.),CHEMBL618776,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10768,In vivo,,,,4722,,50597,,N,1,,Percent bioavailability (F) in rats after iv administration,CHEMBL618777,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10769,In vivo,,,,4722,,50597,,N,1,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,CHEMBL618778,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10770,In vivo,,,,4353,,50597,,N,1,,Bioavailability in rat (dose 5 uM/kg p.o.),CHEMBL618779,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10771,In vivo,,,,15662,,50597,,N,1,,Oral bioavailability,CHEMBL618780,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10772,In vivo,,,,4756,,50597,,N,1,,Bioavailability in rat (dose 2 mg/kg p.o.),CHEMBL618781,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10773,In vivo,,,,4756,,50597,,N,1,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,CHEMBL618782,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10774,In vivo,,,,3436,,50597,,N,1,,Oral bioavailability in rat (dose 20 mg/kg),CHEMBL618783,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10775,In vivo,,,,17800,,50597,,N,1,,Oral bioavailability in rat,CHEMBL618784,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10776,In vivo,,,,15762,,50597,,N,1,,Percent oral bioavailability evaluated in rat,CHEMBL618785,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10777,In vivo,,,,5089,,50597,,N,1,,Oral bioavailability in rat,CHEMBL618786,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10778,In vivo,,,,5089,,50597,,N,1,,Percent oral bioavailability in rat; Not determined,CHEMBL618787,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10779,In vivo,,,,3185,,50597,,N,1,,Oral bioavailability in rat,CHEMBL618788,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10780,In vivo,,,,5145,,50597,,N,1,,Bioavailability in rat,CHEMBL618789,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10781,In vivo,,,,3457,,50597,,N,1,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),CHEMBL618790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10782,In vivo,,,,3457,,50597,,N,1,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),CHEMBL618791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10783,In vivo,,,,5983,,50597,,N,1,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,CHEMBL875843,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10784,In vivo,,,,5739,,50597,,N,1,,Oral bioavailability in rat (dose 20 mg/kg p.o.),CHEMBL618792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10785,In vivo,,,,3579,,50597,,N,1,,Cmax at a dose of 30 mg/kg in rat,CHEMBL623395,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,10786,In vivo,,,,17788,,22224,,U,1,,Cmax in monkeys at a dose of 1 mg/kg,CHEMBL623396,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10787,In vivo,,,,14956,,50597,,N,1,,Cmax in rat,CHEMBL623397,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10788,In vivo,,,,17788,,50597,,N,1,,Cmax in rats at a dose of 1 mg/kg,CHEMBL623398,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10789,In vivo,,,,9750,,50594,,N,1,,Cmax was measured in mice after an oral dose of 50 mg/kg.,CHEMBL623399,,1,A
Autocuration,BAO_0000218,,,,,10790,In vivo,,,,12767,,22224,,U,1,,"Cmax value at a dose of 12.7 uM/kg, po",CHEMBL623400,,0,A
Autocuration,BAO_0000218,,,,,10791,In vivo,,,,12767,,22224,,U,1,,"Cmax value at a dose of 6.3 uM/kg, iv",CHEMBL623401,,0,A
Autocuration,BAO_0000218,,,,,10792,In vivo,,,,12767,,22224,,U,1,,"Cmax value at a dose of 7.1 uM/kg, iv",CHEMBL623402,,0,A
Autocuration,BAO_0000218,,,,,10793,In vivo,,,,12703,,22224,,U,1,,Cmax value of compound was determined after 1 hr,CHEMBL623403,,0,A
Autocuration,BAO_0000218,,,,,10794,In vivo,,,,15778,,22224,,U,1,,Cmax value of the compound,CHEMBL623404,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10795,In vivo,,,,12818,,50597,,N,1,,Cmax value administered intraintestinal in rats.,CHEMBL625997,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10796,In vivo,,,,14964,,50597,,N,1,,Cmax value administered perorally was determined in rat; Not determined,CHEMBL625998,,1,A
Autocuration,BAO_0000218,,,,,10797,In vivo,,,,15808,,22224,,U,1,,Cmax value at the dose of 2.3 mg/kg,CHEMBL625999,,0,A
Autocuration,BAO_0000218,,,,,10798,In vivo,,,,15808,,22224,,U,1,,Cmax value at the dose of 5 mg/kg,CHEMBL626000,,0,A
Autocuration,BAO_0000218,,,,,10799,In vivo,,,,15778,,22224,,U,1,,Cmax value in the period of 8 hr after dosing. ,CHEMBL626001,,0,A
Autocuration,BAO_0000218,,,,,10800,In vivo,,,,3715,,22224,,U,1,,Cmax value at a oral dose of 20 mg/kg; Not tested,CHEMBL626002,,0,A
Autocuration,BAO_0000218,,,,,10801,In vivo,,,,3715,,22224,,U,1,,Cmax value at a oral dose of 20 mg/kg,CHEMBL626003,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10802,In vivo,,,,1446,,50597,,N,1,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,CHEMBL626004,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,10803,In vivo,,,,15240,,50512,,N,1,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,CHEMBL626005,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10804,In vivo,,,,15240,,50597,,N,1,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,CHEMBL626006,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10805,In vivo,,Plasma,,14810,1969.0,50597,,N,1,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,CHEMBL626007,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10806,In vivo,,Plasma,,14239,1969.0,50594,,N,1,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,CHEMBL626008,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10807,In vivo,,Liver,,12555,2107.0,50588,,N,1,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,CHEMBL626009,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10808,In vivo,,,,10754,,50588,,N,1,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,CHEMBL626010,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10809,In vivo,,Blood,,10754,178.0,50594,,N,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,CHEMBL626011,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10810,In vivo,,Blood,,10754,178.0,50594,,N,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,CHEMBL626012,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10811,In vivo,,Blood,,10754,178.0,50594,,N,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,CHEMBL626013,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10812,In vivo,,Blood,,10754,178.0,50594,,N,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,CHEMBL626014,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10813,In vivo,,Blood,,10754,178.0,50594,,N,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,CHEMBL877496,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10814,In vivo,,,,14600,,50588,,N,1,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,CHEMBL626015,,1,F
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10815,In vivo,,,,14600,,50588,,N,1,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,CHEMBL626016,,1,F
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10816,In vivo,,,,14600,,50588,,N,1,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,CHEMBL626017,,1,F
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10817,In vivo,,Plasma,,13543,1969.0,50588,,N,1,,Bioavailability as maximal plasma concentration in dogs,CHEMBL626018,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10818,In vivo,,Plasma,,13543,1969.0,50588,,N,1,,Bioavailability as maximal plasma concentration in dogs,CHEMBL626692,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10819,In vivo,,Plasma,,13543,1969.0,50597,,N,1,,Bioavailability as maximal plasma concentration in rats,CHEMBL626693,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,10820,In vivo,,Plasma,,13543,1969.0,22224,,U,1,,Bioavailability as maximal plasma concentration in rats,CHEMBL626694,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10821,In vivo,,Blood,,14600,178.0,50588,,N,1,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626695,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10822,In vivo,,Blood,,14600,178.0,50588,,N,1,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626696,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10823,In vivo,,Blood,,14600,178.0,50588,,N,1,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626697,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10824,In vivo,,Blood,,14600,178.0,50588,,N,1,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,CHEMBL626859,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10825,In vivo,,Blood,,14600,178.0,50588,,N,1,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626860,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10826,In vivo,,Blood,,14600,178.0,50588,,N,1,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626861,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10827,In vivo,,,,14681,,50597,,N,1,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,CHEMBL626296,,1,A
Autocuration,BAO_0000218,,,,,10828,In vivo,,,,15905,,22224,,U,1,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,CHEMBL626297,,0,A
Autocuration,BAO_0000218,,,,,10829,In vivo,,Plasma,,15905,1969.0,22224,,U,1,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,CHEMBL626298,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10830,In vivo,,Plasma,,13304,1969.0,50597,,N,1,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",CHEMBL626299,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10831,In vivo,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,CHEMBL626300,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10832,In vivo,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,CHEMBL626301,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10833,In vivo,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,CHEMBL626962,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10834,In vivo,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,CHEMBL626963,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10835,In vivo,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,CHEMBL626964,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,10836,In vivo,,Plasma,,14839,1969.0,100710,,N,1,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,CHEMBL626965,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10837,In vivo,,Plasma,,14839,1969.0,50594,,N,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL626966,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10838,In vivo,,Plasma,,14839,1969.0,50594,,N,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL626967,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,10839,In vivo,,Plasma,,14839,1969.0,100710,,N,1,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,CHEMBL626968,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10840,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,CHEMBL626969,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10841,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,CHEMBL627126,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10842,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,CHEMBL631276,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10843,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,CHEMBL631277,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10844,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,CHEMBL631278,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10845,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,CHEMBL874457,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10846,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,CHEMBL631279,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10847,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,CHEMBL631280,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10848,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,CHEMBL631281,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10849,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,CHEMBL631968,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10850,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,CHEMBL631969,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10851,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,CHEMBL631970,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10852,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,CHEMBL631971,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10853,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,CHEMBL631972,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10854,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,CHEMBL630435,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10855,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,CHEMBL630436,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10856,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,CHEMBL630437,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10857,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,CHEMBL630438,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10858,,,Heart,,8418,948.0,50597,,N,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,CHEMBL630439,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10859,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,CHEMBL630440,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10860,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,CHEMBL630441,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10861,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,CHEMBL630442,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10862,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,CHEMBL625234,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10863,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,CHEMBL625235,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10864,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,CHEMBL625236,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10865,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,CHEMBL625237,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10866,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,CHEMBL626125,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10867,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,CHEMBL626126,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10868,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,CHEMBL626127,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10869,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,CHEMBL626128,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10870,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,CHEMBL626129,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10871,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,CHEMBL626130,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10872,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,CHEMBL626131,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10873,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,CHEMBL626132,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10874,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,CHEMBL626752,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10875,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,CHEMBL626753,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10876,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,CHEMBL626754,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10877,,,Kidney,,8418,2113.0,50597,,N,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,CHEMBL626755,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10878,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,CHEMBL626756,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10879,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,CHEMBL626757,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10880,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,CHEMBL626758,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10881,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,CHEMBL626759,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10882,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,CHEMBL626760,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10883,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),CHEMBL626394,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10884,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,CHEMBL626395,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10885,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),CHEMBL626396,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10886,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),CHEMBL626397,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10887,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),CHEMBL626398,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10888,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),CHEMBL626399,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10889,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,CHEMBL874653,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10890,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL626400,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10891,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),CHEMBL626401,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10892,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),CHEMBL626402,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10893,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),CHEMBL626403,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10894,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL626404,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10895,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,CHEMBL626405,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10896,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL625529,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10897,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),CHEMBL625530,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10898,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),CHEMBL625531,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10899,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),CHEMBL625532,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10900,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL625533,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10901,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,CHEMBL875474,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10902,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL625534,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10903,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),CHEMBL625535,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10904,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),CHEMBL625536,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10905,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),CHEMBL625537,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10906,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL625538,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10907,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,CHEMBL625539,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10908,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL625540,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10909,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL625541,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10910,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),CHEMBL625542,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10911,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),CHEMBL625543,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10912,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL625544,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10913,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,CHEMBL625545,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10914,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),CHEMBL625546,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10915,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,CHEMBL625547,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10916,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),CHEMBL625548,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10917,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),CHEMBL625549,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10918,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),CHEMBL625550,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10919,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),CHEMBL625551,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10920,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),CHEMBL875475,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10921,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),CHEMBL625552,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10922,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),CHEMBL625553,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10923,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),CHEMBL625554,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10924,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),CHEMBL625555,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10925,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),CHEMBL625556,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10926,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,CHEMBL624986,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10927,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),CHEMBL624987,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10928,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624988,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10929,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,CHEMBL624989,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10930,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,CHEMBL624990,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10931,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,CHEMBL874391,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10932,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,CHEMBL624991,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10933,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,CHEMBL624992,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10934,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,CHEMBL624993,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10935,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,CHEMBL624994,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10936,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,CHEMBL624995,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10937,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,CHEMBL624996,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10938,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,CHEMBL624997,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10939,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,CHEMBL624998,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10940,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,CHEMBL624999,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10941,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,CHEMBL882955,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10942,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,CHEMBL625000,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10943,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,CHEMBL625001,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10944,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,CHEMBL625089,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10945,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,CHEMBL625090,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10946,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,CHEMBL625091,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10947,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,CHEMBL625092,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10948,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,CHEMBL625093,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10949,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,CHEMBL625094,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10950,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,CHEMBL625095,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10951,In vivo,,,,2249,,50588,,N,1,,Compound was evaluated for its bioavailability in the dogs,CHEMBL625096,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10952,In vivo,,,,2249,,50597,,N,1,,Compound was evaluated for its bioavailability in the rats,CHEMBL625097,,1,A
Autocuration,BAO_0000218,,,,,10953,In vivo,,,,17515,,22224,,U,1,,Compound was evaluated for oral bioavailability,CHEMBL882956,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10954,In vivo,,,,14541,,50597,,N,1,,Compound was evaluated for percentage of Oral bioavailability in rats,CHEMBL625098,,1,A
Autocuration,BAO_0000218,,10141.0,,Cavia porcellus,10955,In vivo,,,,12797,,22224,,U,1,,Bioavailability in guinea pig,CHEMBL625099,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10956,In vivo,,,,12797,,50597,,N,1,,Compound was evaluated for the oral bioavailability in rat,CHEMBL625100,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10957,In vivo,,,,12797,,50588,,N,1,,Compound was evaluated for the oral bioavailability in dog,CHEMBL625101,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10958,In vivo,,,,12797,,50597,,N,1,,Compound was evaluated for the oral bioavailability in rat,CHEMBL874396,,1,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,10959,In vivo,,,,11727,,22224,,U,1,,Bioavailability in dog (dosed i.v.),CHEMBL625102,,0,F
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,10960,In vivo,,,,13249,,50588,,N,1,,Compound was tested for in vivo bioavailability in dog,CHEMBL625103,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,10961,In vivo,,,,13249,,100712,,N,1,,Compound was tested for in vivo bioavailability in hamsters,CHEMBL625104,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,10962,In vivo,,,,13249,,22224,,U,1,,Compound was tested for in vivo bioavailability in monkey,CHEMBL625105,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10963,In vivo,,,,13249,,50597,,N,1,,Compound was tested for in vivo bioavailability in rat,CHEMBL625106,,1,A
Autocuration,BAO_0000218,,10090.0,,Mus musculus,10964,In vivo,,,,9552,,22224,,U,1,,Oral bioavailability in mouse,CHEMBL625107,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10965,In vivo,,,,9552,,50594,,N,1,,Compound was tested for percent of oral bioavailability in mice; 56-74,CHEMBL625108,,1,A
Autocuration,BAO_0000218,,10090.0,,Mus musculus,10966,In vivo,,,,14839,,22224,,U,1,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),CHEMBL625109,,0,A
Autocuration,BAO_0000218,,9541.0,,Macaca fascicularis,10967,In vivo,,,,14839,,22224,,U,1,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),CHEMBL625110,,0,A
Autocuration,BAO_0000218,,9541.0,,Macaca fascicularis,10968,In vivo,,,,14839,,22224,,U,1,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),CHEMBL625111,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10969,In vivo,,,,14839,,50594,,N,1,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),CHEMBL625112,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10970,In vivo,,,,14839,,50594,,N,1,,Oral bioavailability in nude mice,CHEMBL875334,,1,A
Autocuration,BAO_0000218,,9443.0,,Primates,10971,In vivo,,,,11219,,22224,,U,1,,Bioavailability in monkey (i.d. dosing),CHEMBL628617,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,10972,In vivo,,,,9552,,22224,,U,1,,Bioavailability in rat,CHEMBL628618,,0,A
Autocuration,BAO_0000218,,,,,10973,In vivo,,,,11732,,22224,,U,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,CHEMBL628619,,0,A
Autocuration,BAO_0000218,,,,,10974,In vivo,,,,11732,,22224,,U,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,CHEMBL628620,,0,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,10975,In vivo,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",CHEMBL628621,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,10976,In vivo,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",CHEMBL628622,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,10977,In vivo,,,,14839,,100710,,N,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",CHEMBL628623,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,10978,In vivo,,Plasma,,14839,1969.0,100710,,N,1,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,CHEMBL628624,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10979,In vivo,,Plasma,,14839,1969.0,50594,,N,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL628625,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,10980,In vivo,,Plasma,,14839,1969.0,100710,,N,1,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,CHEMBL628626,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10981,In vivo,,Plasma,,14839,1969.0,50594,,N,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL627041,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10982,In vivo,,Plasma,,14839,1969.0,50594,,N,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL627042,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10983,In vivo,,Plasma,,14839,1969.0,50594,,N,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL627043,,1,A
Autocuration,BAO_0000218,,,,,10984,In vivo,,Plasma,,13932,1969.0,22224,,U,1,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,CHEMBL627044,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10985,In vivo,,Plasma,,11637,1969.0,50594,,N,1,,Cmax in mouse plasma,CHEMBL627045,,1,A
Autocuration,BAO_0000218,,,,,10986,In vivo,,Plasma,,11637,1969.0,22224,,U,1,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,CHEMBL627046,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10987,In vivo,,Plasma,,13960,1969.0,50597,,N,1,,Maximal plasma concentration in rat,CHEMBL627047,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10988,In vivo,,Plasma,,15905,1969.0,50597,,N,1,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,CHEMBL627048,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10989,In vivo,,,,14062,,50597,,N,1,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,CHEMBL627049,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10990,In vivo,,,,14062,,50597,,N,1,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,CHEMBL627050,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10991,In vivo,,,,14062,,50597,,N,1,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,CHEMBL627051,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10992,In vivo,,,,14062,,50597,,N,1,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,CHEMBL627052,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10993,In vivo,,,,14062,,50597,,N,1,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,CHEMBL627053,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,10994,In vivo,,,,14062,,50597,,N,1,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,CHEMBL627054,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10995,In vivo,,,,15011,,50594,,N,1,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627055,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10996,In vivo,,,,15011,,50594,,N,1,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL627056,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10997,In vivo,,,,15011,,50594,,N,1,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),CHEMBL627057,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10998,In vivo,,,,15011,,50594,,N,1,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627058,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,10999,In vivo,,,,15011,,50594,,N,1,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL626211,,1,A
Autocuration,BAO_0000218,,,,,11000,In vivo,,,,10291,,22224,,U,1,,Maximum Concentration of the compound.,CHEMBL626212,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11001,In vivo,,,,14599,,50588,,N,1,,Maximum Concentration was measured after iv administration into Beagle dog,CHEMBL626213,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11002,In vivo,,,,14599,,50588,,N,1,,Maximum Concentration was measured after iv administration into Beagle dog.,CHEMBL626214,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11003,In vivo,,,,14599,,50588,,N,1,,Maximum Concentration was measured after po administration into Beagle dog,CHEMBL626215,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11004,In vivo,,,,14599,,50588,,N,1,,Maximum Concentration was measured after po administration into Beagle dog.,CHEMBL626216,,1,A
Autocuration,BAO_0000218,,,,,11005,In vivo,,Blood,,12767,178.0,22224,,U,1,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,CHEMBL626217,,0,A
Autocuration,BAO_0000218,,,,,11006,In vivo,,Blood,,12767,178.0,22224,,U,1,,Maximum blood level reached after an iv dose of 12.2 uM/kg,CHEMBL626218,,0,A
Autocuration,BAO_0000218,,,,,11007,In vivo,,Blood,,12767,178.0,22224,,U,1,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,CHEMBL626219,,0,A
Autocuration,BAO_0000218,,,,,11008,In vivo,,Blood,,12767,178.0,22224,,U,1,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,CHEMBL626220,,0,A
Autocuration,BAO_0000218,,,,,11009,In vivo,,Blood,,12767,178.0,22224,,U,1,,Maximum blood level reached after an oral dose of 5.0 mg/kg,CHEMBL626221,,0,A
Autocuration,BAO_0000218,,,,,11010,In vivo,,Blood,,12767,178.0,22224,,U,1,,Maximum blood level reached at dose of 10.6 uM/kg orally,CHEMBL626222,,0,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,11011,In vivo,,,,14706,,50512,,N,1,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,CHEMBL626223,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,11012,In vivo,,,,14706,,50512,,N,1,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,CHEMBL626224,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11013,In vivo,,Brain,,14793,955.0,50597,,N,1,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL626225,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11014,In vivo,,Brain,,14793,955.0,50597,,N,1,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,CHEMBL626226,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11015,In vivo,,Brain,,14793,955.0,50597,,N,1,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,CHEMBL626227,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11016,In vivo,,Brain,,14793,955.0,50597,,N,1,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,CHEMBL626228,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11017,In vivo,,,,14793,,50597,,N,1,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL626229,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11018,In vivo,,,,14793,,50597,,N,1,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,CHEMBL626921,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11019,In vivo,,,,14793,,50597,,N,1,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,CHEMBL876793,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11020,In vivo,,,,14793,,50597,,N,1,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,CHEMBL625309,,1,A
Intermediate,BAO_0000218,,1423.0,,Bacillus subtilis,11021,In vivo,,,,10524,,50278,,N,1,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),CHEMBL625310,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11022,In vivo,,,,11871,,22224,,U,1,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,CHEMBL625311,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11023,In vivo,,,,11871,,50597,,N,1,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,CHEMBL625312,,1,A
Autocuration,BAO_0000218,,,,,11024,In vivo,,,,3437,,22224,,U,1,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,CHEMBL625313,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11025,In vivo,,,,12038,,50594,,N,1,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,CHEMBL625314,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11026,In vivo,,,,12038,,50597,,N,1,,Maximum concentration in male rats after iv administration of 20 mg/kg,CHEMBL625315,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11027,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,CHEMBL625316,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11028,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,CHEMBL625317,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11029,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,CHEMBL625318,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11030,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,CHEMBL625319,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11031,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,CHEMBL625320,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11032,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,CHEMBL625321,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11033,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,CHEMBL625322,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11034,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,CHEMBL876801,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11035,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,CHEMBL625323,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11036,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,CHEMBL625324,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11037,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,CHEMBL625325,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11038,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,CHEMBL625326,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11039,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,CHEMBL625327,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11040,,,Liver,,8418,2107.0,50597,,N,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,CHEMBL625328,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11041,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,CHEMBL625329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11042,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,CHEMBL625330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11043,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,CHEMBL627774,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11044,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,CHEMBL627775,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11045,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,CHEMBL627949,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11046,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,CHEMBL627950,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11047,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,CHEMBL627951,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11048,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,CHEMBL627952,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11049,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,CHEMBL627953,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11050,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,CHEMBL627954,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11051,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,CHEMBL627955,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11052,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,CHEMBL627956,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11053,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,CHEMBL876802,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11054,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,CHEMBL627957,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11055,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,CHEMBL627958,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11056,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,CHEMBL627959,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11057,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,CHEMBL627960,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11058,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,CHEMBL627961,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11059,,,Lung,,8418,2048.0,50597,,N,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,CHEMBL627962,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11060,,,,,9796,,50597,,N,1,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL627963,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11061,,,,,9796,,50597,,N,1,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624759,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11062,,,,,9796,,50597,,N,1,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL624760,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11063,,,,,9796,,50597,,N,1,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624761,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11064,,,,,9796,,50597,,N,1,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL877607,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11065,,,Liver,,9796,2107.0,50597,,N,1,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL624762,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11066,,,Liver,,9796,2107.0,50597,,N,1,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624763,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11067,,,Liver,,9796,2107.0,50597,,N,1,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL624764,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11068,,,Liver,,9796,2107.0,50597,,N,1,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624765,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11069,,,Liver,,9796,2107.0,50597,,N,1,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624766,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11070,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),CHEMBL624767,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11071,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,CHEMBL624768,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11072,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),CHEMBL624769,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11073,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624770,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11074,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),CHEMBL624771,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11075,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),CHEMBL624772,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11076,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,CHEMBL624773,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11077,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL624774,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11078,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),CHEMBL624775,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11079,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),CHEMBL624776,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11080,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),CHEMBL624777,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11081,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL624778,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11082,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,CHEMBL624779,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11083,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),CHEMBL624780,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11084,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),CHEMBL624781,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11085,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL877608,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11086,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),CHEMBL624782,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11087,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL624783,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11088,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,CHEMBL624784,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11089,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL624785,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11090,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),CHEMBL624786,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11091,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),CHEMBL624787,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11092,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL628676,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11093,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,CHEMBL621842,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11094,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL621843,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11095,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL623873,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11096,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),CHEMBL623874,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11097,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),CHEMBL623875,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11098,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL623876,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11099,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,CHEMBL623877,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11100,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),CHEMBL623878,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11101,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,CHEMBL623879,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11102,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),CHEMBL623880,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11103,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),CHEMBL623881,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11104,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),CHEMBL623957,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11105,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),CHEMBL623958,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11106,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),CHEMBL623959,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11107,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),CHEMBL623960,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11108,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),CHEMBL623961,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11109,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),CHEMBL623962,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11110,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),CHEMBL624676,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11111,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),CHEMBL624677,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11112,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,CHEMBL624678,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11113,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),CHEMBL624679,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11114,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624680,,1,A
Autocuration,BAO_0000218,,,,,11115,In vivo,,,,11732,,22224,,U,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,CHEMBL624849,,0,A
Autocuration,BAO_0000218,,,,,11116,In vivo,,,,11732,,22224,,U,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,CHEMBL624850,,0,A
Autocuration,BAO_0000218,,,,,11117,In vivo,,,,11732,,22224,,U,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,CHEMBL874399,,0,A
Autocuration,BAO_0000218,,,,,11118,In vivo,,,,11732,,22224,,U,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,CHEMBL624851,,0,A
Autocuration,BAO_0000218,,,,,11119,In vivo,,,,11732,,22224,,U,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,CHEMBL624852,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11120,In vivo,,,,13359,,22224,,U,1,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL624853,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11121,In vivo,,,,16618,,22224,,U,1,,Oral bioavailability in rat (Sprague-Dawley),CHEMBL624854,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11122,In vivo,,,,13960,,22224,,U,1,,Oral bioavailability in rat,CHEMBL624855,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11123,In vivo,,,,13917,,22224,,U,1,,Oral bioavailability in rats was determined in vivo,CHEMBL624856,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,11124,In vivo,,,,14266,,22224,,U,1,,Oral bioavailability in dog,CHEMBL882957,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11125,In vivo,,,,12359,,22224,,U,1,,Oral bioavailability of compound in monkey,CHEMBL624857,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11126,In vivo,,,,12359,,50597,,N,1,,Oral bioavailability of compound in rat,CHEMBL622202,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11127,In vivo,,,,12359,,22224,,U,1,,Bioavailability in rat of PMEA prodrug,CHEMBL622203,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11128,In vivo,,,,12359,,50597,,N,1,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,CHEMBL625522,,1,A
Autocuration,BAO_0000218,,9544.0,,Macaca mulatta,11129,In vivo,,,,10791,,22224,,U,1,,Serum conc at 3 hours following 25 mg/kg dose,CHEMBL622868,,0,A
Autocuration,BAO_0000218,,9544.0,,Macaca mulatta,11130,In vivo,,Urine,,10791,1088.0,22224,,U,1,,Urine conc 0-5 hours following 25 mg/kg dose,CHEMBL622869,,0,A
Autocuration,BAO_0000218,,9544.0,,Macaca mulatta,11131,In vivo,,Urine,,10791,1088.0,22224,,U,1,,Urine conc 0-24 hours following 25 mg/kg dose,CHEMBL622870,,0,A
Autocuration,BAO_0000218,,9534.0,,Chlorocebus aethiops,11132,In vivo,,,,138,,22224,,U,1,,Oral bioavailability in African green monkeys; 20-25,CHEMBL622871,,0,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11133,In vivo,,,,14521,,100710,,N,1,,Oral bioavailability in cynomolgus monkey.,CHEMBL620560,,1,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,11134,In vivo,,,,13953,,22224,,U,1,,Oral bioavailability in dog,CHEMBL620561,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11135,In vivo,,,,12836,,50588,,N,1,,Oral bioavailability in dog at 10 mg/kg oral dose,CHEMBL620562,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11136,In vivo,,,,12836,,100712,,N,1,,Oral bioavailability in hamster at 10 mg/kg oral dose,CHEMBL620563,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11137,In vivo,,,,12836,,50597,,N,1,,Oral bioavailability in rat at 10 mg/kg oral dose,CHEMBL620564,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11138,In vivo,,,,14521,,22224,,U,1,,Oral bioavailability in rat,CHEMBL872265,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11139,In vivo,,,,13953,,22224,,U,1,,Oral bioavailability in rat,CHEMBL620565,,0,A
Autocuration,BAO_0000218,,9347.0,,Eutheria,11140,In vivo,,,,6799,,22224,,U,1,,Oral bioavailability,CHEMBL620566,,0,A
Autocuration,BAO_0000218,,,,,11141,In vivo,,,,11311,,22224,,U,1,,Oral bioavailability was determined; range 49-102%,CHEMBL620567,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11142,In vivo,,,,4013,,50588,,N,1,,Oral bioavailability was determined in dogs,CHEMBL620568,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11143,In vivo,,,,4013,,22224,,U,1,,Oral bioavailability in rat,CHEMBL620569,,0,A
Autocuration,BAO_0000218,,9347.0,,Eutheria,11144,In vivo,,,,17591,,22224,,U,1,,Oral bioavailability,CHEMBL620570,,0,A
Autocuration,BAO_0000218,,,,,11145,In vivo,,,,17591,,22224,,U,1,,Oral bioavailability was determined; Not orally available,CHEMBL620571,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11146,In vivo,,,,15011,,50594,,N,1,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),CHEMBL620572,,1,A
Autocuration,BAO_0000218,,10090.0,,Mus musculus,11147,In vivo,,,,15011,,22224,,U,1,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),CHEMBL620573,,0,A
Autocuration,BAO_0000218,,10090.0,,Mus musculus,11148,In vivo,,,,15011,,22224,,U,1,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,CHEMBL620574,,0,A
Autocuration,BAO_0000218,,9544.0,,Macaca mulatta,11149,In vivo,,,,9552,,22224,,U,1,,Oral bioavailability in Rhesus monkey,CHEMBL620575,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,11150,In vivo,,,,9552,,22224,,U,1,,Oral bioavailability in dog (female mongrel),CHEMBL620576,,0,A
Autocuration,BAO_0000218,,,,,11151,In vivo,,,,3639,,22224,,U,1,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,CHEMBL875846,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,11152,In vivo,,,,13397,,22224,,U,1,,Oral bioavailability in dog,CHEMBL620577,,0,A
Autocuration,BAO_0000218,,,,,11153,In vivo,,,,3031,,22224,,U,1,,Percentage Bioavailability was evaluated.,CHEMBL620578,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11154,In vivo,,,,12818,,22224,,U,1,,Bioavailability in rat administered i.d.,CHEMBL620579,,0,A
Autocuration,BAO_0000218,,9347.0,,Eutheria,11155,In vivo,,,,4847,,22224,,U,1,,Bioavailability,CHEMBL621248,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,11156,In vivo,,,,12421,,22224,,U,1,,Bioavailability in dog (male Beagle) i.v. administration,CHEMBL625390,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11157,In vivo,,,,11966,,22224,,U,1,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",CHEMBL625391,,0,A
Autocuration,BAO_0000218,,9443.0,,Primates,11158,In vivo,,,,11218,,22224,,U,1,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),CHEMBL872266,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11159,In vivo,,,,13129,,22224,,U,1,,Oral bioavailability in rat (Sprague-Dawley) (male),CHEMBL625392,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11160,In vivo,,,,12350,,50597,,N,1,,The oral bioavailability was measured on rats after oral administration,CHEMBL625393,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11161,In vivo,,,,2231,,50597,,N,1,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,CHEMBL625394,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,11162,In vivo,,,,2231,,50797,,N,1,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,CHEMBL625395,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11163,In vivo,,,,12187,,22224,,U,1,,Bioavailability in rat (dose 10 mg/kg i.d.),CHEMBL625396,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,11164,In vivo,,,,12421,,22224,,U,1,,Bioavailability in dog (male Beagle) i.v. administration,CHEMBL625397,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11165,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625398,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11166,In vivo,,Blood,,13256,178.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625399,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11167,In vivo,,Cerebellum,,13256,2037.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL626074,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11168,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL626075,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11169,In vivo,,Plasma,,2231,1969.0,50597,,N,1,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,CHEMBL626076,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,11170,In vivo,,Plasma,,2231,1969.0,50797,,N,1,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,CHEMBL626077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11171,In vivo,,Blood,,12178,178.0,50597,,N,1,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),CHEMBL626078,,1,A
Autocuration,BAO_0000218,,,,,11172,In vivo,,Blood,,12178,178.0,22224,,U,1,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),CHEMBL625846,,0,A
Autocuration,BAO_0000218,,,,,11173,In vivo,,Blood,,12178,178.0,22224,,U,1,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),CHEMBL625847,,0,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,11174,In vivo,,,,15633,,50597,,N,1,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,CHEMBL625848,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11175,In vivo,,Plasma,,14258,1969.0,50597,,N,1,,Maximum concentration of compound in plasma administered orally to rats,CHEMBL625849,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11176,In vivo,,Plasma,,14224,1969.0,50588,,N,1,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",CHEMBL626023,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11177,In vivo,,Plasma,,14224,1969.0,50588,,N,1,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",CHEMBL626024,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11178,In vivo,,Plasma,,14224,1969.0,50588,,N,1,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",CHEMBL626025,,1,A
Autocuration,BAO_0000218,,,,,11179,In vivo,,,,5566,,22224,,U,1,,Maximum concentration after 10 mg/kg by oral administration,CHEMBL626026,,0,A
Autocuration,BAO_0000218,,,,,11180,In vivo,,,,16935,,22224,,U,1,,Maximum concentration at a dose of 1.5 mg/kg,CHEMBL626027,,0,A
Autocuration,BAO_0000218,,,,,11181,In vivo,,,,16935,,22224,,U,1,,Maximum concentration at a dose of 2.0 mg/kg,CHEMBL626028,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11182,In vivo,,Plasma,,14224,1969.0,50588,,N,1,,Maximum concentration in dog plasma,CHEMBL626029,,1,A
Autocuration,BAO_0000218,,,,,11183,In vivo,,Plasma,,12536,1969.0,22224,,U,1,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,CHEMBL626030,,0,A
Autocuration,BAO_0000218,,,,,11184,In vivo,,Plasma,,12536,1969.0,22224,,U,1,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,CHEMBL626031,,0,A
Autocuration,BAO_0000218,,,,,11185,In vivo,,Plasma,,12536,1969.0,22224,,U,1,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,CHEMBL626032,,0,A
Autocuration,BAO_0000218,,,,,11186,In vivo,,Plasma,,12536,1969.0,22224,,U,1,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,CHEMBL626033,,0,A
Autocuration,BAO_0000218,,,,,11187,In vivo,,Plasma,,12536,1969.0,22224,,U,1,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,CHEMBL626034,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11188,In vivo,,Plasma,,9994,1969.0,50588,,N,1,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),CHEMBL626035,,1,A
Autocuration,BAO_0000218,,,,,11189,In vivo,,Plasma,,1434,1969.0,22224,,U,1,,Maximum concentration in plasma at Tmax,CHEMBL626036,,0,A
Expert,BAO_0000218,,9615.0,,Canis lupus familiaris,11190,In vivo,,Plasma,,12836,1969.0,50588,,N,1,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,CHEMBL626037,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11191,In vivo,,Plasma,,12836,1969.0,100712,,N,1,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,CHEMBL626038,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11192,In vivo,,Plasma,,12836,1969.0,50597,,N,1,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,CHEMBL626039,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11193,In vivo,,Plasma,,12545,1969.0,50597,,N,1,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,CHEMBL626040,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,11194,In vivo,,Plasma,,13856,1969.0,50592,,N,1,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,CHEMBL626041,,1,A
Autocuration,BAO_0000218,,,,,11195,In vivo,,,,3550,,22224,,U,1,,Maximum concentration was calculated,CHEMBL626042,,0,A
Autocuration,BAO_0000218,,,,,11196,In vivo,,,,2632,,22224,,U,1,,Maximum concentration was calculated.,CHEMBL626043,,0,A
Autocuration,BAO_0000218,,,,,11197,In vivo,,,,5566,,22224,,U,1,,Maximum concentration at a peroral dose of 10 mg/kg,CHEMBL626044,,0,A
Autocuration,BAO_0000218,,,,,11198,In vivo,,,,11883,,22224,,U,1,,Maximum concentration of the drug at 10 uM/dg administered perorally,CHEMBL626045,,0,A
Autocuration,BAO_0000218,,,,,11199,In vivo,,,,11883,,22224,,U,1,,Maximum concentration of the drug at 2 uM/dg administered intravenously,CHEMBL626046,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11200,In vivo,,Plasma,,14122,1969.0,50588,,N,1,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",CHEMBL626047,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11201,In vivo,,Plasma,,14122,1969.0,100712,,N,1,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",CHEMBL626048,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11202,In vivo,,Plasma,,14122,1969.0,50597,,N,1,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",CHEMBL626049,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11203,In vivo,,Plasma,,12542,1969.0,50597,,N,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,CHEMBL626050,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11204,In vivo,,Plasma,,12542,1969.0,50588,,N,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,CHEMBL874541,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11205,In vivo,,Plasma,,12542,1969.0,100712,,N,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,CHEMBL622826,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11206,In vivo,,Plasma,,12542,1969.0,100712,,N,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,CHEMBL622827,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11207,In vivo,,Plasma,,12542,1969.0,50597,,N,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,CHEMBL622828,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11208,In vivo,,Plasma,,14080,1969.0,50597,,N,1,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,CHEMBL622829,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11209,In vivo,,,,11911,,50597,,N,1,,Maximum concentration reached following intravenous administration in male rat,CHEMBL876806,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11210,In vivo,,,,13204,,50588,,N,1,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,CHEMBL622830,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11211,In vivo,,,,13204,,50597,,N,1,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,CHEMBL622831,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11212,In vivo,,,,14346,,50588,,N,1,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,CHEMBL626794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11213,In vivo,,,,14346,,50597,,N,1,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,CHEMBL626795,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11214,In vivo,,,,14346,,50597,,N,1,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,CHEMBL626796,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11215,In vivo,,,,14346,,50597,,N,1,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,CHEMBL626797,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11216,In vivo,,,,14127,,50597,,N,1,,Maximum drug concentration is determined after oral dosing in rats.,CHEMBL626798,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11217,In vivo,,,,14339,,50588,,N,1,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,CHEMBL626799,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11218,In vivo,,,,14339,,50588,,N,1,,Maximum observed concentration in oral (5 mg/kg) fed dogs,CHEMBL626800,,1,A
Autocuration,BAO_0000218,,,,,11219,In vivo,,Plasma,,13494,1969.0,22224,,U,1,,Maximum plasma concentration,CHEMBL626801,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11220,In vivo,,Plasma,,14925,1969.0,50597,,N,1,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,CHEMBL876816,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11221,In vivo,,Plasma,,14474,1969.0,50597,,N,1,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,CHEMBL626802,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11222,In vivo,,Plasma,,14474,1969.0,50588,,N,1,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,CHEMBL626803,,1,A
Autocuration,BAO_0000218,,,,,11223,In vivo,,Plasma,,13917,1969.0,22224,,U,1,,Maximum plasma concentration following oral administration of 30 umol/kg,CHEMBL626804,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11224,,,Plasma,,9796,1969.0,50597,,N,1,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,CHEMBL626805,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11225,,,Plasma,,9796,1969.0,50597,,N,1,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL626309,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11226,,,Plasma,,9796,1969.0,50597,,N,1,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL626310,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11227,,,Plasma,,9796,1969.0,50597,,N,1,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626311,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11228,,,Plasma,,9796,1969.0,50597,,N,1,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626312,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11229,,,Uterus,,9796,995.0,50597,,N,1,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626313,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11230,,,Uterus,,9796,995.0,50597,,N,1,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL626314,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11231,,,Uterus,,9796,995.0,50597,,N,1,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL626315,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11232,,,Uterus,,9796,995.0,50597,,N,1,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626316,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11233,,,Uterus,,9796,995.0,50597,,N,1,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626317,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11234,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626318,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11235,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626319,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11236,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626320,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11237,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL875053,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11238,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626321,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11239,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626322,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11240,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626323,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11241,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626324,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11242,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626325,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11243,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626326,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11244,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626327,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11245,,,,,8363,,50597,,N,1,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626328,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11246,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",CHEMBL626329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11247,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",CHEMBL626330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11248,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",CHEMBL626331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11249,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",CHEMBL626332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11250,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",CHEMBL626333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11251,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",CHEMBL626334,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11252,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",CHEMBL626335,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11253,,,Blood,,8684,178.0,50597,,N,1,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",CHEMBL624798,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11254,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",CHEMBL624799,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11255,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",CHEMBL624800,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11256,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",CHEMBL624801,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11257,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",CHEMBL624802,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11258,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",CHEMBL624803,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11259,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",CHEMBL624804,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11260,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",CHEMBL624805,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11261,,,Brain,,8684,955.0,50597,,N,1,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",CHEMBL624806,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11262,,,,,8684,,50597,,N,1,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",CHEMBL624807,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11263,,,,,8684,,50597,,N,1,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",CHEMBL624808,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11264,,,,,8684,,50597,,N,1,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",CHEMBL624809,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11265,,,,,8684,,50597,,N,1,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",CHEMBL624810,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11266,,,,,8684,,50597,,N,1,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",CHEMBL877618,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11267,,,,,8684,,50597,,N,1,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",CHEMBL624811,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11268,,,,,8684,,50597,,N,1,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",CHEMBL624812,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11269,,,,,8684,,50597,,N,1,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",CHEMBL624813,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11270,,,,,8684,,50597,,N,1,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",CHEMBL624814,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11271,,,,,8684,,50597,,N,1,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",CHEMBL624815,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11272,,,,,8684,,50597,,N,1,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",CHEMBL624816,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11273,,,,,8684,,50597,,N,1,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",CHEMBL624817,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11274,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),CHEMBL624818,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11275,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,CHEMBL624819,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11276,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),CHEMBL624820,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11277,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624821,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11278,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),CHEMBL624822,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11279,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),CHEMBL624823,,1,A
Intermediate,BAO_0000218,,562.0,,Escherichia coli,11280,,,,,15599,,50212,,N,1,,Observed diffusion coefficient in organic solvent for Escherichia coli,CHEMBL624824,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11281,,,Blood,,9614,178.0,50597,,N,1,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624825,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11282,,,Blood,,9614,178.0,50597,,N,1,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624826,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11283,,,Cardiac atrium,,9614,2081.0,50597,,N,1,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL876817,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11284,,,Cardiac atrium,,9614,2081.0,50597,,N,1,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624827,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11285,,,,,9614,,50597,,N,1,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624828,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11286,,,,,9614,,50597,,N,1,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624829,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11287,,,Liver,,9614,2107.0,50597,,N,1,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624830,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11288,,,Liver,,9614,2107.0,50597,,N,1,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624831,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11289,,,Cardiac atrium,,9614,2081.0,50597,,N,1,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624832,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11290,,,Cardiac atrium,,9614,2081.0,50597,,N,1,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624833,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11291,,,,,9614,,50597,,N,1,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624834,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11292,,,,,9614,,50597,,N,1,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624835,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11293,,,Spleen,,9614,2106.0,50597,,N,1,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624836,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11294,,,Spleen,,9614,2106.0,50597,,N,1,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624837,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11295,,,Blood,,9071,178.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,CHEMBL624838,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11296,,,Blood,,9071,178.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,CHEMBL622188,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11297,,,Heart,,9071,948.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,CHEMBL622189,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11298,,,Heart,,9071,948.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,CHEMBL622190,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11299,,,Heart,,9071,948.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,CHEMBL625170,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11300,,,Kidney,,9071,2113.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,CHEMBL625171,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11301,,,Kidney,,9071,2113.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,CHEMBL625172,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11302,,,Kidney,,9071,2113.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,CHEMBL625173,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11303,,,Liver,,9071,2107.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,CHEMBL625174,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11304,,,Liver,,9071,2107.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,CHEMBL625175,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11305,,,Liver,,9071,2107.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,CHEMBL625176,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11306,,,Lung,,9071,2048.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,CHEMBL625177,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11307,,,Lung,,9071,2048.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,CHEMBL625178,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11308,,,Lung,,9071,2048.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,CHEMBL625179,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11309,,,Lung,,9071,2048.0,50597,,N,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,CHEMBL625180,,1,A
Autocuration,BAO_0000218,,,,,11310,,,,,10677,,22224,,U,1,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",CHEMBL625181,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11311,,,Urine,,9750,1088.0,50594,,N,1,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,CHEMBL625182,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11312,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL625183,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11313,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL875848,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11314,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL622260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11315,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL622261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11316,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL622262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11317,,,Kidney,,8319,2113.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL622263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11318,,,Kidney,,8319,2113.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL622418,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11319,,,Liver,,8319,2107.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL622419,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11320,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623388,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11321,In vivo,,Liver,,13256,2107.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623389,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11322,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623390,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11323,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623391,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11324,In vivo,,Blood,,13256,178.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623392,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11325,In vivo,,Cerebellum,,13256,2037.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623393,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11326,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623394,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11327,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL618885,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11328,In vivo,,Liver,,13256,2107.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL618886,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11329,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL618887,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11330,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619535,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11331,In vivo,,Blood,,13256,178.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619536,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11332,In vivo,,Cerebellum,,13256,2037.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619537,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11333,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619705,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11334,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619706,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11335,In vivo,,Liver,,13256,2107.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619707,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11336,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619708,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11337,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625219,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11338,In vivo,,Blood,,13256,178.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625220,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11339,In vivo,,Cerebellum,,13256,2037.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625221,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11340,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625222,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11341,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625223,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11342,In vivo,,Liver,,13256,2107.0,50594,,N,1,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625224,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11343,In vivo,,,,13256,,50594,,N,1,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625225,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11344,In vivo,,Blood,,8829,178.0,50597,,N,1,,Biodistribution in Rat blood after 24 hours of iv administration,CHEMBL625226,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11345,In vivo,,Blood,,8829,178.0,50597,,N,1,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,CHEMBL625227,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11346,In vivo,,Blood,,8829,178.0,50597,,N,1,,Biodistribution in Rat blood after 30 minutes of iv administration,CHEMBL625228,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11347,In vivo,,Blood,,8829,178.0,50597,,N,1,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,CHEMBL875354,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11348,In vivo,,Blood,,8829,178.0,50597,,N,1,,Biodistribution in Rat blood after 5 minutes of iv administration,CHEMBL625229,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11349,In vivo,,Blood,,8829,178.0,50597,,N,1,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,CHEMBL625230,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11350,In vivo,,Heart,,8829,948.0,50597,,N,1,,Biodistribution in Rat heart after 24 hours of iv administration,CHEMBL625231,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11351,In vivo,,Heart,,8829,948.0,50597,,N,1,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,CHEMBL625900,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11352,In vivo,,Heart,,8829,948.0,50597,,N,1,,Biodistribution in Rat heart after 30 minutes of iv administration,CHEMBL625901,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11353,In vivo,,Heart,,8829,948.0,50597,,N,1,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,CHEMBL625902,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11354,In vivo,,Heart,,8829,948.0,50597,,N,1,,Biodistribution in Rat heart after 5 minutes of iv administration,CHEMBL625903,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11355,In vivo,,Heart,,8829,948.0,50597,,N,1,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,CHEMBL625904,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11356,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 24 hours of iv administration,CHEMBL625905,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11357,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,CHEMBL627861,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11358,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 30 minutes of iv administration,CHEMBL627862,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11359,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,CHEMBL627863,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11360,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 30 minutes of iv administration,CHEMBL627769,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11361,In vivo,,Plasma,,13249,1969.0,50588,,N,1,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,CHEMBL627770,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11362,In vivo,,,,13622,,100710,,N,1,,Cmax in cynomolgus monkey (PO dose),CHEMBL627771,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11363,In vivo,,,,13622,,50597,,N,1,,Cmax in rat (PO dose),CHEMBL627772,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11364,In vivo,,,,13622,,50597,,N,1,,Cmax in rat (PO dose),CHEMBL627773,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11365,In vivo,,Plasma,,13494,1969.0,50597,,N,1,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,CHEMBL621922,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11366,In vivo,,Plasma,,12170,1969.0,50597,,N,1,,Cmax in rat plasma after oral dose (10 mg/kg),CHEMBL621923,,1,A
Autocuration,BAO_0000218,,,,,11367,In vivo,,Plasma,,12170,1969.0,22224,,U,1,,Cmax in plasma after oral dose (10 mg/kg),CHEMBL621924,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11368,In vivo,,Plasma,,17025,1969.0,50588,,N,1,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,CHEMBL621925,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11369,In vivo,,Plasma,,17025,1969.0,22224,,U,1,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,CHEMBL621926,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,11370,In vivo,,Plasma,,17025,1969.0,50592,,N,1,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,CHEMBL621927,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11371,In vivo,,Plasma,,17025,1969.0,50597,,N,1,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,CHEMBL621928,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11372,In vivo,,Plasma,,14187,1969.0,50597,,N,1,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,CHEMBL621929,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11373,In vivo,,Plasma,,14816,1969.0,50594,,N,1,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,CHEMBL621930,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11374,In vivo,,Plasma,,17820,1969.0,50597,,N,1,,Maximum plasma concentration after oral dosing in rat,CHEMBL621931,,1,A
Autocuration,BAO_0000218,,,,,11375,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,CHEMBL621932,,0,A
Autocuration,BAO_0000218,,,,,11376,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL621933,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11377,In vivo,,Plasma,,14691,1969.0,50588,,N,1,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,CHEMBL621934,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11378,In vivo,,Plasma,,14691,1969.0,50588,,N,1,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,CHEMBL621935,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11379,In vivo,,Plasma,,13375,1969.0,50597,,N,1,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,CHEMBL621936,,1,A
Autocuration,BAO_0000218,,,,,11380,In vivo,,Plasma,,6236,1969.0,22224,,U,1,,Maximum plasma concentration was determined,CHEMBL621937,,0,A
Autocuration,BAO_0000218,,,,,11381,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL621938,,0,A
Autocuration,BAO_0000218,,,,,11382,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL621939,,0,A
Autocuration,BAO_0000218,,,,,11383,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,CHEMBL621940,,0,A
Autocuration,BAO_0000218,,,,,11384,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,CHEMBL621941,,0,A
Autocuration,BAO_0000218,,,,,11385,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,CHEMBL621942,,0,A
Autocuration,BAO_0000218,,,,,11386,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL626178,,0,A
Autocuration,BAO_0000218,,,,,11387,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL626179,,0,A
Autocuration,BAO_0000218,,,,,11388,In vivo,,Plasma,,14380,1969.0,22224,,U,1,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,CHEMBL626180,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11389,In vivo,,Plasma,,13622,1969.0,50597,,N,1,,Plasma Cmax in rat (PO dose),CHEMBL626181,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11390,In vivo,,,,15372,,50597,,N,1,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,CHEMBL626182,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11391,In vivo,,,,15372,,50597,,N,1,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,CHEMBL626183,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11392,In vivo,,,,15372,,50597,,N,1,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,CHEMBL626184,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11393,In vivo,,,,15372,,50597,,N,1,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,CHEMBL626185,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11394,In vivo,,Plasma,,14925,1969.0,50588,,N,1,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,CHEMBL626186,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11395,In vivo,,Plasma,,14925,1969.0,50588,,N,1,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,CHEMBL877589,,1,A
Autocuration,BAO_0000218,,,,,11396,In vivo,,,,11883,,22224,,U,1,,Maximum concentration of the drug at 1 uM/dg administered intravenously,CHEMBL626187,,0,A
Autocuration,BAO_0000218,,,,,11397,In vivo,,,,11883,,22224,,U,1,,Maximum concentration of the drug at 20 uM/dg administered perorally,CHEMBL626188,,0,A
Autocuration,BAO_0000218,,,,,11398,In vivo,,,,13391,,22224,,U,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,CHEMBL626189,,0,A
Autocuration,BAO_0000218,,,,,11399,In vivo,,Blood,,13391,178.0,22224,,U,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL626855,,0,A
Autocuration,BAO_0000218,,,,,11400,In vivo,,Blood,,13391,178.0,22224,,U,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL623781,,0,A
Autocuration,BAO_0000218,,,,,11401,In vivo,,Blood,,13391,178.0,22224,,U,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL623782,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11402,In vivo,,Plasma,,16360,1969.0,50597,,N,1,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,CHEMBL623783,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11403,In vivo,,Plasma,,3673,1969.0,50588,,N,1,,Cmax in dog plasma after 1mg/kg oral dose,CHEMBL623784,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11404,In vivo,,Plasma,,14431,1969.0,50588,,N,1,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,CHEMBL623785,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11405,In vivo,,Plasma,,14431,1969.0,50597,,N,1,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,CHEMBL623786,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11406,In vivo,,,,14964,,50597,,N,1,,Oral maximum concentration in rat,CHEMBL623787,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11407,In vivo,,,,14964,,50597,,N,1,,Oral maximum concentration in rat,CHEMBL623788,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11408,In vivo,,Plasma,,14209,1969.0,50594,,N,1,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,CHEMBL623789,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11409,In vivo,,Blood,,11355,178.0,50594,,N,1,,Peak concentration in blood after intravenous administration to mice,CHEMBL623790,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11410,In vivo,,Blood,,11355,178.0,50594,,N,1,,Peak concentration in blood after peroral administration to mice,CHEMBL623791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11411,In vivo,,Plasma,,11966,1969.0,50597,,N,1,,Peak concentration in rat plasma was determined,CHEMBL623792,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11412,In vivo,,Plasma,,8918,1969.0,22224,,U,1,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,CHEMBL623793,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11413,In vivo,,Plasma,,8918,1969.0,50594,,N,1,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,CHEMBL623794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11414,In vivo,,Plasma,,8918,1969.0,50597,,N,1,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,CHEMBL623795,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11415,,,,,8684,,50597,,N,1,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",CHEMBL623796,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11416,,,,,8684,,50597,,N,1,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",CHEMBL623797,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11417,,,,,8684,,50597,,N,1,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",CHEMBL623798,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11418,,,,,8684,,50597,,N,1,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",CHEMBL623799,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11419,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",CHEMBL624490,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11420,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",CHEMBL624491,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11421,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",CHEMBL624492,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11422,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",CHEMBL624493,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11423,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",CHEMBL877595,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11424,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",CHEMBL624494,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11425,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",CHEMBL624495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11426,,,Intestine,,8684,160.0,50597,,N,1,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",CHEMBL624681,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11427,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",CHEMBL624682,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11428,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",CHEMBL624683,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11429,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",CHEMBL624684,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11430,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",CHEMBL624685,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11431,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",CHEMBL624686,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11432,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",CHEMBL624687,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11433,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",CHEMBL624688,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11434,,,,,8684,,50597,,N,1,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",CHEMBL627161,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11435,,,,,8684,,50597,,N,1,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",CHEMBL622127,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11436,,,,,8684,,50597,,N,1,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",CHEMBL622128,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11437,,,,,8684,,50597,,N,1,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",CHEMBL874384,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11438,,,,,8684,,50597,,N,1,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",CHEMBL624898,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11439,,,,,8684,,50597,,N,1,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",CHEMBL624899,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11440,,,,,8684,,50597,,N,1,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",CHEMBL624900,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11441,,,,,8684,,50597,,N,1,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",CHEMBL624901,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11442,,,,,8684,,50597,,N,1,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",CHEMBL624902,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11443,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",CHEMBL624903,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11444,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",CHEMBL624904,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11445,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",CHEMBL624905,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11446,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",CHEMBL624906,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11447,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",CHEMBL624907,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11448,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",CHEMBL624908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11449,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",CHEMBL624909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11450,,,,,8684,,50597,,N,1,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",CHEMBL624910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11451,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",CHEMBL624911,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11452,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",CHEMBL874388,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11453,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",CHEMBL624912,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11454,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",CHEMBL622930,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11455,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",CHEMBL623121,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11456,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",CHEMBL623122,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11457,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",CHEMBL623123,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11458,,,Muscle tissue,,8684,2385.0,50597,,N,1,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",CHEMBL623124,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11459,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",CHEMBL623125,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11460,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",CHEMBL623126,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11461,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",CHEMBL623127,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11462,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",CHEMBL623128,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11463,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",CHEMBL623129,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11464,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",CHEMBL623130,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11465,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",CHEMBL623131,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11466,,,,,8684,,50597,,N,1,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",CHEMBL623132,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11467,,,Liver,,8319,2107.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL623133,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11468,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL623134,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11469,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL874389,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11470,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL623135,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11471,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL623136,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11472,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL623137,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11473,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL623138,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11474,,,Kidney,,8319,2113.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL623139,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11475,,,Kidney,,8319,2113.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL623140,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11476,,,Liver,,8319,2107.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL623141,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11477,,,Liver,,8319,2107.0,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL623142,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11478,,,,,8319,,50597,,N,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL623143,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11479,,,Urine,,14571,1088.0,50594,,N,1,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,CHEMBL623144,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11480,,,Urine,,14571,1088.0,50597,,N,1,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,CHEMBL623405,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11481,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL624074,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11482,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL624075,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11483,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL624076,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11484,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL624077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11485,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL624078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11486,,,Kidney,,8319,2113.0,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL624079,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11487,,,Kidney,,8319,2113.0,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL624261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11488,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL624262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11489,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL624263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11490,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL624264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11491,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL624265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11492,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL624266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11493,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL624267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11494,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL624268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11495,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL875227,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11496,,,Kidney,,8319,2113.0,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL624269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11497,,,Kidney,,8319,2113.0,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL624270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11498,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL624271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11499,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL624272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11500,,,,,8319,,50597,,N,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL624273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11501,,,Urine,,12064,1088.0,50597,,N,1,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,CHEMBL624274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11502,,,Urine,,12064,1088.0,50597,,N,1,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,CHEMBL624275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11503,,,Urine,,12064,1088.0,50597,,N,1,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,CHEMBL624276,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11504,,,Urine,,12038,1088.0,50597,,N,1,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,CHEMBL624277,,1,A
Autocuration,BAO_0000019,,,,,11505,,,,,14314,,22224,,U,1,,% dose converted to 2-amino-5-chlorophenyl sulfate,CHEMBL624278,,0,A
Autocuration,BAO_0000019,,,,,11506,,,,,14314,,22224,,U,1,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),CHEMBL624279,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11507,,,Feces,,11488,1988.0,50597,,N,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL624280,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11508,,,Feces,,11488,1988.0,50597,,N,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL624281,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11509,,,Feces,,11488,1988.0,50597,,N,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL622933,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11510,,,Feces,,11488,1988.0,50597,,N,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL622934,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11511,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,CHEMBL622935,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11512,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 5 minutes of iv administration,CHEMBL622936,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11513,In vivo,,Liver,,8829,2107.0,50597,,N,1,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,CHEMBL875228,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11514,In vivo,,Lung,,8829,2048.0,50597,,N,1,,Biodistribution in Rat lung after 24 hours of iv administration,CHEMBL622937,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11515,In vivo,,Lung,,8829,2048.0,50597,,N,1,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,CHEMBL622938,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11516,In vivo,,Lung,,8829,2048.0,50597,,N,1,,Biodistribution in Rat lung after 30 minutes of iv administration,CHEMBL619736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11517,In vivo,,Lung,,8829,2048.0,50597,,N,1,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,CHEMBL625117,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11518,In vivo,,Lung,,8829,2048.0,50597,,N,1,,Biodistribution in Rat lung after 5 minutes of iv administration,CHEMBL625118,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11519,In vivo,,Lung,,8829,2048.0,50597,,N,1,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,CHEMBL625119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11520,In vivo,,Cerebellum,,14972,2037.0,50597,,N,1,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",CHEMBL625120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11521,In vivo,,,,14972,,50597,,N,1,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",CHEMBL625121,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11522,In vivo,,Thalamus,,14972,10000006.0,50597,,N,1,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",CHEMBL625122,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11523,In vivo,,Blood,,14608,178.0,50597,,N,1,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL622204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11524,In vivo,,Blood,,14608,178.0,50597,,N,1,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL877503,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11525,In vivo,,Blood,,14608,178.0,50597,,N,1,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627127,,1,A
Autocuration,BAO_0000218,,,,,11526,In vivo,,Hippocampus,,14608,10000000.0,22224,,U,1,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL627128,,0,A
Autocuration,BAO_0000218,,,,,11527,In vivo,,Hippocampus,,14608,10000000.0,22224,,U,1,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL627129,,0,A
Autocuration,BAO_0000218,,,,,11528,In vivo,,Hippocampus,,14608,10000000.0,22224,,U,1,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627130,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11529,In vivo,,Brain,,14608,955.0,50597,,N,1,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL627131,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11530,In vivo,,Brain,,14608,955.0,50597,,N,1,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL627132,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11531,In vivo,,Brain,,14608,955.0,50597,,N,1,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627133,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11532,In vivo,,Cerebellum,,14608,2037.0,50597,,N,1,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL627134,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11533,In vivo,,Cerebellum,,14608,2037.0,50597,,N,1,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL627135,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11534,In vivo,,Cerebellum,,14608,2037.0,50597,,N,1,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627136,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11535,In vivo,,,,14608,,50597,,N,1,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628435,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11536,In vivo,,,,14608,,50597,,N,1,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628436,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11537,In vivo,,,,14608,,50597,,N,1,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL628437,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11538,In vivo,,Heart,,14608,948.0,50597,,N,1,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628438,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11539,In vivo,,Heart,,14608,948.0,50597,,N,1,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628439,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11540,In vivo,,Heart,,14608,948.0,50597,,N,1,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL628440,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11541,In vivo,,Hippocampus,,14608,10000000.0,50597,,N,1,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628441,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11542,In vivo,,Hippocampus,,14608,10000000.0,50597,,N,1,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628442,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11543,In vivo,,Hippocampus,,14608,10000000.0,50597,,N,1,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL628443,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11544,In vivo,,Kidney,,14608,2113.0,50597,,N,1,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628444,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11545,In vivo,,Kidney,,14608,2113.0,50597,,N,1,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628445,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11546,In vivo,,Kidney,,14608,2113.0,50597,,N,1,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL877504,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11547,In vivo,,Liver,,14608,2107.0,50597,,N,1,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628446,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11548,In vivo,,Liver,,14608,2107.0,50597,,N,1,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL626874,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11549,In vivo,,Liver,,14608,2107.0,50597,,N,1,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL626875,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11550,In vivo,,Lung,,14608,2048.0,50597,,N,1,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL626876,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11551,In vivo,,Lung,,14608,2048.0,50597,,N,1,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL626877,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11552,In vivo,,Lung,,14608,2048.0,50597,,N,1,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL626878,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11553,In vivo,,Muscle tissue,,14608,2385.0,50597,,N,1,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL626879,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11554,In vivo,,Plasma,,8918,1969.0,22224,,U,1,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,CHEMBL626880,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11555,In vivo,,Plasma,,8918,1969.0,50594,,N,1,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,CHEMBL626881,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11556,In vivo,,Plasma,,8918,1969.0,50597,,N,1,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,CHEMBL626882,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11557,In vivo,,Plasma,,14470,1969.0,50588,,N,1,,Peak plasma concentration was measured in dogs,CHEMBL626883,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11558,In vivo,,,,14393,,50597,,N,1,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL626884,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11559,In vivo,,,,14886,,50597,,N,1,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,CHEMBL626885,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11560,In vivo,,,,14886,,50597,,N,1,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,CHEMBL626886,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11561,In vivo,,,,14886,,50597,,N,1,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,CHEMBL626887,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11562,In vivo,,,,14393,,50597,,N,1,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL626888,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11563,In vivo,,,,13465,,50588,,N,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,CHEMBL626889,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11564,In vivo,,,,13465,,22224,,U,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,CHEMBL626761,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11565,In vivo,,,,13465,,50588,,N,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,CHEMBL626762,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11566,In vivo,,,,13465,,50588,,N,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,CHEMBL626763,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11567,In vivo,,,,13465,,50597,,N,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,CHEMBL626764,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11568,In vivo,,,,13465,,50597,,N,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,CHEMBL626765,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11569,In vivo,,,,13465,,50588,,N,1,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,CHEMBL626766,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11570,In vivo,,,,13465,,50597,,N,1,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,CHEMBL626767,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11571,In vivo,,,,13465,,50597,,N,1,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,CHEMBL626768,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11572,In vivo,,,,13465,,50588,,N,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,CHEMBL626769,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11573,In vivo,,,,13465,,50588,,N,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,CHEMBL874463,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11574,In vivo,,,,13465,,22224,,U,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,CHEMBL626770,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11575,In vivo,,,,13465,,22224,,U,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,CHEMBL626771,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11576,In vivo,,,,13465,,50597,,N,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,CHEMBL626772,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11577,In vivo,,,,14731,,100710,,N,1,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,CHEMBL626773,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11578,In vivo,,,,14731,,50594,,N,1,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,CHEMBL626774,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11579,In vivo,,,,13376,,50588,,N,1,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,CHEMBL626775,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11580,In vivo,,,,13376,,50588,,N,1,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,CHEMBL626776,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11581,In vivo,,,,14443,,50597,,N,1,,Maximum concentration (Cmax) in rat when administered orally,CHEMBL626777,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11582,In vivo,,Plasma,,13465,1969.0,22224,,U,1,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,CHEMBL626778,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11583,In vivo,,,,16359,,22224,,U,1,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",CHEMBL626779,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11584,In vivo,,,,16359,,22224,,U,1,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",CHEMBL626780,,0,A
Autocuration,BAO_0000218,,,,,11585,In vivo,,Plasma,,15618,1969.0,22224,,U,1,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,CHEMBL626781,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11586,In vivo,,,,14554,,50597,,N,1,,Pharmacokinetic profile Cmax was evaluated in rats,CHEMBL632164,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11587,In vivo,,,,11537,,50588,,N,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),CHEMBL632165,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11588,In vivo,,,,11537,,50594,,N,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),CHEMBL632166,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11589,In vivo,,,,11537,,50588,,N,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),CHEMBL632167,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11590,In vivo,,,,11537,,50594,,N,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),CHEMBL632168,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,11591,In vivo,,Plasma,,2021,1969.0,22224,,U,1,,Cmax in rat plasma,CHEMBL632169,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11592,In vivo,,Plasma,,5932,1969.0,50588,,N,1,,Cmax in dog plasma after 30mg/kg oral dose,CHEMBL632170,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11593,In vivo,,Plasma,,5932,1969.0,50597,,N,1,,Cmax in rat plasma after 30mg/kg oral dose,CHEMBL632171,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11594,In vivo,,Plasma,,17320,1969.0,50597,,N,1,,Plasma level in rats at 30 mg/kg,CHEMBL632172,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11595,In vivo,,Plasma,,15831,1969.0,50594,,N,1,,Tested for maximum plasma concentration in mice,CHEMBL632173,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11596,In vivo,,,,15078,,50597,,N,1,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL632174,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11597,In vivo,,,,14941,,50597,,N,1,,The Cmax values in female wistar rats.,CHEMBL632175,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11598,In vivo,,Plasma,,15343,1969.0,50588,,N,1,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,CHEMBL632176,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11599,In vivo,,Plasma,,15343,1969.0,50597,,N,1,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,CHEMBL632177,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11600,In vivo,,Plasma,,14856,1969.0,50597,,N,1,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,CHEMBL632178,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11601,In vivo,,,,13129,,50597,,N,1,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,CHEMBL632179,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11602,In vivo,,Blood,,13098,178.0,50597,,N,1,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,CHEMBL632180,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11603,In vivo,,Blood,,13098,178.0,50597,,N,1,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,CHEMBL632181,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11604,In vivo,,Blood,,13098,178.0,50597,,N,1,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,CHEMBL632182,,1,A
Autocuration,BAO_0000218,,10090.0,,Mus musculus,11605,In vivo,,Blood,,15478,178.0,22224,,U,1,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,CHEMBL632183,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11606,In vivo,,,,15341,,50588,,N,1,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,CHEMBL632184,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11607,In vivo,,,,15341,,50597,,N,1,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,CHEMBL874470,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11608,,,,,8684,,50597,,N,1,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",CHEMBL631302,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11609,,,,,8684,,50597,,N,1,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",CHEMBL631303,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11610,,,,,8684,,50597,,N,1,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",CHEMBL631304,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11611,,,,,8684,,50597,,N,1,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",CHEMBL631305,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11612,,,,,8684,,50597,,N,1,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",CHEMBL631306,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11613,,,,,8684,,50597,,N,1,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",CHEMBL631307,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11614,,,,,8684,,50597,,N,1,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",CHEMBL631308,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11615,,,,,8684,,50597,,N,1,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",CHEMBL625557,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11616,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",CHEMBL625558,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11617,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",CHEMBL625559,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11618,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",CHEMBL625560,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11619,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",CHEMBL625561,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11620,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",CHEMBL625562,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11621,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",CHEMBL875320,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11622,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",CHEMBL625563,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11623,,,Spleen,,8684,2106.0,50597,,N,1,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",CHEMBL625564,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11624,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",CHEMBL625565,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11625,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",CHEMBL625566,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11626,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",CHEMBL625567,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11627,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",CHEMBL625568,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11628,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",CHEMBL628217,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11629,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",CHEMBL628218,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11630,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",CHEMBL628219,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11631,,,Uterus,,8684,995.0,50597,,N,1,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",CHEMBL628220,,1,A
Autocuration,BAO_0000019,,,,,11632,,,,,8926,,22224,,U,1,,Distribution in the blood after 120 min of intravenous administration,CHEMBL628221,,0,A
Autocuration,BAO_0000019,,,,,11633,,,,,8926,,22224,,U,1,,Distribution in the blood after 15 min of intravenous administration,CHEMBL628222,,0,A
Autocuration,BAO_0000019,,,,,11634,,,,,8926,,22224,,U,1,,Distribution in the blood after 30 min of intravenous administration,CHEMBL628223,,0,A
Autocuration,BAO_0000019,,,,,11635,,,,,8926,,22224,,U,1,,Distribution in the blood after 5 min of intravenous administration,CHEMBL628224,,0,A
Autocuration,BAO_0000019,,,,,11636,,,,,8926,,22224,,U,1,,Distribution in the blood after 60 min of intravenous administration,CHEMBL628225,,0,A
Autocuration,BAO_0000019,,,,,11637,,,,,8926,,22224,,U,1,,Distribution in the blood after 90 min of intravenous administration,CHEMBL628226,,0,A
Autocuration,BAO_0000019,,,,,11638,,,,,8926,,22224,,U,1,,Distribution in the bone after 120 min of intravenous administration,CHEMBL628227,,0,A
Autocuration,BAO_0000019,,,,,11639,,,,,8926,,22224,,U,1,,Distribution in the bone after 15 min of intravenous administration,CHEMBL875481,,0,A
Autocuration,BAO_0000019,,,,,11640,,,,,8926,,22224,,U,1,,Distribution in the bone after 30 min of intravenous administration,CHEMBL628228,,0,A
Autocuration,BAO_0000019,,,,,11641,,,,,8926,,22224,,U,1,,Distribution in the bone after 5 min of intravenous administration,CHEMBL628229,,0,A
Autocuration,BAO_0000019,,,,,11642,,,,,8926,,22224,,U,1,,Distribution in the bone after 60 min of intravenous administration,CHEMBL628230,,0,A
Autocuration,BAO_0000019,,,,,11643,,,,,8926,,22224,,U,1,,Distribution in the bone after 90 min of intravenous administration,CHEMBL628231,,0,A
Autocuration,BAO_0000019,,,,,11644,,,,,8926,,22224,,U,1,,Distribution in the heart after 120 min of intravenous administration,CHEMBL628232,,0,A
Autocuration,BAO_0000019,,,,,11645,,,,,8926,,22224,,U,1,,Distribution in the heart after 15 min of intravenous administration,CHEMBL628233,,0,A
Autocuration,BAO_0000019,,,,,11646,,,,,8926,,22224,,U,1,,Distribution in the heart after 30 min of intravenous administration,CHEMBL628234,,0,A
Autocuration,BAO_0000019,,,,,11647,,,,,8926,,22224,,U,1,,Distribution in the heart after 5 min of intravenous administration,CHEMBL628235,,0,A
Autocuration,BAO_0000019,,,,,11648,,,,,8926,,22224,,U,1,,Distribution in the heart after 60 min of intravenous administration,CHEMBL628236,,0,A
Autocuration,BAO_0000019,,,,,11649,,,,,8926,,22224,,U,1,,Distribution in the heart after 90 min of intravenous administration,CHEMBL628237,,0,A
Autocuration,BAO_0000019,,,,,11650,,,,,8926,,22224,,U,1,,Distribution in the kidneys after 120 min of intravenous administration,CHEMBL628238,,0,A
Autocuration,BAO_0000019,,,,,11651,,,,,8926,,22224,,U,1,,Distribution in the kidneys after 15 min of intravenous administration,CHEMBL628239,,0,A
Autocuration,BAO_0000019,,,,,11652,,,,,8926,,22224,,U,1,,Distribution in the kidneys after 30 min of intravenous administration,CHEMBL628240,,0,A
Autocuration,BAO_0000019,,,,,11653,,,,,8926,,22224,,U,1,,Distribution in the kidneys after 5 min of intravenous administration,CHEMBL628241,,0,A
Autocuration,BAO_0000019,,,,,11654,,,,,8926,,22224,,U,1,,Distribution in the kidneys after 60 min of intravenous administration,CHEMBL628242,,0,A
Autocuration,BAO_0000019,,,,,11655,,,,,8926,,22224,,U,1,,Distribution in the kidneys after 90 min of intravenous administration,CHEMBL875482,,0,A
Autocuration,BAO_0000019,,,,,11656,,,,,8926,,22224,,U,1,,Distribution in the liver after 120 min of intravenous administration,CHEMBL628243,,0,A
Autocuration,BAO_0000019,,,,,11657,,,,,8926,,22224,,U,1,,Distribution in the liver after 15 min of intravenous administration,CHEMBL628244,,0,A
Autocuration,BAO_0000019,,,,,11658,,,,,8926,,22224,,U,1,,Distribution in the liver after 30 min of intravenous administration,CHEMBL628245,,0,A
Autocuration,BAO_0000019,,,,,11659,,,,,8926,,22224,,U,1,,Distribution in the liver after 5 min of intravenous administration,CHEMBL628246,,0,A
Autocuration,BAO_0000019,,,,,11660,,,,,8926,,22224,,U,1,,Distribution in the liver after 60 min of intravenous administration,CHEMBL628247,,0,A
Autocuration,BAO_0000019,,,,,11661,,,,,8926,,22224,,U,1,,Distribution in the liver after 90 min of intravenous administration,CHEMBL628248,,0,A
Autocuration,BAO_0000019,,,,,11662,,,,,8926,,22224,,U,1,,Distribution in the lung after 120 min of intravenous administration,CHEMBL628249,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11663,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",CHEMBL625452,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11664,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",CHEMBL625453,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11665,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",CHEMBL625454,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11666,,,,,14839,,50594,,N,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",CHEMBL623844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11667,,,,,12178,,50597,,N,1,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,CHEMBL623845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11668,,,,,12178,,50597,,N,1,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,CHEMBL623846,,1,A
Autocuration,BAO_0000218,,,,,11669,,,,,12178,,22224,,U,1,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,CHEMBL623847,,0,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11670,,,,,12186,,100710,,N,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL623848,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11671,,,,,12186,,100710,,N,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,CHEMBL623849,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11672,,,,,12186,,100710,,N,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL623850,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11673,,,,,12186,,100710,,N,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,CHEMBL623851,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11674,,,,,12187,,22224,,U,1,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL623852,,0,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,11675,,,,,12187,,50506,,N,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,CHEMBL624551,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,11676,,,,,12187,,50506,,N,1,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",CHEMBL624552,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11677,,,,,12187,,22224,,U,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL624553,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11678,,,,,12187,,22224,,U,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,CHEMBL624554,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11679,,,,,12187,,50597,,N,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,CHEMBL624555,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11680,,,,,12187,,50597,,N,1,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",CHEMBL624741,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11681,,,,,14122,,50588,,N,1,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",CHEMBL624742,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11682,,,,,14122,,100712,,N,1,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",CHEMBL624743,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11683,,,,,14122,,50597,,N,1,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",CHEMBL877606,,1,A
Autocuration,BAO_0000218,,,,,11684,,,,,13391,,22224,,U,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,CHEMBL624744,,0,A
Autocuration,BAO_0000218,,,,,11685,,,Blood,,13391,178.0,22224,,U,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL624745,,0,A
Autocuration,BAO_0000218,,,,,11686,,,Blood,,13391,178.0,22224,,U,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL624746,,0,A
Autocuration,BAO_0000218,,,,,11687,,,Blood,,13391,178.0,22224,,U,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL624747,,0,A
Autocuration,BAO_0000019,,,,,11688,,,,,16360,,22224,,U,1,,Oral absorption expressed as Area under curve was determined,CHEMBL624748,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11689,,,,,3673,,50588,,N,1,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,CHEMBL622504,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11690,,,,,14122,,50588,,N,1,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",CHEMBL622505,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11691,,,,,14122,,100712,,N,1,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",CHEMBL622506,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,11692,,,,,14122,,100712,,N,1,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",CHEMBL622507,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11693,,,,,14122,,50597,,N,1,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",CHEMBL622508,,1,A
Autocuration,BAO_0000019,,,,,11694,,,,,13889,,22224,,U,1,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,CHEMBL622509,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11695,,,,,14393,,50597,,N,1,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL622510,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11696,,,,,17279,,50597,,N,1,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),CHEMBL622511,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11697,,,,,14548,,100710,,N,1,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,CHEMBL622512,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11698,,,,,14548,,100710,,N,1,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,CHEMBL622513,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11699,,,,,14548,,100710,,N,1,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,CHEMBL622514,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11700,,,,,14548,,50588,,N,1,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,CHEMBL622515,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11701,,,,,14548,,50588,,N,1,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,CHEMBL622516,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11702,,,,,14548,,50597,,N,1,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,CHEMBL622517,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11703,,,,,14548,,50597,,N,1,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,CHEMBL622518,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11704,,,,,14548,,50597,,N,1,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,CHEMBL622519,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11705,In vivo,,Muscle tissue,,14608,2385.0,50597,,N,1,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL622520,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11706,In vivo,,Muscle tissue,,14608,2385.0,50597,,N,1,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL622521,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11707,In vivo,,Zone of skin,,14608,14.0,50594,,N,1,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL625113,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11708,In vivo,,Zone of skin,,14608,14.0,50597,,N,1,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL625114,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11709,In vivo,,Zone of skin,,14608,14.0,50597,,N,1,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL874397,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11710,In vivo,,Spleen,,14608,2106.0,50597,,N,1,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL625115,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11711,In vivo,,Spleen,,14608,2106.0,50597,,N,1,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL625116,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11712,In vivo,,Spleen,,14608,2106.0,50597,,N,1,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL623932,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11713,In vivo,,Striatum,,14608,2435.0,50597,,N,1,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL623933,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11714,In vivo,,Striatum,,14608,2435.0,50597,,N,1,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL623934,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11715,In vivo,,Striatum,,14608,2435.0,50597,,N,1,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL623935,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11716,In vivo,,Thyroid gland,,14608,2046.0,50597,,N,1,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL623936,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11717,In vivo,,Thyroid gland,,14608,2046.0,50597,,N,1,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL623937,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11718,In vivo,,Thyroid gland,,14608,2046.0,50597,,N,1,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL623938,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11719,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL623939,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11720,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL623940,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11721,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL623941,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11722,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL627216,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11723,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL623942,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11724,,,Brain,,15383,955.0,50594,,N,1,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618793,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11725,,,Brain,,15383,955.0,50594,,N,1,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618794,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11726,,,Brain,,15383,955.0,50594,,N,1,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618795,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11727,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618796,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11728,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618797,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11729,,,Kidney,,15383,2113.0,50594,,N,1,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,CHEMBL618798,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11730,,,Kidney,,15383,2113.0,50594,,N,1,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618799,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11731,,,Kidney,,15383,2113.0,50594,,N,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL618800,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11732,,,Kidney,,15383,2113.0,50594,,N,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL618801,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11733,,,Kidney,,15383,2113.0,50594,,N,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618802,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11734,,,Kidney,,15383,2113.0,50594,,N,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618803,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11735,,,Liver,,15383,2107.0,50594,,N,1,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,CHEMBL618804,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11736,,,Liver,,15383,2107.0,50594,,N,1,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618805,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11737,,,Liver,,15383,2107.0,50594,,N,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL618806,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11738,,,Liver,,15383,2107.0,50594,,N,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL618807,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11739,,,Liver,,15383,2107.0,50594,,N,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618808,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11740,,,Liver,,15383,2107.0,50594,,N,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618809,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11741,,,Muscle tissue,,15383,2385.0,50594,,N,1,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618810,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11742,,,Muscle tissue,,15383,2385.0,50594,,N,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL618811,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11743,,,Muscle tissue,,15383,2385.0,50594,,N,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL875844,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11744,,,Muscle tissue,,15383,2385.0,50594,,N,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618812,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11745,,,Muscle tissue,,15383,2385.0,50594,,N,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618813,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11746,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618814,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11747,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618815,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11748,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618816,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11749,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618817,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11750,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL620544,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11751,In vivo,,,,15341,,50597,,N,1,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,CHEMBL626230,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11752,In vivo,,,,15341,,50597,,N,1,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,CHEMBL626231,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11753,In vivo,,,,15341,,50597,,N,1,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,CHEMBL626232,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11754,In vivo,,Plasma,,14906,1969.0,50588,,N,1,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,CHEMBL626233,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11755,In vivo,,Plasma,,14906,1969.0,50597,,N,1,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,CHEMBL626234,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11756,In vivo,,Plasma,,14906,1969.0,50597,,N,1,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,CHEMBL875341,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,11757,In vivo,,Plasma,,14215,1969.0,50587,,N,1,,The maximum plasma concentration (100 mg/kg) administered orally in human,CHEMBL626235,,1,A
Autocuration,BAO_0000218,,9481.0,,Callithrix,11758,In vivo,,Plasma,,14215,1969.0,22224,,U,1,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,CHEMBL626236,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11759,In vivo,,Plasma,,14215,1969.0,22224,,U,1,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,CHEMBL626237,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11760,In vivo,,Plasma,,14215,1969.0,50588,,N,1,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,CHEMBL626238,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,11761,In vivo,,Plasma,,14215,1969.0,50587,,N,1,,The maximum plasma concentration (200 mg/kg) administered orally in human,CHEMBL622412,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11762,In vivo,,Plasma,,14215,1969.0,50597,,N,1,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,CHEMBL623114,,1,A
Autocuration,BAO_0000218,,9481.0,,Callithrix,11763,In vivo,,Plasma,,14215,1969.0,22224,,U,1,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,CHEMBL623115,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11764,In vivo,,Plasma,,14215,1969.0,22224,,U,1,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,CHEMBL623116,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,11765,In vivo,,Plasma,,14215,1969.0,22224,,U,1,,The maximum plasma concentration (30 mg/kg) administered orally in dog,CHEMBL623117,,0,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,11766,In vivo,,Plasma,,14215,1969.0,50587,,N,1,,The maximum plasma concentration (400 mg/kg) administered orally in human,CHEMBL623118,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11767,In vivo,,Plasma,,14215,1969.0,50597,,N,1,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,CHEMBL623119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11768,In vivo,,Plasma,,14215,1969.0,50597,,N,1,,The maximum plasma concentration (50 mg/kg) administered orally in rat,CHEMBL623120,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,11769,In vivo,,Plasma,,14215,1969.0,50587,,N,1,,The maximum plasma concentration (800 mg/kg) administered orally in human,CHEMBL623286,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11770,In vivo,,Plasma,,14067,1969.0,50597,,N,1,,The maximum plasma concentration was measured on rats,CHEMBL623287,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11771,In vivo,,Plasma,,12350,1969.0,50597,,N,1,,The maximum plasma concentration was measured on rats after oral administration,CHEMBL623288,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11772,In vivo,,Plasma,,14813,1969.0,50597,,N,1,,Plasma drug Cmax in rat (PO dose),CHEMBL623289,,1,A
Autocuration,BAO_0000218,,,,,11773,In vivo,,,,12536,,22224,,U,1,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,CHEMBL623290,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11774,In vivo,,Plasma,,14169,1969.0,50588,,N,1,,maximum Plasma concentration in Dog was determined after Peroral administration,CHEMBL623291,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11775,In vivo,,Plasma,,14169,1969.0,50597,,N,1,,maximum Plasma concentration in Rats was determined after Peroral administration,CHEMBL623292,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11776,In vivo,,Plasma,,15604,1969.0,50588,,N,1,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,CHEMBL623293,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,11777,In vivo,,Plasma,,15604,1969.0,22224,,U,1,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,CHEMBL623294,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11778,In vivo,,Plasma,,15604,1969.0,50597,,N,1,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,CHEMBL623295,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11779,In vivo,,,,14387,,50594,,N,1,,maximum concentration was measured when administered through oral route in mice,CHEMBL623296,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11780,,,,,15115,,50594,,N,1,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,CHEMBL875349,,1,A
Autocuration,BAO_0000019,,314293.0,,Simiiformes,11781,,,,,15115,,22224,,U,1,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,CHEMBL623297,,0,A
Autocuration,BAO_0000019,,314293.0,,Simiiformes,11782,,,,,15115,,22224,,U,1,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,CHEMBL623298,,0,A
Autocuration,BAO_0000019,,314293.0,,Simiiformes,11783,,,,,15115,,22224,,U,1,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,CHEMBL623299,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11784,,,,,16359,,50597,,N,1,,Pharmacokinetic parameter was evaluated in rats,CHEMBL623300,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11785,,,,,12829,,50594,,N,1,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,CHEMBL623301,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11786,,,,,12829,,50594,,N,1,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,CHEMBL623302,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11787,,,,,12829,,50594,,N,1,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,CHEMBL623303,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11788,,,,,12829,,50594,,N,1,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,CHEMBL623304,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11789,,,,,12829,,50594,,N,1,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,CHEMBL623305,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11790,,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,CHEMBL623306,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11791,,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,CHEMBL623307,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11792,,,Plasma,,15137,1969.0,50597,,N,1,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,CHEMBL623308,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11793,,,Plasma,,15137,1969.0,50594,,N,1,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,CHEMBL623309,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11794,,,,,13509,,50594,,N,1,,Plasma Concentration after 120 min of oral administration to mice,CHEMBL623310,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11795,,,,,13509,,50594,,N,1,,Plasma Concentration after 30 min of oral administration to mice,CHEMBL623311,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11796,,,,,13509,,100710,,N,1,,Plasma Concentration after 60 min of oral administration to mice,CHEMBL623312,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11797,,,,,13509,,50594,,N,1,,Plasma Concentration after 60 min of oral administration to mice; Not determined,CHEMBL875350,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11798,,,,,13509,,50594,,N,1,,Plasma Concentration after 90 min of oral administration to mice,CHEMBL628635,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11799,,,,,12064,,50597,,N,1,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,CHEMBL628636,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11800,,,,,12064,,50597,,N,1,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,CHEMBL628637,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11801,,,,,12064,,50597,,N,1,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,CHEMBL628058,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11802,,,,,10677,,50597,,N,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,CHEMBL628059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11803,,,,,10677,,50597,,N,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,CHEMBL628060,,1,A
Autocuration,BAO_0000019,,,,,11804,,,,,8926,,22224,,U,1,,Distribution in the lung after 15 min of intravenous administration,CHEMBL628061,,0,A
Autocuration,BAO_0000019,,,,,11805,,,,,8926,,22224,,U,1,,Distribution in the lung after 30 min of intravenous administration,CHEMBL628062,,0,A
Autocuration,BAO_0000019,,,,,11806,,,,,8926,,22224,,U,1,,Distribution in the lung after 5 min of intravenous administration,CHEMBL628063,,0,A
Autocuration,BAO_0000019,,,,,11807,,,,,8926,,22224,,U,1,,Distribution in the lung after 60 min of intravenous administration,CHEMBL628064,,0,A
Autocuration,BAO_0000019,,,,,11808,,,,,8926,,22224,,U,1,,Distribution in the lung after 90 min of intravenous administration,CHEMBL628065,,0,A
Autocuration,BAO_0000019,,,,,11809,,,Muscle tissue,,8926,2385.0,22224,,U,1,,Distribution in the muscle after 120 min of intravenous administration,CHEMBL628066,,0,A
Autocuration,BAO_0000019,,,,,11810,,,Muscle tissue,,8926,2385.0,22224,,U,1,,Distribution in the muscle after 15 min of intravenous administration,CHEMBL628067,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11811,,,Muscle tissue,,8926,2385.0,50594,,N,1,,Distribution in the muscle after 30 min of intravenous administration,CHEMBL874646,,1,A
Autocuration,BAO_0000019,,,,,11812,,,Muscle tissue,,8926,2385.0,22224,,U,1,,Distribution in the muscle after 5 min of intravenous administration,CHEMBL628068,,0,A
Autocuration,BAO_0000019,,,,,11813,,,Muscle tissue,,8926,2385.0,22224,,U,1,,Distribution in the muscle after 60 min of intravenous administration,CHEMBL628069,,0,A
Autocuration,BAO_0000019,,,,,11814,,,Muscle tissue,,8926,2385.0,22224,,U,1,,Distribution in the muscle after 90 min of intravenous administration,CHEMBL628070,,0,A
Autocuration,BAO_0000019,,,,,11815,,,Spleen,,8926,2106.0,22224,,U,1,,Distribution in the spleen after 120 min of intravenous administration,CHEMBL628071,,0,A
Autocuration,BAO_0000019,,,,,11816,,,Spleen,,8926,2106.0,22224,,U,1,,Distribution in the spleen after 15 min of intravenous administration,CHEMBL628072,,0,A
Autocuration,BAO_0000019,,,,,11817,,,Spleen,,8926,2106.0,22224,,U,1,,Distribution in the spleen after 30 min of intravenous administration,CHEMBL628073,,0,A
Autocuration,BAO_0000019,,,,,11818,,,Spleen,,8926,2106.0,22224,,U,1,,Distribution in the spleen after 5 min of intravenous administration,CHEMBL628074,,0,A
Autocuration,BAO_0000019,,,,,11819,,,Spleen,,8926,2106.0,22224,,U,1,,Distribution in the spleen after 60 min of intravenous administration,CHEMBL628075,,0,A
Autocuration,BAO_0000019,,,,,11820,,,Spleen,,8926,2106.0,22224,,U,1,,Distribution in the spleen after 90 min of intravenous administration,CHEMBL628076,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11821,,,Adrenal cortex,,7570,1235.0,50597,,N,1,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,CHEMBL628077,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11822,,,Blood,,7570,178.0,50597,,N,1,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,CHEMBL628078,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11823,,,Liver,,7570,2107.0,50597,,N,1,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,CHEMBL628079,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11824,,,Female gonad,,7570,992.0,50597,,N,1,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,CHEMBL628080,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11825,,,Thyroid gland,,7570,2046.0,50597,,N,1,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,CHEMBL628081,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11826,,,Adrenal cortex,,7570,1235.0,50597,,N,1,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,CHEMBL628082,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11827,,,Blood,,7570,178.0,50597,,N,1,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,CHEMBL874647,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11828,,,Liver,,7570,2107.0,50597,,N,1,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,CHEMBL626406,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11829,,,Female gonad,,7570,992.0,50597,,N,1,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,CHEMBL626407,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11830,,,Thyroid gland,,7570,2046.0,50597,,N,1,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,CHEMBL626408,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11831,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",CHEMBL626409,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11832,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",CHEMBL626410,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11833,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",CHEMBL626411,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11834,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",CHEMBL626412,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11835,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",CHEMBL626413,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11836,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",CHEMBL626414,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11837,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",CHEMBL626415,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11838,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",CHEMBL626416,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11839,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",CHEMBL627062,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11840,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",CHEMBL627063,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11841,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",CHEMBL627064,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11842,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",CHEMBL627227,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11843,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",CHEMBL627228,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11844,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",CHEMBL627229,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11845,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",CHEMBL625792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11846,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",CHEMBL625793,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11847,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",CHEMBL625794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11848,,,Blood,,8608,178.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",CHEMBL625795,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11849,,,,,13792,,50594,,N,1,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,CHEMBL625796,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11850,,,,,13376,,50588,,N,1,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,CHEMBL625797,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,11851,,,,,13376,,50588,,N,1,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,CHEMBL625798,,1,A
Autocuration,BAO_0000218,,,,,11852,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL875613,,0,A
Autocuration,BAO_0000218,,,,,11853,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL625799,,0,A
Autocuration,BAO_0000218,,,,,11854,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,CHEMBL625800,,0,A
Autocuration,BAO_0000218,,,,,11855,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,CHEMBL625801,,0,A
Autocuration,BAO_0000218,,,,,11856,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,CHEMBL625802,,0,A
Autocuration,BAO_0000218,,,,,11857,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL625803,,0,A
Autocuration,BAO_0000019,,,,,11858,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,CHEMBL625804,,0,A
Autocuration,BAO_0000218,,,,,11859,,,,,14380,,22224,,U,1,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,CHEMBL622530,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11860,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,CHEMBL622531,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11861,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),CHEMBL622532,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11862,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),CHEMBL623176,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11863,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),CHEMBL623177,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11864,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),CHEMBL623178,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11865,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,CHEMBL623179,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11866,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),CHEMBL623180,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11867,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),CHEMBL623181,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11868,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),CHEMBL624131,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11869,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),CHEMBL624132,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11870,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),CHEMBL624133,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11871,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,CHEMBL624846,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11872,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),CHEMBL624847,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11873,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),CHEMBL624848,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11874,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),CHEMBL625012,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11875,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),CHEMBL625013,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11876,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,CHEMBL625014,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11877,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),CHEMBL625015,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11878,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),CHEMBL625016,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11879,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,CHEMBL625017,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11880,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),CHEMBL625018,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11881,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),CHEMBL625019,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11882,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),CHEMBL625020,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11883,,,,,13701,,50594,,N,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,CHEMBL625021,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11884,,,,,14393,,50597,,N,1,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL625022,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11885,,,,,14731,,50594,,N,1,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,CHEMBL625023,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11886,,,,,14731,,100710,,N,1,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,CHEMBL625024,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,11887,,,,,14731,,100710,,N,1,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,CHEMBL627626,,1,A
Autocuration,BAO_0000218,,,,,11888,,,Brain,,13758,955.0,22224,,U,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,CHEMBL627627,,0,A
Autocuration,BAO_0000218,,,,,11889,,,Serum,,13758,1977.0,22224,,U,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,CHEMBL627628,,0,A
Autocuration,BAO_0000218,,,,,11890,,,Brain,,13758,955.0,22224,,U,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,CHEMBL627629,,0,A
Autocuration,BAO_0000218,,,,,11891,,,Serum,,13758,1977.0,22224,,U,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,CHEMBL627630,,0,A
Autocuration,BAO_0000019,,,,,11892,,,,,16359,,22224,,U,1,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),CHEMBL627631,,0,A
Autocuration,BAO_0000218,,,,,11893,,,,,16359,,22224,,U,1,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),CHEMBL629515,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11894,,,Spleen,,15383,2106.0,50594,,N,1,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL629516,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11895,,,Spleen,,15383,2106.0,50594,,N,1,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL629517,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11896,,,Spleen,,15383,2106.0,50594,,N,1,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL629518,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11897,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL877499,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11898,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL629519,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11899,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL629520,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11900,,,,,15383,,50594,,N,1,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL629521,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11901,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),CHEMBL629522,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11902,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),CHEMBL629523,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11903,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),CHEMBL629524,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11904,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),CHEMBL629525,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11905,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),CHEMBL629526,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11906,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),CHEMBL629527,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11907,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),CHEMBL629528,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11908,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),CHEMBL629529,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11909,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),CHEMBL629530,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11910,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),CHEMBL629531,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11911,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),CHEMBL628656,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,11912,,,,,14439,,50594,,N,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),CHEMBL628657,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11913,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL628658,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11914,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL628659,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11915,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL877500,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11916,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL628660,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11917,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL628661,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11918,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL628662,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11919,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL628663,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11920,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL628664,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11921,In vivo,,Blood,,13751,178.0,50597,,N,1,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL628665,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11922,In vivo,,Blood,,13751,178.0,50597,,N,1,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL628666,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11923,In vivo,,Blood,,13751,178.0,50597,,N,1,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL628667,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11924,In vivo,,Blood,,13751,178.0,50597,,N,1,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL628668,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11925,In vivo,,Blood,,13751,178.0,50597,,N,1,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL628669,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11926,In vivo,,Blood,,13751,178.0,50597,,N,1,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL628670,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11927,In vivo,,Blood,,13751,178.0,50597,,N,1,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL628671,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11928,In vivo,,Bone,,13751,10000001.0,50597,,N,1,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL628672,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11929,In vivo,,Bone,,13751,10000001.0,50597,,N,1,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL630300,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11930,In vivo,,Bone,,13751,10000001.0,50597,,N,1,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL629787,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11931,In vivo,,Bone,,13751,10000001.0,50597,,N,1,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629788,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11932,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL629789,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11933,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL629790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11934,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL629791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11935,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL629792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11936,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629793,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11937,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL629794,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11938,,,,,10677,,50597,,N,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,CHEMBL874459,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11939,,,,,10677,,50597,,N,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,CHEMBL629795,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11940,,,,,10677,,50597,,N,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,CHEMBL629796,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11941,,,,,10677,,50597,,N,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,CHEMBL629797,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11942,,,,,10677,,50597,,N,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,CHEMBL629798,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11943,In vivo,,Adrenal gland,,10911,2369.0,50597,,N,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629799,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11944,In vivo,,Adrenal gland,,10911,2369.0,50597,,N,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629800,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11945,In vivo,,Adrenal gland,,10911,2369.0,50597,,N,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629801,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11946,In vivo,,Adrenal gland,,10911,2369.0,50597,,N,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,CHEMBL629802,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11947,In vivo,,Adrenal gland,,10911,2369.0,50597,,N,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL629803,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11948,In vivo,,Blood,,10911,178.0,50597,,N,1,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629804,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11949,In vivo,,Blood,,10911,178.0,50597,,N,1,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629805,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11950,In vivo,,Blood,,10911,178.0,50597,,N,1,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,CHEMBL629806,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11951,In vivo,,Blood,,10911,178.0,50597,,N,1,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629807,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11952,In vivo,,Blood,,10911,178.0,50597,,N,1,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL629808,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11953,In vivo,,Brain,,10911,955.0,50597,,N,1,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629809,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11954,In vivo,,Brain,,10911,955.0,50597,,N,1,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629810,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11955,In vivo,,Brain,,10911,955.0,50597,,N,1,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,CHEMBL629811,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11956,In vivo,,Brain,,10911,955.0,50597,,N,1,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629812,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11957,In vivo,,Brain,,10911,955.0,50597,,N,1,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,CHEMBL629813,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11958,In vivo,,Brain,,10911,955.0,50597,,N,1,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL874460,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11959,In vivo,,,,10911,,50597,,N,1,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629814,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11960,In vivo,,,,10911,,50597,,N,1,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629815,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11961,In vivo,,,,10911,,50597,,N,1,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629816,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11962,In vivo,,,,10911,,50597,,N,1,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL629817,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11963,In vivo,,Kidney,,10911,2113.0,50597,,N,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL626643,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11964,In vivo,,Kidney,,10911,2113.0,50597,,N,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL626644,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11965,In vivo,,Kidney,,10911,2113.0,50597,,N,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL626806,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11966,In vivo,,Kidney,,10911,2113.0,50597,,N,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL626807,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11967,In vivo,,Liver,,10911,2107.0,50597,,N,1,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11968,In vivo,,Liver,,10911,2107.0,50597,,N,1,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11969,In vivo,,Liver,,10911,2107.0,50597,,N,1,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11970,In vivo,,Liver,,10911,2107.0,50597,,N,1,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11971,In vivo,,Lung,,10911,2048.0,50597,,N,1,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11972,In vivo,,Lung,,10911,2048.0,50597,,N,1,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11973,In vivo,,Lung,,10911,2048.0,50597,,N,1,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11974,In vivo,,Lung,,10911,2048.0,50597,,N,1,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11975,In vivo,,Muscle tissue,,10911,2385.0,50597,,N,1,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11976,In vivo,,Muscle tissue,,10911,2385.0,50597,,N,1,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11977,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",CHEMBL627271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11978,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",CHEMBL627946,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11979,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",CHEMBL875472,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11980,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",CHEMBL627947,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11981,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",CHEMBL627948,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11982,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",CHEMBL628113,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11983,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",CHEMBL628114,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11984,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",CHEMBL628115,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11985,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",CHEMBL628116,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11986,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",CHEMBL628117,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11987,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",CHEMBL628118,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11988,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",CHEMBL628119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11989,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",CHEMBL628120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11990,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",CHEMBL628121,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11991,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",CHEMBL628122,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11992,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",CHEMBL627297,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11993,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",CHEMBL627298,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11994,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",CHEMBL627299,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11995,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",CHEMBL627300,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11996,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",CHEMBL627301,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11997,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",CHEMBL627302,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11998,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",CHEMBL627303,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,11999,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",CHEMBL627304,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12000,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",CHEMBL627305,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12001,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",CHEMBL627306,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12002,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",CHEMBL623982,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12003,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",CHEMBL623983,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12004,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",CHEMBL623984,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12005,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",CHEMBL623985,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12006,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",CHEMBL623986,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12007,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",CHEMBL623987,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12008,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",CHEMBL623988,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12009,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",CHEMBL623989,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12010,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",CHEMBL622215,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12011,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",CHEMBL622216,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12012,,,,,8608,,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",CHEMBL877481,,1,A
Autocuration,BAO_0000218,,,,,12013,,,,,16359,,22224,,U,1,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),CHEMBL622217,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12014,,,,,13701,,50594,,N,1,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),CHEMBL622218,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12015,,,,,14554,,50597,,N,1,,Pharmacokinetic profile AUC was evaluated in rats,CHEMBL622219,,1,A
Autocuration,BAO_0000019,,,,,12016,,,,,6241,,22224,,U,1,,Pharmacokinetic property (Area under curve),CHEMBL622220,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12017,,,,,11537,,50588,,N,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",CHEMBL622221,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12018,,,,,11537,,50594,,N,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",CHEMBL622222,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12019,,,,,11537,,50588,,N,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",CHEMBL622223,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12020,,,,,11537,,50594,,N,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",CHEMBL622224,,1,A
Autocuration,BAO_0000019,,,,,12021,,,,,13118,,22224,,U,1,,Plasma concentration (AUC) was determined,CHEMBL622225,,0,A
Autocuration,BAO_0000019,,,,,12022,,,,,13118,,22224,,U,1,,Plasma concentration (AUC) was determined; Not detectable,CHEMBL622226,,0,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,12023,,,,,9562,,50512,,N,1,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),CHEMBL624154,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12024,,,,,10363,,50597,,N,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,CHEMBL624155,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12025,,,,,10363,,50597,,N,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,CHEMBL624156,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12026,,,,,10363,,50597,,N,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,CHEMBL624157,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12027,,,,,10363,,50597,,N,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,CHEMBL624158,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12028,,,,,12504,,50597,,N,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,CHEMBL624159,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12029,,,,,12504,,50597,,N,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,CHEMBL624160,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12030,,,,,12504,,50597,,N,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,CHEMBL624161,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12031,,,,,12504,,50597,,N,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,CHEMBL624162,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12032,,,,,13317,,50588,,N,1,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,CHEMBL624163,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12033,,,,,15078,,50597,,N,1,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL624164,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12034,,,,,14941,,50597,,N,1,,The AUC(0-infinity) values in female wistar rats.,CHEMBL624165,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12035,,,,,15078,,50597,,N,1,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL624166,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12036,,,,,15078,,50597,,N,1,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",CHEMBL624167,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12037,,,,,14941,,50597,,N,1,,The AUC(0-t)values in female wistar rats.,CHEMBL624168,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12038,,,,,14067,,50597,,N,1,,The Area under the concentration time curve of compound was measured on rats,CHEMBL624169,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12039,,,,,14215,,50587,,N,1,,The area under curve (100 mg/kg) administered orally in humans,CHEMBL624170,,1,A
Autocuration,BAO_0000218,,9481.0,,Callithrix,12040,,,,,14215,,22224,,U,1,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,CHEMBL624171,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12041,,,,,14215,,22224,,U,1,,The area under curve (12.5 mg/kg) administered intravenously in monkey,CHEMBL624172,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12042,,,,,14215,,50588,,N,1,,The area under curve (15 mg/kg) administered intravenously in dog,CHEMBL624173,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12043,,,,,14215,,50587,,N,1,,The area under curve (200 mg/kg) administered orally in humans,CHEMBL877488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12044,,,,,14215,,50597,,N,1,,The area under curve (25 mg/kg) administered intravenously in rat,CHEMBL624174,,1,A
Autocuration,BAO_0000218,,9481.0,,Callithrix,12045,,,,,14215,,22224,,U,1,,The area under curve (25 mg/kg) administered orally in marmoset,CHEMBL624175,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12046,,,,,14215,,22224,,U,1,,The area under curve (25 mg/kg) administered orally in monkey,CHEMBL624176,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12047,,,,,14215,,50588,,N,1,,The area under curve (30 mg/kg) administered orally in dog,CHEMBL624177,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12048,,,,,14215,,50587,,N,1,,The area under curve (400 mg/kg) administered orally in humans,CHEMBL624178,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12049,,,,,14215,,50597,,N,1,,The area under curve (50 mg/kg) administered orally in fasted rat,CHEMBL624179,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12050,,,,,14215,,50597,,N,1,,The area under curve (50 mg/kg) administered orally in rat,CHEMBL627689,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12051,,,,,14215,,50587,,N,1,,The area under curve (800 mg/kg) administered orally in humans,CHEMBL627690,,1,A
Autocuration,BAO_0000019,,,,,12052,,,,,11324,,22224,,U,1,,The compound was evaluated for area under the curve,CHEMBL627691,,0,A
Autocuration,BAO_0000019,,9481.0,,Callithrix,12053,,,,,11324,,22224,,U,1,,The compound was evaluated for area under the curve in marmosets,CHEMBL627692,,0,A
Autocuration,BAO_0000019,,9481.0,,Callithrix,12054,,,,,11324,,22224,,U,1,,The compound was evaluated for area under the curve in marmosets,CHEMBL627693,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12055,,,,,13875,,50597,,N,1,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627694,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12056,,,,,13875,,50597,,N,1,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627695,,1,A
Autocuration,BAO_0000218,,,,,12057,,,,,13875,,22224,,U,1,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),CHEMBL627696,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12058,,,,,13875,,50597,,N,1,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627697,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12059,,,,,13875,,50597,,N,1,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627698,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12060,,,,,13875,,50597,,N,1,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627699,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12061,,,,,13807,,50597,,N,1,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,CHEMBL627700,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12062,,,,,14127,,50597,,N,1,,Total drug exposure is determined after oral dosing in rats.,CHEMBL627701,,1,A
Autocuration,BAO_0000218,,,,,12063,,,,,15116,,22224,,U,1,,Total drug exposure (5 mg/kg) when administered intravenously,CHEMBL627702,,0,A
Autocuration,BAO_0000218,,,,,12064,,,,,15116,,22224,,U,1,,Total drug exposure (5 mg/kg) when administered orally,CHEMBL627703,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12065,,,,,15604,,22224,,U,1,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,CHEMBL626873,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12066,,,,,15604,,50597,,N,1,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,CHEMBL629583,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12067,,,,,15604,,50588,,N,1,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,CHEMBL629584,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12068,,,,,15604,,50588,,N,1,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,CHEMBL629585,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12069,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL629586,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12070,In vivo,,Brain,,13751,955.0,50597,,N,1,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629587,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12071,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL629588,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12072,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL629589,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12073,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL629590,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12074,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL629591,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12075,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629592,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12076,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL629593,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12077,In vivo,,,,13751,,50597,,N,1,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL629594,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12078,In vivo,,Heart,,13751,948.0,50597,,N,1,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL629595,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12079,In vivo,,Heart,,13751,948.0,50597,,N,1,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL630290,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12080,In vivo,,Heart,,13751,948.0,50597,,N,1,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL627137,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12081,In vivo,,Heart,,13751,948.0,50597,,N,1,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627138,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12082,In vivo,,Heart,,13751,948.0,50597,,N,1,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627139,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12083,In vivo,,Heart,,13751,948.0,50597,,N,1,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL627140,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12084,In vivo,,Heart,,13751,948.0,50597,,N,1,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627141,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12085,In vivo,,Kidney,,13751,2113.0,50597,,N,1,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627142,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12086,In vivo,,Kidney,,13751,2113.0,50597,,N,1,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL627143,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12087,In vivo,,Kidney,,13751,2113.0,50597,,N,1,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL874449,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12088,In vivo,,Kidney,,13751,2113.0,50597,,N,1,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627144,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12089,In vivo,,Kidney,,13751,2113.0,50597,,N,1,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627145,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12090,In vivo,,Kidney,,13751,2113.0,50597,,N,1,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL627146,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12091,In vivo,,Kidney,,13751,2113.0,50597,,N,1,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627147,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12092,In vivo,,Liver,,13751,2107.0,50597,,N,1,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627148,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12093,In vivo,,Lung,,13751,2048.0,50597,,N,1,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627149,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12094,In vivo,,Lung,,13751,2048.0,50597,,N,1,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL632160,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12095,In vivo,,Lung,,13751,2048.0,50597,,N,1,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL632161,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12096,In vivo,,Lung,,13751,2048.0,50597,,N,1,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL632162,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12097,In vivo,,Lung,,13751,2048.0,50597,,N,1,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL632163,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12098,In vivo,,Lung,,13751,2048.0,50597,,N,1,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL874469,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12099,In vivo,,Lung,,13751,2048.0,50597,,N,1,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627182,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12100,In vivo,,Muscle tissue,,13751,2385.0,50597,,N,1,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627183,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12101,In vivo,,Muscle tissue,,13751,2385.0,50597,,N,1,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL627184,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12102,In vivo,,Muscle tissue,,13751,2385.0,50597,,N,1,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL627185,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12103,In vivo,,Muscle tissue,,13751,2385.0,50597,,N,1,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627186,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12104,In vivo,,Muscle tissue,,13751,2385.0,50597,,N,1,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627187,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12105,In vivo,,Muscle tissue,,13751,2385.0,50597,,N,1,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL627188,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12106,In vivo,,Muscle tissue,,13751,2385.0,50597,,N,1,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627189,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12107,In vivo,,,,13751,,50597,,N,1,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627190,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12108,In vivo,,Liver,,13751,2107.0,50597,,N,1,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL627191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12109,In vivo,,Liver,,13751,2107.0,50597,,N,1,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627192,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12110,In vivo,,Liver,,13751,2107.0,50597,,N,1,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627193,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12111,In vivo,,Muscle tissue,,10911,2385.0,50597,,N,1,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,CHEMBL874590,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12112,In vivo,,Muscle tissue,,10911,2385.0,50597,,N,1,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627194,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12113,In vivo,,Muscle tissue,,10911,2385.0,50597,,N,1,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627195,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12114,In vivo,,Female gonad,,10911,992.0,50597,,N,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627196,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12115,In vivo,,Female gonad,,10911,992.0,50597,,N,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627197,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12116,In vivo,,Female gonad,,10911,992.0,50597,,N,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627198,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12117,In vivo,,Female gonad,,10911,992.0,50597,,N,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,CHEMBL627199,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12118,In vivo,,Female gonad,,10911,992.0,50597,,N,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627200,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12119,In vivo,,Plasma,,10911,1969.0,50597,,N,1,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12120,In vivo,,Plasma,,10911,1969.0,50597,,N,1,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627202,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12121,In vivo,,Plasma,,10911,1969.0,50597,,N,1,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627203,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12122,In vivo,,Plasma,,10911,1969.0,50597,,N,1,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12123,In vivo,,Spleen,,10911,2106.0,50597,,N,1,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12124,In vivo,,Spleen,,10911,2106.0,50597,,N,1,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627206,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12125,In vivo,,Spleen,,10911,2106.0,50597,,N,1,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627207,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12126,In vivo,,Spleen,,10911,2106.0,50597,,N,1,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12127,In vivo,,Thyroid gland,,10911,2046.0,50597,,N,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12128,In vivo,,Thyroid gland,,10911,2046.0,50597,,N,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12129,In vivo,,Thyroid gland,,10911,2046.0,50597,,N,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627211,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12130,In vivo,,Thyroid gland,,10911,2046.0,50597,,N,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627212,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12131,In vivo,,Uterus,,10911,995.0,50597,,N,1,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627213,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12132,In vivo,,Uterus,,10911,995.0,50597,,N,1,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL626599,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12133,In vivo,,Uterus,,10911,995.0,50597,,N,1,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL626600,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12134,In vivo,,Uterus,,10911,995.0,50597,,N,1,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL626601,,1,A
Autocuration,BAO_0000019,,,,,12135,,,,,8081,,22224,,U,1,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,CHEMBL627484,,0,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12136,,,Plasma,,17248,1969.0,100710,,N,1,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),CHEMBL627485,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12137,,,Plasma,,17248,1969.0,100710,,N,1,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,CHEMBL628147,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12138,,,Plasma,,17248,1969.0,100710,,N,1,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,CHEMBL628148,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12139,,,Plasma,,17248,1969.0,50588,,N,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),CHEMBL628149,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12140,,,Plasma,,17248,1969.0,50588,,N,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,CHEMBL628150,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12141,,,Plasma,,17248,1969.0,50588,,N,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,CHEMBL628318,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12142,,,Plasma,,17248,1969.0,50588,,N,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,CHEMBL628319,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12143,,,,,15592,,50588,,N,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",CHEMBL875609,,1,A
Autocuration,BAO_0000019,,,,,12144,,,,,7040,,22224,,U,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,CHEMBL628320,,0,A
Autocuration,BAO_0000019,,,,,12145,,,,,7040,,22224,,U,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,CHEMBL628321,,0,A
Autocuration,BAO_0000019,,,,,12146,,,,,7040,,22224,,U,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,CHEMBL628322,,0,A
Autocuration,BAO_0000019,,,,,12147,,,,,7040,,22224,,U,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,CHEMBL628323,,0,A
Autocuration,BAO_0000019,,,,,12148,,,,,7040,,22224,,U,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,CHEMBL628324,,0,A
Autocuration,BAO_0000019,,,,,12149,,,,,7040,,22224,,U,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,CHEMBL628325,,0,A
Autocuration,BAO_0000019,,,,,12150,,,,,7040,,22224,,U,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,CHEMBL628326,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12151,,,Adrenal medulla,,9614,1236.0,50588,,N,1,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",CHEMBL628327,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12152,,,Adrenal medulla,,9614,1236.0,50588,,N,1,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",CHEMBL628328,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12153,,,Blood,,9614,178.0,50588,,N,1,,"Concentration of compound in blood of dog 1, after administering intravenously",CHEMBL628329,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12154,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",CHEMBL628330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12155,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",CHEMBL628331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12156,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",CHEMBL628332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12157,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",CHEMBL628333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12158,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",CHEMBL628334,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12159,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",CHEMBL628335,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12160,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",CHEMBL628336,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12161,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",CHEMBL628337,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12162,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",CHEMBL628338,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12163,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",CHEMBL875610,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12164,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",CHEMBL628339,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12165,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",CHEMBL628340,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12166,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",CHEMBL628341,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12167,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",CHEMBL622214,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12168,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",CHEMBL623167,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12169,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",CHEMBL623168,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12170,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",CHEMBL623169,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12171,,,Liver,,8608,2107.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",CHEMBL623170,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12172,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",CHEMBL627224,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12173,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",CHEMBL875634,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12174,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",CHEMBL627225,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12175,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",CHEMBL627226,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12176,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",CHEMBL626083,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12177,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",CHEMBL626084,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12178,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",CHEMBL626085,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12179,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",CHEMBL626086,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12180,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",CHEMBL626087,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12181,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",CHEMBL626088,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12182,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",CHEMBL626089,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12183,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",CHEMBL626090,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12184,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",CHEMBL626091,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12185,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",CHEMBL626092,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12186,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",CHEMBL626093,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12187,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",CHEMBL626094,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12188,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",CHEMBL626095,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12189,,,Lung,,8608,2048.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",CHEMBL626096,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12190,,,,,15604,,22224,,U,1,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,CHEMBL626097,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12191,,,,,15604,,50597,,N,1,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,CHEMBL626098,,1,A
Autocuration,BAO_0000218,,,,,12192,,,Plasma,,1806,1969.0,22224,,U,1,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,CHEMBL626099,,0,A
Autocuration,BAO_0000218,,,,,12193,,,Plasma,,1806,1969.0,22224,,U,1,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,CHEMBL626100,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12194,,,Plasma,,17237,1969.0,50588,,N,1,,AUC 0-inf in dog,CHEMBL626101,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,12195,,,Plasma,,17237,1969.0,50512,,N,1,,AUC 0-inf in guinea pig,CHEMBL626102,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12196,,,Plasma,,17237,1969.0,50588,,N,1,,AUC 0-t in dog,CHEMBL626103,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,12197,,,Plasma,,17237,1969.0,50512,,N,1,,AUC 0-t in guinea pig,CHEMBL628391,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12198,,,,,15194,,50597,,N,1,,The compound was tested for brain to plasma partition in rat,CHEMBL628392,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12199,,,,,15194,,50597,,N,1,,The compound was tested for brain to plasma partition in rat.,CHEMBL628393,,1,A
Autocuration,BAO_0000019,,,,,12200,,,Blood,,8787,178.0,22224,,U,1,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,CHEMBL628394,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12201,,,,,17025,,50588,,N,1,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,CHEMBL628395,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12202,,,,,17025,,22224,,U,1,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,CHEMBL628396,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12203,,,,,17025,,50592,,N,1,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,CHEMBL628397,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12204,,,,,17025,,50597,,N,1,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,CHEMBL628398,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,12205,,,,,4236,,50797,,N,1,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,CHEMBL628399,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12206,,,,,15343,,50588,,N,1,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,CHEMBL628400,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12207,,,,,15343,,50597,,N,1,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,CHEMBL874907,,1,A
Autocuration,BAO_0000019,,,,,12208,,,,,17720,,22224,,U,1,,Area under curve of the compound was determined,CHEMBL628401,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12209,,,Plasma,,17788,1969.0,22224,,U,1,,AUC in monkeys at a dose of 1 mg/kg,CHEMBL628402,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12210,,,Plasma,,17788,1969.0,50597,,N,1,,AUC in rats at a dose of 1 mg/kg,CHEMBL628403,,1,A
Autocuration,BAO_0000019,,,,,12211,,,,,8778,,22224,,U,1,,Compound was evaluated for the overall absorbance loss at pH of 2,CHEMBL628404,,0,A
Autocuration,BAO_0000019,,,,,12212,,,,,8778,,22224,,U,1,,Compound was evaluated for the overall absorbance loss at pH of 4,CHEMBL628405,,0,A
Autocuration,BAO_0000019,,,,,12213,,,,,8778,,22224,,U,1,,Compound was evaluated for the overall absorbance loss at pH of 7,CHEMBL628406,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12214,,,,,2249,,50597,,N,1,,Compound was evaluated for its absorption in the rats,CHEMBL628407,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12215,,,Urine,,8881,1088.0,50597,,N,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,CHEMBL628408,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12216,,,Urine,,8881,1088.0,50597,,N,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,CHEMBL629171,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12217,,,Urine,,8881,1088.0,50597,,N,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,CHEMBL629172,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12218,,,Urine,,8881,1088.0,50597,,N,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,CHEMBL629173,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12219,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum,CHEMBL629174,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12220,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 10-17,CHEMBL629175,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12221,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 10-18,CHEMBL629176,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12222,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 10-19,CHEMBL629177,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12223,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 12-15,CHEMBL629178,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12224,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 13-19,CHEMBL631869,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12225,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 14-17,CHEMBL631870,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12226,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 15-18,CHEMBL631871,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12227,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 2-5,CHEMBL631872,,1,A
Autocuration,BAO_0000221,,,,,12228,,,Ileum,,15286,2116.0,22224,,U,1,,In vitro percent permeability into rat ileum; Range is 23-42,CHEMBL875775,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12229,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 28-36,CHEMBL631873,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12230,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 29-35,CHEMBL631874,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12231,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 46-66,CHEMBL631875,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12232,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 50-68,CHEMBL631876,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12233,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; Range is 78-81,CHEMBL631877,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12234,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,CHEMBL631878,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12235,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; nd indicates not detected,CHEMBL631879,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12236,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; nt indicates not detected,CHEMBL631880,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12237,,,,,15286,,50597,,N,1,,In vitro percent permeability into rat ileum; nt indicates not tested,CHEMBL631881,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12238,,,,,13770,,50597,,N,1,,Compound was tested for oral absorption in bile-duct cannulated rats,CHEMBL631882,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12239,,,,,13770,,50597,,N,1,,Compound was tested for oral absorption in bile-duct cannulated rats.,CHEMBL630749,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12240,,,,,5202,,50587,,N,1,,Oral absorption using Caco-2 cell monolayers.,CHEMBL630750,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12241,,,,,14920,,50587,,N,1,,Percent of the drug absorbed after administration to humans was determined,CHEMBL630253,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12242,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,CHEMBL630254,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12243,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,CHEMBL630255,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12244,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,CHEMBL630256,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12245,In vivo,,Liver,,13751,2107.0,50597,,N,1,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL875781,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12246,In vivo,,Liver,,13751,2107.0,50597,,N,1,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL630257,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12247,In vivo,,Liver,,13751,2107.0,50597,,N,1,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL630258,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12248,,,,,15807,,50597,,N,1,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",CHEMBL630259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12249,,,Striatum,,15807,2435.0,50597,,N,1,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",CHEMBL630260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12250,,,Striatum,,15807,2435.0,50597,,N,1,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",CHEMBL630261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12251,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,CHEMBL630262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12252,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,CHEMBL630263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12253,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,CHEMBL630264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12254,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,CHEMBL630265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12255,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,CHEMBL630266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12256,,,Kidney,,14950,2113.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,CHEMBL630267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12257,,,Kidney,,14950,2113.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,CHEMBL630268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12258,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,CHEMBL630269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12259,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,CHEMBL630270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12260,,,Lung,,14950,2048.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,CHEMBL630141,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12261,,,Lung,,14950,2048.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,CHEMBL630142,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12262,,,Muscle tissue,,14950,2385.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,CHEMBL630143,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12263,,,Muscle tissue,,14950,2385.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,CHEMBL630144,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12264,,,Prostate gland,,14950,2367.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,CHEMBL630145,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12265,,,Prostate gland,,14950,2367.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,CHEMBL630146,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12266,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,CHEMBL630147,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12267,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,CHEMBL630148,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12268,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,CHEMBL630149,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12269,,,Spleen,,14950,2106.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,CHEMBL630150,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12270,,,Spleen,,14950,2106.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,CHEMBL630151,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12271,,,Thyroid gland,,14950,2046.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,CHEMBL632031,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12272,,,Thyroid gland,,14950,2046.0,50597,,N,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,CHEMBL632032,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12273,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,CHEMBL632033,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12274,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,CHEMBL632034,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12275,,,Muscle tissue,,14950,2385.0,50597,,N,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,CHEMBL632035,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12276,,,,,14950,,50597,,N,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,CHEMBL632036,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12277,,,Thyroid gland,,14950,2046.0,50597,,N,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,CHEMBL632037,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12278,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,CHEMBL632038,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12279,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,CHEMBL632039,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12280,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,CHEMBL632040,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12281,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,CHEMBL632041,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12282,,,Blood,,9614,178.0,50588,,N,1,,"Concentration of compound in blood of dog 2, after administering intravenously",CHEMBL632042,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12283,,,,,9614,,50588,,N,1,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",CHEMBL632043,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12284,,,,,9614,,50588,,N,1,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",CHEMBL632044,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12285,,,Liver,,9614,2107.0,50588,,N,1,,"Concentration of compound in liver of dog 1, after administering intravenously",CHEMBL632045,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12286,,,Liver,,9614,2107.0,50588,,N,1,,"Concentration of compound in liver of dog 2, after administering intravenously",CHEMBL632046,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12287,,,Lung,,9614,2048.0,50588,,N,1,,"Concentration of compound in lung of dog 1, after administering intravenously",CHEMBL632047,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12288,,,Lung,,9614,2048.0,50588,,N,1,,"Concentration of compound in lung of dog 2, after administering intravenously",CHEMBL632048,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12289,,,Muscle tissue,,9614,2385.0,50588,,N,1,,"Concentration of compound in muscle of dog 1, after administering intravenously",CHEMBL632049,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12290,,,Muscle tissue,,9614,2385.0,50588,,N,1,,"Concentration of compound in muscle of dog 2, after administering intravenously",CHEMBL876418,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12291,,,Spleen,,9614,2106.0,50588,,N,1,,"Concentration of compound in spleen of dog 1,after administering intravenously",CHEMBL632050,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12292,,,Spleen,,9614,2106.0,50588,,N,1,,"Concentration of compound in spleen of dog 2, after administering intravenously",CHEMBL632051,,1,A
Autocuration,BAO_0000218,,,,,12293,,,,,10353,,22224,,U,1,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,CHEMBL632052,,0,F
Autocuration,BAO_0000218,,,,,12294,,,,,10353,,22224,,U,1,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,CHEMBL632053,,0,F
Autocuration,BAO_0000218,,,,,12295,,,,,10353,,22224,,U,1,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,CHEMBL632054,,0,A
Autocuration,BAO_0000218,,,,,12296,,,,,10353,,22224,,U,1,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,CHEMBL632055,,0,F
Autocuration,BAO_0000218,,,,,12297,,,,,10353,,22224,,U,1,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,CHEMBL631181,,0,F
Autocuration,BAO_0000218,,,,,12298,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,CHEMBL631182,,0,A
Autocuration,BAO_0000218,,,,,12299,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,CHEMBL631183,,0,A
Autocuration,BAO_0000218,,,,,12300,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL631184,,0,A
Autocuration,BAO_0000218,,,,,12301,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL629774,,0,A
Autocuration,BAO_0000218,,,,,12302,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL629775,,0,A
Autocuration,BAO_0000218,,,,,12303,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL876549,,0,A
Autocuration,BAO_0000218,,,,,12304,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL628172,,0,A
Autocuration,BAO_0000218,,,,,12305,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,CHEMBL628173,,0,A
Autocuration,BAO_0000218,,,,,12306,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,CHEMBL628174,,0,A
Autocuration,BAO_0000218,,,,,12307,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,CHEMBL628175,,0,A
Autocuration,BAO_0000218,,,,,12308,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,CHEMBL628176,,0,A
Autocuration,BAO_0000218,,,,,12309,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,CHEMBL628177,,0,A
Autocuration,BAO_0000218,,,,,12310,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL628178,,0,A
Autocuration,BAO_0000218,,,,,12311,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,CHEMBL628179,,0,A
Autocuration,BAO_0000218,,,,,12312,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,CHEMBL628180,,0,A
Autocuration,BAO_0000218,,,,,12313,,,,,9196,,22224,,U,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,CHEMBL628181,,0,A
Autocuration,BAO_0000218,,,,,12314,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL628182,,0,A
Autocuration,BAO_0000218,,,,,12315,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL628183,,0,A
Autocuration,BAO_0000218,,,,,12316,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,CHEMBL628184,,0,A
Autocuration,BAO_0000218,,,,,12317,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL628185,,0,A
Autocuration,BAO_0000218,,,,,12318,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL875617,,0,A
Autocuration,BAO_0000218,,,,,12319,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,CHEMBL628186,,0,A
Autocuration,BAO_0000218,,,,,12320,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL628187,,0,A
Autocuration,BAO_0000218,,,,,12321,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,CHEMBL628188,,0,A
Autocuration,BAO_0000218,,,,,12322,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,CHEMBL628189,,0,A
Autocuration,BAO_0000218,,,,,12323,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,CHEMBL628190,,0,A
Autocuration,BAO_0000218,,,,,12324,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,CHEMBL628191,,0,A
Autocuration,BAO_0000218,,,,,12325,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,CHEMBL626513,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12326,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",CHEMBL626514,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12327,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",CHEMBL626515,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12328,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",CHEMBL626516,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12329,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",CHEMBL626517,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12330,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",CHEMBL626518,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12331,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",CHEMBL626519,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12332,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",CHEMBL626520,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12333,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",CHEMBL626521,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12334,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",CHEMBL626522,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12335,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",CHEMBL626523,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12336,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",CHEMBL626524,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12337,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",CHEMBL626688,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12338,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",CHEMBL626689,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12339,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",CHEMBL626690,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12340,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",CHEMBL626691,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12341,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",CHEMBL627319,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12342,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",CHEMBL624052,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12343,,,Thyroid gland,,8608,2046.0,50597,,N,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",CHEMBL624053,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12344,,,,,8085,,50597,,N,1,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624054,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12345,,,,,8085,,50597,,N,1,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624055,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12346,,,,,8085,,50597,,N,1,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624056,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12347,,,Uterus,,8085,995.0,50597,,N,1,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624057,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12348,,,Uterus,,8085,995.0,50597,,N,1,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622281,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12349,,,Uterus,,8085,995.0,50597,,N,1,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622282,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12350,,,Uterus,,8085,995.0,50597,,N,1,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622283,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12351,,,Uterus,,8085,995.0,50597,,N,1,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622284,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12352,,,Uterus,,8085,995.0,50597,,N,1,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622285,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12353,,,Uterus,,8085,995.0,50597,,N,1,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622286,,1,A
Autocuration,BAO_0000100,,,,,12354,,,,,7657,,22224,,U,1,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,CHEMBL622287,,0,P
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12355,,,,,8935,,50594,,N,1,,Partition coefficient (logD7.4),CHEMBL622288,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12356,,,,,13792,,50594,,N,1,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",CHEMBL622289,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12357,,,Brain,,13792,955.0,50594,,N,1,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",CHEMBL622290,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12358,,,,,13792,,50594,,N,1,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,CHEMBL622291,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12359,,,Brain,,13792,955.0,50594,,N,1,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,CHEMBL622292,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12360,,,,,13792,,50594,,N,1,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",CHEMBL622293,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12361,,,Brain,,13792,955.0,50594,,N,1,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",CHEMBL622294,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12362,,,,,13792,,50594,,N,1,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,CHEMBL622295,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12363,,,Brain,,13792,955.0,50597,,N,1,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,CHEMBL622296,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12364,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,CHEMBL874409,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12365,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,CHEMBL622297,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12366,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,CHEMBL622298,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12367,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,CHEMBL622299,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12368,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,CHEMBL622300,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12369,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,CHEMBL622301,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12370,,,Plasma,,14103,1969.0,50597,,N,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,CHEMBL622302,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12371,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,CHEMBL622303,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12372,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,CHEMBL622304,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12373,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,CHEMBL622305,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12374,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,CHEMBL622306,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12375,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,CHEMBL626864,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12376,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,CHEMBL626865,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12377,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,CHEMBL626866,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12378,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,CHEMBL626867,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12379,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,CHEMBL626868,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12380,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,CHEMBL626869,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12381,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,CHEMBL626870,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12382,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,CHEMBL626871,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12383,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,CHEMBL626872,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12384,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,CHEMBL632185,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12385,,,Plasma,,14103,1969.0,50597,,N,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,CHEMBL632186,,1,A
Autocuration,BAO_0000019,,,,,12386,,,,,12904,,22224,,U,1,,Amount of acetic acid produced by the compound,CHEMBL629310,,0,A
Autocuration,BAO_0000019,,,,,12387,,,,,12904,,22224,,U,1,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,CHEMBL629311,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12388,,,,,9663,,50597,,N,1,,Log of (Cbrain/Cblood) in rats,CHEMBL629312,,1,A
Autocuration,BAO_0000221,,,,,12389,,,,,7652,,22224,,U,1,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),CHEMBL629313,,0,A
Autocuration,BAO_0000221,,,,,12390,,,,,7652,,22224,,U,1,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),CHEMBL629314,,0,A
Autocuration,BAO_0000221,,,,,12391,,,,,7652,,22224,,U,1,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),CHEMBL629315,,0,A
Autocuration,BAO_0000219,,,,,12392,,,,,7652,,22224,,U,1,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),CHEMBL629316,,0,B
Autocuration,BAO_0000221,,,,,12393,,,,,7652,,22224,,U,1,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),CHEMBL629317,,0,A
Autocuration,BAO_0000019,,,,,12394,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),CHEMBL629318,,0,A
Autocuration,BAO_0000019,,,,,12395,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),CHEMBL877497,,0,A
Autocuration,BAO_0000019,,,,,12396,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),CHEMBL629319,,0,A
Autocuration,BAO_0000019,,,,,12397,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),CHEMBL629320,,0,A
Autocuration,BAO_0000019,,,,,12398,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),CHEMBL629496,,0,A
Autocuration,BAO_0000019,,,,,12399,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),CHEMBL629497,,0,A
Autocuration,BAO_0000019,,,,,12400,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),CHEMBL629498,,0,A
Autocuration,BAO_0000019,,,,,12401,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),CHEMBL629499,,0,A
Autocuration,BAO_0000019,,,,,12402,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),CHEMBL629500,,0,A
Autocuration,BAO_0000019,,,,,12403,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),CHEMBL629501,,0,A
Autocuration,BAO_0000019,,,,,12404,,,,,7652,,22224,,U,1,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),CHEMBL629502,,0,A
Autocuration,BAO_0000218,,,,,12405,In vivo,,,,8267,,22224,,U,1,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,CHEMBL629503,,0,F
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12406,,,,,8267,,50588,,N,1,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,CHEMBL629504,,1,A
Autocuration,BAO_0000019,,,,,12407,,,,,14479,,22224,,U,1,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,CHEMBL629505,,0,A
Autocuration,BAO_0000019,,,,,12408,,,,,17515,,22224,,U,1,,Compound was evaluated for total body clearance,CHEMBL629506,,0,A
Autocuration,BAO_0000019,,,,,12409,,,,,17515,,22224,,U,1,,Compound was evaluated for volume of distribution at steady state,CHEMBL629507,,0,A
Autocuration,BAO_0000019,,,,,12410,,,,,8142,,22224,,U,1,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,CHEMBL877498,,0,A
Autocuration,BAO_0000019,,,,,12411,,,,,14849,,22224,,U,1,,Percentage of the diamine which is monoprotonated at pH 7.4,CHEMBL629508,,0,A
Autocuration,BAO_0000019,,,,,12412,,,,,7653,,22224,,U,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,CHEMBL629509,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12413,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,CHEMBL629510,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12414,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,CHEMBL629511,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12415,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL629512,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12416,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL629513,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12417,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,CHEMBL629514,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12418,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL628447,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12419,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,CHEMBL628448,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12420,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,CHEMBL628449,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12421,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,CHEMBL631119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12422,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,CHEMBL631120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12423,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,CHEMBL631121,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12424,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,CHEMBL874458,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12425,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL631122,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12426,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL631123,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12427,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL631124,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12428,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,CHEMBL631125,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12429,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL631290,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12430,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL631291,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12431,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL631292,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12432,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,CHEMBL631293,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12433,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL631294,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12434,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL631295,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12435,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,CHEMBL631296,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12436,,,Blood,,8631,178.0,50597,,N,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL631297,,1,A
Autocuration,BAO_0000218,,,,,12437,,,,,10263,,22224,,U,1,,Maximum biodistribution (Bmax) was determined.,CHEMBL631298,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12438,,,,,12364,,50594,,N,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,CHEMBL631299,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12439,,,,,12364,,50594,,N,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,CHEMBL631300,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12440,,,,,12364,,50594,,N,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,CHEMBL631301,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12441,,,,,12364,,50594,,N,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,CHEMBL630291,,1,A
Autocuration,BAO_0000218,,,,,12442,,,,,14793,,22224,,U,1,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL630292,,0,A
Autocuration,BAO_0000218,,,,,12443,,,,,14793,,22224,,U,1,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,CHEMBL630293,,0,A
Autocuration,BAO_0000218,,,,,12444,,,,,14793,,22224,,U,1,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,CHEMBL630294,,0,A
Autocuration,BAO_0000218,,,,,12445,,,,,14793,,22224,,U,1,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL630295,,0,A
Autocuration,BAO_0000218,,,,,12446,,,,,14793,,22224,,U,1,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL630296,,0,A
Autocuration,BAO_0000218,,,,,12447,,,,,14793,,22224,,U,1,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626782,,0,A
Autocuration,BAO_0000218,,,,,12448,,,,,14793,,22224,,U,1,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,CHEMBL626783,,0,A
Autocuration,BAO_0000218,,,,,12449,,,,,14793,,22224,,U,1,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL626784,,0,A
Autocuration,BAO_0000218,,,,,12450,,,,,14793,,22224,,U,1,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL626785,,0,A
Autocuration,BAO_0000218,,,,,12451,,,,,14793,,22224,,U,1,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626786,,0,A
Autocuration,BAO_0000218,,,,,12452,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL626787,,0,A
Autocuration,BAO_0000218,,,,,12453,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,CHEMBL626788,,0,A
Autocuration,BAO_0000218,,,,,12454,,,,,9196,,22224,,U,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,CHEMBL625927,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12455,,,Blood,,8374,178.0,50597,,N,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625928,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12456,,,Blood,,8374,178.0,50597,,N,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL625929,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12457,,,Blood,,8374,178.0,50597,,N,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,CHEMBL625930,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12458,,,Blood,,8374,178.0,50597,,N,1,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",CHEMBL625931,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12459,,,Blood,,8374,178.0,50597,,N,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,CHEMBL627230,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12460,,,Blood,,8374,178.0,50597,,N,1,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627231,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12461,,,Blood,,8374,178.0,50597,,N,1,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL627232,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12462,,,Blood,,8374,178.0,50597,,N,1,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,CHEMBL627233,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12463,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL875470,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12464,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627234,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12465,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627235,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12466,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627236,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12467,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627237,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12468,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627238,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12469,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627239,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12470,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627240,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12471,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627241,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12472,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627242,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12473,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,CHEMBL627243,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12474,,,Blood,,8374,178.0,50597,,N,1,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL627244,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12475,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627245,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12476,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627246,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12477,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627247,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12478,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627248,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12479,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627249,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12480,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625569,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12481,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625570,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12482,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625571,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12483,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL625572,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12484,,,Blood,,8374,178.0,50597,,N,1,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL625573,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12485,,,Blood,,8374,178.0,50597,,N,1,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,CHEMBL625574,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12486,,,Blood,,8374,178.0,50597,,N,1,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL626245,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12487,,,Blood,,8374,178.0,50597,,N,1,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL626246,,1,A
Autocuration,BAO_0000218,,,,,12488,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL626247,,0,A
Autocuration,BAO_0000218,,,,,12489,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL626248,,0,A
Autocuration,BAO_0000218,,,,,12490,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,CHEMBL626249,,0,A
Autocuration,BAO_0000218,,,,,12491,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL626420,,0,A
Autocuration,BAO_0000218,,,,,12492,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,CHEMBL626421,,0,A
Autocuration,BAO_0000218,,,,,12493,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,CHEMBL626422,,0,A
Autocuration,BAO_0000218,,,,,12494,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL626423,,0,A
Autocuration,BAO_0000218,,,,,12495,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL626424,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12496,,,,,12023,,50588,,N,1,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,CHEMBL626425,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12497,,,,,12023,,50597,,N,1,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,CHEMBL875476,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12498,,,,,12023,,100710,,N,1,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,CHEMBL626426,,1,A
Autocuration,BAO_0000100,,,,,12499,,,,,10580,,22224,,U,1,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,CHEMBL626427,,0,P
Autocuration,BAO_0000100,,,,,12500,,,,,10580,,22224,,U,1,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,CHEMBL626428,,0,P
Autocuration,BAO_0000019,,,,,12501,,,,,16032,,22224,,U,1,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,CHEMBL626429,,0,A
Autocuration,BAO_0000019,,,,,12502,,,Urine,,16032,1088.0,22224,,U,1,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,CHEMBL625025,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12503,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL625026,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12504,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL625027,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12505,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL874410,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12506,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL625028,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12507,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL625029,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12508,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL625030,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12509,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL625031,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12510,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL625032,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12511,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL625033,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12512,,,Blood,,8594,178.0,50597,,N,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL625034,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12513,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL624872,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12514,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL624873,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12515,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL624874,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12516,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624875,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12517,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL624876,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12518,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624877,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12519,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624878,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12520,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL624879,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12521,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL624880,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12522,,,Heart,,8594,948.0,50597,,N,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,CHEMBL624881,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12523,,,Heart,,8594,948.0,50597,,N,1,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",CHEMBL624882,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12524,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL624883,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12525,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL624884,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12526,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL624885,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12527,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624886,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12528,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL624887,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12529,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624888,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12530,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624889,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12531,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL624890,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12532,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL621964,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12533,,,Kidney,,8594,2113.0,50597,,N,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL621965,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12534,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL621966,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12535,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL621967,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12536,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL622164,,1,A
Autocuration,BAO_0000019,,,,,12537,,,,,7653,,22224,,U,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),CHEMBL623097,,0,A
Autocuration,BAO_0000019,,,,,12538,,,,,7653,,22224,,U,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),CHEMBL623098,,0,A
Autocuration,BAO_0000019,,,,,12539,,,,,7653,,22224,,U,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,CHEMBL623099,,0,A
Autocuration,BAO_0000019,,,,,12540,,,,,7653,,22224,,U,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,CHEMBL623100,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12541,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",CHEMBL628673,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12542,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",CHEMBL628674,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12543,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",CHEMBL628675,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12544,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",CHEMBL627644,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12545,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",CHEMBL627645,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12546,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",CHEMBL627646,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12547,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",CHEMBL627647,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12548,,,,,9104,,50597,,N,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",CHEMBL627648,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12549,,,,,12902,,50597,,N,1,,Free level in rat plasma,CHEMBL627649,,1,A
Autocuration,BAO_0000019,,,,,12550,,,,,6614,,22224,,U,1,,Level reaching in blood plasma of rat or human was determined,CHEMBL628313,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12551,,,,,9663,,50597,,N,1,,Log (Cbrain/Cblood) in rats,CHEMBL628314,,1,A
Autocuration,BAO_0000019,,,,,12552,,,,,17658,,22224,,U,1,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,CHEMBL628315,,0,A
Autocuration,BAO_0000019,,,,,12553,,,,,17658,,22224,,U,1,,Mean percentage of compound transport through membrane; expressed as membrane transport,CHEMBL628316,,0,A
Autocuration,BAO_0000218,,,,,12554,,,,,14314,,22224,,U,1,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,CHEMBL628317,,0,A
Autocuration,BAO_0000019,,,,,12555,,,,,7385,,22224,,U,1,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,CHEMBL628473,,0,A
Autocuration,BAO_0000019,,,,,12556,,,,,7385,,22224,,U,1,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",CHEMBL628474,,0,A
Autocuration,BAO_0000019,,,,,12557,,,,,7385,,22224,,U,1,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,CHEMBL628475,,0,A
Autocuration,BAO_0000019,,,,,12558,,,,,1329,,22224,,U,1,,Net water uptake by a carrier mediated transport (%cm) mechanism,CHEMBL628476,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12559,,,,,12187,,22224,,U,1,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL628477,,0,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,12560,,,,,12187,,50506,,N,1,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,CHEMBL628478,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,12561,,,,,12187,,50506,,N,1,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",CHEMBL628479,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12562,,,,,12187,,22224,,U,1,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL628480,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12563,,,,,12187,,22224,,U,1,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",CHEMBL628481,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12564,,,,,12187,,50597,,N,1,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,CHEMBL628482,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12565,,,,,12187,,50597,,N,1,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",CHEMBL628483,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12566,,,Plasma,,9278,1969.0,50597,,N,1,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",CHEMBL628484,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12567,,,Plasma,,9278,1969.0,50597,,N,1,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",CHEMBL628485,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12568,,,Plasma,,9278,1969.0,100710,,N,1,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",CHEMBL628486,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12569,,,Plasma,,9278,1969.0,50587,,N,1,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",CHEMBL628487,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12570,,,Plasma,,9278,1969.0,50597,,N,1,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",CHEMBL628488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12571,,,Plasma,,9278,1969.0,50597,,N,1,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",CHEMBL628489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12572,,,Plasma,,9278,1969.0,50597,,N,1,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",CHEMBL628490,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12573,,,,,12186,,100710,,N,1,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL628491,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12574,,,,,12186,,100710,,N,1,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL877507,,1,A
Autocuration,BAO_0000218,,,,,12575,,,,,12186,,22224,,U,1,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,CHEMBL628492,,0,A
Autocuration,BAO_0000019,,314293.0,,Simiiformes,12576,,,,,12041,,22224,,U,1,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),CHEMBL628493,,0,A
Autocuration,BAO_0000019,,314293.0,,Simiiformes,12577,,,,,12041,,22224,,U,1,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),CHEMBL628494,,0,A
Autocuration,BAO_0000019,,314293.0,,Simiiformes,12578,,,,,12041,,22224,,U,1,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),CHEMBL628495,,0,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12579,,,,,6737,,50587,,N,1,,Permeability in Caco-2 assay at 10E-6,CHEMBL628496,,1,A
Autocuration,BAO_0000218,,,,,12580,,,Brain,,13758,955.0,22224,,U,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,CHEMBL628497,,0,A
Autocuration,BAO_0000218,,,,,12581,,,Brain,,13758,955.0,22224,,U,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,CHEMBL628498,,0,A
Autocuration,BAO_0000019,,,,,12582,,,,,5676,,22224,,U,1,,Plasma protein binding was determined,CHEMBL628499,,0,A
Autocuration,BAO_0000218,,,,,12583,,,,,14793,,22224,,U,1,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,CHEMBL627656,,0,A
Autocuration,BAO_0000218,,,,,12584,,,,,14793,,22224,,U,1,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL627657,,0,A
Autocuration,BAO_0000218,,,,,12585,,,,,14793,,22224,,U,1,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL626808,,0,A
Autocuration,BAO_0000218,,,,,12586,,,,,14793,,22224,,U,1,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626809,,0,A
Autocuration,BAO_0000218,,,,,12587,,,,,14793,,22224,,U,1,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,CHEMBL626810,,0,A
Autocuration,BAO_0000218,,,,,12588,,,,,14793,,22224,,U,1,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL626811,,0,A
Autocuration,BAO_0000218,,,,,12589,,,,,14793,,22224,,U,1,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL874465,,0,A
Autocuration,BAO_0000218,,,,,12590,,,,,14793,,22224,,U,1,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626812,,0,A
Autocuration,BAO_0000218,,,,,12591,,,,,14793,,22224,,U,1,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,CHEMBL626813,,0,A
Autocuration,BAO_0000218,,,,,12592,,,,,14793,,22224,,U,1,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626814,,0,A
Autocuration,BAO_0000019,,,,,12593,,,,,14000,,22224,,U,1,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,CHEMBL626815,,0,A
Autocuration,BAO_0000019,,,,,12594,,,,,5948,,22224,,U,1,,Partition coefficient (logP),CHEMBL628566,,0,A
Autocuration,BAO_0000100,,,,,12595,,,,,13824,,22229,,U,1,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),CHEMBL628567,,0,P
Autocuration,BAO_0000100,,,,,12596,,,,,10778,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL628568,,0,P
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12597,In vivo,,,,17237,,50588,,N,1,,C max in dog,CHEMBL628569,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,12598,In vivo,,,,17237,,50512,,N,1,,C max in guinea pig,CHEMBL628570,,1,A
Autocuration,BAO_0000218,,,,,12599,In vivo,,,,2809,,22224,,U,1,,C max value was evaluated,CHEMBL628571,,0,A
Autocuration,BAO_0000218,,,,,12600,In vivo,,,,11954,,22224,,U,1,,Cmax value after oral dose of 0.1 mg//kg,CHEMBL628572,,0,A
Autocuration,BAO_0000218,,,,,12601,In vivo,,,,11954,,22224,,U,1,,Cmax value after oral dose of 0.3 mg/kg,CHEMBL628573,,0,A
Autocuration,BAO_0000218,,,,,12602,In vivo,,,,11954,,22224,,U,1,,Cmax value after oral dose of 1 mg/kg,CHEMBL628574,,0,A
Autocuration,BAO_0000218,,,,,12603,In vivo,,,,11954,,22224,,U,1,,Cmax value after oral dose of 10 mg/kg,CHEMBL628575,,0,A
Autocuration,BAO_0000218,,,,,12604,In vivo,,,,11954,,22224,,U,1,,Cmax value after oral dose of 23.4 mg/kg,CHEMBL628576,,0,A
Autocuration,BAO_0000218,,,,,12605,In vivo,,,,11954,,22224,,U,1,,Cmax value after oral dose of 3 mg/kg,CHEMBL628577,,0,A
Autocuration,BAO_0000218,,,,,12606,In vivo,,,,11954,,22224,,U,1,,Cmax value after oral dose of 3.87 mg/kg,CHEMBL628578,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12607,In vivo,,,,12768,,50588,,N,1,,Cmax value in female Beagle dogs,CHEMBL874466,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12608,In vivo,,,,12768,,50597,,N,1,,Cmax value in male rats,CHEMBL628579,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12609,In vivo,,Plasma,,12780,1969.0,50597,,N,1,,Cmax value in rat plasma when administered 20 mg/kg perorally,CHEMBL628580,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12610,In vivo,,Plasma,,15592,1969.0,50588,,N,1,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,CHEMBL628581,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12611,In vivo,,Plasma,,15592,1969.0,50588,,N,1,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,CHEMBL628582,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12612,,,,,17025,,50588,,N,1,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,CHEMBL628583,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12613,,,,,17025,,22224,,U,1,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,CHEMBL625782,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12614,,,,,17025,,50592,,N,1,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,CHEMBL625783,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12615,,,,,17025,,50597,,N,1,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,CHEMBL625784,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,12616,,,Plasma,,4236,1969.0,50797,,N,1,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,CHEMBL625785,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12617,,,,,15791,,50597,,N,1,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,CHEMBL625786,,1,A
Autocuration,BAO_0000019,,,,,12618,,,,,11149,,22224,,U,1,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,CHEMBL874467,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12619,,,,,15592,,50588,,N,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",CHEMBL625787,,1,A
Intermediate,BAO_0000218,,12721.0,,Human immunodeficiency virus,12620,,,,,15778,,50677,,N,1,,cytotoxicity against HIV protease enzyme.,CHEMBL625964,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12621,,,,,12745,,50594,,N,1,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,CHEMBL625965,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12622,,,,,12745,,50594,,N,1,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,CHEMBL625966,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12623,In vivo,,Plasma,,13941,1969.0,50588,,N,1,,The plasma clearance in dog.,CHEMBL625967,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12624,In vivo,,Plasma,,13941,1969.0,50597,,N,1,,The plasma clearance in rat.,CHEMBL625968,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12625,In vivo,,Plasma,,16449,1969.0,50597,,N,1,,Clearance from plasma in male Sprague-Dawley rats,CHEMBL625969,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,12626,In vivo,,Plasma,,16449,1969.0,100710,,N,1,,Clearance from plasma in male cynomolgus monkeys,CHEMBL625970,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12627,In vivo,,Plasma,,14224,1969.0,50588,,N,1,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",CHEMBL625971,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12628,In vivo,,Plasma,,14224,1969.0,50588,,N,1,,Clearance of compound in dog plasma,CHEMBL625972,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12629,In vivo,,Plasma,,14224,1969.0,50587,,N,1,,Clearance of compound in human plasma,CHEMBL625973,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12630,In vivo,,,,14317,,50588,,N,1,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,CHEMBL625974,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12631,In vivo,,,,14317,,50588,,N,1,,Clearance of compound when administered intravenously as an individual dose to a single dog.,CHEMBL625975,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12632,In vivo,,Plasma,,14224,1969.0,50588,,N,1,,"Clearance (10 mg/kg, intravenously) in dog plasma",CHEMBL625976,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12633,In vivo,,,,17237,,50588,,N,1,,Clearance value in dog,CHEMBL625977,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,12634,In vivo,,,,17237,,50512,,N,1,,Clearance value in guinea pig,CHEMBL625978,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12635,In vivo,,,,14187,,50597,,N,1,,Clearance values in rats after iv administration.,CHEMBL874468,,1,A
Autocuration,BAO_0000218,,,,,12636,In vivo,,Plasma,,4806,1969.0,22224,,U,1,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,CHEMBL625421,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12637,In vivo,,,,15025,,50592,,N,1,,In vivo clearance (5 mg/kg) was determined in rabbits,CHEMBL625422,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12638,In vivo,,,,13197,,50597,,N,1,,Plasma Clearance rate was determined for the compound in rats,CHEMBL625423,,1,A
Autocuration,BAO_0000218,,9520.0,,Saimiri,12639,In vivo,,,,13197,,22224,,U,1,,Plasma Clearance rate was determined for the compound in squirrel monkeys,CHEMBL625424,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12640,In vivo,,,,13960,,50597,,N,1,,Plasma clearance in rat,CHEMBL625425,,1,A
Autocuration,BAO_0000218,,,,,12641,In vivo,,,,17820,,22224,,U,1,,Plasma clearance of the compound,CHEMBL625426,,0,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,12642,In vivo,,,,14706,,50512,,N,1,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,CHEMBL625427,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,12643,In vivo,,,,14706,,50512,,N,1,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,CHEMBL625428,,1,A
Autocuration,BAO_0000218,,,,,12644,In vivo,,,,6504,,22224,,U,1,,Plasma clearance was determined,CHEMBL625429,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12645,In vivo,,,,14925,,50588,,N,1,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,CHEMBL625430,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12646,In vivo,,,,13197,,50597,,N,1,,Plasma clearance rate was determined for the compound in rats,CHEMBL625431,,1,A
Autocuration,BAO_0000218,,9520.0,,Saimiri,12647,In vivo,,,,13197,,22224,,U,1,,Plasma clearance rate was determined for the compound in squirrel monkeys,CHEMBL627307,,0,A
Autocuration,BAO_0000218,,,,,12648,In vivo,,,,3437,,22224,,U,1,,Slow clearance (CL) was determined,CHEMBL627308,,0,A
Autocuration,BAO_0000218,,,,,12649,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,CHEMBL627309,,0,A
Autocuration,BAO_0000218,,,,,12650,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,CHEMBL627310,,0,A
Autocuration,BAO_0000218,,,,,12651,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,CHEMBL627311,,0,A
Autocuration,BAO_0000218,,,,,12652,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,CHEMBL627312,,0,A
Autocuration,BAO_0000218,,,,,12653,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,CHEMBL627313,,0,A
Autocuration,BAO_0000218,,,,,12654,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,CHEMBL627314,,0,A
Autocuration,BAO_0000218,,,,,12655,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,CHEMBL627315,,0,A
Autocuration,BAO_0000218,,,,,12656,,,,,9196,,22224,,U,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL627316,,0,A
Autocuration,BAO_0000218,,,,,12657,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL627317,,0,A
Autocuration,BAO_0000218,,,,,12658,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL627318,,0,A
Autocuration,BAO_0000218,,,,,12659,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,CHEMBL627999,,0,A
Autocuration,BAO_0000218,,,,,12660,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL628000,,0,A
Autocuration,BAO_0000218,,,,,12661,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,CHEMBL628001,,0,A
Autocuration,BAO_0000218,,,,,12662,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL628002,,0,A
Autocuration,BAO_0000218,,,,,12663,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,CHEMBL625610,,0,A
Autocuration,BAO_0000218,,,,,12664,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL625611,,0,A
Autocuration,BAO_0000218,,,,,12665,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,CHEMBL625612,,0,A
Autocuration,BAO_0000218,,,,,12666,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,CHEMBL625613,,0,A
Autocuration,BAO_0000218,,,,,12667,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL875479,,0,A
Autocuration,BAO_0000218,,,,,12668,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,CHEMBL625614,,0,A
Autocuration,BAO_0000218,,,,,12669,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,CHEMBL625615,,0,A
Autocuration,BAO_0000218,,,,,12670,,,,,9196,,22224,,U,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,CHEMBL626302,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12671,,,Blood,,8374,178.0,50597,,N,1,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL626303,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12672,,,Blood,,8374,178.0,50597,,N,1,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627420,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12673,,,,,13477,,50597,,N,1,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,CHEMBL627421,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12674,,,,,13477,,50597,,N,1,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,CHEMBL625695,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12675,,,,,13477,,50597,,N,1,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,CHEMBL625696,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12676,,,Brain,,10009,955.0,50594,,N,1,,Distribution of compound in mice brain was measured after 1 hr,CHEMBL875606,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12677,,,Brain,,10009,955.0,50594,,N,1,,Distribution of compound in mice brain was measured after 24 hr r,CHEMBL625697,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12678,,,Brain,,10009,955.0,50594,,N,1,,Distribution of compound in mice brain was measured after 2 hr,CHEMBL625698,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12679,,,Brain,,10009,955.0,50594,,N,1,,Distribution of compound in mice brain was measured after 3 hr,CHEMBL625699,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12680,,,Brain,,10009,955.0,50594,,N,1,,Distribution of compound in mice brain was measured after 6 hr,CHEMBL625700,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12681,,,,,10009,,50594,,N,1,,Distribution of compound in mice liver was measured after 1 hr,CHEMBL625701,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12682,,,,,10009,,50594,,N,1,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,CHEMBL625702,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12683,,,,,10009,,50594,,N,1,,Distribution of compound in mice liver was measured after 2 hr,CHEMBL625703,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12684,,,,,10009,,50594,,N,1,,Distribution of compound in mice liver was measured after 3 hr,CHEMBL625704,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12685,,,,,10009,,50594,,N,1,,Distribution of compound in mice liver was measured after 6 hr,CHEMBL625705,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12686,,,Adrenal medulla,,8170,1236.0,50588,,N,1,,Distribution in dog adrenal medulla 30 min after administration.,CHEMBL625706,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12687,,,Adrenal medulla,,8170,1236.0,50588,,N,1,,Distribution in dog adrenal medulla 72 hours after administration.,CHEMBL625707,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12688,,,,,8170,,50588,,N,1,,Distribution in female dog Ovary 24 hours after administration.,CHEMBL625708,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12689,,,,,8170,,50588,,N,1,,Distribution in female dog Ovary 72 hours after administration.,CHEMBL625709,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12690,,,,,8170,,50588,,N,1,,Distribution in female dog adipose 24 hours after administration.,CHEMBL624180,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12691,,,,,8170,,50588,,N,1,,Distribution in female dog adipose 72 hours after administration.,CHEMBL624181,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12692,,,Adrenal cortex,,8170,1235.0,50588,,N,1,,Distribution in female dog adrenal cortex 72 hours after administration.,CHEMBL624182,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12693,,,Adrenal cortex,,8170,1235.0,50588,,N,1,,Distribution in female dog adrenal cortex 72 hours after administration.,CHEMBL624183,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12694,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624184,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12695,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL877489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12696,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL624185,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12697,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL624186,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12698,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624187,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12699,,,Liver,,8594,2107.0,50597,,N,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624188,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12700,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL624189,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12701,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL624190,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12702,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL624191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12703,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL624192,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12704,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624193,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12705,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL624194,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12706,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624891,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12707,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624892,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12708,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL624893,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12709,,,Lung,,8594,2048.0,50597,,N,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL627632,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12710,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL627633,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12711,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL627634,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12712,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL627635,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12713,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL627636,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12714,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL626816,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12715,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL626817,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12716,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL626818,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12717,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL626819,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12718,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL626820,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12719,,,,,8594,,50597,,N,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL626821,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12720,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL626822,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12721,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL626823,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12722,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL626824,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12723,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL626825,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12724,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL626826,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12725,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL626827,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12726,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL626828,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12727,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL626829,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12728,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL626830,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12729,,,,,8594,,50597,,N,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL627150,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12730,,,,,8594,,50597,,N,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL627151,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12731,,,,,8594,,50597,,N,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL627152,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12732,,,,,8594,,50597,,N,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL627153,,1,A
Autocuration,BAO_0000019,,,,,12733,,,,,12904,,22224,,U,1,,Rate of acetate production by the compound was determined,CHEMBL627154,,0,A
Autocuration,BAO_0000019,,,,,12734,,,,,12904,,22224,,U,1,,Rate of acetate production by the compound was determined; Not determined,CHEMBL627155,,0,A
Autocuration,BAO_0000019,,,,,12735,,,,,3730,,22224,,U,1,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,CHEMBL627156,,0,A
Autocuration,BAO_0000019,,,,,12736,,,,,3627,,22224,,U,1,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,CHEMBL627157,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12737,,,,,13799,,50592,,N,1,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,CHEMBL627158,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12738,,,Plasma,,13799,1969.0,50592,,N,1,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,CHEMBL627159,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12739,,,,,13799,,50594,,N,1,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL627160,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12740,,,,,13799,,50597,,N,1,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL628540,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12741,,,Plasma,,13799,1969.0,50597,,N,1,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL628541,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12742,,,Plasma,,13799,1969.0,50597,,N,1,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL628542,,1,A
Autocuration,BAO_0000100,,,,,12743,,,,,6629,,22229,,U,1,,Solubility after at a pH 1.2,CHEMBL628543,,0,P
Autocuration,BAO_0000100,,,,,12744,,,,,6629,,22229,,U,1,,Solubility after at pH 1.2,CHEMBL628544,,0,P
Autocuration,BAO_0000100,,,,,12745,,,,,6629,,22229,,U,1,,Solubility after injection of water,CHEMBL628545,,0,P
Autocuration,BAO_0000019,,,,,12746,,,,,14000,,22224,,U,1,,Statistical significance of IC 50 values; Expressed as R value,CHEMBL628546,,0,A
Autocuration,BAO_0000019,,,,,12747,,,,,8267,,22224,,U,1,,Systemic availability with respect to methyldopa was determined,CHEMBL874455,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12748,,,,,13799,,50597,,N,1,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,CHEMBL628547,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12749,,,Plasma,,13799,1969.0,50597,,N,1,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,CHEMBL628548,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12750,,,Feces,,7132,1988.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",CHEMBL628549,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12751,,,Feces,,7132,1988.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",CHEMBL628550,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12752,,,Feces,,7132,1988.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",CHEMBL628551,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12753,,,Urine,,7132,1088.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",CHEMBL628552,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12754,,,Urine,,7132,1088.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",CHEMBL628553,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12755,,,Urine,,7132,1088.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",CHEMBL628554,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12756,,,Urine,,7132,1088.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",CHEMBL628555,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12757,,,Urine,,7132,1088.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",CHEMBL628556,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12758,,,Kidney,,7132,2113.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",CHEMBL628557,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12759,,,Feces,,7132,1988.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",CHEMBL628558,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12760,,,Feces,,7132,1988.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",CHEMBL628559,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12761,,,Feces,,7132,1988.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",CHEMBL628560,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12762,,,Urine,,7132,1088.0,50592,,N,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",CHEMBL874456,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12763,,,Feces,,7132,1988.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",CHEMBL628561,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12764,,,Feces,,7132,1988.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",CHEMBL628562,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12765,,,Urine,,7132,1088.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",CHEMBL628563,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12766,,,Urine,,7132,1088.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",CHEMBL628564,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12767,,,Urine,,7132,1088.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",CHEMBL628565,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12768,,,Urine,,7132,1088.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",CHEMBL631248,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12769,,,Urine,,7132,1088.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",CHEMBL631249,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12770,,,Kidney,,7132,2113.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",CHEMBL627214,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12771,,,Feces,,7132,1988.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",CHEMBL874591,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12772,,,Feces,,7132,1988.0,50592,,N,1,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",CHEMBL627215,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12773,,,Feces,,7132,1988.0,50592,,N,1,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,CHEMBL625471,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12774,,,,,7132,,50592,,N,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,CHEMBL625472,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12775,,,,,7132,,50592,,N,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,CHEMBL625473,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12776,In vivo,,,,13317,,50588,,N,1,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,CHEMBL625474,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12777,In vivo,,,,15341,,50588,,N,1,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,CHEMBL625475,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12778,In vivo,,,,15341,,50597,,N,1,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,CHEMBL625476,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12779,In vivo,,,,15341,,50597,,N,1,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,CHEMBL625477,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12780,In vivo,,,,15341,,50597,,N,1,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,CHEMBL625478,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12781,In vitro,,esophageal tunica muscularis mucosae,,12801,,50597,,N,1,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,CHEMBL625479,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12782,In vitro,,esophageal tunica muscularis mucosae,,12801,,50597,,N,1,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,CHEMBL625480,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12783,In vivo,,Plasma,,14856,1969.0,50597,,N,1,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,CHEMBL625481,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12784,In vivo,,,,14062,,50597,,N,1,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,CHEMBL625482,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12785,In vivo,,,,14062,,50597,,N,1,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,CHEMBL625483,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12786,In vivo,,,,14062,,50597,,N,1,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,CHEMBL625484,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12787,In vivo,,,,14062,,50597,,N,1,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,CHEMBL625485,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12788,In vivo,,Plasma,,14346,1969.0,50588,,N,1,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,CHEMBL625486,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12789,In vivo,,Plasma,,14346,1969.0,50597,,N,1,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,CHEMBL625487,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12790,In vivo,,Plasma,,14346,1969.0,50597,,N,1,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,CHEMBL625488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12791,In vivo,,Plasma,,14346,1969.0,50597,,N,1,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,CHEMBL625489,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12792,In vivo,,Plasma,,14346,1969.0,50597,,N,1,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,CHEMBL625490,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12793,In vivo,,Plasma,,14346,1969.0,50588,,N,1,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,CHEMBL625491,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12794,In vivo,,Plasma,,14346,1969.0,50597,,N,1,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,CHEMBL625492,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12795,In vivo,,Plasma,,15711,1969.0,50587,,N,1,,plasma clearance in human,CHEMBL625493,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12796,In vivo,,,,14886,,50597,,N,1,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,CHEMBL625494,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12797,In vivo,,,,14886,,50597,,N,1,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,CHEMBL625495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12798,In vivo,,,,14886,,50597,,N,1,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,CHEMBL625496,,1,A
Autocuration,BAO_0000100,,,,,12799,,,,,4115,,22229,,U,1,,1-Octanol/water partition coefficient measured at 7.4,CHEMBL625497,,0,P
Autocuration,BAO_0000100,,,,,12800,,,,,13733,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625498,,0,P
Autocuration,BAO_0000019,,,,,12801,,,,,12102,,22224,,U,1,,Partition coefficient (logP),CHEMBL625499,,0,A
Autocuration,BAO_0000100,,,,,12802,,,,,12676,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625500,,0,P
Autocuration,BAO_0000100,,,,,12803,,,,,13733,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625501,,0,P
Autocuration,BAO_0000100,,,,,12804,,,,,13740,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625502,,0,P
Autocuration,BAO_0000100,,,,,12805,,,,,12766,,22229,,U,1,,Calculated partition coefficient (clogP) (relative to BAY K 8644),CHEMBL625503,,0,P
Autocuration,BAO_0000100,,,,,12806,,,,,2764,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625504,,0,P
Autocuration,BAO_0000100,,,,,12807,,,,,12355,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625505,,0,P
Autocuration,BAO_0000100,,,,,12808,,,,,11314,,22229,,U,1,,Calculated partition coefficient of the compound,CHEMBL625506,,0,P
Autocuration,BAO_0000019,,,,,12809,,,,,12706,,22224,,U,1,,Partition coefficient (logP),CHEMBL625507,,0,A
Autocuration,BAO_0000100,,,,,12810,,,,,12645,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625508,,0,P
Autocuration,BAO_0000100,,,,,12811,,,,,13668,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625509,,0,P
Autocuration,BAO_0000100,,,,,12812,,,,,12819,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625510,,0,P
Autocuration,BAO_0000100,,,,,12813,,,,,13668,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL883125,,0,P
Autocuration,BAO_0000100,,,,,12814,,,,,13017,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625511,,0,P
Autocuration,BAO_0000019,,,,,12815,,,,,2448,,22224,,U,1,,Partition coefficient of the compound,CHEMBL874650,,0,A
Autocuration,BAO_0000019,,,,,12816,,,,,11526,,22224,,U,1,,Partition coefficient of the compound,CHEMBL625512,,0,A
Autocuration,BAO_0000019,,,,,12817,,,,,12426,,22224,,U,1,,Partition coefficient of compound was determined,CHEMBL625513,,0,A
Autocuration,BAO_0000019,,,,,12818,,,,,2448,,22224,,U,1,,Partition coefficient was determined,CHEMBL625514,,0,A
Autocuration,BAO_0000100,,,,,12819,,,,,12001,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625515,,0,P
Autocuration,BAO_0000100,,,,,12820,,,,,12426,,22229,,U,1,,partition coefficient of compound was determined,CHEMBL625516,,0,P
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12821,In vivo,,,,13204,,50588,,N,1,,The total body administered intravenously in dog,CHEMBL625517,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12822,In vivo,,,,13204,,50597,,N,1,,The total body administered intravenously in rats,CHEMBL625518,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,12823,,,,,13889,,50594,,N,1,,Time taken for the administration to female NIH mice weighing 25-30 g.,CHEMBL625519,,1,A
Autocuration,BAO_0000019,,,,,12824,,,,,13889,,22224,,U,1,,Time taken for the administration,CHEMBL625520,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12825,In vivo,,,,17025,,50588,,N,1,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,CHEMBL874651,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,12826,In vivo,,,,17025,,22224,,U,1,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,CHEMBL625521,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12827,In vivo,,,,17025,,50592,,N,1,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,CHEMBL623171,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12828,In vivo,,,,17025,,50597,,N,1,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,CHEMBL623853,,1,A
Autocuration,BAO_0000019,,,,,12829,,,,,15067,,22224,,U,1,,Plasma clearance for the compound was determined.,CHEMBL623854,,0,A
Autocuration,BAO_0000100,,,,,12830,,,,,3091,,22224,,U,1,,CLog P value of the compound,CHEMBL874405,,0,P
Autocuration,BAO_0000100,,,,,12831,,,,,15592,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL623855,,0,P
Autocuration,BAO_0000100,,,,,12832,,,,,14738,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL623856,,0,P
Autocuration,BAO_0000100,,,,,12833,,,,,14738,,22224,,U,1,,ClogP value of the compound; nd ='no data',CHEMBL623857,,0,P
Autocuration,BAO_0000100,,,,,12834,,,,,14738,,22224,,U,1,,ClogP value of the compound; nd ='not determined',CHEMBL623858,,0,P
Autocuration,BAO_0000100,,,,,12835,,,,,6076,,22224,,U,1,,CLog P was determined,CHEMBL623859,,0,P
Autocuration,BAO_0000100,,,,,12836,,,,,17840,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL839829,,0,P
Autocuration,BAO_0000019,,,,,12837,,,,,13589,,22224,,U,1,,CLogP was calculated,CHEMBL623860,,0,A
Autocuration,BAO_0000019,,,,,12838,,,,,17655,,22224,,U,1,,CLogP value was determined,CHEMBL623861,,0,A
Autocuration,BAO_0000019,,,,,12839,,,,,5867,,22224,,U,1,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,CHEMBL623862,,0,A
Autocuration,BAO_0000100,,,,,12840,,,,,5867,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL874406,,0,P
Autocuration,BAO_0000100,,,,,12841,,,,,10783,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL623863,,0,P
Autocuration,BAO_0000100,,,,,12842,,,,,14849,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624021,,0,P
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12843,,,Adrenal medulla,,8170,1236.0,50588,,N,1,,Distribution in female dog adrenal medulla 24 hours after administration.,CHEMBL624022,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12844,,,Adrenal medulla,,8170,1236.0,50588,,N,1,,Distribution in female dog adrenal medulla 72 hours after administration.,CHEMBL624023,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12845,,,,,8170,,50588,,N,1,,Distribution in female dog bile 24 hours after administration.,CHEMBL624024,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12846,,,,,8170,,50588,,N,1,,Distribution in female dog bile 72 hr after administration.,CHEMBL624025,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12847,,,,,8170,,50588,,N,1,,Distribution in female dog blood 24 hours after administration.,CHEMBL624026,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12848,,,,,8170,,50588,,N,1,,Distribution in female dog blood 72 hours after administration.,CHEMBL624027,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12849,,,,,8170,,50588,,N,1,,Distribution in female dog heart 24 hours after administration.,CHEMBL624028,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12850,,,,,8170,,50588,,N,1,,Distribution in female dog heart 72 hours after administration.,CHEMBL624029,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12851,,,,,8170,,50588,,N,1,,Distribution in female dog kidney 24 hours after administration.,CHEMBL624030,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12852,,,,,8170,,50588,,N,1,,Distribution in female dog kidney 72 hours after administration.,CHEMBL624031,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12853,,,Intestine,,8170,160.0,50588,,N,1,,Distribution in female dog large intestine 24 hours after administration.,CHEMBL624032,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12854,,,Intestine,,8170,160.0,50588,,N,1,,Distribution in female dog large intestine 72 hours after administration.,CHEMBL874407,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12855,,,,,8170,,50588,,N,1,,Distribution in female dog liver 24 hours after administration.,CHEMBL624033,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12856,,,,,8170,,50588,,N,1,,Distribution in female dog liver 72 hours after administration.,CHEMBL624034,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12857,,,,,8170,,50588,,N,1,,Distribution in female dog lung 24 hours after administration.,CHEMBL624035,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12858,,,,,8170,,50588,,N,1,,Distribution in female dog lung 72 hours after administration.,CHEMBL624036,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12859,,,Muscle tissue,,8170,2385.0,50588,,N,1,,Distribution in female dog muscle 24 hours after administration.,CHEMBL624037,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12860,,,Muscle tissue,,8170,2385.0,50588,,N,1,,Distribution in female dog muscle 72 hours after administration.,CHEMBL624038,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12861,,,,,8170,,50588,,N,1,,Distribution in female dog pancreas 24 hours after administration.,CHEMBL624039,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12862,,,,,8170,,50588,,N,1,,Distribution in female dog pancreas 72 hours after administration.,CHEMBL624040,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12863,,,Intestine,,8170,160.0,50588,,N,1,,Distribution in female dog small intestine 24 hours after administration.,CHEMBL624041,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12864,,,Intestine,,8170,160.0,50588,,N,1,,Distribution in female dog small intestine 72 hours after administration.,CHEMBL624042,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12865,,,Spleen,,8170,2106.0,50588,,N,1,,Distribution in female dog spleen 24 hours after administration.,CHEMBL624043,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12866,,,Spleen,,8170,2106.0,50588,,N,1,,Distribution in female dog spleen 72 hours after administration.,CHEMBL624044,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12867,,,Stomach,,8170,945.0,50588,,N,1,,Distribution in female dog stomach 24 hours after administration.,CHEMBL624045,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12868,,,Stomach,,8170,945.0,50588,,N,1,,Distribution in female dog stomach 72 hours after administration.,CHEMBL624046,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12869,,,Thyroid gland,,8170,2046.0,50588,,N,1,,Distribution in female dog thyroid 24 hours after administration.,CHEMBL624047,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12870,,,Thyroid gland,,8170,2046.0,50588,,N,1,,Distribution in female dog thyroid 72 hours after administration.,CHEMBL624048,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12871,,,Urine,,8170,1088.0,50588,,N,1,,Distribution in female dog urine 24 hours after administration.,CHEMBL874408,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12872,,,Urine,,8170,1088.0,50588,,N,1,,Distribution in female dog urine 72 hr after administration.,CHEMBL624049,,1,A
Autocuration,BAO_0000218,,,,,12873,,,Plasma,,14283,1969.0,22224,,U,1,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,CHEMBL624050,,0,A
Autocuration,BAO_0000019,,,,,12874,,,,,5623,,22224,,U,1,,Plasma concentration at 7 hr after intravenous dosing,CHEMBL624051,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12875,,,,,13477,,50597,,N,1,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,CHEMBL623278,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12876,,,,,13477,,50597,,N,1,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,CHEMBL623279,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12877,,,,,13477,,50597,,N,1,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,CHEMBL623280,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12878,,,,,13477,,50597,,N,1,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,CHEMBL623963,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12879,,,,,13477,,50597,,N,1,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,CHEMBL623964,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12880,,,,,13477,,50597,,N,1,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,CHEMBL623965,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12881,,,,,13477,,50597,,N,1,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,CHEMBL623966,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12882,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,CHEMBL874415,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12883,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,CHEMBL623967,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12884,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,CHEMBL623968,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12885,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,CHEMBL623969,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12886,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,CHEMBL628409,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12887,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,CHEMBL628410,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12888,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,CHEMBL628411,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12889,,,,,13477,,50597,,N,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,CHEMBL628412,,1,A
Autocuration,BAO_0000019,,,,,12890,,,,,12553,,22224,,U,1,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,CHEMBL628413,,0,A
Autocuration,BAO_0000019,,,,,12891,,,Plasma,,14548,1969.0,22224,,U,1,,The concentration in plasmat; Not determined,CHEMBL628414,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12892,,,,,14393,,50597,,N,1,,Tissue level at 10 mg/kg/po in wistar rats in blood,CHEMBL628415,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12893,,,,,14393,,50597,,N,1,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,CHEMBL628416,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12894,,,,,14393,,50597,,N,1,,Tissue level at 10 mg/kg/po in wistar rats in heart,CHEMBL628417,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12895,,,Liver,,14393,2107.0,50597,,N,1,,Tissue level at 10 mg/kg/po in wistar rats in liver,CHEMBL874908,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12896,,,,,14393,,50597,,N,1,,Tissue level at 10 mg/kg/po in wistar rats in plasma,CHEMBL628418,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12897,,,Muscle tissue,,14393,2385.0,50597,,N,1,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,CHEMBL628419,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12898,,,,,14393,,50597,,N,1,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,CHEMBL628420,,1,A
Autocuration,BAO_0000019,,,,,12899,,,,,1629,,22224,,U,1,,Water solubility at 37 degree C.,CHEMBL628421,,0,A
Autocuration,BAO_0000100,,,,,12900,,,,,8194,,22229,,U,1,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,CHEMBL626726,,0,P
Autocuration,BAO_0000100,,,,,12901,,,,,8194,,22229,,U,1,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,CHEMBL626727,,0,P
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12902,,,Blood,,8594,178.0,50597,,N,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL626728,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12903,,,Blood,,8594,178.0,50597,,N,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL626729,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12904,,,Blood,,8594,178.0,50597,,N,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL626730,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12905,,,Blood,,8594,178.0,50597,,N,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL626731,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12906,,,Blood,,8594,178.0,50597,,N,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL626732,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12907,,,Heart,,8594,948.0,50597,,N,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL626733,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12908,,,Heart,,8594,948.0,50597,,N,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL626734,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12909,,,Heart,,8594,948.0,50597,,N,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL626735,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12910,,,Heart,,8594,948.0,50597,,N,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL874909,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12911,,,Heart,,8594,948.0,50597,,N,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL626736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12912,,,Kidney,,8594,2113.0,50597,,N,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL626737,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12913,,,Kidney,,8594,2113.0,50597,,N,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL630999,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12914,,,Kidney,,8594,2113.0,50597,,N,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL631000,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12915,,,Kidney,,8594,2113.0,50597,,N,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL631001,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12916,,,Kidney,,8594,2113.0,50597,,N,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL631002,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12917,,,Liver,,8594,2107.0,50597,,N,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL631003,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12918,,,Liver,,8594,2107.0,50597,,N,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL631004,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12919,,,Liver,,8594,2107.0,50597,,N,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL631005,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12920,,,Liver,,8594,2107.0,50597,,N,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL631006,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12921,,,Liver,,8594,2107.0,50597,,N,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL631007,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12922,,,Lung,,8594,2048.0,50597,,N,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL631008,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12923,,,Lung,,8594,2048.0,50597,,N,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL631009,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12924,,,Lung,,8594,2048.0,50597,,N,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL631010,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12925,,,Lung,,8594,2048.0,50597,,N,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL631011,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12926,,,Lung,,8594,2048.0,50597,,N,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL631012,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12927,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL630271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12928,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL630272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12929,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL630273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12930,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL630274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12931,,,Thyroid gland,,8594,2046.0,50597,,N,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL630275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12932,,,,,8594,,50597,,N,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,CHEMBL875782,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12933,,,,,8594,,50597,,N,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,CHEMBL630276,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12934,,,,,8594,,50597,,N,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,CHEMBL630277,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12935,,,,,8594,,50597,,N,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,CHEMBL630278,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12936,,,,,8594,,50597,,N,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,CHEMBL630279,,1,A
Autocuration,BAO_0000019,,,,,12937,,,,,8151,,22224,,U,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,CHEMBL630280,,0,A
Autocuration,BAO_0000019,,,,,12938,,,,,8151,,22224,,U,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL630281,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12939,,,,,7132,,50592,,N,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,CHEMBL630282,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12940,,,,,7132,,50592,,N,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,CHEMBL630283,,1,A
Autocuration,BAO_0000019,,,,,12941,,,,,5797,,22224,,U,1,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),CHEMBL630284,,0,A
Autocuration,BAO_0000019,,,,,12942,,,,,7849,,22224,,U,1,,Alkylating activity was determined,CHEMBL630285,,0,A
Autocuration,BAO_0000251,,,,,12943,,Microsomes,,,14220,,22224,,U,1,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),CHEMBL630286,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12944,,,,,8650,,50592,,N,1,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",CHEMBL630069,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12945,,,,,8650,,50592,,N,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",CHEMBL630070,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12946,,,,,8650,,50592,,N,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",CHEMBL630071,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12947,,,,,8650,,50592,,N,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",CHEMBL630072,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12948,,,,,8650,,50592,,N,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",CHEMBL875110,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12949,,,,,7116,,50597,,N,1,,Compound was tested for antidiuretic activity in rats,CHEMBL630073,,1,A
Autocuration,BAO_0000019,,,,,12950,,,,,14131,,22224,,U,1,,Compound was tested for inactivation kinetic values,CHEMBL630074,,0,A
Autocuration,BAO_0000218,,,,,12951,In vivo,,,,7415,,22224,,U,1,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,CHEMBL630075,,0,A
Autocuration,BAO_0000019,,,,,12952,,,,,13178,,22224,,U,1,,Dissociation rate calculated from the first-order equation using the t1/2 value,CHEMBL630076,,0,A
Autocuration,BAO_0000100,,,,,12953,,,,,8815,,22229,,U,1,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,CHEMBL630077,,0,P
Autocuration,BAO_0000100,,,,,12954,,,,,1450,,22229,,U,1,,Aqueous solubility was measured,CHEMBL630078,,0,P
Autocuration,BAO_0000100,,,,,12955,,,,,1450,,22229,,U,1,,Aqueous solubility was measured at a pH 4,CHEMBL630079,,0,P
Autocuration,BAO_0000100,,,,,12956,,,,,1450,,22229,,U,1,,Aqueous solubility (pH 7),CHEMBL630080,,0,P
Autocuration,BAO_0000100,,,,,12957,,,,,1450,,22229,,U,1,,Aqueous solubility was measured at a pH 9,CHEMBL630081,,0,P
Autocuration,BAO_0000019,,,,,12958,,,,,12711,,22224,,U,1,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",CHEMBL630082,,0,A
Autocuration,BAO_0000019,,,,,12959,,,,,12711,,22224,,U,1,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",CHEMBL630083,,0,A
Autocuration,BAO_0000019,,,,,12960,,,,,12711,,22224,,U,1,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",CHEMBL630084,,0,A
Autocuration,BAO_0000100,,,,,12961,,,,,15032,,22229,,U,1,,Aqueous solubility of the compound,CHEMBL629198,,0,P
Autocuration,BAO_0000100,,,,,12962,,,,,9964,,22229,,U,1,,Aqueous solubility at 37 degree Celsius at pH 7.38,CHEMBL629199,,0,P
Autocuration,BAO_0000100,,,,,12963,,,,,14962,,22229,,U,1,,Aqueous solubility in pH 7.4 phosphate buffer,CHEMBL629200,,0,P
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12964,,,,,12487,,50588,,N,1,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,CHEMBL629201,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,12965,,,,,12487,,50588,,N,1,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,CHEMBL629202,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12966,,,,,10026,,50587,,N,1,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL875111,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12967,,,,,10026,,50587,,N,1,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629203,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12968,,,,,10026,,50587,,N,1,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629204,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12969,,,,,10026,,50587,,N,1,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629205,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,12970,,,,,10026,,50587,,N,1,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629206,,1,A
Autocuration,BAO_0000019,,,,,12971,,,,,10026,,22224,,U,1,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL631185,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,12972,,,,,7415,,50597,,N,1,,Compound was evaluated for the average bile flow rat in rats,CHEMBL631186,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12973,,,,,17025,,50592,,N,1,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",CHEMBL631187,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,12974,,,,,17025,,50592,,N,1,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",CHEMBL631188,,1,A
Autocuration,BAO_0000019,,,,,12975,,,,,10184,,22224,,U,1,,Average half life period was determined,CHEMBL876419,,0,A
Autocuration,BAO_0000019,,,,,12976,,,,,10184,,22224,,U,1,,Average half life period was determined,CHEMBL631189,,0,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12977,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,CHEMBL631190,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12978,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,CHEMBL631191,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12979,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,CHEMBL631192,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12980,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,CHEMBL632400,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12981,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,CHEMBL630564,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12982,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,CHEMBL630565,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12983,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,CHEMBL630566,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12984,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,CHEMBL631229,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,12985,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,CHEMBL631230,,1,A
Autocuration,BAO_0000100,,,,,12986,,,,,6030,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL876428,,0,P
Autocuration,BAO_0000100,,,,,12987,,,,,6147,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631231,,0,P
Autocuration,BAO_0000100,,,,,12988,,,,,14556,,22229,,U,1,,Calculated partition coefficient (clogP) (MacLogP),CHEMBL631232,,0,P
Autocuration,BAO_0000019,,,,,12989,,,,,768,,22224,,U,1,,Hydrophilicity was determined,CHEMBL631233,,0,A
Autocuration,BAO_0000100,,,,,12990,,,,,14452,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631234,,0,P
Autocuration,BAO_0000019,,,,,12991,,,,,5237,,22224,,U,1,,Increased absorption was determined,CHEMBL883126,,0,A
Autocuration,BAO_0000100,,,,,12992,,,,,14378,,22224,,U,1,,Lipophilicity value was evaluated,CHEMBL631235,,0,P
Autocuration,BAO_0000100,,,,,12993,,,,,14418,,22224,,U,1,,Log P value of the compound.,CHEMBL631236,,0,P
Autocuration,BAO_0000019,,,,,12994,,,,,5249,,22224,,U,1,,Partition coefficient of compound was determined,CHEMBL631237,,0,A
Autocuration,BAO_0000100,,,,,12995,,,,,14621,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631238,,0,P
Autocuration,BAO_0000100,,,,,12996,,,,,12542,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL876429,,0,P
Autocuration,BAO_0000019,,,,,12997,,,,,12542,,22224,,U,1,,Partition coefficient was measured by medchem software; Not calculated,CHEMBL631414,,0,A
Autocuration,BAO_0000100,,,,,12998,,,,,12542,,22224,,U,1,,Partition coefficient was measured by octanol-water using standard shake-flask method,CHEMBL631415,,0,P
Autocuration,BAO_0000100,,,,,12999,,,,,15462,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631416,,0,P
Autocuration,BAO_0000019,,,,,13000,,,,,14884,,22224,,U,1,,Partition coefficient (logP),CHEMBL631417,,0,A
Autocuration,BAO_0000100,,,,,13001,,,,,16526,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631418,,0,P
Autocuration,BAO_0000100,,,,,13002,,,,,13693,,22229,,U,1,,The Octanol/Water partition coefficient CLogP,CHEMBL631419,,0,P
Autocuration,BAO_0000019,,,,,13003,,,,,13693,,22224,,U,1,,The pharmacokinetic parameter C Log p was reported,CHEMBL631420,,0,A
Autocuration,BAO_0000100,,,,,13004,,,,,13779,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631421,,0,P
Autocuration,BAO_0000100,,,,,13005,,,,,14772,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631422,,0,P
Autocuration,BAO_0000100,,,,,13006,,,,,14393,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL631423,,0,P
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13007,In vivo,,Plasma,,14793,1969.0,50597,,N,1,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL876430,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13008,In vivo,,Plasma,,14793,1969.0,50597,,N,1,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,CHEMBL631424,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13009,In vivo,,Plasma,,13744,1969.0,50588,,N,1,,Compound was administered intravenously in dog to evaluate plasma clearance values,CHEMBL631425,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13010,In vivo,,Plasma,,13744,1969.0,22224,,U,1,,Compound was administered intravenously in monkey to evaluate plasma clearance values,CHEMBL631426,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13011,In vivo,,Plasma,,13744,1969.0,50594,,N,1,,Compound was administered intravenously in mouse to evaluate plasma clearance values,CHEMBL631427,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13012,In vivo,,Plasma,,13207,1969.0,50588,,N,1,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,CHEMBL631428,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,13013,In vitro,Microsomes,Liver,,5669,2107.0,50797,,N,1,,Intrinsic clearance in Rhesus liver microsome,CHEMBL631429,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13014,In vitro,Microsomes,Liver,,5669,2107.0,50588,,N,1,,Intrinsic clearance in dog liver microsome,CHEMBL631430,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13015,In vitro,Microsomes,Liver,,5669,2107.0,50597,,N,1,,Intrinsic clearance in rat liver microsome,CHEMBL631431,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,13016,In vivo,,Plasma,,4853,1969.0,50797,,N,1,,Low plasma clearance was calculated in rhesus monkey,CHEMBL631432,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13017,In vivo,,,,16452,,50588,,N,1,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,CHEMBL631433,,1,A
Autocuration,BAO_0000218,,,,,13018,In vivo,,,,11954,,22224,,U,1,,Plasma clearance after intravenous dose of 0.3 mg/kg,CHEMBL631434,,0,A
Autocuration,BAO_0000218,,,,,13019,In vivo,,,,11954,,22224,,U,1,,Plasma clearance after intravenous dose of 1 mg/kg,CHEMBL631435,,0,A
Autocuration,BAO_0000218,,,,,13020,In vivo,,,,11954,,22224,,U,1,,Plasma clearance after intravenous dose of 3 mg/kg,CHEMBL631436,,0,A
Autocuration,BAO_0000218,,,,,13021,In vivo,,,,11954,,22224,,U,1,,Plasma clearance after intravenous dose of 3.87 mg/kg,CHEMBL631437,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13022,In vivo,,,,5669,,50597,,N,1,,Plasma clearance after peroral administration at 10 mpk in Rat,CHEMBL631438,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,13023,In vivo,,,,5669,,50797,,N,1,,Plasma clearance after peroral administration at 10 mpk in Rhesus,CHEMBL876431,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13024,In vivo,,,,5669,,50588,,N,1,,Plasma clearance after peroral administration at 10 mpk in dog,CHEMBL631439,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13025,In vivo,,,,13662,,50597,,N,1,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,CHEMBL631440,,1,A
Autocuration,BAO_0000019,,,,,13026,,,,,8272,,22224,,U,1,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),CHEMBL631441,,0,A
Autocuration,BAO_0000019,,,,,13027,,,,,13410,,22224,,U,1,,Critical Micellar concentration was determined,CHEMBL631442,,0,A
Autocuration,BAO_0000019,,,,,13028,,,,,13410,,22224,,U,1,,Critical Micellar concentration of the compound. was determined,CHEMBL626525,,0,A
Autocuration,BAO_0000019,,,,,13029,,,,,12628,,22224,,U,1,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,CHEMBL627168,,0,A
Autocuration,BAO_0000019,,,,,13030,,,,,9675,,22224,,U,1,,Critical micellar concentration was measured in water by the dye solubilization method,CHEMBL875618,,0,A
Autocuration,BAO_0000019,,,,,13031,,,,,12628,,22224,,U,1,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,CHEMBL626612,,0,B
Autocuration,BAO_0000019,,,,,13032,,,,,12766,,22224,,U,1,,CMR value (relative to BAY K 8644),CHEMBL626613,,0,A
Autocuration,BAO_0000019,,,,,13033,,,,,7849,,22224,,U,1,,Carbamoylating activity was determined,CHEMBL626614,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13034,,,,,12187,,22224,,U,1,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,CHEMBL626615,,0,A
Autocuration,BAO_0000019,,,,,13035,,,,,2040,,22224,,U,1,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,CHEMBL626616,,0,A
Autocuration,BAO_0000019,,,,,13036,,,,,2040,,22224,,U,1,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,CHEMBL626617,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13037,In vivo,,Plasma,,14180,1969.0,50588,,N,1,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,CHEMBL626618,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13038,In vivo,,Plasma,,14180,1969.0,50597,,N,1,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,CHEMBL626619,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13039,In vivo,,,,14474,,50588,,N,1,,"Clearance rate at 0.46 mg/kg, iv, in dogs",CHEMBL626620,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13040,In vivo,,,,14474,,50597,,N,1,,"Clearance rate at 5.5 mg/kg, iv, in rat",CHEMBL626621,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,13041,In vivo,,,,14548,,100710,,N,1,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,CHEMBL626622,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,13042,In vivo,,,,14548,,100710,,N,1,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,CHEMBL626623,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13043,In vivo,,,,14548,,50588,,N,1,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,CHEMBL626624,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13044,In vivo,,,,14548,,50597,,N,1,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,CHEMBL626625,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13045,Ex vivo,,Liver,,6125,2107.0,50597,,N,1,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,CHEMBL626626,,1,A
Autocuration,BAO_0000218,,,,,13046,In vivo,,,,6874,,22224,,U,1,,Tested for the total clearance of the compound,CHEMBL626627,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13047,In vivo,,,,15343,,50588,,N,1,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,CHEMBL626628,,1,A
Autocuration,BAO_0000218,,,,,13048,In vivo,,,,6236,,22224,,U,1,,Total body clearance was determined,CHEMBL626629,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13049,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,CHEMBL626630,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13050,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,CHEMBL626631,,1,A
Autocuration,BAO_0000100,,,,,13051,,,,,8194,,22229,,U,1,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,CHEMBL626632,,0,P
Autocuration,BAO_0000100,,,,,13052,,,,,8194,,22229,,U,1,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,CHEMBL626633,,0,P
Autocuration,BAO_0000100,,,,,13053,,,,,8194,,22229,,U,1,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,CHEMBL626634,,0,P
Autocuration,BAO_0000100,,,,,13054,,,,,8194,,22229,,U,1,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,CHEMBL626635,,0,P
Autocuration,BAO_0000100,,,,,13055,,,,,8194,,22229,,U,1,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,CHEMBL626636,,0,P
Autocuration,BAO_0000100,,,,,13056,,,,,8194,,22229,,U,1,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,CHEMBL626637,,0,P
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13057,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),CHEMBL626638,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13058,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,CHEMBL626639,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13059,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,CHEMBL626640,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13060,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,CHEMBL626641,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13061,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,CHEMBL627272,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13062,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,CHEMBL627273,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13063,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),CHEMBL627441,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13064,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),CHEMBL628355,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13065,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),CHEMBL628356,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13066,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),CHEMBL628357,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13067,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),CHEMBL628358,,1,A
Intermediate,BAO_0000218,,4754.0,,Pneumocystis carinii,13068,,,,,13273,,50339,,N,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),CHEMBL622307,,1,A
Autocuration,BAO_0000019,,,,,13069,,,,,13118,,22224,,U,1,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,CHEMBL622527,,0,A
Autocuration,BAO_0000019,,,,,13070,,,,,13118,,22224,,U,1,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,CHEMBL622528,,0,A
Autocuration,BAO_0000019,,,,,13071,,,,,13118,,22224,,U,1,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,CHEMBL622529,,0,A
Autocuration,BAO_0000019,,,,,13072,,,,,13118,,22224,,U,1,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,CHEMBL622992,,0,A
Autocuration,BAO_0000019,,,,,13073,,,,,13118,,22224,,U,1,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,CHEMBL622993,,0,A
Autocuration,BAO_0000019,,,,,13074,,,,,13118,,22224,,U,1,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,CHEMBL622994,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13075,,,,,10633,,50597,,N,1,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",CHEMBL622995,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13076,,,,,10633,,50597,,N,1,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",CHEMBL622996,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13077,,,,,10633,,50597,,N,1,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",CHEMBL622997,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13078,,,,,10633,,50597,,N,1,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",CHEMBL622998,,1,A
Autocuration,BAO_0000218,,,,,13079,,,,,5767,,22224,,U,1,,Cp max following ip administration at 1 mg/kg,CHEMBL622999,,0,A
Autocuration,BAO_0000218,,,,,13080,In vivo,,Plasma,,3302,1969.0,22224,,U,1,,Maximum concentration in plasma was reported at 0.5 hour,CHEMBL623000,,0,A
Autocuration,BAO_0000218,,,,,13081,In vivo,,Plasma,,3302,1969.0,22224,,U,1,,Maximum concentration in plasma was reported at 2 hour,CHEMBL623001,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13082,,,,,12467,,50594,,N,1,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,CHEMBL623002,,1,A
Autocuration,BAO_0000100,,,,,13083,,,,,11778,,22229,,U,1,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),CHEMBL623003,,0,P
Autocuration,BAO_0000019,,,,,13084,,,,,4321,,22224,,U,1,,Steady state concentration was evaluated,CHEMBL623004,,0,A
Autocuration,BAO_0000019,,,,,13085,,,,,14884,,22224,,U,1,,Partition coefficient (logP),CHEMBL623005,,0,A
Autocuration,BAO_0000019,,,,,13086,,,,,15234,,22224,,U,1,,Partition coefficient (logD7.4),CHEMBL623006,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13087,In vivo,,Liver,,14198,2107.0,50597,,N,1,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,CHEMBL623007,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13088,In vivo,,Bone,,14198,10000001.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,CHEMBL623008,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13089,In vivo,,Cerebellum,,14198,2037.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,CHEMBL876654,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13090,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,CHEMBL623009,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13091,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,CHEMBL623010,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13092,In vivo,,Heart,,14198,948.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,CHEMBL623011,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13093,In vivo,,Intestine,,14198,160.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,CHEMBL623012,,1,A
Autocuration,BAO_0000019,,,,,13094,,,,,8151,,22224,,U,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,CHEMBL623013,,0,A
Autocuration,BAO_0000019,,,,,13095,,,,,8151,,22224,,U,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL623014,,0,A
Autocuration,BAO_0000019,,,,,13096,,,Urine,,8151,1088.0,22224,,U,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,CHEMBL623015,,0,A
Autocuration,BAO_0000019,,,,,13097,,,Urine,,8151,1088.0,22224,,U,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,CHEMBL623016,,0,A
Autocuration,BAO_0000019,,,,,13098,,,Urine,,8151,1088.0,22224,,U,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,CHEMBL624858,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13099,,,,,8151,,50597,,N,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,CHEMBL624859,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13100,,,,,8151,,50597,,N,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL624860,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13101,,,,,8151,,50597,,N,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,CHEMBL624861,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13102,,,,,8151,,50597,,N,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,CHEMBL624862,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13103,,,,,8151,,50597,,N,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,CHEMBL624863,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13104,,,,,8151,,50597,,N,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,CHEMBL876655,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13105,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,CHEMBL624864,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13106,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,CHEMBL624865,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13107,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,CHEMBL624866,,1,A
Expert,BAO_0000218,,9615.0,,Canis lupus familiaris,13108,,,,,6996,,50588,,N,1,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,CHEMBL624867,,1,F
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13109,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,CHEMBL624868,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13110,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,CHEMBL628450,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13111,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,CHEMBL628451,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13112,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,CHEMBL628452,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13113,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,CHEMBL628453,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13114,,,,,6996,,50588,,N,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,CHEMBL628454,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13115,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,CHEMBL628455,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13116,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,CHEMBL628456,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13117,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,CHEMBL628457,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13118,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,CHEMBL877505,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13119,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,CHEMBL628458,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13120,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,CHEMBL628459,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13121,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,CHEMBL628460,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13122,,,,,6996,,50588,,N,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,CHEMBL628461,,1,A
Autocuration,BAO_0000218,,,,,13123,,,,,6996,,22224,,U,1,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",CHEMBL628462,,0,B
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13124,,,,,6996,,50588,,N,1,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL628463,,1,A
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,13125,,,,,6996,,50597,,N,1,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",CHEMBL625666,,1,F
Autocuration,BAO_0000218,,,,,13126,,,,,6996,,22224,,U,1,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL625667,,0,B
Expert,BAO_0000218,,10116.0,,Rattus norvegicus,13127,,,,,6996,,50597,,N,1,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL625668,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13128,,,,,6996,,50597,,N,1,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL625669,,1,A
Autocuration,BAO_0000019,,,,,13129,,,,,7114,,22224,,U,1,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,CHEMBL625670,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13130,,,,,7114,,50597,,N,1,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,CHEMBL625671,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13131,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,CHEMBL625672,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13132,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,CHEMBL625673,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13133,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,CHEMBL625674,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13134,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,CHEMBL625675,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13135,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,CHEMBL627637,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13136,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,CHEMBL627638,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13137,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,CHEMBL627639,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13138,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,CHEMBL627640,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13139,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,CHEMBL627641,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13140,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,CHEMBL627642,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,13141,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,CHEMBL877506,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13142,,,,,8613,,50594,,N,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,CHEMBL627275,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,13143,,,,,11219,,50506,,N,1,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",CHEMBL627643,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,13144,,,,,11219,,50506,,N,1,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",CHEMBL631246,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,13145,,,,,11219,,50506,,N,1,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",CHEMBL631247,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,13146,,,,,11219,,50506,,N,1,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,CHEMBL629532,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,13147,,,,,11219,,50506,,N,1,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,CHEMBL629533,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,13148,,,,,11219,,50506,,N,1,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,CHEMBL629534,,1,A
Intermediate,BAO_0000218,,9669.0,,Mustela putorius furo,13149,,,,,11219,,50506,,N,1,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,CHEMBL629535,,1,A
Autocuration,BAO_0000019,,,,,13150,,,,,14837,,22224,,U,1,,Pharmacokinetic parameter :drug bound to plasma was reported,CHEMBL625932,,0,A
Autocuration,BAO_0000019,,,,,13151,,,,,14837,,22224,,U,1,,compound was evaluated for drug bound in plasma,CHEMBL625933,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13152,,,,,15343,,50597,,N,1,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,CHEMBL625934,,1,A
Autocuration,BAO_0000218,,9347.0,,Eutheria,13153,,,,,13761,,22224,,U,1,,Bioavailability,CHEMBL625935,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13154,,,,,14810,,50597,,N,1,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,CHEMBL625936,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13155,,,,,14810,,50597,,N,1,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,CHEMBL625937,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13156,,,,,13249,,50588,,N,1,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,CHEMBL625938,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13157,,,Bile,,9267,1970.0,50597,,N,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,CHEMBL625939,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13158,,,Bile,,9267,1970.0,50597,,N,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,CHEMBL625940,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13159,,,Bile,,9267,1970.0,50597,,N,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,CHEMBL874464,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13160,,,Bile,,9267,1970.0,50597,,N,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,CHEMBL625941,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13161,,,Bile,,9267,1970.0,50597,,N,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,CHEMBL625942,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13162,,,Bile,,9267,1970.0,50597,,N,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,CHEMBL625943,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,13163,,,Serum,,15549,1977.0,50587,,N,1,,In vitro protein binding in human serum at 5 ug/ml,CHEMBL625944,,1,A
Autocuration,BAO_0000019,,,,,13164,,,,,10929,,22224,,U,1,,Serum protein binding ability was measured,CHEMBL625945,,0,A
Autocuration,BAO_0000019,,,,,13165,,,,,15444,,22224,,U,1,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),CHEMBL625946,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,13166,In vivo,,,,12860,,22224,,U,1,,Oral bioavailability in dog,CHEMBL625947,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13167,In vivo,,,,12170,,50597,,N,1,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,CHEMBL625948,,1,A
Autocuration,BAO_0000218,,,,,13168,In vivo,,,,15173,,22224,,U,1,,Absolute oral bioavailability at an iv dose of 14 mg/kg,CHEMBL625949,,0,A
Autocuration,BAO_0000218,,,,,13169,In vivo,,,,15173,,22224,,U,1,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,CHEMBL625950,,0,A
Autocuration,BAO_0000218,,9347.0,,Eutheria,13170,In vivo,,,,15173,,22224,,U,1,,Oral bioavailability (dose 15 mg/kg i.v.),CHEMBL625951,,0,A
Autocuration,BAO_0000218,,,,,13171,In vivo,,,,15173,,22224,,U,1,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,CHEMBL625952,,0,A
Autocuration,BAO_0000218,,,,,13172,In vivo,,,,15173,,22224,,U,1,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,CHEMBL625953,,0,A
Autocuration,BAO_0000218,,,,,13173,In vivo,,,,15173,,22224,,U,1,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,CHEMBL625954,,0,A
Autocuration,BAO_0000218,,,,,13174,In vivo,,,,15173,,22224,,U,1,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,CHEMBL882959,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13175,In vivo,,,,11767,,50588,,N,1,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,CHEMBL625955,,1,A
Autocuration,BAO_0000218,,9669.0,,Mustela putorius furo,13176,In vivo,,,,11219,,22224,,U,1,,Bioavailability in ferret,CHEMBL625956,,0,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,13177,In vivo,,,,12186,,100710,,N,1,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,CHEMBL625957,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13178,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,CHEMBL625958,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13179,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,CHEMBL625959,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13180,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,CHEMBL626642,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13181,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,CHEMBL631330,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13182,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,CHEMBL631331,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13183,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,CHEMBL631332,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13184,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,CHEMBL631333,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13185,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,CHEMBL632018,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13186,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,CHEMBL632019,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13187,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,CHEMBL632020,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13188,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,CHEMBL632021,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13189,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,CHEMBL632022,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13190,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,CHEMBL632023,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13191,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,CHEMBL632024,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13192,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,CHEMBL874472,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13193,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,CHEMBL632025,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13194,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,CHEMBL632026,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13195,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,CHEMBL632027,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13196,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,CHEMBL632028,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13197,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,CHEMBL626430,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13198,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,CHEMBL626431,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13199,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,CHEMBL626432,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13200,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,CHEMBL626433,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13201,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,CHEMBL626434,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13202,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,CHEMBL627280,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13203,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,CHEMBL627281,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13204,,,,,11510,,50597,,N,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,CHEMBL627282,,1,A
Autocuration,BAO_0000019,,,,,13205,,,,,7199,,22224,,U,1,,Total body clearance was measured at given dose,CHEMBL627283,,0,A
Autocuration,BAO_0000218,,,,,13206,,,,,7199,,22224,,U,1,,Total body clearance was measured at given dose.,CHEMBL627284,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13207,,,,,7095,,50597,,N,1,,Metabolic clearance from the body in rat,CHEMBL627285,,1,A
Autocuration,BAO_0000218,,,,,13208,In vivo,,,,7095,,22224,,U,1,,Renal clearance from the body,CHEMBL627286,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13209,In vivo,,,,7095,,50597,,N,1,,Renal clearance from the body in rat,CHEMBL875477,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13210,In vivo,,,,12528,,50597,,N,1,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,CHEMBL627287,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13211,In vivo,,,,12528,,50588,,N,1,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,CHEMBL627288,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13212,,,,,7095,,50597,,N,1,,Total clearance from the body in rat,CHEMBL627289,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13213,In vivo,,Plasma,,14223,1969.0,50597,,N,1,,Clearance into cortex from rat plasma or PBS,CHEMBL627290,,1,A
Autocuration,BAO_0000218,,,,,13214,In vivo,,,,13569,,22224,,U,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,CHEMBL627291,,0,A
Autocuration,BAO_0000218,,,,,13215,In vivo,,,,13569,,22224,,U,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,CHEMBL627292,,0,A
Autocuration,BAO_0000218,,,,,13216,In vivo,,,,13569,,22224,,U,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,CHEMBL627293,,0,A
Autocuration,BAO_0000218,,,,,13217,In vivo,,,,13569,,22224,,U,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,CHEMBL627294,,0,A
Autocuration,BAO_0000218,,,,,13218,In vivo,,,,13569,,22224,,U,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,CHEMBL875478,,0,A
Autocuration,BAO_0000218,,,,,13219,In vivo,,,,13979,,22224,,U,1,,Clearance was determined,CHEMBL627295,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13220,In vivo,,,,14315,,50594,,N,1,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,CHEMBL627296,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,13221,In vivo,,,,14315,,50592,,N,1,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,CHEMBL626119,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13222,In vivo,,,,14315,,50597,,N,1,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,CHEMBL626120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13223,In vivo,,,,12174,,50597,,N,1,,Clearance in rat after iv dose (100 ug/kg),CHEMBL626121,,1,A
Autocuration,BAO_0000218,,10141.0,,Cavia porcellus,13224,In vivo,,,,12797,,22224,,U,1,,Clearance in guinea pig,CHEMBL626122,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13225,In vivo,,,,12797,,50597,,N,1,,Compound was evaluated for clearance in rat,CHEMBL626123,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13226,In vivo,,,,12797,,50588,,N,1,,Compound was evaluated for the clearance in dog,CHEMBL623456,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13227,In vivo,,,,12797,,50597,,N,1,,Compound was evaluated for the clearance in rat,CHEMBL623457,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13228,In vivo,,,,11500,,50597,,N,1,,Compound was tested in vivo for clearance after iv administration in the rat,CHEMBL623458,,1,A
Autocuration,BAO_0000218,,,,,13229,In vivo,,,,15173,,22224,,U,1,,IV clearance determined at an iv dose of 14 mg/kg,CHEMBL623459,,0,A
Autocuration,BAO_0000218,,,,,13230,In vivo,,,,15173,,22224,,U,1,,IV clearance determined at an iv dose of 15.2 mg/kg,CHEMBL875484,,0,A
Autocuration,BAO_0000218,,,,,13231,In vivo,,,,15173,,22224,,U,1,,IV clearance determined at an iv dose of 15 mg/kg,CHEMBL623460,,0,A
Autocuration,BAO_0000218,,,,,13232,In vivo,,,,15173,,22224,,U,1,,IV clearance determined at an peroral dose of 30 mg/kg.,CHEMBL623461,,0,A
Autocuration,BAO_0000218,,,,,13233,In vivo,,,,15173,,22224,,U,1,,IV clearance determined at an peroral dose of 30.2 mg/kg.,CHEMBL623462,,0,A
Autocuration,BAO_0000218,,,,,13234,In vivo,,,,15173,,22224,,U,1,,IV clearance determined at an peroral dose of 30.3 mg/kg.,CHEMBL627386,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13235,In vivo,,Kidney,,14198,2113.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,CHEMBL627387,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13236,In vivo,,Liver,,14198,2107.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,CHEMBL627388,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13237,In vivo,,Lung,,14198,2048.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,CHEMBL627389,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13238,In vivo,,Muscle tissue,,14198,2385.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,CHEMBL627390,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13239,In vivo,,Plasma,,14198,1969.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,CHEMBL627391,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13240,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,CHEMBL627392,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13241,In vivo,,Spleen,,14198,2106.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,CHEMBL627393,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13242,In vivo,,Trachea,,14198,3126.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,CHEMBL627394,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13243,In vivo,,Bone,,14198,10000001.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,CHEMBL627395,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13244,In vivo,,Cerebellum,,14198,2037.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,CHEMBL875485,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13245,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,CHEMBL627396,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13246,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,CHEMBL627397,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13247,In vivo,,Heart,,14198,948.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,CHEMBL627398,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13248,In vivo,,Bone,,14198,10000001.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,CHEMBL627399,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13249,In vivo,,Kidney,,14198,2113.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,CHEMBL627400,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13250,In vivo,,Liver,,14198,2107.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,CHEMBL627401,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13251,In vivo,,Lung,,14198,2048.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,CHEMBL627402,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13252,In vivo,,Muscle tissue,,14198,2385.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,CHEMBL627403,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13253,In vivo,,Plasma,,14198,1969.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,CHEMBL627404,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13254,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,CHEMBL623101,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13255,In vivo,,Spleen,,14198,2106.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,CHEMBL877480,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13256,In vivo,,Trachea,,14198,3126.0,50597,,N,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,CHEMBL623102,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13257,In vivo,,Bone,,14198,10000001.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,CHEMBL623103,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13258,In vivo,,Cerebellum,,14198,2037.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,CHEMBL623104,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13259,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,CHEMBL623105,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13260,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,CHEMBL623106,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13261,In vivo,,Heart,,14198,948.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,CHEMBL623107,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13262,In vivo,,Intestine,,14198,160.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,CHEMBL623108,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13263,In vivo,,Kidney,,14198,2113.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,CHEMBL623109,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13264,In vivo,,Liver,,14198,2107.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,CHEMBL623110,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13265,In vivo,,Lung,,14198,2048.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,CHEMBL623111,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13266,In vivo,,Muscle tissue,,14198,2385.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,CHEMBL625060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13267,In vivo,,Plasma,,14198,1969.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,CHEMBL625061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13268,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,CHEMBL625062,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13269,In vivo,,Spleen,,14198,2106.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,CHEMBL625063,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13270,In vivo,,Trachea,,14198,3126.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,CHEMBL625064,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13271,In vivo,,Bone,,14198,10000001.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,CHEMBL625065,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13272,In vivo,,Cerebellum,,14198,2037.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,CHEMBL625066,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13273,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,CHEMBL625067,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13274,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,CHEMBL625068,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13275,In vivo,,Heart,,14198,948.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,CHEMBL622159,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13276,In vivo,,Intestine,,14198,160.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,CHEMBL622160,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13277,In vivo,,Kidney,,14198,2113.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,CHEMBL622161,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13278,In vivo,,Lung,,14198,2048.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,CHEMBL622162,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13279,In vivo,,Muscle tissue,,14198,2385.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,CHEMBL622163,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13280,In vivo,,Plasma,,14198,1969.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,CHEMBL622313,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13281,In vivo,,,,14198,,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,CHEMBL622314,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13282,In vivo,,Spleen,,14198,2106.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,CHEMBL622315,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13283,In vivo,,Trachea,,14198,3126.0,50597,,N,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,CHEMBL622316,,1,A
Intermediate,BAO_0000218,,562.0,,Escherichia coli,13284,,,,,15599,,50212,,N,1,,Normal diffusion coefficient in water for Escherichia coli,CHEMBL877486,,1,A
Autocuration,BAO_0000019,,,,,13285,,,,,8204,,22224,,U,1,,Average max percent decrease in RVR (renal vascular resistance) was determined,CHEMBL622317,,0,A
Autocuration,BAO_0000019,,,,,13286,,,,,8204,,22224,,U,1,,Average max percent decrease in RVR (renal vascular resistance) was determined.,CHEMBL622318,,0,A
Autocuration,BAO_0000019,,,,,13287,,,,,6154,,22224,,U,1,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,CHEMBL622319,,0,A
Autocuration,BAO_0000019,,,,,13288,,,,,6154,,22224,,U,1,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,CHEMBL622320,,0,A
Autocuration,BAO_0000019,,,,,13289,,,,,6154,,22224,,U,1,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,CHEMBL622321,,0,A
Autocuration,BAO_0000019,,,,,13290,,,,,6154,,22224,,U,1,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,CHEMBL622322,,0,A
Autocuration,BAO_0000019,,,,,13291,,,,,7114,,22224,,U,1,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,CHEMBL622323,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13292,,,,,7114,,50597,,N,1,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,CHEMBL622324,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13293,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",CHEMBL622325,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13294,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",CHEMBL622326,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13295,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",CHEMBL877487,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13296,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",CHEMBL622327,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13297,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",CHEMBL622328,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13298,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",CHEMBL622329,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13299,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",CHEMBL622330,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13300,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",CHEMBL622331,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13301,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",CHEMBL622332,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13302,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",CHEMBL622333,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13303,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",CHEMBL627658,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13304,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",CHEMBL630428,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13305,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",CHEMBL630429,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13306,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",CHEMBL630430,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13307,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",CHEMBL630431,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13308,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",CHEMBL630432,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13309,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",CHEMBL630433,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13310,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",CHEMBL630434,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13311,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",CHEMBL629372,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13312,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",CHEMBL629553,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13313,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",CHEMBL629554,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13314,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",CHEMBL874447,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13315,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",CHEMBL629555,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13316,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",CHEMBL629556,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13317,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",CHEMBL629557,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13318,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",CHEMBL629558,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13319,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",CHEMBL629559,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13320,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",CHEMBL629560,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13321,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",CHEMBL629561,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13322,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",CHEMBL629562,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13323,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",CHEMBL629563,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13324,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",CHEMBL629564,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13325,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",CHEMBL629565,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13326,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",CHEMBL629566,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13327,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",CHEMBL629567,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13328,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",CHEMBL629568,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13329,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",CHEMBL629569,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13330,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",CHEMBL629570,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13331,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",CHEMBL629571,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13332,In vivo,,,,12170,,22224,,U,1,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,CHEMBL629572,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13333,In vivo,,,,12170,,22224,,U,1,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,CHEMBL629573,,0,A
Autocuration,BAO_0000218,,9347.0,,Eutheria,13334,In vivo,,,,4985,,22224,,U,1,,Bioavailability (dose 20 mg/kg),CHEMBL629574,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,13335,In vivo,,,,15145,,22224,,U,1,,Bioavailability in dog,CHEMBL629575,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13336,In vivo,,,,14080,,22224,,U,1,,Bioavailability in rat (Sprague-Dawley) (male),CHEMBL874448,,0,A
Autocuration,BAO_0000218,,9443.0,,Primates,13337,In vivo,,,,11219,,22224,,U,1,,Bioavailability in monkey (dose 10 mg/kg i.d.),CHEMBL629576,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13338,In vivo,,,,15145,,22224,,U,1,,Bioavailability in rat,CHEMBL629577,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13339,In vivo,,,,15145,,22224,,U,1,,Bioavailability in rat,CHEMBL629578,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,13340,In vivo,,,,1202,,22224,,U,1,,Bioavailability in dog (dose 3.0 mg/kg p.o.),CHEMBL629579,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,13341,In vivo,,,,1202,,22224,,U,1,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,CHEMBL882958,,0,A
Intermediate,BAO_0000218,,9598.0,,Pan troglodytes,13342,In vivo,,,,1202,,50505,,N,1,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,CHEMBL629580,,1,A
Autocuration,BAO_0000218,,9347.0,,Eutheria,13343,In vivo,,,,4026,,22224,,U,1,,Bioavailability,CHEMBL629581,,0,A
Autocuration,BAO_0000218,,9520.0,,Saimiri,13344,In vivo,,,,1492,,22224,,U,1,,Bioavailability in squirrel monkey,CHEMBL629582,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13345,In vivo,,,,12793,,50588,,N,1,,Bioavailability was evaluated in dog,CHEMBL628522,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,13346,In vivo,,,,12793,,100712,,N,1,,Bioavailability was evaluated in hamster,CHEMBL625432,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13347,In vivo,,,,12793,,22224,,U,1,,Bioavailability in rat,CHEMBL625433,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13348,In vivo,,Plasma,,14793,1969.0,50597,,N,1,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL625434,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13349,In vivo,,Plasma,,14793,1969.0,50597,,N,1,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,CHEMBL625435,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13350,In vivo,,,,14793,,22224,,U,1,,Bioavailability in rat (dose 10 mg/kg p.o.),CHEMBL625436,,0,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,13351,In vivo,,,,14731,,100710,,N,1,,Bioavailability was measured in cynomolgus monkeys.,CHEMBL874588,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13352,In vivo,,,,14731,,50594,,N,1,,Bioavailability was measured in nude mice.,CHEMBL625437,,1,A
Autocuration,BAO_0000218,,9669.0,,Mustela putorius furo,13353,In vivo,,,,12187,,22224,,U,1,,Bioavailability in ferret (dose 10 mg/kg i.d.),CHEMBL625438,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13354,In vivo,,,,12187,,22224,,U,1,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),CHEMBL625439,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13355,In vivo,,,,12187,,22224,,U,1,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",CHEMBL625440,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13356,In vivo,,,,12187,,22224,,U,1,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),CHEMBL625441,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13357,In vivo,,,,12187,,22224,,U,1,,Bioavailability in rat (dose 10 mg/kg i.d.),CHEMBL625442,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13358,In vivo,,,,12187,,50597,,N,1,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",CHEMBL625443,,1,A
Autocuration,BAO_0000218,,,,,13359,In vivo,,,,17431,,22224,,U,1,,Bioavailability was determined; extremely poor,CHEMBL625444,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13360,In vivo,,,,13318,,50594,,N,1,,% bioavailability in mice after oral administration of prodrug,CHEMBL625445,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13361,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,CHEMBL625446,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13362,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,CHEMBL882960,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13363,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,CHEMBL625447,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13364,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,CHEMBL625448,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13365,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,CHEMBL625449,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13366,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),CHEMBL874589,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13367,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,CHEMBL625450,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13368,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,CHEMBL625451,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13369,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,CHEMBL626584,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13370,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,CHEMBL626585,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13371,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,CHEMBL626586,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13372,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,CHEMBL626587,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13373,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,CHEMBL626588,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13374,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,CHEMBL626589,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13375,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,CHEMBL626590,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13376,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,CHEMBL626591,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13377,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,CHEMBL627181,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13378,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,CHEMBL628083,,1,A
Autocuration,BAO_0000218,,,,,13379,In vivo,,,,15173,,22224,,U,1,,IV clearance determined at an peroral dose of 15 mg/kg.,CHEMBL628084,,0,A
Expert,BAO_0000218,,102285.0,,Hymenolepis nana,13380,In vivo,,,,7732,,50064,,N,1,,Mouse oral clearance was measured against Hymenolepiasis nana.,CHEMBL628085,,1,F
Expert,BAO_0000218,,6339.0,,Heligmosomoides polygyrus,13381,In vivo,,,,7732,,50545,,N,1,,Mouse oral clearance was measured against Nematospiroides dubius,CHEMBL628086,,1,F
Autocuration,BAO_0000218,,,,,13382,In vivo,,,,7732,,22224,,U,1,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,CHEMBL628087,,0,F
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13383,In vivo,,,,7732,,50594,,N,1,,Mouse oral clearance was measured against N. nana; NT is Not Tested,CHEMBL628088,,1,A
Autocuration,BAO_0000218,,,,,13384,In vivo,,,,7732,,22224,,U,1,,Mouse oral clearance was measured against N. nana; NT is Not Tested,CHEMBL628089,,0,B
Autocuration,BAO_0000218,,,,,13385,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,CHEMBL628090,,0,A
Autocuration,BAO_0000218,,,,,13386,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,CHEMBL628091,,0,A
Autocuration,BAO_0000218,,,,,13387,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,CHEMBL628092,,0,A
Autocuration,BAO_0000218,,,,,13388,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,CHEMBL628093,,0,A
Autocuration,BAO_0000218,,,,,13389,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,CHEMBL875607,,0,A
Autocuration,BAO_0000218,,,,,13390,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,CHEMBL625710,,0,A
Autocuration,BAO_0000218,,,,,13391,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,CHEMBL625711,,0,A
Autocuration,BAO_0000218,,,,,13392,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,CHEMBL625712,,0,A
Autocuration,BAO_0000218,,,,,13393,In vivo,,,,8328,,22224,,U,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,CHEMBL625713,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13394,In vivo,,,,13376,,50588,,N,1,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,CHEMBL625714,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,13395,In vivo,,,,13477,,50797,,N,1,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,CHEMBL625715,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13396,In vivo,,,,13477,,50597,,N,1,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,CHEMBL625716,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13397,In vivo,,,,13477,,50597,,N,1,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,CHEMBL625717,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13398,In vivo,,,,13313,,50597,,N,1,,Plasma clearance was determined for the compound in rats,CHEMBL625718,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13399,In vivo,,,,12504,,50597,,N,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,CHEMBL625719,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13400,In vivo,,,,12504,,50597,,N,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,CHEMBL625720,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13401,In vivo,,,,12504,,50597,,N,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,CHEMBL625721,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13402,In vivo,,,,12504,,50597,,N,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,CHEMBL625722,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13403,In vivo,,,,13129,,50597,,N,1,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,CHEMBL625723,,1,A
Intermediate,BAO_0000218,,6339.0,,Heligmosomoides polygyrus,13404,In vivo,,,,7732,,50545,,N,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,CHEMBL625724,,1,A
Intermediate,BAO_0000218,,6339.0,,Heligmosomoides polygyrus,13405,In vivo,,,,7732,,50545,,N,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,CHEMBL625725,,1,A
Intermediate,BAO_0000218,,6339.0,,Heligmosomoides polygyrus,13406,In vivo,,,,7732,,50545,,N,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,CHEMBL625726,,1,A
Intermediate,BAO_0000218,,6339.0,,Heligmosomoides polygyrus,13407,In vivo,,,,7732,,50545,,N,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,CHEMBL875608,,1,A
Intermediate,BAO_0000218,,6339.0,,Heligmosomoides polygyrus,13408,In vivo,,,,7732,,50545,,N,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,CHEMBL625727,,1,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13409,In vivo,,Urine,,9278,1088.0,22224,,U,1,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,CHEMBL625728,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13410,In vivo,,,,9278,,22224,,U,1,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,CHEMBL625729,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13411,In vivo,,,,9278,,22224,,U,1,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,CHEMBL625730,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13412,In vivo,,Urine,,9278,1088.0,22224,,U,1,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,CHEMBL625731,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,13413,In vivo,,Urine,,9278,1088.0,22224,,U,1,,Urinary clearance was determined in rat at 25 mg/kg os dosage,CHEMBL626417,,0,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,13414,In vivo,,Urine,,9278,1088.0,50587,,N,1,,Urinary clearance was determined at 100 mg/kg oral dosage in human,CHEMBL626418,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13415,In vivo,,Urine,,9278,1088.0,50588,,N,1,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,CHEMBL626419,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13416,In vivo,,Plasma,,5932,1969.0,50588,,N,1,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,CHEMBL626592,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13417,In vivo,,Plasma,,5932,1969.0,50597,,N,1,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,CHEMBL626593,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13418,In vivo,,,,5182,,50597,,N,1,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,CHEMBL626594,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13419,In vivo,,,,10499,,50588,,N,1,,Clearance rate in dogs,CHEMBL625035,,1,A
Autocuration,BAO_0000019,,,,,13420,In vitro,,,,6051,,22224,,U,1,,Compound was measured for intrinsic clearance,CHEMBL625036,,0,A
Autocuration,BAO_0000100,,,,,13421,,,,,17508,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625037,,0,P
Autocuration,BAO_0000100,,,,,13422,,,,,6228,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625038,,0,P
Autocuration,BAO_0000100,,,,,13423,,,,,6231,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625039,,0,P
Autocuration,BAO_0000100,,,,,13424,,,,,17740,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625040,,0,P
Autocuration,BAO_0000100,,,,,13425,,,,,6495,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625041,,0,P
Autocuration,BAO_0000100,,,,,13426,,,,,2171,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625042,,0,P
Autocuration,BAO_0000019,,,,,13427,,,,,3255,,22224,,U,1,,Partition coefficient of the compound,CHEMBL874411,,0,A
Autocuration,BAO_0000019,,,,,13428,,,,,6821,,22224,,U,1,,Permeability,CHEMBL625043,,0,A
Autocuration,BAO_0000100,,,,,13429,,,,,2685,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625044,,0,P
Autocuration,BAO_0000019,,,,,13430,,,,,17584,,22224,,U,1,,Partition coefficient (logD),CHEMBL625045,,0,A
Autocuration,BAO_0000100,,,,,13431,,,,,13824,,22229,,U,1,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),CHEMBL625046,,0,P
Autocuration,BAO_0000100,,,,,13432,,,,,13824,,22229,,U,1,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),CHEMBL625047,,0,P
Autocuration,BAO_0000100,,,,,13433,,,,,16479,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625048,,0,P
Autocuration,BAO_0000100,,,,,13434,,,,,11997,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625049,,0,P
Autocuration,BAO_0000100,,,,,13435,,,,,2988,,22229,,U,1,,Calculated logarithm of partition coefficient (P) was determined,CHEMBL625050,,0,P
Autocuration,BAO_0000100,,,,,13436,,,,,931,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625051,,0,P
Autocuration,BAO_0000100,,,,,13437,,,,,4381,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL874412,,0,P
Autocuration,BAO_0000100,,,,,13438,,,,,4397,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625052,,0,P
Autocuration,BAO_0000100,,,,,13439,,,,,5889,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL625053,,0,P
Autocuration,BAO_0000019,,,,,13440,,,,,6154,,22224,,U,1,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,CHEMBL623250,,0,A
Autocuration,BAO_0000019,,,,,13441,,,,,6154,,22224,,U,1,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,CHEMBL623251,,0,A
Autocuration,BAO_0000019,,,,,13442,,,,,6154,,22224,,U,1,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,CHEMBL623252,,0,A
Autocuration,BAO_0000019,,,,,13443,,,,,6154,,22224,,U,1,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,CHEMBL623253,,0,A
Autocuration,BAO_0000019,,,,,13444,,,,,6154,,22224,,U,1,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,CHEMBL623254,,0,A
Autocuration,BAO_0000019,,,,,13445,,,,,6154,,22224,,U,1,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,CHEMBL623255,,0,A
Autocuration,BAO_0000019,,,,,13446,,,,,6887,,22224,,U,1,,Percent degradation of compound at a pH of 1 over a 18 hr period,CHEMBL626831,,0,A
Autocuration,BAO_0000019,,,,,13447,,,,,6887,,22224,,U,1,,Percent degradation of compound at pH of 1 over an 18 hr period,CHEMBL877494,,0,A
Autocuration,BAO_0000019,,,,,13448,,,,,14116,,22224,,U,1,,Delta Logarithm of Partition Coefficient value was determined.,CHEMBL626832,,0,A
Autocuration,BAO_0000019,,,,,13449,,,,,11137,,22224,,U,1,,Delta logPoct-cyc,CHEMBL626833,,0,A
Autocuration,BAO_0000100,,,,,13450,,,,,7230,,22224,,U,1,,Lipophilicity estimated on reversed phase TLC,CHEMBL626834,,0,P
Autocuration,BAO_0000019,,,,,13451,,,,,15741,,22224,,U,1,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,CHEMBL626835,,0,A
Autocuration,BAO_0000019,,,,,13452,,,,,9663,,22224,,U,1,,Delta logPoct-cyc,CHEMBL626836,,0,A
Autocuration,BAO_0000100,,,,,13453,,,,,9663,,22229,,U,1,,Change in logarithm of partition coefficient of the compound,CHEMBL626837,,0,P
Autocuration,BAO_0000019,,,,,13454,,,,,13807,,22224,,U,1,,Delta logD (pH 6.5),CHEMBL626838,,0,A
Autocuration,BAO_0000100,,,,,13455,,,,,13807,,22224,,U,1,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",CHEMBL626839,,0,P
Autocuration,BAO_0000019,,,,,13456,,,,,17425,,22224,,U,1,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,CHEMBL626840,,0,A
Autocuration,BAO_0000019,,,,,13457,,,,,12143,,22224,,U,1,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),CHEMBL626841,,0,A
Autocuration,BAO_0000219,,,,,13458,,,,,12608,,22224,,U,1,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,CHEMBL626842,,0,A
Autocuration,BAO_0000219,,,,,13459,,,,,12608,,22224,,U,1,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,CHEMBL626843,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13460,,,,,8649,,50597,,N,1,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,CHEMBL626844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13461,,,,,8649,,50597,,N,1,,Amount of deuterium retained was reported after normal workup in rats,CHEMBL877495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13462,,,,,8649,,50597,,N,1,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,CHEMBL626845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13463,,,,,8649,,50597,,N,1,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,CHEMBL626846,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13464,,,,,8649,,50597,,N,1,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,CHEMBL626847,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13465,,,,,8649,,50597,,N,1,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,CHEMBL628677,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13466,,,,,8649,,50597,,N,1,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,CHEMBL628678,,1,A
Autocuration,BAO_0000019,,,,,13467,,,,,9659,,22224,,U,1,,Compound was subjected to electrochemical oxidation,CHEMBL628679,,0,A
Autocuration,BAO_0000019,,,,,13468,,,,,9659,,22224,,U,1,,Compound was subjected to photochemical oxidation,CHEMBL628680,,0,A
Autocuration,BAO_0000019,,,,,13469,,,,,9659,,22224,,U,1,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,CHEMBL628681,,0,A
Autocuration,BAO_0000019,,,,,13470,,,,,9659,,22224,,U,1,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,CHEMBL628682,,0,A
Autocuration,BAO_0000019,,,,,13471,,,,,9659,,22224,,U,1,,Oxidation of compound by methemoglobin in presence of hydroperoxide,CHEMBL628683,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13472,,,,,9607,,50597,,N,1,,Percent diffusion through fuzzy rat skin after 48 h of incubation,CHEMBL628684,,1,A
Autocuration,BAO_0000100,,,,,13473,,,,,7057,,22229,,U,1,,Dissociation constant (pKa),CHEMBL877501,,0,P
Autocuration,BAO_0000100,,,,,13474,,,,,7057,,22224,,U,1,,Dissociation constant value of the compound; ND means not determined.,CHEMBL628685,,0,P
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13475,,,Blood,,7911,178.0,50597,,N,1,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,CHEMBL628686,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13476,,,Blood,,7911,178.0,50597,,N,1,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL628687,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13477,,,,,7911,,50597,,N,1,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,CHEMBL628688,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13478,,,,,7911,,50597,,N,1,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL628689,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13479,,,Liver,,7911,2107.0,50597,,N,1,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,CHEMBL628690,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13480,,,Liver,,7911,2107.0,50597,,N,1,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,CHEMBL629363,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13481,,,Spleen,,7911,2106.0,50597,,N,1,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,CHEMBL629364,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13482,,,Spleen,,7911,2106.0,50597,,N,1,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL629365,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13483,,,,,7911,,50597,,N,1,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,CHEMBL629366,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13484,,,Urine,,7911,1088.0,50597,,N,1,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,CHEMBL629367,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13485,,,Feces,,7911,1988.0,50597,,N,1,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL629368,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13486,,,Urine,,7911,1088.0,50597,,N,1,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,CHEMBL877502,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13487,,,Cerebellum,,13792,2037.0,50594,,N,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,CHEMBL629369,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13488,,,Brain,,13792,955.0,50594,,N,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,CHEMBL629370,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13489,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",CHEMBL629371,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13490,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",CHEMBL626276,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13491,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",CHEMBL626277,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13492,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",CHEMBL631250,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13493,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",CHEMBL631251,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13494,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",CHEMBL631252,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13495,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",CHEMBL631253,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13496,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",CHEMBL631254,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13497,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",CHEMBL631255,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13498,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",CHEMBL631256,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13499,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",CHEMBL631257,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13500,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",CHEMBL628009,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13501,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",CHEMBL628010,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13502,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",CHEMBL628011,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13503,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",CHEMBL628012,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13504,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",CHEMBL628013,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13505,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",CHEMBL628014,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13506,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",CHEMBL628015,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13507,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",CHEMBL628016,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13508,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",CHEMBL874461,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13509,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",CHEMBL628017,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13510,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",CHEMBL628018,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13511,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",CHEMBL628019,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13512,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",CHEMBL628020,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13513,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",CHEMBL628021,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13514,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",CHEMBL628022,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13515,,,Urine,,8133,1088.0,50588,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",CHEMBL628023,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13516,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",CHEMBL628024,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13517,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",CHEMBL628025,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13518,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",CHEMBL628026,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13519,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",CHEMBL628027,,0,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13520,,,Urine,,8133,1088.0,22224,,U,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",CHEMBL628028,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13521,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",CHEMBL628029,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13522,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",CHEMBL628030,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13523,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",CHEMBL628031,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13524,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",CHEMBL628032,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13525,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",CHEMBL628033,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13526,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",CHEMBL628034,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13527,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",CHEMBL628035,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13528,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",CHEMBL628036,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13529,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",CHEMBL874462,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13530,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,CHEMBL628037,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13531,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,CHEMBL628123,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13532,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,CHEMBL628124,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13533,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,CHEMBL628125,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13534,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,CHEMBL628126,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13535,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),CHEMBL628127,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13536,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,CHEMBL628128,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13537,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,CHEMBL628129,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13538,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,CHEMBL628130,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13539,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,CHEMBL628131,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13540,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,CHEMBL628132,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13541,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,CHEMBL628133,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13542,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,CHEMBL628134,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13543,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,CHEMBL628135,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13544,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,CHEMBL628136,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13545,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,CHEMBL628137,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13546,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,CHEMBL628138,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13547,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,CHEMBL628139,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13548,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,CHEMBL628140,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13549,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,CHEMBL628141,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13550,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,CHEMBL628142,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13551,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,CHEMBL628143,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13552,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,CHEMBL628144,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13553,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,CHEMBL628145,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13554,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,CHEMBL628146,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13555,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,CHEMBL625355,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13556,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,CHEMBL625356,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13557,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,CHEMBL625357,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13558,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,CHEMBL625527,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13559,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),CHEMBL875473,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13560,In vivo,,,,9025,,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,CHEMBL625528,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13561,In vivo,,,,9025,,50597,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,CHEMBL626304,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13562,In vivo,,Artery,,9025,1637.0,50588,,N,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,CHEMBL624138,,1,A
Autocuration,BAO_0000100,,,,,13563,,,,,6448,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624139,,0,P
Autocuration,BAO_0000100,,,,,13564,,,,,17221,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624140,,0,P
Autocuration,BAO_0000100,,,,,13565,,,,,6545,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624141,,0,P
Autocuration,BAO_0000100,,,,,13566,,,,,577,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624142,,0,P
Autocuration,BAO_0000100,,,,,13567,,,,,6285,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624143,,0,P
Autocuration,BAO_0000100,,,,,13568,,,,,6500,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624144,,0,P
Autocuration,BAO_0000100,,,,,13569,,,,,6716,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624145,,0,P
Autocuration,BAO_0000100,,,,,13570,,,,,13658,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624146,,0,P
Autocuration,BAO_0000100,,,,,13571,,,,,6549,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624147,,0,P
Autocuration,BAO_0000100,,,,,13572,,,,,14685,,22229,,U,1,,Calculated partition coefficient (clogP) (MacLogP),CHEMBL883123,,0,P
Autocuration,BAO_0000019,,,,,13573,,,,,6893,,22224,,U,1,,Partition coefficient (logP),CHEMBL624148,,0,A
Autocuration,BAO_0000019,,,,,13574,,,,,3687,,22224,,U,1,,Kinetic parameter was determined,CHEMBL874416,,0,A
Autocuration,BAO_0000100,,,,,13575,,,,,4207,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624149,,0,P
Autocuration,BAO_0000100,,,,,13576,,,,,4626,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL624150,,0,P
Autocuration,BAO_0000100,,,,,13577,,,,,1021,,22224,,U,1,,Lipophilicity was determined,CHEMBL624151,,0,P
Autocuration,BAO_0000100,,,,,13578,,,,,3777,,22224,,U,1,,Lipophilicity was determined,CHEMBL624152,,0,P
Autocuration,BAO_0000100,,,,,13579,,,,,17533,,22224,,U,1,,Lipophilicity was determined,CHEMBL622139,,0,P
Autocuration,BAO_0000100,,,,,13580,,,,,6524,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL622140,,0,P
Autocuration,BAO_0000100,,,,,13581,,,,,17533,,22224,,U,1,,Lipophilicity was determined,CHEMBL622141,,0,P
Autocuration,BAO_0000100,,,,,13582,,,,,6480,,22224,,U,1,,Lipophilicity in octanol-water,CHEMBL622142,,0,P
Autocuration,BAO_0000100,,,,,13583,,,,,17606,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL622143,,0,P
Autocuration,BAO_0000100,,,,,13584,,,,,6863,,22229,,U,1,,Octanol-water partition coefficient was determined,CHEMBL622144,,0,P
Autocuration,BAO_0000019,,,,,13585,,,,,1356,,22224,,U,1,,Partition coefficient (logP),CHEMBL877473,,0,A
Autocuration,BAO_0000100,,,,,13586,,,,,3326,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL622145,,0,P
Autocuration,BAO_0000019,,,,,13587,,,,,1356,,22224,,U,1,,Partition coefficient was determined; ND means not determined,CHEMBL622146,,0,A
Autocuration,BAO_0000100,,,,,13588,,,,,12984,,22229,,U,1,,Calculated partition coefficient (clogP),CHEMBL622147,,0,P
Autocuration,BAO_0000019,,,,,13589,,,,,17363,,22224,,U,1,,Partition coefficient of the compound,CHEMBL622148,,0,A
Autocuration,BAO_0000019,,,,,13590,,,,,6827,,22224,,U,1,,Permeability was determined,CHEMBL883124,,0,A
Autocuration,BAO_0000100,,,,,13591,,,,,261,,22229,,U,1,,The compound was evaluated for the partition coefficient,CHEMBL622149,,0,P
Autocuration,BAO_0000019,,,,,13592,,,,,2685,,22224,,U,1,,Partition coefficient (logP),CHEMBL622150,,0,A
Autocuration,BAO_0000100,,,,,13593,,,,,414,,22224,,U,1,,The lipophilicity was reported,CHEMBL622151,,0,P
Autocuration,BAO_0000100,,,,,13594,,,,,15769,,22229,,U,1,,logarithm of the octanol-water partition coefficient for the compound,CHEMBL622152,,0,P
Autocuration,BAO_0000019,,,,,13595,,,,,17248,,22224,,U,1,,Clogp value was determined,CHEMBL622153,,0,A
Autocuration,BAO_0000218,,,,,13596,In vivo,,,,16935,,22224,,U,1,,Clp at a dose of 1.5 mg/kg,CHEMBL877474,,0,A
Autocuration,BAO_0000218,,,,,13597,In vivo,,,,16935,,22224,,U,1,,Clp at a dose of 2.0 mg/kg,CHEMBL622154,,0,A
Autocuration,BAO_0000218,,,,,13598,In vivo,,Plasma,,14832,1969.0,22224,,U,1,,"Clp, plasma clearance at a dose of 10 mg/kg",CHEMBL622155,,0,A
Autocuration,BAO_0000218,,,,,13599,In vivo,,Plasma,,14832,1969.0,22224,,U,1,,"Clp, plasma clearance at a dose of 50 mg/kg",CHEMBL622156,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13600,In vivo,,Plasma,,2399,1969.0,50597,,N,1,,Compound was tested for plasma clearance in rat,CHEMBL622157,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13601,In vivo,,Plasma,,2399,1969.0,50597,,N,1,,Compound was tested for plasma clearance in rat; Not determined,CHEMBL622158,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13602,In vivo,,,,6227,,50597,,N,1,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,CHEMBL622807,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,13603,In vivo,,,,6227,,50797,,N,1,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,CHEMBL622808,,1,A
Autocuration,BAO_0000218,,,,,13604,In vivo,,,,5623,,22224,,U,1,,Plasma clearance by iv administration at a dose 0.003 ug/mL,CHEMBL622809,,0,A
Autocuration,BAO_0000218,,,,,13605,In vivo,,,,4854,,22224,,U,1,,Plasma clearance determined,CHEMBL622810,,0,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,13606,In vivo,,,,4493,,100712,,N,1,,Plasma clearance after iv administration at 3 mg/kg in hamster,CHEMBL876653,,1,A
Intermediate,BAO_0000218,,10026.0,,Cricetinae,13607,In vivo,,,,4493,,100712,,N,1,,Plasma clearance after iv administration at 4 mg/kg in hamster,CHEMBL622811,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13608,In vivo,,,,14956,,50597,,N,1,,Rate of clearance in rat was determined,CHEMBL622986,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13609,In vivo,,Plasma,,15372,1969.0,50597,,N,1,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,CHEMBL622987,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13610,In vivo,,Plasma,,15372,1969.0,50597,,N,1,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,CHEMBL622988,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13611,In vivo,,Plasma,,15372,1969.0,50597,,N,1,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,CHEMBL622989,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13612,In vivo,,Plasma,,15372,1969.0,50597,,N,1,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,CHEMBL622990,,1,A
Autocuration,BAO_0000218,,314293.0,,Simiiformes,13613,In vivo,,Plasma,,15604,1969.0,22224,,U,1,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,CHEMBL622991,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13614,In vivo,,Plasma,,15604,1969.0,50597,,N,1,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,CHEMBL622227,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13615,In vivo,,Plasma,,15604,1969.0,50588,,N,1,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,CHEMBL622228,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13616,In vivo,,,,14964,,50597,,N,1,,Clpl value in rat,CHEMBL622229,,1,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,13617,In vivo,,,,15240,,50512,,N,1,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,CHEMBL622230,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13618,In vivo,,,,16449,,50597,,N,1,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,CHEMBL622231,,1,A
Intermediate,BAO_0000218,,9541.0,,Macaca fascicularis,13619,In vivo,,,,16449,,100710,,N,1,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,CHEMBL622232,,1,A
Autocuration,BAO_0000218,,,,,13620,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,CHEMBL622233,,0,A
Autocuration,BAO_0000218,,,,,13621,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,CHEMBL622234,,0,A
Autocuration,BAO_0000218,,,,,13622,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,CHEMBL622235,,0,A
Autocuration,BAO_0000218,,,,,13623,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,CHEMBL622236,,0,A
Autocuration,BAO_0000218,,,,,13624,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,CHEMBL622237,,0,A
Autocuration,BAO_0000218,,,,,13625,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,CHEMBL877482,,0,A
Autocuration,BAO_0000218,,,,,13626,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,CHEMBL622238,,0,A
Autocuration,BAO_0000218,,,,,13627,In vivo,,,,12902,,22224,,U,1,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,CHEMBL622239,,0,A
Autocuration,BAO_0000218,,,,,13628,In vivo,,Blood,,11149,178.0,22224,,U,1,,Cmax was calculated as maximum concentration reached in the blood,CHEMBL622240,,0,A
Autocuration,BAO_0000218,,,,,13629,In vivo,,Blood,,11149,178.0,22224,,U,1,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,CHEMBL622241,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13630,In vivo,,,,5669,,50597,,N,1,,Cmax was determine after peroral administration at 10 mpk in Rat,CHEMBL631013,,1,A
Intermediate,BAO_0000218,,9544.0,,Macaca mulatta,13631,In vivo,,,,5669,,50797,,N,1,,Cmax was determine after peroral administration at 10 mpk in Rhesus,CHEMBL631014,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13632,In vivo,,,,5669,,50588,,N,1,,Cmax was determine after peroral administration at 10 mpk in dog,CHEMBL631015,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13633,In vivo,,,,5669,,50597,,N,1,,Cmax was determine after peroral administration at 160 mpk in Rat,CHEMBL631016,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13634,In vivo,,,,5669,,50597,,N,1,,Cmax was determine after peroral administration at 20 mpk in Rat,CHEMBL631017,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13635,In vivo,,,,5669,,50597,,N,1,,Cmax was determine after peroral administration at 50 mpk in Rat,CHEMBL631018,,1,A
Autocuration,BAO_0000218,,,,,13636,In vivo,,,,4236,,22224,,U,1,,Cmax was determined,CHEMBL631019,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13637,,,Brain,,13792,955.0,50594,,N,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,CHEMBL875761,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13638,,,Brain,,13792,955.0,50594,,N,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,CHEMBL631020,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13639,,,Brain,,13792,955.0,50594,,N,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,CHEMBL631669,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13640,,,Brain,,13792,955.0,50594,,N,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,CHEMBL631670,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13641,,,Striatum,,13792,2435.0,50594,,N,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,CHEMBL631671,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13642,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,CHEMBL631672,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13643,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,CHEMBL631673,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13644,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,CHEMBL631856,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13645,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,CHEMBL631857,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13646,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,CHEMBL631858,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13647,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,CHEMBL631859,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13648,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,CHEMBL631860,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13649,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,CHEMBL631861,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13650,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,CHEMBL631862,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13651,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,CHEMBL631863,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13652,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,CHEMBL631864,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13653,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,CHEMBL631865,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13654,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,CHEMBL631866,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13655,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,CHEMBL629360,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13656,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,CHEMBL629361,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13657,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,CHEMBL629362,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13658,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,CHEMBL630740,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13659,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,CHEMBL630741,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13660,,,Blood,,8418,178.0,50597,,N,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,CHEMBL630742,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13661,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,CHEMBL630743,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13662,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,CHEMBL630744,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13663,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,CHEMBL630745,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13664,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,CHEMBL630746,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13665,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,CHEMBL630747,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13666,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,CHEMBL630748,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13667,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,CHEMBL632056,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13668,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,CHEMBL632057,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13669,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,CHEMBL632058,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13670,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,CHEMBL632059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13671,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,CHEMBL632060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13672,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,CHEMBL632061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13673,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,CHEMBL629207,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13674,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,CHEMBL629208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13675,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,CHEMBL629209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13676,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,CHEMBL629210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13677,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,CHEMBL629211,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13678,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,CHEMBL629212,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13679,,,,,8418,,50597,,N,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,CHEMBL629213,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13680,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",CHEMBL629214,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13681,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",CHEMBL629215,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13682,,,Urine,,8133,1088.0,50597,,N,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",CHEMBL635154,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13683,,,,,6996,,50597,,N,1,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL629216,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13684,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,CHEMBL629217,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13685,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL629218,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13686,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),CHEMBL629219,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13687,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),CHEMBL629220,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13688,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),CHEMBL629221,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13689,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL631127,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13690,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,CHEMBL631128,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13691,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL631129,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13692,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),CHEMBL631130,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13693,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),CHEMBL631131,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13694,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),CHEMBL631132,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13695,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL631133,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13696,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,CHEMBL631134,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13697,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL875120,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13698,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),CHEMBL631135,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13699,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),CHEMBL631136,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13700,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),CHEMBL631137,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13701,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL631138,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13702,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,CHEMBL631139,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13703,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL631140,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13704,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL631141,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13705,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),CHEMBL631142,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13706,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),CHEMBL631143,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13707,,,,,6996,,50597,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL631144,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13708,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,CHEMBL631145,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13709,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),CHEMBL631146,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13710,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,CHEMBL631147,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13711,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),CHEMBL631148,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13712,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),CHEMBL631149,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13713,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),CHEMBL631150,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13714,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),CHEMBL631151,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13715,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),CHEMBL631152,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13716,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),CHEMBL631443,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13717,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),CHEMBL631444,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13718,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),CHEMBL631445,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13719,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),CHEMBL631446,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13720,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),CHEMBL631447,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13721,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),CHEMBL631448,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13722,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,CHEMBL631449,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13723,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),CHEMBL631450,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13724,,,,,6996,,50588,,N,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),CHEMBL629724,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13725,In vivo,,Zone of skin,,9716,14.0,50594,,N,1,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL629725,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13726,In vivo,,Zone of skin,,9716,14.0,50594,,N,1,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL629726,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13727,In vivo,,Spleen,,9716,2106.0,50594,,N,1,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL629727,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13728,In vivo,,Spleen,,9716,2106.0,50594,,N,1,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630404,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13729,In vivo,,Spleen,,9716,2106.0,50594,,N,1,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630405,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13730,In vivo,,Spleen,,9716,2106.0,50594,,N,1,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630406,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13731,In vivo,,Stomach,,9716,945.0,50594,,N,1,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630407,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13732,In vivo,,Stomach,,9716,945.0,50594,,N,1,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630573,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13733,In vivo,,Stomach,,9716,945.0,50594,,N,1,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630574,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13734,In vivo,,Stomach,,9716,945.0,50594,,N,1,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630575,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13735,In vivo,,,,9716,,50594,,N,1,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630576,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13736,In vivo,,,,9716,,50594,,N,1,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630577,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13737,In vivo,,,,9716,,50594,,N,1,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630578,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13738,In vivo,,,,9716,,50594,,N,1,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630579,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13739,,,Kidney,,12192,2113.0,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),CHEMBL630580,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13740,,,Kidney,,12192,2113.0,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,CHEMBL630581,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13741,,,Kidney,,12192,2113.0,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),CHEMBL630582,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13742,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,CHEMBL630583,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13743,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),CHEMBL630584,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13744,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,CHEMBL630585,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13745,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),CHEMBL630586,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13746,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,CHEMBL630587,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13747,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),CHEMBL630588,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13748,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,CHEMBL630589,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13749,,,,,12192,,50594,,N,1,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),CHEMBL630590,,1,A
Autocuration,BAO_0000019,,,,,13750,,,Feces,,12192,1988.0,22224,,U,1,,Removal of 238-Plutonium(IV) in feces at 24 h,CHEMBL630591,,0,A
Autocuration,BAO_0000019,,,,,13751,,,Feces,,12192,1988.0,22224,,U,1,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),CHEMBL630592,,0,A
Autocuration,BAO_0000019,,,,,13752,,,,,12192,,22224,,U,1,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,CHEMBL630593,,0,A
Autocuration,BAO_0000019,,,,,13753,,,,,12192,,22224,,U,1,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),CHEMBL630594,,0,A
Autocuration,BAO_0000019,,,,,13754,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),CHEMBL630595,,0,A
Autocuration,BAO_0000019,,,,,13755,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),CHEMBL630596,,0,A
Autocuration,BAO_0000019,,,,,13756,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine after 0-24 h,CHEMBL630597,,0,A
Autocuration,BAO_0000019,,,,,13757,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),CHEMBL630598,,0,A
Autocuration,BAO_0000019,,,,,13758,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine after 0-4 h,CHEMBL630599,,0,A
Autocuration,BAO_0000019,,,,,13759,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),CHEMBL630600,,0,A
Autocuration,BAO_0000019,,,,,13760,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine after 4-24 h,CHEMBL630601,,0,A
Autocuration,BAO_0000019,,,,,13761,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),CHEMBL630602,,0,A
Autocuration,BAO_0000019,,,,,13762,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),CHEMBL630603,,0,A
Autocuration,BAO_0000019,,,,,13763,,,Urine,,12192,1088.0,22224,,U,1,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),CHEMBL630604,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13764,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL624869,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13765,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL624870,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13766,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL623189,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13767,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623190,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13768,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623191,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13769,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623192,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13770,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623193,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13771,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL623194,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13772,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623195,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13773,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623196,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13774,,,,,11836,,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,CHEMBL623197,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13775,,,,,11836,,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623198,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13776,,,,,11836,,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,CHEMBL623199,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13777,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,CHEMBL623200,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13778,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,CHEMBL623201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13779,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,CHEMBL623202,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13780,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623203,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13781,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,CHEMBL623204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13782,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,CHEMBL623205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13783,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,CHEMBL623206,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13784,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,CHEMBL623207,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13785,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,CHEMBL623208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13786,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13787,,,Muscle tissue,,11836,2385.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,CHEMBL623210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13788,,,,,11836,,50597,,N,1,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623211,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13789,,,Uterus,,11836,995.0,50597,,N,1,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,CHEMBL623212,,1,A
Autocuration,BAO_0000019,,,,,13790,,,,,12640,,22224,,U,1,,Tested in vitro for intrinsic activity relative to quinpirole,CHEMBL623213,,0,A
Autocuration,BAO_0000019,,,,,13791,,,,,14218,,22224,,U,1,,"Relative ion enhancement, determined in pulsed ultrafiltration",CHEMBL623214,,0,A
Autocuration,BAO_0000019,,,,,13792,,,,,11296,,22224,,U,1,,% ionization at the pH 7.4 at 37 degree Centigrade,CHEMBL623215,,0,A
Autocuration,BAO_0000019,,,,,13793,,,,,10929,,22224,,U,1,,Percentage ionization was measured,CHEMBL623216,,0,A
Intermediate,BAO_0000218,,9913.0,,Bos taurus,13794,,,,,13841,,50591,,N,1,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,CHEMBL623217,,1,A
Autocuration,BAO_0000019,,,,,13795,,,,,10431,,22224,,U,1,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,CHEMBL623218,,0,A
Autocuration,BAO_0000019,,,,,13796,,,,,10431,,22224,,U,1,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,CHEMBL623913,,0,A
Autocuration,BAO_0000019,,,,,13797,,,,,10431,,22224,,U,1,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,CHEMBL623914,,0,A
Autocuration,BAO_0000100,,,,,13798,,,,,8826,,22229,,U,1,,Compound was evaluated for the partition coefficient in octanol/water,CHEMBL623915,,0,P
Autocuration,BAO_0000100,,,,,13799,,,,,8826,,22229,,U,1,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),CHEMBL624080,,0,P
Autocuration,BAO_0000019,,,,,13800,,,,,9884,,22224,,U,1,,Equilibrium constant measured by the pulse radiolysis at pH 7,CHEMBL624081,,0,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,13801,,,,,9827,,50587,,N,1,,In vitro hydrolytic rate constant determined in human blood,CHEMBL624082,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,13802,,,,,10009,,50587,,N,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,CHEMBL625054,,1,A
Autocuration,BAO_0000019,,,,,13803,,,,,10009,,22224,,U,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,CHEMBL877485,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13804,,,,,10009,,50594,,N,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,CHEMBL625055,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13805,,,,,10009,,50594,,N,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,CHEMBL625056,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,13806,,,,,10009,,50587,,N,1,,In vitro oxidation of compound in presence of human plasma,CHEMBL625057,,1,A
Autocuration,BAO_0000019,,,,,13807,,,,,10009,,22224,,U,1,,In vitro oxidation of compound in presence of hydrogen peroxide,CHEMBL625058,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13808,,,,,10009,,50594,,N,1,,In vitro oxidation of compound in presence of mouse brain homogenate,CHEMBL625059,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13809,,,,,10009,,50594,,N,1,,In vitro oxidation of compound in presence of mouse liver homogenate,CHEMBL629536,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13810,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,CHEMBL629537,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13811,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,CHEMBL629538,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13812,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,CHEMBL629539,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13813,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,CHEMBL874445,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13814,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,CHEMBL629540,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13815,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,CHEMBL629541,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13816,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,CHEMBL629542,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13817,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,CHEMBL630243,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13818,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,CHEMBL630244,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13819,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,CHEMBL630245,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13820,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,CHEMBL630246,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13821,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,CHEMBL630247,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13822,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,CHEMBL630248,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13823,In vivo,,Blood,,13100,178.0,50597,,N,1,,Biodistribution in rat blood at 240 minutes after dose administration.,CHEMBL630249,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13824,In vivo,,Blood,,13100,178.0,50597,,N,1,,Biodistribution in rat blood at 30 minutes after dose administration.,CHEMBL630250,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13825,In vivo,,Blood,,13100,178.0,50597,,N,1,,Biodistribution in rat blood at 360 minutes after dose administration.,CHEMBL630251,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13826,In vivo,,Blood,,13100,178.0,50597,,N,1,,Biodistribution in rat blood at 3 hr after dose administration.,CHEMBL630252,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13827,In vivo,,Blood,,13100,178.0,50597,,N,1,,Biodistribution in rat blood at 60 minutes after dose administration.,CHEMBL630408,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13828,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,CHEMBL630409,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13829,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,CHEMBL874446,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13830,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,CHEMBL630410,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13831,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,CHEMBL630411,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13832,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,CHEMBL630412,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13833,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,CHEMBL630413,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13834,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 3 hr after dose administration.,CHEMBL630414,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13835,In vivo,,Cerebellum,,13100,2037.0,50597,,N,1,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,CHEMBL630415,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13836,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 120 minutes after dose administration.,CHEMBL630416,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13837,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 1440 minutes after dose administration.,CHEMBL630417,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13838,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 15 minutes after dose administration.,CHEMBL630418,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13839,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 240 minutes after dose administration.,CHEMBL630419,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13840,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 30 minutes after dose administration.,CHEMBL630420,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13841,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 360 minutes after dose administration.,CHEMBL630421,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13842,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 3 hr after dose administration.,CHEMBL630422,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13843,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat cortex at 60 minutes after dose administration.,CHEMBL630423,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13844,In vivo,,Heart,,13100,948.0,50597,,N,1,,Biodistribution in rat heart at 120 minutes after dose administration.,CHEMBL630424,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13845,In vivo,,Heart,,13100,948.0,50597,,N,1,,Biodistribution in rat heart at 15 minutes after dose administration.,CHEMBL630425,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13846,In vivo,,Heart,,13100,948.0,50597,,N,1,,Biodistribution in rat heart at 240 minutes after dose administration.,CHEMBL629462,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13847,In vivo,,Heart,,13100,948.0,50597,,N,1,,Biodistribution in rat heart at 30 minutes after dose administration.,CHEMBL630426,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13848,In vivo,,Heart,,13100,948.0,50597,,N,1,,Biodistribution in rat heart at 360 minutes after dose administration.,CHEMBL630427,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13849,In vivo,,Heart,,13100,948.0,50597,,N,1,,Biodistribution in rat heart at 3 hr after dose administration.,CHEMBL625877,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13850,In vivo,,Heart,,13100,948.0,50597,,N,1,,Biodistribution in rat heart at 60 minutes after dose administration.,CHEMBL625878,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13851,In vivo,,Hippocampus,,13100,10000000.0,50597,,N,1,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,CHEMBL625879,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13852,In vivo,,Hippocampus,,13100,10000000.0,50597,,N,1,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,CHEMBL625880,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13853,In vivo,,Hippocampus,,13100,10000000.0,50597,,N,1,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,CHEMBL625881,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13854,In vivo,,Hippocampus,,13100,10000000.0,50597,,N,1,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,CHEMBL625882,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13855,In vivo,,Hippocampus,,13100,10000000.0,50597,,N,1,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,CHEMBL625883,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13856,In vivo,,Kidney,,13100,2113.0,50597,,N,1,,Biodistribution in rat kidney at 120 minutes after dose administration.,CHEMBL625884,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13857,In vivo,,Kidney,,13100,2113.0,50597,,N,1,,Biodistribution in rat kidney at 1440 minutes after dose administration.,CHEMBL625885,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13858,In vivo,,Kidney,,13100,2113.0,50597,,N,1,,Biodistribution in rat kidney at 15 minutes after dose administration.,CHEMBL628649,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13859,In vivo,,Kidney,,13100,2113.0,50597,,N,1,,Biodistribution in rat kidney at 240 minutes after dose administration.,CHEMBL628650,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13860,In vivo,,Kidney,,13100,2113.0,50597,,N,1,,Biodistribution in rat kidney at 30 minutes after dose administration.,CHEMBL628651,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13861,In vivo,,Kidney,,13100,2113.0,50597,,N,1,,Biodistribution in rat kidney at 360 minutes after dose administration.,CHEMBL628652,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13862,In vivo,,Kidney,,13100,2113.0,50597,,N,1,,Biodistribution in rat kidney at 60 minutes after dose administration.,CHEMBL628653,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13863,In vivo,,Liver,,13100,2107.0,50597,,N,1,,Biodistribution in rat liver at 120 minutes after dose administration.,CHEMBL628654,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13864,In vivo,,Liver,,13100,2107.0,50597,,N,1,,Biodistribution in rat liver at 1440 minutes after dose administration.,CHEMBL628655,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13865,In vivo,,Liver,,13100,2107.0,50597,,N,1,,Biodistribution in rat liver at 15 minutes after dose administration.,CHEMBL625238,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13866,In vivo,,Liver,,13100,2107.0,50597,,N,1,,Biodistribution in rat liver at 240 minutes after dose administration.,CHEMBL625239,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13867,In vivo,,Liver,,13100,2107.0,50597,,N,1,,Biodistribution in rat liver at 30 minutes after dose administration.,CHEMBL625240,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13868,In vivo,,Liver,,13100,2107.0,50597,,N,1,,Biodistribution in rat liver at 360 minutes after dose administration.,CHEMBL625241,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13869,In vivo,,Liver,,13100,2107.0,50597,,N,1,,Biodistribution in rat liver at 60 minutes after dose administration.,CHEMBL625242,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13870,In vivo,,Lung,,13100,2048.0,50597,,N,1,,Biodistribution in rat lung at 120 minutes after dose administration.,CHEMBL874587,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13871,In vivo,,Lung,,13100,2048.0,50597,,N,1,,Biodistribution in rat lung at 1440 minutes after dose administration.,CHEMBL625405,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13872,In vivo,,Lung,,13100,2048.0,50597,,N,1,,Biodistribution in rat lung at 15 minutes after dose administration.,CHEMBL625406,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13873,In vivo,,Lung,,13100,2048.0,50597,,N,1,,Biodistribution in rat lung at 240 minutes after dose administration.,CHEMBL625407,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13874,In vivo,,Lung,,13100,2048.0,50597,,N,1,,Biodistribution in rat lung at 30 minutes after dose administration.,CHEMBL625408,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13875,In vivo,,Lung,,13100,2048.0,50597,,N,1,,Biodistribution in rat lung at 360 minutes after dose administration.,CHEMBL625409,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13876,,,Thoracic aorta,,12361,1515.0,50597,,N,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,CHEMBL625410,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13877,,,Thoracic aorta,,12361,1515.0,50597,,N,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,CHEMBL625411,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13878,,,Thoracic aorta,,12361,1515.0,50597,,N,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,CHEMBL625412,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13879,,,Thoracic aorta,,12361,1515.0,50597,,N,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,CHEMBL625413,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13880,,,Thoracic aorta,,12361,1515.0,50597,,N,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,CHEMBL625414,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13881,,,Thoracic aorta,,12361,1515.0,50597,,N,1,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,CHEMBL625415,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13882,,,Thoracic aorta,,12361,1515.0,50597,,N,1,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,CHEMBL625416,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13883,,,Urine,,12712,1088.0,50597,,N,1,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,CHEMBL625417,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13884,,,Feces,,7415,1988.0,50597,,N,1,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,CHEMBL625418,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13885,,,Urine,,7415,1088.0,50597,,N,1,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,CHEMBL625419,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13886,,,,,7415,,50597,,N,1,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,CHEMBL625420,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13887,,,,,7415,,50597,,N,1,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,CHEMBL626996,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13888,,,Feces,,7415,1988.0,50597,,N,1,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",CHEMBL626997,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13889,,,Urine,,7415,1088.0,50597,,N,1,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",CHEMBL626998,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13890,,,,,7415,,50597,,N,1,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",CHEMBL626999,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13891,,,,,8050,,50594,,N,1,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,CHEMBL627000,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13892,,,,,8050,,50594,,N,1,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,CHEMBL627001,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13893,,,,,8050,,50594,,N,1,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,CHEMBL627002,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13894,,,,,8050,,50594,,N,1,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,CHEMBL627003,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13895,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,CHEMBL627004,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13896,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,CHEMBL627005,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13897,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,CHEMBL874594,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13898,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,CHEMBL627006,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13899,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,CHEMBL627007,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13900,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,CHEMBL627884,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13901,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,CHEMBL627885,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13902,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,CHEMBL627886,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13903,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,CHEMBL627887,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13904,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,CHEMBL627888,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13905,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,CHEMBL628057,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,13906,,,Urine,,8050,1088.0,50594,,N,1,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,CHEMBL627405,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13907,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,CHEMBL627406,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13908,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,CHEMBL627407,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13909,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,CHEMBL627408,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13910,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,CHEMBL627409,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13911,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,CHEMBL875486,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13912,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,CHEMBL627410,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13913,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,CHEMBL627411,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13914,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,CHEMBL627412,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13915,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,CHEMBL627413,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13916,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,CHEMBL627414,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13917,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,CHEMBL627415,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13918,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,CHEMBL627416,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13919,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,CHEMBL627417,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13920,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,CHEMBL627418,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13921,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,CHEMBL627419,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13922,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,CHEMBL627320,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,13923,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,CHEMBL627321,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13924,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627322,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13925,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627323,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13926,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL627491,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13927,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627492,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13928,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627493,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13929,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627494,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13930,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627495,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13931,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL627496,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13932,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627497,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13933,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627498,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13934,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627499,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13935,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627500,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13936,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL627501,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13937,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625616,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13938,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625617,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13939,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625618,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13940,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625619,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13941,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL625620,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13942,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625621,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13943,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625622,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13944,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625788,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13945,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625789,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13946,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL625790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13947,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13948,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622334,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13949,In vivo,,Thyroid gland,,12017,2046.0,50597,,N,1,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622335,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13950,In vivo,,Thyroid gland,,12017,2046.0,50597,,N,1,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622336,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13951,In vivo,,Thyroid gland,,12017,2046.0,50597,,N,1,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL622337,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13952,In vivo,,Thyroid gland,,12017,2046.0,50597,,N,1,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622338,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13953,In vivo,,Thyroid gland,,12017,2046.0,50597,,N,1,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622339,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13954,In vivo,,,,12017,,50597,,N,1,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL624153,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13955,In vivo,,,,12017,,50597,,N,1,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL628430,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13956,In vivo,,,,12017,,50597,,N,1,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL628431,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13957,In vivo,,,,12017,,50597,,N,1,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL628432,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13958,In vivo,,,,12017,,50597,,N,1,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL628433,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13959,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL628434,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13960,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626789,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13961,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",CHEMBL626790,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13962,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626791,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13963,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626792,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13964,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626793,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13965,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,CHEMBL627436,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13966,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,CHEMBL627437,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13967,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,CHEMBL627438,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13968,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,CHEMBL627439,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13969,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,CHEMBL627440,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13970,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,CHEMBL627602,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13971,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,CHEMBL627603,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13972,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,CHEMBL627604,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13973,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,CHEMBL627605,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13974,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,CHEMBL627606,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13975,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,CHEMBL627607,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13976,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,CHEMBL627608,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13977,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,CHEMBL627609,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13978,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,CHEMBL627610,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13979,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,CHEMBL627611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,13980,,,,,11510,,50597,,N,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,CHEMBL627612,,1,A
Autocuration,BAO_0000100,,,,,13981,,,,,8362,,22229,,U,1,,Octanol:water partition coefficient is evaluated,CHEMBL627613,,0,P
Autocuration,BAO_0000100,,,,,13982,,,,,8257,,22224,,U,1,,Partition coefficient in 1-octanol/water system,CHEMBL627614,,0,P
Autocuration,BAO_0000100,,,,,13983,,,,,8257,,22224,,U,1,,Partition coefficient in 1-octanol/water system measured using radio active compounds,CHEMBL627615,,0,P
Autocuration,BAO_0000100,,,,,13984,,,,,9468,,22224,,U,1,,Partition coefficient in octanol/water system was determined,CHEMBL627616,,0,P
Autocuration,BAO_0000100,,,,,13985,,,,,9468,,22224,,U,1,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,CHEMBL627617,,0,P
Autocuration,BAO_0000019,,,,,13986,,,,,10568,,22224,,U,1,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,CHEMBL627618,,0,A
Autocuration,BAO_0000019,,,,,13987,,,,,10568,,22224,,U,1,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",CHEMBL627619,,0,A
Autocuration,BAO_0000019,,,,,13988,,,,,15359,,22224,,U,1,,Pseudo-first-order rate constant of the compound,CHEMBL627620,,0,A
Autocuration,BAO_0000019,,,,,13989,,,,,15359,,22224,,U,1,,Pseudo-first-order rate constant with 1-min time point,CHEMBL627621,,0,A
Autocuration,BAO_0000019,,,,,13990,,,,,15359,,22224,,U,1,,Pseudo-first-order rate constant without 1-min time point,CHEMBL627622,,0,A
Autocuration,BAO_0000019,,,,,13991,,,,,10431,,22224,,U,1,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,CHEMBL627623,,0,A
Autocuration,BAO_0000019,,,,,13992,,,,,10431,,22224,,U,1,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,CHEMBL627624,,0,A
Autocuration,BAO_0000019,,,,,13993,,,,,10431,,22224,,U,1,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,CHEMBL627625,,0,A
Autocuration,BAO_0000019,,,,,13994,,,,,15704,,22224,,U,1,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,CHEMBL628523,,0,A
Autocuration,BAO_0000019,,,,,13995,,,,,15287,,22224,,U,1,,The alkaline hydrolysis second order rate constant(K OH) of the compound,CHEMBL628524,,0,A
Autocuration,BAO_0000019,,,,,13996,,,,,7516,,22224,,U,1,,The efflux rate constant of the compound,CHEMBL628525,,0,A
Autocuration,BAO_0000019,,,,,13997,,,,,12973,,22224,,U,1,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,CHEMBL625732,,0,A
Autocuration,BAO_0000019,,,,,13998,,,,,12973,,22224,,U,1,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,CHEMBL625733,,0,A
Autocuration,BAO_0000019,,,,,13999,,,,,12973,,22224,,U,1,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,CHEMBL625734,,0,F
Autocuration,BAO_0000019,,,,,14000,,,,,12973,,22224,,U,1,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,CHEMBL625913,,0,A
Autocuration,BAO_0000019,,,,,14001,,,,,8696,,22224,,U,1,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,CHEMBL625914,,0,A
Autocuration,BAO_0000019,,,,,14002,,,,,15052,,22224,,U,1,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,CHEMBL625915,,0,A
Autocuration,BAO_0000019,,,,,14003,,,,,15052,,22224,,U,1,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,CHEMBL625916,,0,A
Autocuration,BAO_0000019,,,,,14004,,,,,10503,,22224,,U,1,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),CHEMBL625917,,0,A
Autocuration,BAO_0000019,,,,,14005,,,,,8354,,22224,,U,1,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625918,,0,A
Autocuration,BAO_0000019,,,,,14006,,,,,8354,,22224,,U,1,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625919,,0,A
Autocuration,BAO_0000019,,,,,14007,,,,,8354,,22224,,U,1,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625920,,0,A
Autocuration,BAO_0000019,,,,,14008,,,,,8354,,22224,,U,1,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL874453,,0,A
Autocuration,BAO_0000019,,,,,14009,,,,,8354,,22224,,U,1,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",CHEMBL625921,,0,A
Autocuration,BAO_0000019,,,,,14010,,,,,10503,,22224,,U,1,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,CHEMBL625922,,0,A
Autocuration,BAO_0000019,,,,,14011,,,,,8354,,22224,,U,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625923,,0,A
Autocuration,BAO_0000019,,,,,14012,,,,,8354,,22224,,U,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625924,,0,A
Autocuration,BAO_0000019,,,,,14013,,,,,8354,,22224,,U,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625925,,0,A
Autocuration,BAO_0000019,,,,,14014,,,,,8354,,22224,,U,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625926,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14015,In vivo,,Lung,,13100,2048.0,50597,,N,1,,Biodistribution in rat lung at 60 minutes after dose administration.,CHEMBL627704,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14016,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,CHEMBL627705,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14017,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,CHEMBL627706,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14018,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,CHEMBL627707,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14019,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,CHEMBL627708,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14020,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,CHEMBL628361,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14021,In vivo,,,,13100,,50597,,N,1,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,CHEMBL628362,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14022,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 120 minutes after dose administration.,CHEMBL628363,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14023,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 1440 minutes after dose administration.,CHEMBL628364,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14024,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 15 minutes after dose administration.,CHEMBL628365,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14025,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 240 minutes after dose administration.,CHEMBL874454,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14026,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 30 minutes after dose administration.,CHEMBL628531,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14027,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 360 minutes after dose administration.,CHEMBL628532,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14028,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 3 hr after dose administration.,CHEMBL628533,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14029,In vivo,,Striatum,,13100,2435.0,50597,,N,1,,Biodistribution in rat striatum at 60 minutes after dose administration.,CHEMBL628534,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14030,In vivo,,Thyroid gland,,13100,2046.0,50597,,N,1,,Biodistribution in rat thyroid at 120 minutes after dose administration.,CHEMBL628535,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14031,In vivo,,Thyroid gland,,13100,2046.0,50597,,N,1,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,CHEMBL628536,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14032,In vivo,,Thyroid gland,,13100,2046.0,50597,,N,1,,Biodistribution in rat thyroid at 15 minutes after dose administration.,CHEMBL628537,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14033,In vivo,,Thyroid gland,,13100,2046.0,50597,,N,1,,Biodistribution in rat thyroid at 240 minutes after dose administration.,CHEMBL628538,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14034,In vivo,,Thyroid gland,,13100,2046.0,50597,,N,1,,Biodistribution in rat thyroid at 30 minutes after dose administration.,CHEMBL628539,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14035,In vivo,,Thyroid gland,,13100,2046.0,50597,,N,1,,Biodistribution in rat thyroid at 360 minutes after dose administration.,CHEMBL630297,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14036,In vivo,,Thyroid gland,,13100,2046.0,50597,,N,1,,Biodistribution in rat thyroid at 60 minutes after dose administration.,CHEMBL630298,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14037,In vivo,,Brain,,13100,955.0,50597,,N,1,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,CHEMBL630299,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14038,In vivo,,Brain,,13100,955.0,50597,,N,1,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,CHEMBL628094,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14039,In vivo,,Brain,,13100,955.0,50597,,N,1,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,CHEMBL628095,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14040,In vivo,,Brain,,13100,955.0,50597,,N,1,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,CHEMBL874648,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14041,In vivo,,Brain,,13100,955.0,50597,,N,1,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,CHEMBL628096,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14042,In vivo,,Brain,,13100,955.0,50597,,N,1,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,CHEMBL628097,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14043,In vivo,,Brain,,13100,955.0,50597,,N,1,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,CHEMBL628098,,1,A
Autocuration,BAO_0000019,,,,,14044,,,,,13331,,22224,,U,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",CHEMBL628099,,0,A
Autocuration,BAO_0000019,,,,,14045,,,,,13331,,22224,,U,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",CHEMBL628100,,0,A
Autocuration,BAO_0000019,,,,,14046,,,,,13331,,22224,,U,1,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),CHEMBL628101,,0,A
Autocuration,BAO_0000019,,,,,14047,,,,,13331,,22224,,U,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",CHEMBL628102,,0,A
Autocuration,BAO_0000019,,,,,14048,,,,,13331,,22224,,U,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",CHEMBL628103,,0,A
Autocuration,BAO_0000019,,,,,14049,,,,,13331,,22224,,U,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",CHEMBL628104,,0,A
Autocuration,BAO_0000019,,,,,14050,,,,,13331,,22224,,U,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",CHEMBL628105,,0,A
Autocuration,BAO_0000019,,,,,14051,,,,,13331,,22224,,U,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",CHEMBL628106,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14052,,,Urine,,10086,1088.0,50597,,N,1,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,CHEMBL628107,,1,A
Autocuration,BAO_0000218,,,,,14053,,,Urine,,10086,1088.0,22224,,U,1,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,CHEMBL628108,,0,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14054,,,Urine,,10086,1088.0,50597,,N,1,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,CHEMBL628109,,1,A
Autocuration,BAO_0000218,,,,,14055,,,Urine,,10086,1088.0,22224,,U,1,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,CHEMBL625299,,0,F
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14056,,,Urine,,10086,1088.0,50597,,N,1,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,CHEMBL625300,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14057,,,Urine,,10086,1088.0,50597,,N,1,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,CHEMBL625301,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14058,,,Urine,,10086,1088.0,50597,,N,1,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,CHEMBL625302,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14059,,,Urine,,10086,1088.0,50597,,N,1,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,CHEMBL874649,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14060,,,,,13248,,50597,,N,1,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,CHEMBL625303,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14061,,,,,13248,,50597,,N,1,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,CHEMBL625463,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,14062,,,Liver,,14527,2107.0,50587,,N,1,,In vitro metabolism in human liver microsomes,CHEMBL625464,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,14063,,,,,3008,,50587,,N,1,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,CHEMBL625465,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14064,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,CHEMBL625466,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14065,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,CHEMBL625467,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14066,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,CHEMBL625468,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14067,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,CHEMBL625469,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14068,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,CHEMBL625470,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14069,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,CHEMBL632418,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14070,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,CHEMBL627250,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14071,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,CHEMBL627251,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14072,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,CHEMBL627252,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14073,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,CHEMBL627253,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14074,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,CHEMBL627254,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14075,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,CHEMBL875471,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14076,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,CHEMBL627255,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14077,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,CHEMBL627256,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14078,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,CHEMBL627257,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14079,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,CHEMBL627258,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14080,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,CHEMBL627259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14081,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,CHEMBL627260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14082,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,CHEMBL623256,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14083,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,CHEMBL874413,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14084,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,CHEMBL623257,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14085,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,CHEMBL623258,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14086,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,CHEMBL623259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14087,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,CHEMBL623260,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14088,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,CHEMBL623261,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14089,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,CHEMBL623262,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14090,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,CHEMBL623263,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14091,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,CHEMBL623264,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14092,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,CHEMBL623265,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14093,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,CHEMBL623266,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14094,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,CHEMBL623267,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14095,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,CHEMBL623268,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14096,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,CHEMBL623269,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14097,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,CHEMBL623270,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14098,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,CHEMBL623271,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14099,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,CHEMBL623272,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14100,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,CHEMBL623273,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14101,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,CHEMBL623274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14102,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,CHEMBL874414,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14103,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,CHEMBL623275,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14104,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,CHEMBL629150,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14105,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,CHEMBL623276,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14106,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,CHEMBL623277,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14107,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,CHEMBL623112,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14108,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,CHEMBL623113,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14109,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,CHEMBL623800,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14110,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,CHEMBL623801,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14111,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL623802,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14112,In vivo,,Uterus,,12017,995.0,50597,,N,1,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623803,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14113,In vivo,,Uterus,,12017,995.0,50597,,N,1,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623970,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14114,In vivo,,Uterus,,12017,995.0,50597,,N,1,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623971,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14115,In vivo,,Blood,,14045,178.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),CHEMBL623972,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14116,In vivo,,Blood,,14045,178.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),CHEMBL623973,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14117,In vivo,,Blood,,14045,178.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),CHEMBL623974,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14118,In vivo,,Blood,,14045,178.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),CHEMBL623975,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14119,In vivo,,Brain,,14045,955.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),CHEMBL623976,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14120,In vivo,,Brain,,14045,955.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),CHEMBL623977,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14121,In vivo,,Brain,,14045,955.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),CHEMBL623978,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14122,In vivo,,Brain,,14045,955.0,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),CHEMBL623979,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14123,In vivo,,,,14045,,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),CHEMBL623980,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14124,In vivo,,,,14045,,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),CHEMBL623981,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14125,In vivo,,,,14045,,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),CHEMBL626278,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14126,In vivo,,,,14045,,50597,,N,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),CHEMBL626279,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14127,In vivo,,,,14045,,50594,,N,1,,Biodistribution in mice bladder plus excreted urine was determined,CHEMBL626280,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14128,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse blood, 10 minutes post injection",CHEMBL626281,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14129,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse blood, 30 minutes post injection",CHEMBL626282,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14130,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse blood, 5 minutes post injection",CHEMBL626283,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14131,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse blood, 60 minutes post injection",CHEMBL626284,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14132,,,Brain,,14045,955.0,50594,,N,1,,"Percentage biodistribution in mouse brain, 10 minutes post injection",CHEMBL626285,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14133,,,Brain,,14045,955.0,50594,,N,1,,"Percentage biodistribution in mouse brain, 30 minutes post injection",CHEMBL626286,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14134,,,Brain,,14045,955.0,50594,,N,1,,"Percentage biodistribution in mouse brain, 5 minutes post injection",CHEMBL626287,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14135,,,Brain,,14045,955.0,50594,,N,1,,"Percentage biodistribution in mouse brain, 60 minutes post injection",CHEMBL626288,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14136,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse heart, 10 minutes post injection",CHEMBL626289,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14137,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse heart, 30 minutes post injection",CHEMBL626290,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14138,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse heart, 5 minutes post injection",CHEMBL626291,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14139,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse heart, 60 minutes post injection",CHEMBL839888,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14140,,,Intestine,,14045,160.0,50594,,N,1,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",CHEMBL626292,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14141,,,Intestine,,14045,160.0,50594,,N,1,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",CHEMBL626293,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14142,,,Intestine,,14045,160.0,50594,,N,1,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",CHEMBL626294,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14143,,,Intestine,,14045,160.0,50594,,N,1,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",CHEMBL626295,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14144,,,Liver,,14045,2107.0,50594,,N,1,,"Percentage biodistribution in mouse liver, 10 minutes post injection",CHEMBL627659,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14145,,,Liver,,14045,2107.0,50594,,N,1,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",CHEMBL627660,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14146,,,Liver,,14045,2107.0,50594,,N,1,,"Percentage biodistribution in mouse liver, 5 minutes post injection",CHEMBL627661,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14147,In vivo,,Liver,,14045,2107.0,50594,,N,1,,Biodistribution in mice liver at 60 minutes of post injection,CHEMBL627662,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14148,In vivo,,Lung,,14045,2048.0,50594,,N,1,,Biodistribution in mice lungs at 10 min of post injection,CHEMBL627663,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14149,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mouse lung, 30 minutes post injection",CHEMBL627664,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14150,,,,,14045,,50594,,N,1,,"Percentage biodistribution in mousee lung, 5 minutes post injection",CHEMBL627665,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14151,In vivo,,Lung,,14045,2048.0,50594,,N,1,,Biodistribution in mice lungs at 60 min of post injection,CHEMBL627666,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14152,,,Spleen,,14045,2106.0,50594,,N,1,,Percentage biodistribution in mouse spleen,CHEMBL627667,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14153,,,Stomach,,14045,945.0,50594,,N,1,,Percentage biodistribution in mouse stomach,CHEMBL627668,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14154,,,Urine,,11745,1088.0,50594,,N,1,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,CHEMBL627669,,1,A
Autocuration,BAO_0000218,,,,,14155,In vivo,,Urinary bladder,,13257,1255.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,CHEMBL627670,,0,A
Autocuration,BAO_0000218,,,,,14156,In vivo,,Blood,,13257,178.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,CHEMBL627671,,0,A
Autocuration,BAO_0000218,,,,,14157,In vivo,,Bone element,,13257,1474.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,CHEMBL627672,,0,A
Autocuration,BAO_0000218,,,,,14158,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,CHEMBL627673,,0,A
Autocuration,BAO_0000218,,,,,14159,In vivo,,Kidney,,13257,2113.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,CHEMBL627674,,0,A
Autocuration,BAO_0000218,,,,,14160,In vivo,,Liver,,13257,2107.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,CHEMBL627675,,0,A
Autocuration,BAO_0000218,,,,,14161,In vivo,,Lung,,13257,2048.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,CHEMBL627676,,0,A
Autocuration,BAO_0000218,,,,,14162,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,CHEMBL627677,,0,A
Autocuration,BAO_0000019,,,,,14163,,,,,8354,,22224,,U,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",CHEMBL627678,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14164,,,Serum,,7095,1977.0,50597,,N,1,,Affinity for protein binding expressed as association constant in fresh rat serum,CHEMBL627679,,1,A
Autocuration,BAO_0000019,,,,,14165,,,,,12185,,22224,,U,1,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,CHEMBL627680,,0,A
Autocuration,BAO_0000019,,,,,14166,,,,,12185,,22224,,U,1,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,CHEMBL627681,,0,A
Autocuration,BAO_0000019,,,,,14167,,,,,12185,,22224,,U,1,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,CHEMBL627682,,0,A
Autocuration,BAO_0000019,,,,,14168,,,,,12185,,22224,,U,1,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,CHEMBL627683,,0,A
Autocuration,BAO_0000019,,,,,14169,,,,,12686,,22224,,U,1,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,CHEMBL627684,,0,A
Autocuration,BAO_0000019,,,,,14170,,,,,12686,,22224,,U,1,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",CHEMBL874441,,0,A
Autocuration,BAO_0000019,,,,,14171,,,,,12686,,22224,,U,1,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,CHEMBL627685,,0,A
Autocuration,BAO_0000019,,,,,14172,,,,,12686,,22224,,U,1,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",CHEMBL627686,,0,A
Autocuration,BAO_0000019,,,,,14173,,,,,8057,,22224,,U,1,,Apparent rate constant Koff for inactivation of dTMP synthase.,CHEMBL627687,,0,A
Autocuration,BAO_0000019,,,,,14174,,,,,15778,,22224,,U,1,,The irreversible inhibitor activity by second order rate equation.,CHEMBL627688,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14175,,,,,12375,,50597,,N,1,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,CHEMBL628038,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14176,,,,,12375,,50597,,N,1,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,CHEMBL628039,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14177,,,,,12375,,50597,,N,1,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,CHEMBL628040,,1,A
Autocuration,BAO_0000019,,,,,14178,,,,,13588,,22224,,U,1,,Dissociation rate calculated from the first-order equation using t1/2 value,CHEMBL628041,,0,A
Autocuration,BAO_0000019,,,,,14179,,,,,15039,,22224,,U,1,,The compound was tested for Binding constant against DNA,CHEMBL630226,,0,A
Autocuration,BAO_0000019,,,,,14180,,,,,9500,,22224,,U,1,,First order rate constant for cyclization of the compound,CHEMBL628042,,0,A
Autocuration,BAO_0000019,,,,,14181,,,,,10014,,22224,,U,1,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,CHEMBL625232,,0,A
Autocuration,BAO_0000019,,,,,14182,,,,,10014,,22224,,U,1,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,CHEMBL625233,,0,A
Autocuration,BAO_0000019,,,,,14183,,,,,568,,22224,,U,1,,Hydrolysis rate constant was determined,CHEMBL625979,,0,A
Autocuration,BAO_0000019,,,,,14184,,,,,10026,,22224,,U,1,,Observed first order rate constant,CHEMBL625980,,0,A
Autocuration,BAO_0000019,,,,,14185,,,,,10281,,22224,,U,1,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,CHEMBL625981,,0,A
Autocuration,BAO_0000019,,,,,14186,,,,,10281,,22224,,U,1,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,CHEMBL625982,,0,A
Autocuration,BAO_0000019,,,,,14187,,,,,9680,,22224,,U,1,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,CHEMBL625983,,0,A
Autocuration,BAO_0000019,,,,,14188,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625984,,0,A
Autocuration,BAO_0000019,,,,,14189,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625985,,0,A
Autocuration,BAO_0000019,,,,,14190,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625986,,0,A
Autocuration,BAO_0000019,,,,,14191,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625987,,0,A
Autocuration,BAO_0000019,,,,,14192,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625988,,0,A
Autocuration,BAO_0000019,,,,,14193,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625989,,0,A
Autocuration,BAO_0000019,,,,,14194,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625990,,0,A
Autocuration,BAO_0000019,,,,,14195,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625991,,0,A
Autocuration,BAO_0000019,,,,,14196,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625992,,0,A
Autocuration,BAO_0000019,,,,,14197,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625993,,0,A
Autocuration,BAO_0000019,,,,,14198,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL631973,,0,A
Autocuration,BAO_0000019,,,,,14199,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632143,,0,A
Autocuration,BAO_0000019,,,,,14200,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632144,,0,A
Autocuration,BAO_0000019,,,,,14201,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632145,,0,A
Autocuration,BAO_0000019,,,,,14202,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632146,,0,A
Autocuration,BAO_0000019,,,,,14203,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632147,,0,A
Autocuration,BAO_0000019,,,,,14204,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632148,,0,A
Autocuration,BAO_0000019,,,,,14205,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632149,,0,A
Autocuration,BAO_0000019,,,,,14206,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632150,,0,A
Autocuration,BAO_0000019,,,,,14207,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632151,,0,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,14208,,,,,3008,,50587,,N,1,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,CHEMBL632152,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,14209,,,,,4509,,50587,,N,1,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,CHEMBL632153,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,14210,,,,,4509,,50587,,N,1,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,CHEMBL632154,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14211,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,CHEMBL632155,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14212,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,CHEMBL632156,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14213,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,CHEMBL632157,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14214,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,CHEMBL632158,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14215,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,CHEMBL632159,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14216,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,CHEMBL626305,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14217,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,CHEMBL626306,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14218,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,CHEMBL626307,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14219,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,CHEMBL626308,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14220,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,CHEMBL626479,,1,A
Intermediate,BAO_0000218,,10298.0,,Human herpesvirus 1,14221,,,,,8613,,50602,,N,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,CHEMBL626480,,1,A
Autocuration,BAO_0000100,,,,,14222,,,,,6021,,22229,,U,1,,Calculated partition coefficient (clogP) (MlogP),CHEMBL626481,,0,P
Autocuration,BAO_0000019,,,,,14223,,,,,9348,,22224,,U,1,,Equipotent potent ratio relative to carbachol (nicotinic activity),CHEMBL626482,,0,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14224,,,,,15592,,50588,,N,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",CHEMBL626483,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14225,,,,,15592,,50588,,N,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",CHEMBL626484,,1,A
Autocuration,BAO_0000100,,,,,14226,,,,,15592,,22229,,U,1,,Solubility at pH 7.4 in micro g/mL;NA denotes available,CHEMBL626485,,0,P
Autocuration,BAO_0000100,,,,,14227,,,,,15592,,22229,,U,1,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,CHEMBL626486,,0,P
Autocuration,BAO_0000100,,,,,14228,,,,,15592,,22229,,U,1,,Solubility at pH 7.4 in ug/mL;NA denotes not available,CHEMBL626487,,0,P
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14229,In vivo,,Plasma,,15592,1969.0,50588,,N,1,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,CHEMBL626488,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14230,,,Serum,,7095,1977.0,50597,,N,1,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,CHEMBL626489,,1,A
Autocuration,BAO_0000019,,,,,14231,,,,,16618,,22224,,U,1,,Area under the MAP curve measured over 5 min; ND means Not determined,CHEMBL626490,,0,A
Autocuration,BAO_0000100,,,,,14232,,,,,16835,,22224,,U,1,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,CHEMBL626491,,0,P
Autocuration,BAO_0000100,,,,,14233,,,,,15284,,22229,,U,1,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,CHEMBL626492,,0,P
Autocuration,BAO_0000019,,,,,14234,,,,,15750,,22224,,U,1,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,CHEMBL626493,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14235,In vivo,,,,16618,,50597,,N,1,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,CHEMBL626494,,1,A
Autocuration,BAO_0000218,,,,,14236,In vivo,,,,16618,,22224,,U,1,,Half life after oral tested,CHEMBL626495,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14237,,,Plasma,,15812,1969.0,50597,,N,1,,Half life was determined in plasma of rat; NT indicates not tested,CHEMBL626496,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14238,In vivo,,,,16618,,50597,,N,1,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,CHEMBL626497,,1,A
Autocuration,BAO_0000218,,,,,14239,In vivo,,,,16618,,22224,,U,1,,Oral bioavailability after oral tested,CHEMBL626498,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14240,,,,,13098,,50597,,N,1,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),CHEMBL626499,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14241,,,,,13098,,50597,,N,1,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),CHEMBL626500,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14242,,,Plasma,,15812,1969.0,50597,,N,1,,half life was determined in plasma of rat; NT indicates not tested,CHEMBL626501,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14243,,,Plasma,,15812,1969.0,50597,,N,1,,half life was determined in plasma of rat; NT means not tested,CHEMBL626502,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14244,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,CHEMBL626503,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14245,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,CHEMBL626504,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14246,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,CHEMBL626505,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14247,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,CHEMBL626506,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14248,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,CHEMBL626507,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14249,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,CHEMBL626508,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14250,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,CHEMBL626509,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14251,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,CHEMBL875480,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14252,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,CHEMBL626510,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14253,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,CHEMBL626511,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14254,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,CHEMBL626512,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14255,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,CHEMBL628208,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14256,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,CHEMBL628209,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14257,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,CHEMBL628210,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14258,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,CHEMBL628211,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14259,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,CHEMBL628212,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14260,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,CHEMBL628213,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14261,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,CHEMBL628214,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14262,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,CHEMBL628215,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14263,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,CHEMBL628216,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14264,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,CHEMBL626595,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14265,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,CHEMBL626596,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14266,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,CHEMBL626597,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14267,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,CHEMBL626598,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14268,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,CHEMBL622242,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14269,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,CHEMBL622243,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14270,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,CHEMBL622244,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14271,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,CHEMBL622245,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14272,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,CHEMBL622246,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14273,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,CHEMBL622247,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14274,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,CHEMBL622248,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14275,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,CHEMBL877483,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14276,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,CHEMBL622249,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14277,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,CHEMBL622250,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14278,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,CHEMBL622251,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14279,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,CHEMBL622252,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14280,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,CHEMBL622253,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14281,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,CHEMBL622254,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14282,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,CHEMBL622255,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14283,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,CHEMBL622256,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14284,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,CHEMBL622257,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14285,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,CHEMBL622258,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14286,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,CHEMBL622259,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14287,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,CHEMBL622927,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14288,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,CHEMBL622928,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14289,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,CHEMBL622929,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14290,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,CHEMBL623182,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14291,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,CHEMBL623183,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14292,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,CHEMBL623184,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14293,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,CHEMBL623185,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14294,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,CHEMBL877484,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14295,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,CHEMBL627274,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14296,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,CHEMBL623186,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14297,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,CHEMBL623187,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14298,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,CHEMBL623188,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14299,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,CHEMBL628055,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14300,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,CHEMBL628056,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14301,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,CHEMBL628200,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14302,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,CHEMBL628201,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14303,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,CHEMBL628202,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14304,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,CHEMBL628203,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14305,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,CHEMBL628204,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14306,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,CHEMBL628205,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14307,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,CHEMBL628206,,1,A
Autocuration,BAO_0000218,,,,,14308,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),CHEMBL628207,,0,A
Autocuration,BAO_0000218,,,,,14309,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,CHEMBL627220,,0,A
Autocuration,BAO_0000218,,,,,14310,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,CHEMBL627221,,0,A
Autocuration,BAO_0000218,,,,,14311,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),CHEMBL627222,,0,A
Autocuration,BAO_0000218,,,,,14312,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,CHEMBL627223,,0,A
Autocuration,BAO_0000218,,,,,14313,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,CHEMBL632062,,0,A
Autocuration,BAO_0000218,,,,,14314,In vivo,,Spleen,,13257,2106.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,CHEMBL632063,,0,A
Autocuration,BAO_0000218,,,,,14315,In vivo,,Urinary bladder,,13257,1255.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,CHEMBL632064,,0,A
Autocuration,BAO_0000218,,,,,14316,In vivo,,Blood,,13257,178.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,CHEMBL632065,,0,A
Autocuration,BAO_0000218,,,,,14317,In vivo,,Bone element,,13257,1474.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,CHEMBL632066,,0,A
Autocuration,BAO_0000218,,,,,14318,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,CHEMBL632067,,0,A
Autocuration,BAO_0000218,,,,,14319,In vivo,,Kidney,,13257,2113.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,CHEMBL629188,,0,A
Autocuration,BAO_0000218,,,,,14320,In vivo,,Liver,,13257,2107.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,CHEMBL629189,,0,A
Autocuration,BAO_0000218,,,,,14321,In vivo,,Lung,,13257,2048.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,CHEMBL629190,,0,A
Autocuration,BAO_0000218,,,,,14322,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,CHEMBL629191,,0,A
Autocuration,BAO_0000218,,,,,14323,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),CHEMBL629192,,0,A
Autocuration,BAO_0000218,,,,,14324,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,CHEMBL629193,,0,A
Autocuration,BAO_0000218,,,,,14325,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),CHEMBL629194,,0,A
Autocuration,BAO_0000218,,,,,14326,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,CHEMBL629195,,0,A
Autocuration,BAO_0000218,,,,,14327,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,CHEMBL629373,,0,A
Autocuration,BAO_0000218,,,,,14328,In vivo,,Spleen,,13257,2106.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,CHEMBL629374,,0,A
Autocuration,BAO_0000218,,,,,14329,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,CHEMBL629375,,0,A
Autocuration,BAO_0000218,,,,,14330,In vivo,,Urinary bladder,,13257,1255.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,CHEMBL629376,,0,A
Autocuration,BAO_0000218,,,,,14331,In vivo,,Blood,,13257,178.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,CHEMBL629377,,0,A
Autocuration,BAO_0000218,,,,,14332,In vivo,,Bone element,,13257,1474.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,CHEMBL629378,,0,A
Autocuration,BAO_0000218,,,,,14333,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,CHEMBL629379,,0,A
Autocuration,BAO_0000218,,,,,14334,In vivo,,Kidney,,13257,2113.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,CHEMBL629151,,0,A
Autocuration,BAO_0000218,,,,,14335,In vivo,,Liver,,13257,2107.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,CHEMBL629152,,0,A
Autocuration,BAO_0000218,,,,,14336,In vivo,,Lung,,13257,2048.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,CHEMBL629153,,0,A
Autocuration,BAO_0000218,,,,,14337,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,CHEMBL629154,,0,A
Autocuration,BAO_0000218,,,,,14338,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),CHEMBL629155,,0,A
Autocuration,BAO_0000218,,,,,14339,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,CHEMBL629156,,0,A
Autocuration,BAO_0000218,,,,,14340,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,CHEMBL629157,,0,A
Autocuration,BAO_0000218,,,,,14341,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),CHEMBL629158,,0,A
Autocuration,BAO_0000218,,,,,14342,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,CHEMBL629159,,0,A
Autocuration,BAO_0000218,,,,,14343,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,CHEMBL629160,,0,A
Autocuration,BAO_0000218,,,,,14344,In vivo,,Spleen,,13257,2106.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,CHEMBL629161,,0,A
Autocuration,BAO_0000218,,,,,14345,In vivo,,Urinary bladder,,13257,1255.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,CHEMBL629162,,0,A
Autocuration,BAO_0000218,,,,,14346,In vivo,,Blood,,13257,178.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,CHEMBL629163,,0,A
Autocuration,BAO_0000218,,,,,14347,In vivo,,Bone element,,13257,1474.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,CHEMBL629164,,0,A
Autocuration,BAO_0000218,,,,,14348,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,CHEMBL629165,,0,A
Autocuration,BAO_0000218,,,,,14349,In vivo,,Liver,,13257,2107.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,CHEMBL629166,,0,A
Autocuration,BAO_0000218,,,,,14350,In vivo,,Lung,,13257,2048.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,CHEMBL629167,,0,A
Autocuration,BAO_0000218,,,,,14351,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,CHEMBL629168,,0,A
Autocuration,BAO_0000019,,,,,14352,,,,,2193,,22224,,U,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,CHEMBL629169,,0,A
Autocuration,BAO_0000019,,,,,14353,,,,,2193,,22224,,U,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,CHEMBL629170,,0,A
Autocuration,BAO_0000019,,,,,14354,,,,,2193,,22224,,U,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,CHEMBL631153,,0,A
Autocuration,BAO_0000019,,,,,14355,,,,,2193,,22224,,U,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,CHEMBL875121,,0,A
Autocuration,BAO_0000019,,,,,14356,,,,,2193,,22224,,U,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,CHEMBL631154,,0,A
Autocuration,BAO_0000019,,,,,14357,,,,,2193,,22224,,U,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,CHEMBL631155,,0,A
Autocuration,BAO_0000019,,,,,14358,,,,,568,,22224,,U,1,,Hydrolysis rate constant was determined,CHEMBL631156,,0,A
Autocuration,BAO_0000019,,,,,14359,,,,,9680,,22224,,U,1,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",CHEMBL631157,,0,A
Autocuration,BAO_0000019,,,,,14360,,,,,9680,,22224,,U,1,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",CHEMBL631158,,0,A
Autocuration,BAO_0000019,,,,,14361,,,,,9680,,22224,,U,1,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",CHEMBL631159,,0,A
Autocuration,BAO_0000019,,,,,14362,,,,,10026,,22224,,U,1,,Observed second order rate constant,CHEMBL631160,,0,A
Autocuration,BAO_0000019,,,,,14363,,,,,10281,,22224,,U,1,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,CHEMBL631161,,0,A
Autocuration,BAO_0000019,,,,,14364,,,,,10014,,22224,,U,1,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,CHEMBL631162,,0,A
Autocuration,BAO_0000019,,,,,14365,,,,,10014,,22224,,U,1,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,CHEMBL630313,,0,A
Autocuration,BAO_0000019,,,,,14366,,,,,9680,,22224,,U,1,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",CHEMBL630314,,0,A
Autocuration,BAO_0000019,,,,,14367,,,,,9680,,22224,,U,1,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",CHEMBL630315,,0,A
Autocuration,BAO_0000019,,,,,14368,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630316,,0,A
Autocuration,BAO_0000019,,,,,14369,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630986,,0,A
Autocuration,BAO_0000019,,,,,14370,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630987,,0,A
Autocuration,BAO_0000019,,,,,14371,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630988,,0,A
Autocuration,BAO_0000019,,,,,14372,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630989,,0,A
Autocuration,BAO_0000019,,,,,14373,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630990,,0,A
Autocuration,BAO_0000019,,,,,14374,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630991,,0,A
Autocuration,BAO_0000019,,,,,14375,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630992,,0,A
Autocuration,BAO_0000019,,,,,14376,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630993,,0,A
Autocuration,BAO_0000019,,,,,14377,,,,,13028,,22224,,U,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630994,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14378,,,,,10014,,50597,,N,1,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,CHEMBL630995,,1,A
Autocuration,BAO_0000019,,,,,14379,,,,,9962,,22224,,U,1,,Association constant for compound at 31 degree C was determined,CHEMBL629252,,0,A
Autocuration,BAO_0000019,,,,,14380,,,,,12029,,22224,,U,1,,Calculated antagonist equilibrium dissociation constant of the compound,CHEMBL629253,,0,A
Autocuration,BAO_0000019,,,,,14381,,,,,12029,,22224,,U,1,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,CHEMBL629944,,0,A
Intermediate,BAO_0000218,,10141.0,,Cavia porcellus,14382,,,Trachea,,10583,3126.0,50512,,N,1,,Dissociation constants vs LTE4 on guinea pig trachea,CHEMBL629945,,1,A
Autocuration,BAO_0000019,,,,,14383,,,,,568,,22224,,U,1,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",CHEMBL629946,,0,A
Autocuration,BAO_0000019,,,,,14384,,,,,568,,22224,,U,1,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",CHEMBL629947,,0,A
Autocuration,BAO_0000019,,,,,14385,,,,,568,,22224,,U,1,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",CHEMBL629948,,0,A
Autocuration,BAO_0000019,,,,,14386,,,,,568,,22224,,U,1,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",CHEMBL856024,,0,A
Autocuration,BAO_0000019,,,,,14387,,,,,7493,,22224,,U,1,,Affinity constant KD value was derived from TMP,CHEMBL629949,,0,A
Autocuration,BAO_0000019,,,,,14388,,,,,8371,,22224,,U,1,,Apparent dissociation (binding) rate constant was evaluated,CHEMBL629950,,0,A
Autocuration,BAO_0000100,,,,,14389,,,,,13114,,22224,,U,1,,Dissociation constant (KD) of the compound,CHEMBL630127,,0,P
Autocuration,BAO_0000100,,,,,14390,,,,,15515,,22224,,U,1,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,CHEMBL630128,,0,P
Autocuration,BAO_0000100,,,,,14391,,,,,522,,22224,,U,1,,Dissociation constant from ESR titration experiments,CHEMBL630129,,0,P
Autocuration,BAO_0000019,,,,,14392,,,,,13888,,22224,,U,1,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),CHEMBL630130,,0,
Autocuration,BAO_0000100,,,,,14393,,,,,2616,,22224,,U,1,,Dissociation constant was evaluated.,CHEMBL875234,,0,P
Autocuration,BAO_0000100,,,,,14394,,,,,3798,,22224,,U,1,,Dissociation constant was reported,CHEMBL630131,,0,P
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14395,,,,,8731,,50597,,N,1,,Dissociation constant was determined in rat pituitary cells.,CHEMBL630132,,1,A
Autocuration,BAO_0000019,,,,,14396,,,,,11892,,22224,,U,1,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,CHEMBL630133,,0,A
Autocuration,BAO_0000019,,,,,14397,,,,,11892,,22224,,U,1,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,CHEMBL630134,,0,A
Autocuration,BAO_0000019,,,,,14398,,,,,2582,,22224,,U,1,,Equilibrium dissociation constant of the compound,CHEMBL630135,,0,A
Autocuration,BAO_0000019,,,,,14399,,,,,11892,,22224,,U,1,,Equilibrium dissociation constant was determined,CHEMBL630136,,0,A
Autocuration,BAO_0000019,,,,,14400,,,,,13396,,22224,,U,1,,Kinetic constant KD was evaluated,CHEMBL630137,,0,A
Autocuration,BAO_0000019,,,,,14401,,,,,603,,22224,,U,1,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,CHEMBL630138,,0,A
Autocuration,BAO_0000019,,,,,14402,,,,,15673,,22224,,U,1,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,CHEMBL630139,,0,A
Autocuration,BAO_0000019,,,,,14403,,,,,10368,,22224,,U,1,,Rate constant for hydrolysis in aqueous acetone.,CHEMBL630140,,0,A
Autocuration,BAO_0000019,,,,,14404,,,,,14228,,22224,,U,1,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,CHEMBL875235,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14405,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,CHEMBL876439,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14406,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,CHEMBL630605,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14407,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,CHEMBL630606,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14408,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,CHEMBL630607,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14409,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,CHEMBL630608,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14410,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,CHEMBL630609,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14411,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,CHEMBL630610,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14412,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,CHEMBL630611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14413,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,CHEMBL629552,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14414,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,CHEMBL629733,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14415,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,CHEMBL629734,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14416,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,CHEMBL629735,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14417,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,CHEMBL629736,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14418,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,CHEMBL629737,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14419,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,CHEMBL629738,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14420,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,CHEMBL629739,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14421,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,CHEMBL629740,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14422,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,CHEMBL629741,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14423,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,CHEMBL629742,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14424,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,CHEMBL629743,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14425,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,CHEMBL629744,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14426,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,CHEMBL629745,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14427,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,CHEMBL629746,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14428,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,CHEMBL629747,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14429,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,CHEMBL629748,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14430,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,CHEMBL629749,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14431,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,CHEMBL629750,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14432,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,CHEMBL629751,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14433,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,CHEMBL629752,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14434,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,CHEMBL629753,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14435,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,CHEMBL629754,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14436,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,CHEMBL629755,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14437,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,CHEMBL629756,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14438,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,CHEMBL629757,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14439,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,CHEMBL629758,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14440,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,CHEMBL629759,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14441,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,CHEMBL629760,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14442,,,,,11510,,50597,,N,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,CHEMBL876443,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14443,,,,,8310,,50588,,N,1,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,CHEMBL629761,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14444,,,,,8310,,50588,,N,1,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,CHEMBL629762,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14445,,,,,8310,,50594,,N,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629763,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14446,,,,,8310,,50594,,N,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,CHEMBL629764,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14447,,,,,8310,,50594,,N,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,CHEMBL629765,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14448,,,,,8310,,50594,,N,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,CHEMBL629766,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14449,,,,,8310,,50594,,N,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629767,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14450,,,,,8310,,50588,,N,1,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,CHEMBL629768,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14451,,,,,8310,,50594,,N,1,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,CHEMBL629769,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14452,,,,,8310,,50588,,N,1,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,CHEMBL629770,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14453,,,,,8310,,50588,,N,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,CHEMBL629771,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14454,,,,,8310,,50594,,N,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629772,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14455,,,,,8310,,50594,,N,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629773,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14456,,,,,8310,,50594,,N,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,CHEMBL625455,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14457,,,,,8310,,50594,,N,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,CHEMBL625456,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14458,,,,,8310,,50594,,N,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,CHEMBL625457,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14459,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,CHEMBL625458,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14460,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,CHEMBL625459,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14461,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,CHEMBL875483,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14462,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,CHEMBL634779,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14463,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,CHEMBL625460,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14464,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,CHEMBL626117,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14465,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,CHEMBL626118,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14466,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,CHEMBL628342,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14467,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,CHEMBL628343,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14468,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,CHEMBL628344,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14469,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,CHEMBL628345,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14470,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,CHEMBL628346,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14471,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,CHEMBL628347,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14472,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,CHEMBL628348,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14473,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,CHEMBL628349,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14474,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,CHEMBL875611,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14475,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,CHEMBL628350,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14476,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,CHEMBL628351,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14477,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,CHEMBL628352,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14478,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,CHEMBL628353,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14479,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,CHEMBL628354,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14480,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,CHEMBL626667,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14481,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,CHEMBL626668,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14482,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,CHEMBL626669,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14483,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,CHEMBL626670,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14484,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,CHEMBL626671,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14485,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,CHEMBL626672,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14486,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,CHEMBL626673,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14487,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,CHEMBL626674,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14488,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,CHEMBL626675,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14489,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,CHEMBL626676,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14490,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,CHEMBL626677,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14491,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,CHEMBL626678,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14492,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,CHEMBL626679,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14493,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,CHEMBL875612,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14494,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,CHEMBL626680,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14495,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,CHEMBL626681,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14496,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,CHEMBL626682,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14497,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,CHEMBL626683,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14498,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,CHEMBL626684,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14499,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,CHEMBL626685,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14500,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,CHEMBL626686,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14501,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,CHEMBL626687,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14502,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,CHEMBL624978,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14503,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,CHEMBL624979,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14504,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,CHEMBL624980,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14505,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,CHEMBL624981,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14506,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,CHEMBL624982,,1,A
Autocuration,BAO_0000218,,,,,14507,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),CHEMBL627564,,0,A
Autocuration,BAO_0000218,,,,,14508,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),CHEMBL627565,,0,A
Autocuration,BAO_0000218,,,,,14509,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,CHEMBL627566,,0,A
Autocuration,BAO_0000218,,,,,14510,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,CHEMBL627567,,0,A
Autocuration,BAO_0000218,,,,,14511,In vivo,,Spleen,,13257,2106.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,CHEMBL627568,,0,A
Autocuration,BAO_0000218,,,,,14512,In vivo,,Kidney,,13257,2113.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,CHEMBL627569,,0,A
Autocuration,BAO_0000218,,,,,14513,In vivo,,Urinary bladder,,13257,1255.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,CHEMBL627570,,0,A
Autocuration,BAO_0000218,,,,,14514,In vivo,,Blood,,13257,178.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,CHEMBL627571,,0,A
Autocuration,BAO_0000218,,,,,14515,In vivo,,Bone element,,13257,1474.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,CHEMBL627572,,0,A
Autocuration,BAO_0000218,,,,,14516,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,CHEMBL627573,,0,A
Autocuration,BAO_0000218,,,,,14517,In vivo,,Kidney,,13257,2113.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,CHEMBL627574,,0,A
Autocuration,BAO_0000218,,,,,14518,In vivo,,Liver,,13257,2107.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,CHEMBL627575,,0,A
Autocuration,BAO_0000218,,,,,14519,In vivo,,Lung,,13257,2048.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,CHEMBL627576,,0,A
Autocuration,BAO_0000218,,,,,14520,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,CHEMBL627577,,0,A
Autocuration,BAO_0000218,,,,,14521,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),CHEMBL627578,,0,A
Autocuration,BAO_0000218,,,,,14522,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,CHEMBL627579,,0,A
Autocuration,BAO_0000218,,,,,14523,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,CHEMBL627580,,0,A
Autocuration,BAO_0000218,,,,,14524,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),CHEMBL627581,,0,A
Autocuration,BAO_0000218,,,,,14525,In vivo,,,,13257,,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,CHEMBL627582,,0,A
Autocuration,BAO_0000218,,,,,14526,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,CHEMBL627583,,0,A
Autocuration,BAO_0000218,,,,,14527,In vivo,,Spleen,,13257,2106.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,CHEMBL627584,,0,A
Autocuration,BAO_0000218,,,,,14528,In vivo,,Prostate gland,,13257,2367.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,CHEMBL627585,,0,A
Autocuration,BAO_0000218,,,,,14529,In vivo,,Muscle tissue,,13257,2385.0,22224,,U,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,CHEMBL627586,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14530,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL627587,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14531,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL627588,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14532,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL628250,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14533,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628251,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14534,In vivo,,Hippocampus,,15413,10000000.0,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL628252,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14535,In vivo,,Hippocampus,,15413,10000000.0,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628253,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14536,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL628254,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14537,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL877493,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14538,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628255,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14539,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628256,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14540,In vivo,,Hippocampus,,15413,10000000.0,50597,,N,1,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628257,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14541,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628258,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14542,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628259,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14543,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628429,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14544,In vivo,,Hippocampus,,15413,10000000.0,50597,,N,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL626862,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14545,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,CHEMBL626863,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14546,In vivo,,Cerebellum,,15413,2037.0,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,CHEMBL625886,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14547,In vivo,,Cerebellum,,15413,2037.0,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,CHEMBL625887,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14548,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,CHEMBL625888,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14549,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,CHEMBL625889,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14550,In vivo,,Hippocampus,,15413,10000000.0,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,CHEMBL625890,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14551,In vivo,,Hippocampus,,15413,10000000.0,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,CHEMBL625891,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14552,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,CHEMBL625892,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14553,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,CHEMBL625893,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14554,In vivo,,Cerebellum,,15413,2037.0,50597,,N,1,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,CHEMBL625894,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14555,In vivo,,,,15413,,50597,,N,1,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,CHEMBL625895,,1,A
Autocuration,BAO_0000019,,,,,14556,,,,,12404,,22224,,U,1,,Reaction rate parameter value for phosphate with transfer with respect to ATP,CHEMBL625896,,0,A
Autocuration,BAO_0000019,,,,,14557,,,,,568,,22224,,U,1,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",CHEMBL625897,,0,A
Autocuration,BAO_0000019,,,,,14558,,,,,568,,22224,,U,1,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",CHEMBL625898,,0,A
Autocuration,BAO_0000019,,,,,14559,,,,,568,,22224,,U,1,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",CHEMBL625899,,0,A
Autocuration,BAO_0000019,,,,,14560,,,,,12404,,22224,,U,1,,Reaction rate parameter value for phosphate with transfer with respect to ATP,CHEMBL626124,,0,A
Intermediate,BAO_0000218,,562.0,,Escherichia coli,14561,,,,,7624,,50212,,N,1,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,CHEMBL628500,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14562,,,,,7624,,50597,,N,1,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",CHEMBL857856,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14563,,,,,7624,,50597,,N,1,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",CHEMBL628501,,1,A
Autocuration,BAO_0000019,,,,,14564,,,,,4643,,22224,,U,1,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",CHEMBL628502,,0,A
Autocuration,BAO_0000019,,,,,14565,,,,,11532,,22224,,U,1,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,CHEMBL628503,,0,A
Autocuration,BAO_0000019,,,,,14566,,,,,11018,,22224,,U,1,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,CHEMBL628504,,0,A
Autocuration,BAO_0000019,,,,,14567,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",CHEMBL628505,,0,A
Autocuration,BAO_0000019,,,,,14568,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",CHEMBL874452,,0,A
Autocuration,BAO_0000019,,,,,14569,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",CHEMBL628506,,0,A
Autocuration,BAO_0000019,,,,,14570,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",CHEMBL628507,,0,A
Autocuration,BAO_0000019,,,,,14571,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",CHEMBL628508,,0,A
Autocuration,BAO_0000019,,,,,14572,,,,,8949,,22224,,U,1,,Michaelis constant (KM) was evaluated,CHEMBL628509,,0,A
Autocuration,BAO_0000019,,,,,14573,,,,,12404,,22224,,U,1,,Reaction rate parameter value for phosphate with transfer with respect to ATP,CHEMBL628510,,0,A
Autocuration,BAO_0000019,,,,,14574,,,,,7625,,22224,,U,1,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,CHEMBL628511,,0,B
Autocuration,BAO_0000019,,,,,14575,,,,,7625,,22224,,U,1,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,CHEMBL628512,,0,B
Autocuration,BAO_0000019,,,,,14576,,,,,7625,,22224,,U,1,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,CHEMBL628513,,0,B
Autocuration,BAO_0000019,,,,,14577,,,,,7625,,22224,,U,1,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,CHEMBL628514,,0,B
Autocuration,BAO_0000019,,,,,14578,,,,,12908,,22224,,U,1,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,CHEMBL628515,,0,A
Autocuration,BAO_0000019,,,,,14579,,,,,10368,,22224,,U,1,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,CHEMBL628516,,0,A
Autocuration,BAO_0000019,,,,,14580,,,,,13108,,22224,,U,1,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),CHEMBL628517,,0,A
Autocuration,BAO_0000019,,,,,14581,,,,,13108,,22224,,U,1,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),CHEMBL628518,,0,A
Autocuration,BAO_0000019,,,,,14582,,,,,15217,,22224,,U,1,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,CHEMBL628519,,0,A
Autocuration,BAO_0000019,,,,,14583,,,,,15217,,22224,,U,1,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,CHEMBL628520,,0,A
Autocuration,BAO_0000019,,,,,14584,,,,,10933,,22224,,U,1,,Binding constant was determined,CHEMBL628521,,0,A
Autocuration,BAO_0000019,,,,,14585,,,,,2363,,22224,,U,1,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,CHEMBL630443,,0,A
Autocuration,BAO_0000019,,,,,14586,,,,,2363,,22224,,U,1,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,CHEMBL630444,,0,A
Autocuration,BAO_0000019,,,,,14587,,,,,2276,,22224,,U,1,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,CHEMBL857732,,0,A
Autocuration,BAO_0000100,,,,,14588,,,,,14915,,22224,,U,1,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,CHEMBL630445,,0,P
Autocuration,BAO_0000019,,,,,14589,,,,,8847,,22224,,U,1,,Catalytic rate constant of the compound,CHEMBL630446,,0,A
Autocuration,BAO_0000019,,,,,14590,,,,,15357,,22224,,U,1,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,CHEMBL630447,,0,B
Autocuration,BAO_0000019,,,,,14591,,,,,2869,,22224,,U,1,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),CHEMBL630448,,0,A
Autocuration,BAO_0000019,,,,,14592,,,,,3484,,22224,,U,1,,Catalytic rate constant against phospholipase A2 was determined,CHEMBL630449,,0,A
Autocuration,BAO_0000019,,,,,14593,,,,,1373,,22224,,U,1,,"Compound was evaluated for catalytic constant, Kcat",CHEMBL630450,,0,A
Autocuration,BAO_0000019,,,,,14594,,,,,8142,,22224,,U,1,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,CHEMBL630451,,0,A
Autocuration,BAO_0000019,,,,,14595,,,,,14131,,22224,,U,1,,Kcat calculated from 0.693/T1/2,CHEMBL630452,,0,A
Autocuration,BAO_0000019,,,,,14596,,,,,17269,,22224,,U,1,,Kcat was determined,CHEMBL630453,,0,A
Autocuration,BAO_0000019,,,,,14597,,,,,3485,,22224,,U,1,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,CHEMBL630454,,0,A
Autocuration,BAO_0000019,,,,,14598,,,,,3485,,22224,,U,1,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,CHEMBL630455,,0,A
Autocuration,BAO_0000019,,,,,14599,,,,,3485,,22224,,U,1,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,CHEMBL631487,,0,A
Autocuration,BAO_0000019,,,,,14600,,,,,5962,,22224,,U,1,,Kcat value was determined,CHEMBL631488,,0,A
Autocuration,BAO_0000019,,,,,14601,,,,,3133,,22224,,U,1,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,CHEMBL876440,,0,A
Autocuration,BAO_0000019,,,,,14602,,,,,3133,,22224,,U,1,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,CHEMBL631489,,0,A
Autocuration,BAO_0000019,,,,,14603,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",CHEMBL857742,,0,A
Autocuration,BAO_0000019,,,,,14604,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",CHEMBL631490,,0,A
Autocuration,BAO_0000019,,,,,14605,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",CHEMBL631491,,0,A
Autocuration,BAO_0000019,,,,,14606,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",CHEMBL631492,,0,A
Autocuration,BAO_0000019,,,,,14607,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",CHEMBL631493,,0,A
Autocuration,BAO_0000019,,,,,14608,,,,,4892,,22224,,U,1,,Kinetic parameter for rate of conversion to PABA was determined,CHEMBL631494,,0,A
Autocuration,BAO_0000019,,,,,14609,,,,,3133,,22224,,U,1,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,CHEMBL631495,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14610,,,Feces,,11488,1988.0,50597,,N,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",CHEMBL631496,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14611,,,Urine,,11488,1088.0,50597,,N,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL631497,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14612,,,Urine,,11488,1088.0,50597,,N,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL631498,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14613,,,Urine,,11488,1088.0,50597,,N,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL629776,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14614,,,Urine,,11488,1088.0,50597,,N,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL629777,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14615,,,Urine,,11488,1088.0,50597,,N,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",CHEMBL629778,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14616,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,CHEMBL630456,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14617,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,CHEMBL630457,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14618,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,CHEMBL630458,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14619,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,CHEMBL630459,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14620,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,CHEMBL630460,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14621,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,CHEMBL876550,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14622,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,CHEMBL630461,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14623,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,CHEMBL630462,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14624,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,CHEMBL630463,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14625,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,CHEMBL630464,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14626,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,CHEMBL630465,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14627,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,CHEMBL630466,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14628,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,CHEMBL630467,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14629,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,CHEMBL630633,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14630,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,CHEMBL630634,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14631,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,CHEMBL630635,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14632,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,CHEMBL630636,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14633,,,,,11488,,50597,,N,1,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,CHEMBL630637,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14634,,,Feces,,7132,1988.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",CHEMBL630638,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14635,,,Feces,,7132,1988.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",CHEMBL630639,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14636,,,Feces,,7132,1988.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",CHEMBL630640,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14637,,,Feces,,7132,1988.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",CHEMBL876551,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14638,,,Urine,,7132,1088.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",CHEMBL630641,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14639,,,Urine,,7132,1088.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",CHEMBL630642,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14640,,,Urine,,7132,1088.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",CHEMBL630643,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14641,,,Urine,,7132,1088.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",CHEMBL630644,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14642,,,Urine,,7132,1088.0,50592,,N,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",CHEMBL630645,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14643,,,Feces,,7132,1988.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",CHEMBL625599,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14644,,,Feces,,7132,1988.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",CHEMBL625600,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14645,,,Feces,,7132,1988.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",CHEMBL625601,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14646,,,Feces,,7132,1988.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",CHEMBL625602,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14647,,,Urine,,7132,1088.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",CHEMBL627470,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14648,,,Urine,,7132,1088.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",CHEMBL627471,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14649,,,Urine,,7132,1088.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",CHEMBL627472,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14650,,,Urine,,7132,1088.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",CHEMBL627473,,1,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14651,,,Urine,,7132,1088.0,50592,,N,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",CHEMBL627474,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14652,In vivo,,Blood,,13925,178.0,50597,,N,1,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL627475,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14653,In vivo,,Blood,,13925,178.0,50597,,N,1,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL627476,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14654,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,CHEMBL627477,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14655,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,CHEMBL627478,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14656,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,CHEMBL627479,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14657,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,CHEMBL627480,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14658,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,CHEMBL627481,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14659,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,CHEMBL627482,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14660,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,CHEMBL627483,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14661,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,CHEMBL875636,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14662,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,CHEMBL625764,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14663,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,CHEMBL625765,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14664,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,CHEMBL625766,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14665,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,CHEMBL625767,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14666,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,CHEMBL625768,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14667,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,CHEMBL625769,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14668,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,CHEMBL625770,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14669,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,CHEMBL625771,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14670,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,CHEMBL625772,,1,A
Intermediate,BAO_0000218,,9615.0,,Canis lupus familiaris,14671,,,Urine,,12582,1088.0,50588,,N,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,CHEMBL625773,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14672,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,CHEMBL625774,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14673,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,CHEMBL625775,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14674,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,CHEMBL625776,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14675,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,CHEMBL625777,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14676,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,CHEMBL625778,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14677,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,CHEMBL625779,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14678,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,CHEMBL625780,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14679,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,CHEMBL625781,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14680,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,CHEMBL875637,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14681,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,CHEMBL626473,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14682,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,CHEMBL626474,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14683,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,CHEMBL626475,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14684,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,CHEMBL626476,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14685,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,CHEMBL634397,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14686,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,CHEMBL626477,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14687,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,CHEMBL631069,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14688,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,CHEMBL631070,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14689,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,CHEMBL631071,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14690,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,CHEMBL631072,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14691,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,CHEMBL631073,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14692,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,CHEMBL631074,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14693,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,CHEMBL631075,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14694,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,CHEMBL631725,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14695,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,CHEMBL631726,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14696,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,CHEMBL631727,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14697,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,CHEMBL631728,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14698,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,CHEMBL631729,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14699,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,CHEMBL631730,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14700,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,CHEMBL631731,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14701,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,CHEMBL631910,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14702,In vivo,,Hippocampus,,15413,10000000.0,50597,,N,1,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,CHEMBL631911,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14703,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,CHEMBL631912,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14704,In vivo,,Hypothalamus,,15413,1898.0,50597,,N,1,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,CHEMBL631913,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14705,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631914,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14706,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631915,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14707,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL875778,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14708,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631916,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14709,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631917,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14710,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631918,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14711,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631919,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14712,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631920,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14713,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631921,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14714,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631922,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14715,In vivo,,Blood,,12017,178.0,50597,,N,1,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631923,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14716,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631924,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14717,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630234,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14718,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630235,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14719,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630236,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14720,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630237,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14721,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630238,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14722,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630239,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14723,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630303,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14724,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630304,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14725,In vivo,,,,12017,,50597,,N,1,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630305,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14726,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630306,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14727,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630307,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14728,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630308,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14729,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630309,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14730,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL629309,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14731,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL629993,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14732,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL629994,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14733,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL629995,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14734,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631993,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14735,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631994,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14736,In vivo,,Kidney,,12017,2113.0,50597,,N,1,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631995,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14737,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631996,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14738,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631997,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14739,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631998,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14740,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631999,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14741,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL632000,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14742,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL632001,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14743,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL874424,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14744,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL632002,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14745,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL632003,,1,A
Autocuration,BAO_0000019,,,,,14746,,,,,3133,,22224,,U,1,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,CHEMBL632004,,0,A
Autocuration,BAO_0000019,,,,,14747,,,,,2742,,22224,,U,1,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,CHEMBL632005,,0,A
Autocuration,BAO_0000019,,,,,14748,,,,,2742,,22224,,U,1,,Compound was tested for amidase rate in the presence of N62C screen enzyme,CHEMBL632006,,0,A
Autocuration,BAO_0000019,,,,,14749,,,,,2742,,22224,,U,1,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,CHEMBL632007,,0,A
Autocuration,BAO_0000019,,,,,14750,,,,,2742,,22224,,U,1,,Compound was tested for amidase rate in the presence of S166C screen enzyme,CHEMBL632008,,0,A
Autocuration,BAO_0000019,,,,,14751,,,,,2742,,22224,,U,1,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,CHEMBL632009,,0,A
Autocuration,BAO_0000019,,,,,14752,,,,,2742,,22224,,U,1,,Compound was tested for esterase rate in the presence of N62C screen enzyme,CHEMBL632010,,0,A
Autocuration,BAO_0000019,,,,,14753,,,,,2742,,22224,,U,1,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,CHEMBL857750,,0,A
Autocuration,BAO_0000019,,,,,14754,,,,,2742,,22224,,U,1,,Compound was tested for esterase rate in the presence of S166C screen enzyme,CHEMBL632011,,0,A
Autocuration,BAO_0000019,,,,,14755,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL632012,,0,A
Autocuration,BAO_0000019,,,,,14756,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL632013,,0,A
Autocuration,BAO_0000019,,,,,14757,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",CHEMBL632014,,0,A
Autocuration,BAO_0000019,,,,,14758,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL629622,,0,A
Autocuration,BAO_0000019,,,,,14759,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL629623,,0,A
Autocuration,BAO_0000019,,,,,14760,,,,,2276,,22224,,U,1,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",CHEMBL629624,,0,A
Autocuration,BAO_0000019,,,,,14761,,,,,17269,,22224,,U,1,,Ratio of Kcat to that of Km was determined,CHEMBL629625,,0,A
Autocuration,BAO_0000019,,,,,14762,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",CHEMBL629626,,0,A
Autocuration,BAO_0000019,,,,,14763,,,,,2276,,22224,,U,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",CHEMBL629627,,0,A
Autocuration,BAO_0000019,,,,,14764,,,,,15917,,22224,,U,1,,"Compound was evaluated for constant, Kd",CHEMBL629628,,0,A
Autocuration,BAO_0000019,,,,,14765,,,,,10933,,22224,,U,1,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,CHEMBL629629,,0,A
Autocuration,BAO_0000019,,,,,14766,,,,,10933,,22224,,U,1,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,CHEMBL629630,,0,A
Autocuration,BAO_0000019,,,,,14767,,,,,14293,,22224,,U,1,,Dissociation Constant of compound determined,CHEMBL856030,,0,A
Autocuration,BAO_0000019,,,,,14768,,,,,6698,,22224,,U,1,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,CHEMBL629631,,0,B
Autocuration,BAO_0000019,,,,,14769,,,,,6698,,22224,,U,1,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,CHEMBL629632,,0,B
Autocuration,BAO_0000100,,,,,14770,,,,,4318,,22224,,U,1,,Dissociation constant of compound with Fructose was determined,CHEMBL629633,,0,P
Autocuration,BAO_0000100,,,,,14771,,,,,4318,,22224,,U,1,,Dissociation constant of compound with Fructose was determined; Not determined,CHEMBL629634,,0,P
Autocuration,BAO_0000100,,,,,14772,,,,,4318,,22224,,U,1,,Dissociation constant of compound with Lactulose was determined,CHEMBL629635,,0,P
Autocuration,BAO_0000100,,,,,14773,,,,,4318,,22224,,U,1,,Dissociation constant of compound with Lactulose was determined; Not determined,CHEMBL629636,,0,P
Autocuration,BAO_0000100,,,,,14774,,,,,14959,,22224,,U,1,,Dissociation constant of the Compound,CHEMBL629637,,0,P
Autocuration,BAO_0000100,,,,,14775,,,,,5913,,22224,,U,1,,Dissociation constant by non-linear regression analysis,CHEMBL629638,,0,P
Autocuration,BAO_0000100,,,,,14776,,,,,14218,,22224,,U,1,,Dissociation constant was determined,CHEMBL629639,,0,P
Autocuration,BAO_0000100,,,,,14777,,,,,10689,,22224,,U,1,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,CHEMBL629640,,0,P
Autocuration,BAO_0000100,,,,,14778,,,,,13925,,22224,,U,1,,Dissociation constant was determined,CHEMBL629641,,0,P
Autocuration,BAO_0000100,,,,,14779,,,,,16359,,22224,,U,1,,Dissociation constant was determined,CHEMBL631344,,0,P
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14780,,,Muscle tissue,,10944,2385.0,50597,,N,1,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,CHEMBL631345,,1,A
Autocuration,BAO_0000019,,,,,14781,,,,,11080,,22224,,U,1,,The dissociation constant determined by fluorescence displacement assay,CHEMBL631346,,0,A
Autocuration,BAO_0000019,,,,,14782,,,,,17805,,22224,,U,1,,kd value surface plasmon resonance (SPR) method,CHEMBL631524,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14783,,,Muscle tissue,,10944,2385.0,50597,,N,1,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,CHEMBL631525,,1,A
Autocuration,BAO_0000019,,,,,14784,,,,,16645,,22224,,U,1,,First dissociation constant of the binding of compound to V30M TTR,CHEMBL631526,,0,F
Autocuration,BAO_0000019,,,,,14785,,,,,16645,,22224,,U,1,,Second dissociation constant of the binding of compound to V30M TTR,CHEMBL631527,,0,F
Autocuration,BAO_0000019,,,,,14786,,,,,7793,,22224,,U,1,,"Compound was evaluated for equilibrium constant, Ke",CHEMBL631528,,0,A
Autocuration,BAO_0000019,,,,,14787,,,Hypothalamus,,12199,1898.0,22224,,U,1,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,CHEMBL631529,,0,A
Autocuration,BAO_0000019,,,,,14788,,,Hypothalamus,,12199,1898.0,22224,,U,1,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,CHEMBL631530,,0,A
Autocuration,BAO_0000019,,,,,14789,,,,,9680,,22224,,U,1,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,CHEMBL631531,,0,A
Autocuration,BAO_0000019,,,,,14790,,,,,9680,,22224,,U,1,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,CHEMBL631532,,0,A
Autocuration,BAO_0000019,,,,,14791,,,,,9680,,22224,,U,1,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,CHEMBL631533,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14792,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL876552,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14793,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,CHEMBL631534,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14794,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL631535,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14795,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL631536,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14796,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,CHEMBL631537,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14797,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,CHEMBL631538,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14798,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,CHEMBL631539,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14799,,,,,13758,,50594,,N,1,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL631540,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14800,,,,,14393,,50597,,N,1,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL625637,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14801,,,,,14393,,50597,,N,1,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL625638,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14802,,,,,15078,,50597,,N,1,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL625639,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14803,In vivo,,Brain,,13925,955.0,50597,,N,1,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625640,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14804,In vivo,,Brain,,13925,955.0,50597,,N,1,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625641,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14805,In vivo,,Heart,,13925,948.0,50597,,N,1,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625642,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14806,In vivo,,Heart,,13925,948.0,50597,,N,1,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625643,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14807,In vivo,,Kidney,,13925,2113.0,50597,,N,1,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625644,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14808,In vivo,,Kidney,,13925,2113.0,50597,,N,1,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625645,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14809,In vivo,,Liver,,13925,2107.0,50597,,N,1,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625646,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14810,In vivo,,Liver,,13925,2107.0,50597,,N,1,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625647,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14811,In vivo,,Lung,,13925,2048.0,50597,,N,1,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625648,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14812,In vivo,,Lung,,13925,2048.0,50597,,N,1,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,CHEMBL625649,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14813,In vivo,,Muscle tissue,,13925,2385.0,50597,,N,1,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625650,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14814,In vivo,,Muscle tissue,,13925,2385.0,50597,,N,1,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625651,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14815,In vivo,,Zone of skin,,13925,14.0,50597,,N,1,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625652,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14816,In vivo,,Zone of skin,,13925,14.0,50597,,N,1,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625653,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14817,In vivo,,Spleen,,13925,2106.0,50597,,N,1,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625654,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14818,In vivo,,Spleen,,13925,2106.0,50597,,N,1,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625655,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14819,In vivo,,Blood,,9712,178.0,50597,,N,1,,Biodistribution of Compound in rat blood after 15 minutes of administration,CHEMBL625656,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14820,In vivo,,Blood,,9712,178.0,50597,,N,1,,Biodistribution of Compound in rat blood after 2 minutes of administration,CHEMBL625657,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14821,In vivo,,Brain,,9712,955.0,50597,,N,1,,Biodistribution of Compound in rat brain after 15 minutes of administration,CHEMBL625658,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14822,In vivo,,Brain,,9712,955.0,50597,,N,1,,Biodistribution of Compound in rat brain after 2 minutes of administration,CHEMBL625659,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14823,In vivo,,Heart,,9712,948.0,50597,,N,1,,Biodistribution of Compound in rat heart after 15 minutes of administration,CHEMBL625660,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14824,In vivo,,Heart,,9712,948.0,50597,,N,1,,Biodistribution of Compound in rat heart after 2 minutes of administration,CHEMBL625661,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14825,In vivo,,Liver,,9712,2107.0,50597,,N,1,,Biodistribution of Compound in rat liver after 15 minutes of administration,CHEMBL625662,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14826,In vivo,,Liver,,9712,2107.0,50597,,N,1,,Biodistribution of Compound in rat liver after 2 minutes of administration,CHEMBL625663,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14827,In vivo,,Lung,,9712,2048.0,50597,,N,1,,Biodistribution of Compound in rat lung after 15 minutes of administration,CHEMBL875621,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14828,In vivo,,Lung,,9712,2048.0,50597,,N,1,,Biodistribution of Compound in rat lung after 2 minutes of administration,CHEMBL628382,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14829,In vivo,,Muscle tissue,,9712,2385.0,50597,,N,1,,Biodistribution of Compound in rat muscle after 15 minutes of administration,CHEMBL628383,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14830,In vivo,,Muscle tissue,,9712,2385.0,50597,,N,1,,Biodistribution of Compound in rat muscle after 2 minutes of administration,CHEMBL628384,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14831,,,,,13925,,50597,,N,1,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,CHEMBL628385,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14832,,,,,13925,,50597,,N,1,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,CHEMBL875753,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14833,,,,,13925,,50597,,N,1,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,CHEMBL628386,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14834,,,,,6941,,50597,,N,1,,Organ distribution in rat blood 2 minutes after intravenous injection,CHEMBL628387,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14835,,,,,6941,,50597,,N,1,,Organ distribution in rat blood 2 hr after intravenous injection,CHEMBL628388,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14836,,,,,6941,,50597,,N,1,,Organ distribution in rat blood 30 minutes after intravenous injection,CHEMBL628389,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14837,,,,,6941,,50597,,N,1,,Organ distribution in rat blood 30 min after intravenous injection,CHEMBL632756,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14838,,,,,6941,,50597,,N,1,,Organ distribution in rat brain 2 minutes after intravenous injection,CHEMBL628390,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14839,,,,,6941,,50597,,N,1,,Organ distribution in rat brain 2 hr after intravenous injection,CHEMBL631811,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14840,,,,,6941,,50597,,N,1,,Organ distribution in rat brain 30 minutes after intravenous injection,CHEMBL631812,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14841,,,,,6941,,50597,,N,1,,Organ distribution in rat heart 2 minutes after intravenous injection,CHEMBL631813,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14842,,,,,6941,,50597,,N,1,,Organ distribution in rat heart 2 hr after intravenous injection,CHEMBL631814,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14843,,,,,6941,,50597,,N,1,,Organ distribution in rat heart 30 minutes after intravenous injection,CHEMBL631815,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14844,,,,,6941,,50597,,N,1,,Organ distribution in rat kidney 2 minutes after intravenous injection,CHEMBL631816,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14845,,,,,6941,,50597,,N,1,,Organ distribution in rat kidney 2 hr after intravenous injection,CHEMBL875758,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14846,,,,,6941,,50597,,N,1,,Organ distribution in rat kidney 30 minutes after intravenous injection,CHEMBL631817,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14847,,,Liver,,6941,2107.0,50597,,N,1,,Organ distribution in rat liver 2 minutes after intravenous injection,CHEMBL631818,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14848,,,Liver,,6941,2107.0,50597,,N,1,,Organ distribution in rat liver 2 hr after intravenous injection,CHEMBL631819,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14849,,,Liver,,6941,2107.0,50597,,N,1,,Organ distribution in rat liver 30 minutes after intravenous injection,CHEMBL631820,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14850,,,,,6941,,50597,,N,1,,Organ distribution in rat lung 2 minutes after intravenous injection,CHEMBL631821,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14851,,,,,6941,,50597,,N,1,,Organ distribution in rat lung 2 hr after intravenous injection,CHEMBL631822,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14852,,,,,6941,,50597,,N,1,,Organ distribution in rat lung 30 minutes after intravenous injection,CHEMBL631823,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14853,,,Muscle tissue,,6941,2385.0,50597,,N,1,,Organ distribution in rat muscle 2 minutes after intravenous injection,CHEMBL631824,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14854,,,Muscle tissue,,6941,2385.0,50597,,N,1,,Organ distribution in rat muscle 2 hr after intravenous injection,CHEMBL631825,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14855,,,Muscle tissue,,6941,2385.0,50597,,N,1,,Organ distribution in rat muscle 30 minutes after intravenous injection,CHEMBL631826,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14856,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),CHEMBL631827,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14857,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),CHEMBL631828,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14858,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),CHEMBL631829,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14859,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,CHEMBL875759,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14860,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,CHEMBL631830,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14861,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,CHEMBL631831,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14862,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,CHEMBL631832,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14863,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,CHEMBL631833,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14864,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,CHEMBL631834,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14865,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,CHEMBL631835,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14866,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,CHEMBL631836,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14867,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,CHEMBL631837,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14868,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,CHEMBL631838,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14869,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,CHEMBL631839,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14870,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,CHEMBL631840,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14871,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,CHEMBL631841,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14872,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,CHEMBL631842,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14873,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,CHEMBL631843,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14874,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,CHEMBL631844,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14875,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,CHEMBL631845,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14876,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,CHEMBL631846,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14877,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,CHEMBL875760,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14878,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,CHEMBL632199,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14879,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,CHEMBL631847,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14880,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,CHEMBL631848,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14881,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,CHEMBL628707,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14882,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,CHEMBL628708,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14883,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,CHEMBL628709,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14884,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,CHEMBL628710,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14885,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,CHEMBL628711,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14886,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,CHEMBL628712,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14887,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,CHEMBL628713,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14888,,,Urine,,12582,1088.0,50597,,N,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,CHEMBL628714,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14889,,,,,7415,,50597,,N,1,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",CHEMBL628715,,1,A
Autocuration,BAO_0000019,,,,,14890,,,,,7313,,22224,,U,1,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,CHEMBL629179,,0,A
Autocuration,BAO_0000019,,,,,14891,,,,,7313,,22224,,U,1,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,CHEMBL629180,,0,A
Autocuration,BAO_0000019,,,,,14892,,,,,7313,,22224,,U,1,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,CHEMBL875108,,0,A
Autocuration,BAO_0000019,,,,,14893,,,Adrenal cortex,,7570,1235.0,22224,,U,1,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,CHEMBL629181,,0,A
Autocuration,BAO_0000019,,,,,14894,,,Adrenal cortex,,7570,1235.0,22224,,U,1,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,CHEMBL629182,,0,A
Autocuration,BAO_0000019,,,,,14895,,,,,7570,,22224,,U,1,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,CHEMBL629183,,0,A
Autocuration,BAO_0000019,,,,,14896,,,,,7570,,22224,,U,1,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,CHEMBL629184,,0,A
Autocuration,BAO_0000019,,,,,14897,,,Adrenal cortex,,7570,1235.0,22224,,U,1,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,CHEMBL629185,,0,A
Autocuration,BAO_0000019,,,,,14898,,,Adrenal cortex,,7570,1235.0,22224,,U,1,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,CHEMBL629186,,0,A
Autocuration,BAO_0000019,,,,,14899,,,,,7570,,22224,,U,1,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,CHEMBL629187,,0,A
Autocuration,BAO_0000019,,,,,14900,,,,,7570,,22224,,U,1,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,CHEMBL629887,,0,A
Autocuration,BAO_0000019,,,,,14901,,,,,7570,,22224,,U,1,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,CHEMBL629888,,0,A
Autocuration,BAO_0000019,,,,,14902,,,,,7570,,22224,,U,1,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,CHEMBL629889,,0,A
Autocuration,BAO_0000019,,,,,14903,,,Adrenal cortex,,7570,1235.0,22224,,U,1,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,CHEMBL629890,,0,A
Autocuration,BAO_0000019,,,,,14904,,,,,7570,,22224,,U,1,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,CHEMBL629891,,0,A
Autocuration,BAO_0000019,,,,,14905,,,,,7570,,22224,,U,1,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,CHEMBL629892,,0,A
Autocuration,BAO_0000019,,,,,14906,,,Adrenal cortex,,7570,1235.0,22224,,U,1,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,CHEMBL629893,,0,A
Autocuration,BAO_0000019,,,,,14907,,,,,7570,,22224,,U,1,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,CHEMBL629894,,0,A
Autocuration,BAO_0000019,,,,,14908,,,,,7570,,22224,,U,1,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,CHEMBL629895,,0,A
Autocuration,BAO_0000218,,9615.0,,Canis lupus familiaris,14909,In vivo,,,,14122,,22224,,U,1,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",CHEMBL875109,,0,A
Autocuration,BAO_0000218,,9541.0,,Macaca fascicularis,14910,In vivo,,,,16449,,22224,,U,1,,Absolute bioavailability in male cynomolgus monkeys,CHEMBL629896,,0,A
Autocuration,BAO_0000218,,10116.0,,Rattus norvegicus,14911,In vivo,,,,16449,,22224,,U,1,,Absolute bioavailability in maleSprague-Dawley rats,CHEMBL629897,,0,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14912,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL629898,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14913,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630057,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14914,In vivo,,Liver,,12017,2107.0,50597,,N,1,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630058,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14915,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630059,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14916,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630060,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14917,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630061,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14918,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630062,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14919,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630063,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14920,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630064,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14921,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630065,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14922,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630066,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14923,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630067,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14924,In vivo,,Lung,,12017,2048.0,50597,,N,1,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630068,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14925,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631113,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14926,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631114,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14927,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631115,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14928,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631116,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14929,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630528,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14930,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630529,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14931,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630530,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14932,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630531,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14933,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630532,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14934,In vivo,,Muscle tissue,,12017,2385.0,50597,,N,1,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630533,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14935,In vivo,,Blood,,15045,178.0,50594,,N,1,,Biodistribution in normal mice blood after 120 hr,CHEMBL630534,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14936,In vivo,,Blood,,15045,178.0,50594,,N,1,,Biodistribution in normal mice blood after 24 hr,CHEMBL630535,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14937,In vivo,,Blood,,15045,178.0,50594,,N,1,,Biodistribution in normal mice blood after 4 hr,CHEMBL630536,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14938,In vivo,,Bone,,15045,10000001.0,50594,,N,1,,Biodistribution in normal mice bone after 120 hr,CHEMBL630537,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14939,In vivo,,Bone,,15045,10000001.0,50594,,N,1,,Biodistribution in normal mice bone after 24 hr,CHEMBL630538,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14940,In vivo,,Bone,,15045,10000001.0,50594,,N,1,,Biodistribution in normal mice bone after 4 hr,CHEMBL630539,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14941,In vivo,,Heart,,15045,948.0,50594,,N,1,,Biodistribution in normal mice heart after 120 hr,CHEMBL630540,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14942,In vivo,,Heart,,15045,948.0,50594,,N,1,,Biodistribution in normal mice heart after 24 hr,CHEMBL630541,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14943,In vivo,,Heart,,15045,948.0,50594,,N,1,,Biodistribution in normal mice heart after 4 hr,CHEMBL630542,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14944,In vivo,,Kidney,,15045,2113.0,50594,,N,1,,Biodistribution in normal mice kidney after 120 hr,CHEMBL630543,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14945,In vivo,,Kidney,,15045,2113.0,50594,,N,1,,Biodistribution in normal mice kidney after 24 hr,CHEMBL630544,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14946,In vivo,,Kidney,,15045,2113.0,50594,,N,1,,Biodistribution in normal mice kidney after 4 hr,CHEMBL630545,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14947,In vivo,,Liver,,15045,2107.0,50594,,N,1,,Biodistribution in normal mice liver after 120 hr,CHEMBL630546,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14948,In vivo,,Liver,,15045,2107.0,50594,,N,1,,Biodistribution in normal mice liver after 24 hr,CHEMBL630547,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14949,In vivo,,Liver,,15045,2107.0,50594,,N,1,,Biodistribution in normal mice liver after 4 hr,CHEMBL630548,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14950,In vivo,,Spleen,,15045,2106.0,50594,,N,1,,Biodistribution in normal mice spleen after 120 hr,CHEMBL630549,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14951,In vivo,,Spleen,,15045,2106.0,50594,,N,1,,Biodistribution in normal mice spleen after 24 hr,CHEMBL630550,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,14952,In vivo,,Spleen,,15045,2106.0,50594,,N,1,,Biodistribution in normal mice spleen after 4 hr,CHEMBL876426,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14953,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630551,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14954,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630552,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14955,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630553,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14956,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630554,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14957,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630555,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14958,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630556,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14959,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630557,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14960,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630558,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14961,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630559,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14962,In vivo,,Spleen,,12017,2106.0,50597,,N,1,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630560,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14963,In vivo,,Thyroid gland,,12017,2046.0,50597,,N,1,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL876427,,1,A
Intermediate,BAO_0000218,,10116.0,,Rattus norvegicus,14964,,,,,14941,,50597,,N,1,,The Kel values in female wistar rats.,CHEMBL630561,,1,A
Autocuration,BAO_0000019,,,,,14965,,,,,4646,,22224,,U,1,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,CHEMBL630562,,0,A
Autocuration,BAO_0000019,,,,,14966,,,,,8847,,22224,,U,1,,Hydrolysis rate constant of the compound,CHEMBL630563,,0,A
Autocuration,BAO_0000100,,,,,14967,,,,,11778,,22229,,U,1,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,CHEMBL629673,,0,P
Autocuration,BAO_0000019,,,,,14968,,,,,2363,,22224,,U,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",CHEMBL629674,,0,A
Autocuration,BAO_0000019,,,,,14969,,,,,2363,,22224,,U,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",CHEMBL629675,,0,A
Autocuration,BAO_0000019,,,,,14970,,,,,2363,,22224,,U,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",CHEMBL629676,,0,A
Autocuration,BAO_0000019,,,,,14971,,,,,2363,,22224,,U,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",CHEMBL629677,,0,A
Autocuration,BAO_0000019,,,,,14972,,,,,8371,,22224,,U,1,,Apparent inactivation rate constant was evaluated,CHEMBL629678,,0,A
Autocuration,BAO_0000019,,,,,14973,,,,,14883,,22224,,U,1,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,CHEMBL629679,,0,A
Autocuration,BAO_0000019,,,,,14974,,,,,14883,,22224,,U,1,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,CHEMBL629680,,0,A
Autocuration,BAO_0000019,,,,,14975,,,,,4643,,22224,,U,1,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,CHEMBL629681,,0,A
Autocuration,BAO_0000019,,,,,14976,,,,,3519,,22224,,U,1,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,CHEMBL629682,,0,A
Autocuration,BAO_0000019,,,,,14977,,,,,10600,,22224,,U,1,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,CHEMBL629683,,0,A
Autocuration,BAO_0000019,,,,,14978,,,,,8501,,22224,,U,1,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,CHEMBL629684,,0,F
Autocuration,BAO_0000100,,,,,14979,,,,,8505,,22224,,U,1,,Dissociation constant was determined,CHEMBL629685,,0,P
Autocuration,BAO_0000100,,,,,14980,,,,,9778,,22224,,U,1,,Dissociation constant was determined,CHEMBL629686,,0,P
Autocuration,BAO_0000100,,,,,14981,,,,,9778,,22224,,U,1,,Dissociation constant at pH 7.4,CHEMBL872932,,0,P
Autocuration,BAO_0000100,,,,,14982,,,,,9778,,22224,,U,1,,Dissociation constant in presence of 1 mM dithiothreitol,CHEMBL629687,,0,P
Autocuration,BAO_0000019,,,,,14983,,,,,13007,,22224,,U,1,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,CHEMBL872931,,0,A
Autocuration,BAO_0000019,,,,,14984,,,,,13007,,22224,,U,1,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,CHEMBL628151,,0,A
Autocuration,BAO_0000019,,,,,14985,,,,,13007,,22224,,U,1,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,CHEMBL628152,,0,A
Autocuration,BAO_0000019,,,,,14986,,,,,13007,,22224,,U,1,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,CHEMBL628153,,0,A
Autocuration,BAO_0000019,,,,,14987,,,,,11482,,22224,,U,1,,Kinetic constant for aromatization of androstenedione,CHEMBL628154,,0,A
Autocuration,BAO_0000019,,,,,14988,,,,,11482,,22224,,U,1,,Kinetic constant for aromatization of testosterone,CHEMBL628155,,0,A
Autocuration,BAO_0000019,,,,,14989,,,,,2303,,22224,,U,1,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,CHEMBL628156,,0,A
Autocuration,BAO_0000019,,,,,14990,,,,,11964,,22224,,U,1,,Local inhibition constant was determined,CHEMBL628157,,0,A
Intermediate,BAO_0000218,,4932.0,,Saccharomyces cerevisiae,14991,,,,,3140,,50347,,N,1,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,CHEMBL857533,,1,A
Autocuration,BAO_0000100,,,,,14992,,,,,10650,,22224,,U,1,,Dissociation constant value of the compound,CHEMBL628158,,0,P
Autocuration,BAO_0000019,,,,,14993,,,Cornea,,4667,964.0,22224,,U,1,,In vitro permeability through cornea without epithelium,CHEMBL628159,,0,A
Autocuration,BAO_0000019,,,,,14994,,,Cornea,,4667,964.0,22224,,U,1,,In vitro permeability through intact cornea,CHEMBL875616,,0,A
Intermediate,BAO_0000218,,9986.0,,Oryctolagus cuniculus,14995,,,Cornea,,9199,964.0,50592,,N,1,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,CHEMBL628160,,1,A
Autocuration,BAO_0000019,,,,,14996,,,,,11966,,22224,,U,1,,Rate of enzyme inactivation for the compound was determined,CHEMBL628161,,0,A
Autocuration,BAO_0000019,,,,,14997,,,Cornea,,4667,964.0,22224,,U,1,,In vitro permeability through cornea without epithelium,CHEMBL628162,,0,A
Autocuration,BAO_0000019,,,,,14998,,,Cornea,,4667,964.0,22224,,U,1,,In vitro permeability through intact cornea,CHEMBL628163,,0,A
Autocuration,BAO_0000019,,,,,14999,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628164,,0,A
Autocuration,BAO_0000019,,,,,15000,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628165,,0,A
Autocuration,BAO_0000019,,,,,15001,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628166,,0,A
Autocuration,BAO_0000019,,,,,15002,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628167,,0,A
Autocuration,BAO_0000019,,,,,15003,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628168,,0,A
Autocuration,BAO_0000019,,,,,15004,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628169,,0,A
Autocuration,BAO_0000019,,,,,15005,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628170,,0,A
Autocuration,BAO_0000019,,,,,15006,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628171,,0,A
Autocuration,BAO_0000019,,,,,15007,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL627434,,0,A
Autocuration,BAO_0000019,,,,,15008,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL627435,,0,A
Autocuration,BAO_0000019,,,,,15009,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628110,,0,A
Autocuration,BAO_0000019,,,,,15010,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628111,,0,A
Autocuration,BAO_0000019,,,,,15011,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628112,,0,A
Autocuration,BAO_0000019,,,,,15012,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628260,,0,A
Autocuration,BAO_0000019,,,,,15013,,,,,8354,,22224,,U,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628261,,0,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15014,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),CHEMBL628262,,1,A
Intermediate,BAO_0000218,,9606.0,,Homo sapiens,15015,In vivo,,,,14439,,50587,,N,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,CHEMBL628263,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15016,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),CHEMBL628264,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15017,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),CHEMBL628265,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15018,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),CHEMBL628266,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15019,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),CHEMBL628267,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15020,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,CHEMBL628268,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15021,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),CHEMBL628269,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15022,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),CHEMBL628270,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15023,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),CHEMBL628271,,1,A
Intermediate,BAO_0000218,,10090.0,,Mus musculus,15024,In vivo,,,,14439,,50594,,N,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),CHEMBL628272,,1,A
